id	sid	tid	token	lemma	pos
ihlr-28381	1	1	indiana	indiana	PROPN
ihlr-28381	1	2	health	health	PROPN
ihlr-28381	1	3	law	law	PROPN
ihlr-28381	1	4	review	review	NOUN
ihlr-28381	1	5	volume	volume	NOUN
ihlr-28381	1	6	xxi	xxi	ADJ
ihlr-28381	1	7	2024	2024	NUM
ihlr-28381	1	8	number	number	NOUN
ihlr-28381	1	9	1	1	NUM
ihlr-28381	1	10	notes	note	NOUN
ihlr-28381	1	11	incentivizing	incentivize	VERB
ihlr-28381	1	12	drug	drug	NOUN
ihlr-28381	1	13	affordability	affordability	NOUN
ihlr-28381	1	14	:	:	PUNCT
ihlr-28381	1	15	wildcard	wildcard	ADJ
ihlr-28381	1	16	exclusivity	exclusivity	NOUN
ihlr-28381	1	17	vouchers	voucher	NOUN
ihlr-28381	1	18	thomas	thomas	PROPN
ihlr-28381	1	19	abrams	abrams	PROPN
ihlr-28381	1	20	*	*	PROPN
ihlr-28381	1	21	i.	i.	PROPN
ihlr-28381	1	22	introduction	introduction	NOUN
ihlr-28381	1	23	the	the	DET
ihlr-28381	1	24	cost	cost	NOUN
ihlr-28381	1	25	of	of	ADP
ihlr-28381	1	26	medicine	medicine	NOUN
ihlr-28381	1	27	frustrates	frustrate	VERB
ihlr-28381	1	28	most	most	ADJ
ihlr-28381	1	29	of	of	ADP
ihlr-28381	1	30	society	society	NOUN
ihlr-28381	1	31	—	—	PUNCT
ihlr-28381	1	32	especially	especially	ADV
ihlr-28381	1	33	patients	patient	NOUN
ihlr-28381	1	34	,	,	PUNCT
ihlr-28381	1	35	lawmakers	lawmaker	NOUN
ihlr-28381	1	36	,	,	PUNCT
ihlr-28381	1	37	and	and	CCONJ
ihlr-28381	1	38	scientists	scientist	NOUN
ihlr-28381	1	39	—	—	PUNCT
ihlr-28381	1	40	and	and	CCONJ
ihlr-28381	1	41	will	will	AUX
ihlr-28381	1	42	continue	continue	VERB
ihlr-28381	1	43	to	to	PART
ihlr-28381	1	44	frustrate	frustrate	VERB
ihlr-28381	1	45	far	far	ADV
ihlr-28381	1	46	into	into	ADP
ihlr-28381	1	47	the	the	DET
ihlr-28381	1	48	future	future	NOUN
ihlr-28381	1	49	.	.	PUNCT
ihlr-28381	2	1	inventing	invent	VERB
ihlr-28381	2	2	a	a	DET
ihlr-28381	2	3	chemical	chemical	NOUN
ihlr-28381	2	4	or	or	CCONJ
ihlr-28381	2	5	biologic	biologic	NOUN
ihlr-28381	2	6	capable	capable	ADJ
ihlr-28381	2	7	of	of	ADP
ihlr-28381	2	8	improving	improve	VERB
ihlr-28381	2	9	or	or	CCONJ
ihlr-28381	2	10	saving	save	VERB
ihlr-28381	2	11	life	life	NOUN
ihlr-28381	2	12	is	be	AUX
ihlr-28381	2	13	not	not	PART
ihlr-28381	2	14	cheap	cheap	ADJ
ihlr-28381	2	15	,	,	PUNCT
ihlr-28381	2	16	to	to	PART
ihlr-28381	2	17	be	be	AUX
ihlr-28381	2	18	sure	sure	ADJ
ihlr-28381	2	19	.	.	PUNCT
ihlr-28381	3	1	risky	risky	ADJ
ihlr-28381	3	2	private	private	ADJ
ihlr-28381	3	3	investment	investment	NOUN
ihlr-28381	3	4	is	be	AUX
ihlr-28381	3	5	incentivized	incentivize	VERB
ihlr-28381	3	6	by	by	ADP
ihlr-28381	3	7	the	the	DET
ihlr-28381	3	8	windfall	windfall	NOUN
ihlr-28381	3	9	potential	potential	NOUN
ihlr-28381	3	10	created	create	VERB
ihlr-28381	3	11	by	by	ADP
ihlr-28381	3	12	patents	patent	NOUN
ihlr-28381	3	13	and	and	CCONJ
ihlr-28381	3	14	monopoly	monopoly	NOUN
ihlr-28381	3	15	prices	price	NOUN
ihlr-28381	3	16	.	.	PUNCT
ihlr-28381	4	1	monopoly	monopoly	NOUN
ihlr-28381	4	2	prices	price	NOUN
ihlr-28381	4	3	,	,	PUNCT
ihlr-28381	4	4	among	among	ADP
ihlr-28381	4	5	other	other	ADJ
ihlr-28381	4	6	factors	factor	NOUN
ihlr-28381	4	7	outside	outside	ADP
ihlr-28381	4	8	the	the	DET
ihlr-28381	4	9	scope	scope	NOUN
ihlr-28381	4	10	of	of	ADP
ihlr-28381	4	11	this	this	DET
ihlr-28381	4	12	note	note	NOUN
ihlr-28381	4	13	,	,	PUNCT
ihlr-28381	4	14	contribute	contribute	VERB
ihlr-28381	4	15	to	to	ADP
ihlr-28381	4	16	the	the	DET
ihlr-28381	4	17	inability	inability	NOUN
ihlr-28381	4	18	of	of	ADP
ihlr-28381	4	19	many	many	ADJ
ihlr-28381	4	20	patients	patient	NOUN
ihlr-28381	4	21	to	to	PART
ihlr-28381	4	22	afford	afford	VERB
ihlr-28381	4	23	and	and	CCONJ
ihlr-28381	4	24	access	access	VERB
ihlr-28381	4	25	medically	medically	ADV
ihlr-28381	4	26	necessary	necessary	ADJ
ihlr-28381	4	27	treatments	treatment	NOUN
ihlr-28381	4	28	.	.	PUNCT
ihlr-28381	5	1	when	when	SCONJ
ihlr-28381	5	2	patents	patent	NOUN
ihlr-28381	5	3	expire	expire	VERB
ihlr-28381	5	4	,	,	PUNCT
ihlr-28381	5	5	generic	generic	ADJ
ihlr-28381	5	6	substitutes	substitute	NOUN
ihlr-28381	5	7	drive	drive	VERB
ihlr-28381	5	8	down	down	ADP
ihlr-28381	5	9	prices	price	NOUN
ihlr-28381	5	10	.	.	PUNCT
ihlr-28381	6	1	however	however	ADV
ihlr-28381	6	2	,	,	PUNCT
ihlr-28381	6	3	generic	generic	ADJ
ihlr-28381	6	4	access	access	NOUN
ihlr-28381	6	5	can	can	AUX
ihlr-28381	6	6	be	be	AUX
ihlr-28381	6	7	unnecessarily	unnecessarily	ADV
ihlr-28381	6	8	delayed	delay	VERB
ihlr-28381	6	9	when	when	SCONJ
ihlr-28381	6	10	monopolies	monopoly	NOUN
ihlr-28381	6	11	persist	persist	VERB
ihlr-28381	6	12	beyond	beyond	ADP
ihlr-28381	6	13	patent	patent	NOUN
ihlr-28381	6	14	expiration	expiration	NOUN
ihlr-28381	6	15	.	.	PUNCT
ihlr-28381	7	1	when	when	SCONJ
ihlr-28381	7	2	generic	generic	ADJ
ihlr-28381	7	3	availability	availability	NOUN
ihlr-28381	7	4	is	be	AUX
ihlr-28381	7	5	inappropriately	inappropriately	ADV
ihlr-28381	7	6	delayed	delay	VERB
ihlr-28381	7	7	,	,	PUNCT
ihlr-28381	7	8	patients	patient	NOUN
ihlr-28381	7	9	and	and	CCONJ
ihlr-28381	7	10	society	society	NOUN
ihlr-28381	7	11	are	be	AUX
ihlr-28381	7	12	left	leave	VERB
ihlr-28381	7	13	paying	pay	VERB
ihlr-28381	7	14	gratuitous	gratuitous	ADJ
ihlr-28381	7	15	multiples	multiple	NOUN
ihlr-28381	7	16	of	of	ADP
ihlr-28381	7	17	the	the	DET
ihlr-28381	7	18	break	break	NOUN
ihlr-28381	7	19	-	-	PUNCT
ihlr-28381	7	20	even	even	ADV
ihlr-28381	7	21	cost	cost	NOUN
ihlr-28381	7	22	of	of	ADP
ihlr-28381	7	23	their	their	PRON
ihlr-28381	7	24	medicine	medicine	NOUN
ihlr-28381	7	25	,	,	PUNCT
ihlr-28381	7	26	long	long	ADV
ihlr-28381	7	27	after	after	SCONJ
ihlr-28381	7	28	inventors	inventor	NOUN
ihlr-28381	7	29	have	have	AUX
ihlr-28381	7	30	recouped	recoup	VERB
ihlr-28381	7	31	their	their	PRON
ihlr-28381	7	32	initial	initial	ADJ
ihlr-28381	7	33	investment	investment	NOUN
ihlr-28381	7	34	and	and	CCONJ
ihlr-28381	7	35	turned	turn	VERB
ihlr-28381	7	36	a	a	DET
ihlr-28381	7	37	profit	profit	NOUN
ihlr-28381	7	38	.	.	PUNCT
ihlr-28381	8	1	ii	ii	PROPN
ihlr-28381	8	2	.	.	PUNCT
ihlr-28381	9	1	background	background	PROPN
ihlr-28381	9	2	&	&	CCONJ
ihlr-28381	9	3	overview	overview	NOUN
ihlr-28381	9	4	to	to	PART
ihlr-28381	9	5	appreciate	appreciate	VERB
ihlr-28381	9	6	how	how	SCONJ
ihlr-28381	9	7	reduced	reduced	ADJ
ihlr-28381	9	8	generic	generic	ADJ
ihlr-28381	9	9	access	access	NOUN
ihlr-28381	9	10	translates	translate	VERB
ihlr-28381	9	11	to	to	ADP
ihlr-28381	9	12	higher	high	ADJ
ihlr-28381	9	13	costs	cost	NOUN
ihlr-28381	9	14	and	and	CCONJ
ihlr-28381	9	15	poorer	poor	ADJ
ihlr-28381	9	16	health	health	NOUN
ihlr-28381	9	17	outcomes	outcome	NOUN
ihlr-28381	9	18	,	,	PUNCT
ihlr-28381	9	19	one	one	PRON
ihlr-28381	9	20	must	must	AUX
ihlr-28381	9	21	understand	understand	VERB
ihlr-28381	9	22	the	the	DET
ihlr-28381	9	23	relationship	relationship	NOUN
ihlr-28381	9	24	between	between	ADP
ihlr-28381	9	25	innovators	innovator	NOUN
ihlr-28381	9	26	and	and	CCONJ
ihlr-28381	9	27	generic	generic	ADJ
ihlr-28381	9	28	manufacturers	manufacturer	NOUN
ihlr-28381	9	29	.	.	PUNCT
ihlr-28381	10	1	this	this	DET
ihlr-28381	10	2	understanding	understanding	NOUN
ihlr-28381	10	3	can	can	AUX
ihlr-28381	10	4	then	then	ADV
ihlr-28381	10	5	be	be	AUX
ihlr-28381	10	6	applied	apply	VERB
ihlr-28381	10	7	to	to	PART
ihlr-28381	10	8	examine	examine	VERB
ihlr-28381	10	9	price	price	NOUN
ihlr-28381	10	10	-	-	PUNCT
ihlr-28381	10	11	lowering	lower	VERB
ihlr-28381	10	12	policies	policy	NOUN
ihlr-28381	10	13	.	.	PUNCT
ihlr-28381	11	1	rather	rather	ADV
ihlr-28381	11	2	than	than	ADP
ihlr-28381	11	3	“	"	PUNCT
ihlr-28381	11	4	pushing	push	VERB
ihlr-28381	11	5	”	"	PUNCT
ihlr-28381	11	6	low	low	ADJ
ihlr-28381	11	7	prices	price	NOUN
ihlr-28381	11	8	with	with	ADP
ihlr-28381	11	9	more	more	ADV
ihlr-28381	11	10	expensive	expensive	ADJ
ihlr-28381	11	11	red	red	ADJ
ihlr-28381	11	12	tape	tape	NOUN
ihlr-28381	11	13	,	,	PUNCT
ihlr-28381	11	14	new	new	ADJ
ihlr-28381	11	15	policies	policy	NOUN
ihlr-28381	11	16	should	should	AUX
ihlr-28381	11	17	“	"	PUNCT
ihlr-28381	11	18	pull	pull	VERB
ihlr-28381	11	19	”	"	PUNCT
ihlr-28381	11	20	prices	price	NOUN
ihlr-28381	11	21	lower	low	ADJ
ihlr-28381	11	22	by	by	ADP
ihlr-28381	11	23	incentivizing	incentivize	VERB
ihlr-28381	11	24	price	price	NOUN
ihlr-28381	11	25	-	-	PUNCT
ihlr-28381	11	26	lowering	lower	VERB
ihlr-28381	11	27	behavior	behavior	NOUN
ihlr-28381	11	28	.	.	PUNCT
ihlr-28381	12	1	the	the	DET
ihlr-28381	12	2	stick	stick	NOUN
ihlr-28381	12	3	is	be	AUX
ihlr-28381	12	4	exhausted	exhaust	VERB
ihlr-28381	12	5	,	,	PUNCT
ihlr-28381	12	6	and	and	CCONJ
ihlr-28381	12	7	modern	modern	ADJ
ihlr-28381	12	8	policies	policy	NOUN
ihlr-28381	12	9	should	should	AUX
ihlr-28381	12	10	explore	explore	VERB
ihlr-28381	12	11	the	the	DET
ihlr-28381	12	12	carrot	carrot	NOUN
ihlr-28381	12	13	.	.	PUNCT
ihlr-28381	13	1	a.	a.	NOUN
ihlr-28381	13	2	innovative	innovative	PROPN
ihlr-28381	13	3	versus	versus	ADP
ihlr-28381	13	4	generic	generic	ADJ
ihlr-28381	13	5	medicine	medicine	NOUN
ihlr-28381	13	6	innovator	innovator	NOUN
ihlr-28381	13	7	pharmaceutical	pharmaceutical	NOUN
ihlr-28381	13	8	companies	company	NOUN
ihlr-28381	13	9	and	and	CCONJ
ihlr-28381	13	10	generic	generic	ADJ
ihlr-28381	13	11	pharmaceutical	pharmaceutical	ADJ
ihlr-28381	13	12	companies	company	NOUN
ihlr-28381	13	13	appear	appear	VERB
ihlr-28381	13	14	similar	similar	ADJ
ihlr-28381	13	15	at	at	ADP
ihlr-28381	13	16	first	first	ADJ
ihlr-28381	13	17	glance	glance	NOUN
ihlr-28381	13	18	.	.	PUNCT
ihlr-28381	14	1	indeed	indeed	ADV
ihlr-28381	14	2	,	,	PUNCT
ihlr-28381	14	3	the	the	DET
ihlr-28381	14	4	food	food	NOUN
ihlr-28381	14	5	and	and	CCONJ
ihlr-28381	14	6	drug	drug	PROPN
ihlr-28381	14	7	administration	administration	NOUN
ihlr-28381	14	8	(	(	PUNCT
ihlr-28381	14	9	“	"	PUNCT
ihlr-28381	14	10	fda	fda	PROPN
ihlr-28381	14	11	”	"	PUNCT
ihlr-28381	14	12	)	)	PUNCT
ihlr-28381	14	13	requires	require	VERB
ihlr-28381	14	14	generic	generic	ADJ
ihlr-28381	14	15	medicine	medicine	NOUN
ihlr-28381	14	16	to	to	PART
ihlr-28381	14	17	be	be	AUX
ihlr-28381	14	18	manufactured	manufacture	VERB
ihlr-28381	14	19	with	with	ADP
ihlr-28381	14	20	the	the	DET
ihlr-28381	14	21	same	same	ADJ
ihlr-28381	14	22	(	(	PUNCT
ihlr-28381	14	23	1	1	NUM
ihlr-28381	14	24	)	)	PUNCT
ihlr-28381	14	25	active	active	ADJ
ihlr-28381	14	26	/	/	SYM
ihlr-28381	14	27	key	key	ADJ
ihlr-28381	14	28	ingredient	ingredient	NOUN
ihlr-28381	14	29	,	,	PUNCT
ihlr-28381	14	30	(	(	PUNCT
ihlr-28381	14	31	2	2	X
ihlr-28381	14	32	)	)	PUNCT
ihlr-28381	14	33	strength	strength	NOUN
ihlr-28381	14	34	,	,	PUNCT
ihlr-28381	14	35	(	(	PUNCT
ihlr-28381	14	36	3	3	X
ihlr-28381	14	37	)	)	PUNCT
ihlr-28381	14	38	dosage	dosage	NOUN
ihlr-28381	14	39	form	form	NOUN
ihlr-28381	14	40	(	(	PUNCT
ihlr-28381	14	41	e.g.	e.g.	ADV
ihlr-28381	14	42	,	,	PUNCT
ihlr-28381	14	43	tablet	tablet	NOUN
ihlr-28381	14	44	,	,	PUNCT
ihlr-28381	14	45	capsule	capsule	NOUN
ihlr-28381	14	46	,	,	PUNCT
ihlr-28381	14	47	liquid	liquid	NOUN
ihlr-28381	14	48	)	)	PUNCT
ihlr-28381	14	49	,	,	PUNCT
ihlr-28381	14	50	and	and	CCONJ
ihlr-28381	14	51	(	(	PUNCT
ihlr-28381	14	52	4	4	X
ihlr-28381	14	53	)	)	PUNCT
ihlr-28381	14	54	*	*	PUNCT
ihlr-28381	14	55	j.d	j.d	PROPN
ihlr-28381	14	56	.	.	PROPN
ihlr-28381	14	57	candidate	candidate	NOUN
ihlr-28381	14	58	,	,	PUNCT
ihlr-28381	14	59	2024	2024	NUM
ihlr-28381	14	60	,	,	PUNCT
ihlr-28381	14	61	indiana	indiana	PROPN
ihlr-28381	14	62	university	university	PROPN
ihlr-28381	14	63	robert	robert	PROPN
ihlr-28381	14	64	h.	h.	PROPN
ihlr-28381	14	65	mckinney	mckinney	PROPN
ihlr-28381	14	66	school	school	PROPN
ihlr-28381	14	67	of	of	ADP
ihlr-28381	14	68	law	law	NOUN
ihlr-28381	14	69	;	;	PUNCT
ihlr-28381	14	70	b.s	b.s	PROPN
ihlr-28381	14	71	.	.	PROPN
ihlr-28381	14	72	,	,	PUNCT
ihlr-28381	14	73	2021	2021	NUM
ihlr-28381	14	74	,	,	PUNCT
ihlr-28381	14	75	university	university	NOUN
ihlr-28381	14	76	of	of	ADP
ihlr-28381	14	77	dayton	dayton	PROPN
ihlr-28381	14	78	.	.	PUNCT
ihlr-28381	15	1	a	a	DET
ihlr-28381	15	2	special	special	ADJ
ihlr-28381	15	3	thank	thank	VERB
ihlr-28381	15	4	you	you	PRON
ihlr-28381	15	5	to	to	ADP
ihlr-28381	15	6	kurt	kurt	PROPN
ihlr-28381	15	7	karst	karst	PROPN
ihlr-28381	15	8	,	,	PUNCT
ihlr-28381	15	9	professor	professor	PROPN
ihlr-28381	15	10	aila	aila	PROPN
ihlr-28381	15	11	hoss	hoss	PROPN
ihlr-28381	15	12	,	,	PUNCT
ihlr-28381	15	13	jake	jake	PROPN
ihlr-28381	15	14	butz	butz	PROPN
ihlr-28381	15	15	,	,	PUNCT
ihlr-28381	15	16	and	and	CCONJ
ihlr-28381	15	17	ihlr	ihlr	NOUN
ihlr-28381	15	18	colleagues	colleague	NOUN
ihlr-28381	15	19	for	for	ADP
ihlr-28381	15	20	inspiring	inspire	VERB
ihlr-28381	15	21	and	and	CCONJ
ihlr-28381	15	22	supporting	support	VERB
ihlr-28381	15	23	this	this	DET
ihlr-28381	15	24	note	note	NOUN
ihlr-28381	15	25	.	.	PUNCT
ihlr-28381	16	1	122	122	NUM
ihlr-28381	16	2	indiana	indiana	PROPN
ihlr-28381	16	3	health	health	PROPN
ihlr-28381	16	4	law	law	PROPN
ihlr-28381	16	5	review	review	NOUN
ihlr-28381	16	6	[	[	X
ihlr-28381	16	7	vol	vol	NOUN
ihlr-28381	16	8	.	.	NOUN
ihlr-28381	16	9	21:121	21:121	NUM
ihlr-28381	16	10	route	route	NOUN
ihlr-28381	16	11	of	of	ADP
ihlr-28381	16	12	administration	administration	NOUN
ihlr-28381	16	13	(	(	PUNCT
ihlr-28381	16	14	e.g.	e.g.	ADV
ihlr-28381	16	15	,	,	PUNCT
ihlr-28381	16	16	oral	oral	ADJ
ihlr-28381	16	17	,	,	PUNCT
ihlr-28381	16	18	topical	topical	ADJ
ihlr-28381	16	19	,	,	PUNCT
ihlr-28381	16	20	injectable	injectable	ADJ
ihlr-28381	16	21	)	)	PUNCT
ihlr-28381	16	22	as	as	SCONJ
ihlr-28381	16	23	the	the	DET
ihlr-28381	16	24	brand	brand	NOUN
ihlr-28381	16	25	-	-	PUNCT
ihlr-28381	16	26	name.1	name.1	PROPN
ihlr-28381	16	27	the	the	DET
ihlr-28381	16	28	innovator	innovator	NOUN
ihlr-28381	16	29	/	/	SYM
ihlr-28381	16	30	brand	brand	NOUN
ihlr-28381	16	31	-	-	PUNCT
ihlr-28381	16	32	name	name	NOUN
ihlr-28381	16	33	and	and	CCONJ
ihlr-28381	16	34	generic	generic	ADJ
ihlr-28381	16	35	sectors	sector	NOUN
ihlr-28381	16	36	are	be	AUX
ihlr-28381	16	37	differentiated	differentiate	VERB
ihlr-28381	16	38	less	less	ADV
ihlr-28381	16	39	by	by	ADP
ihlr-28381	16	40	the	the	DET
ihlr-28381	16	41	substance	substance	NOUN
ihlr-28381	16	42	of	of	ADP
ihlr-28381	16	43	their	their	PRON
ihlr-28381	16	44	drugs	drug	NOUN
ihlr-28381	16	45	and	and	CCONJ
ihlr-28381	16	46	more	more	ADJ
ihlr-28381	16	47	by	by	ADP
ihlr-28381	16	48	their	their	PRON
ihlr-28381	16	49	business	business	NOUN
ihlr-28381	16	50	models	model	NOUN
ihlr-28381	16	51	,	,	PUNCT
ihlr-28381	16	52	strategies	strategy	NOUN
ihlr-28381	16	53	,	,	PUNCT
ihlr-28381	16	54	operations	operation	NOUN
ihlr-28381	16	55	,	,	PUNCT
ihlr-28381	16	56	goals	goal	NOUN
ihlr-28381	16	57	,	,	PUNCT
ihlr-28381	16	58	and	and	CCONJ
ihlr-28381	16	59	challenges	challenge	NOUN
ihlr-28381	16	60	.	.	PUNCT
ihlr-28381	17	1	innovators	innovator	NOUN
ihlr-28381	17	2	invent	invent	VERB
ihlr-28381	17	3	and	and	CCONJ
ihlr-28381	17	4	patent	patent	NOUN
ihlr-28381	17	5	medicines	medicine	NOUN
ihlr-28381	17	6	,	,	PUNCT
ihlr-28381	17	7	which	which	PRON
ihlr-28381	17	8	are	be	AUX
ihlr-28381	17	9	marketed	market	VERB
ihlr-28381	17	10	exclusively	exclusively	ADV
ihlr-28381	17	11	by	by	ADP
ihlr-28381	17	12	the	the	DET
ihlr-28381	17	13	patent	patent	NOUN
ihlr-28381	17	14	holder	holder	NOUN
ihlr-28381	17	15	during	during	ADP
ihlr-28381	17	16	the	the	DET
ihlr-28381	17	17	patent(s	patent(s	PROPN
ihlr-28381	17	18	)	)	PUNCT
ihlr-28381	17	19	life	life	NOUN
ihlr-28381	17	20	.	.	PUNCT
ihlr-28381	18	1	generic	generic	ADJ
ihlr-28381	18	2	firms	firm	NOUN
ihlr-28381	18	3	target	target	VERB
ihlr-28381	18	4	weak	weak	ADJ
ihlr-28381	18	5	patents	patent	NOUN
ihlr-28381	18	6	or	or	CCONJ
ihlr-28381	18	7	off	off	ADP
ihlr-28381	18	8	-	-	PUNCT
ihlr-28381	18	9	patent	patent	NOUN
ihlr-28381	18	10	drugs	drug	NOUN
ihlr-28381	18	11	,	,	PUNCT
ihlr-28381	18	12	copy	copy	VERB
ihlr-28381	18	13	the	the	DET
ihlr-28381	18	14	formula	formula	NOUN
ihlr-28381	18	15	,	,	PUNCT
ihlr-28381	18	16	and	and	CCONJ
ihlr-28381	18	17	sell	sell	VERB
ihlr-28381	18	18	a	a	DET
ihlr-28381	18	19	“	"	PUNCT
ihlr-28381	18	20	generic	generic	ADJ
ihlr-28381	18	21	”	"	PUNCT
ihlr-28381	18	22	form	form	NOUN
ihlr-28381	18	23	of	of	ADP
ihlr-28381	18	24	the	the	DET
ihlr-28381	18	25	innovator	innovator	NOUN
ihlr-28381	18	26	’s	’s	PART
ihlr-28381	18	27	medicine	medicine	NOUN
ihlr-28381	18	28	at	at	ADP
ihlr-28381	18	29	a	a	DET
ihlr-28381	18	30	discount	discount	NOUN
ihlr-28381	18	31	.	.	PUNCT
ihlr-28381	19	1	thus	thus	ADV
ihlr-28381	19	2	,	,	PUNCT
ihlr-28381	19	3	patent	patent	NOUN
ihlr-28381	19	4	expiration	expiration	NOUN
ihlr-28381	19	5	or	or	CCONJ
ihlr-28381	19	6	invalidation	invalidation	NOUN
ihlr-28381	19	7	results	result	NOUN
ihlr-28381	19	8	in	in	ADP
ihlr-28381	19	9	competition	competition	NOUN
ihlr-28381	19	10	,	,	PUNCT
ihlr-28381	19	11	lower	low	ADJ
ihlr-28381	19	12	prices	price	NOUN
ihlr-28381	19	13	,	,	PUNCT
ihlr-28381	19	14	and	and	CCONJ
ihlr-28381	19	15	higher	high	ADJ
ihlr-28381	19	16	access	access	NOUN
ihlr-28381	19	17	as	as	ADP
ihlr-28381	19	18	generics	generic	NOUN
ihlr-28381	19	19	and	and	CCONJ
ihlr-28381	19	20	innovators	innovator	NOUN
ihlr-28381	19	21	market	market	NOUN
ihlr-28381	19	22	interchangeable	interchangeable	ADJ
ihlr-28381	19	23	products	product	NOUN
ihlr-28381	19	24	to	to	ADP
ihlr-28381	19	25	the	the	DET
ihlr-28381	19	26	same	same	ADJ
ihlr-28381	19	27	patients	patient	NOUN
ihlr-28381	19	28	.	.	PUNCT
ihlr-28381	20	1	although	although	SCONJ
ihlr-28381	20	2	generics	generic	NOUN
ihlr-28381	20	3	rely	rely	VERB
ihlr-28381	20	4	on	on	ADP
ihlr-28381	20	5	innovators	innovator	NOUN
ihlr-28381	20	6	to	to	PART
ihlr-28381	20	7	invent	invent	VERB
ihlr-28381	20	8	the	the	DET
ihlr-28381	20	9	next	next	ADJ
ihlr-28381	20	10	product	product	NOUN
ihlr-28381	20	11	,	,	PUNCT
ihlr-28381	20	12	short	short	ADJ
ihlr-28381	20	13	-	-	PUNCT
ihlr-28381	20	14	term	term	NOUN
ihlr-28381	20	15	success	success	NOUN
ihlr-28381	20	16	can	can	AUX
ihlr-28381	20	17	be	be	AUX
ihlr-28381	20	18	mutually	mutually	ADV
ihlr-28381	20	19	exclusive	exclusive	ADJ
ihlr-28381	20	20	when	when	SCONJ
ihlr-28381	20	21	the	the	DET
ihlr-28381	20	22	two	two	NUM
ihlr-28381	20	23	share	share	NOUN
ihlr-28381	20	24	a	a	DET
ihlr-28381	20	25	market	market	NOUN
ihlr-28381	20	26	.	.	PUNCT
ihlr-28381	21	1	as	as	SCONJ
ihlr-28381	21	2	innovators	innovator	NOUN
ihlr-28381	21	3	’	’	PART
ihlr-28381	21	4	patents	patent	NOUN
ihlr-28381	21	5	age	age	NOUN
ihlr-28381	21	6	,	,	PUNCT
ihlr-28381	21	7	generic	generic	ADJ
ihlr-28381	21	8	suitor(s	suitor(s	NOUN
ihlr-28381	21	9	)	)	PUNCT
ihlr-28381	21	10	prepare	prepare	VERB
ihlr-28381	21	11	to	to	PART
ihlr-28381	21	12	launch	launch	NOUN
ihlr-28381	21	13	—	—	PUNCT
ihlr-28381	21	14	which	which	PRON
ihlr-28381	21	15	may	may	AUX
ihlr-28381	21	16	be	be	AUX
ihlr-28381	21	17	done	do	VERB
ihlr-28381	21	18	“	"	PUNCT
ihlr-28381	21	19	at	at	ADP
ihlr-28381	21	20	-	-	PUNCT
ihlr-28381	21	21	risk	risk	NOUN
ihlr-28381	21	22	”	"	PUNCT
ihlr-28381	21	23	(	(	PUNCT
ihlr-28381	21	24	i.e.	i.e.	X
ihlr-28381	21	25	,	,	PUNCT
ihlr-28381	21	26	before	before	SCONJ
ihlr-28381	21	27	the	the	DET
ihlr-28381	21	28	innovator	innovator	NOUN
ihlr-28381	21	29	’s	’s	PART
ihlr-28381	21	30	patent	patent	NOUN
ihlr-28381	21	31	expires	expire	VERB
ihlr-28381	21	32	)	)	PUNCT
ihlr-28381	21	33	if	if	SCONJ
ihlr-28381	21	34	the	the	DET
ihlr-28381	21	35	generic	generic	ADJ
ihlr-28381	21	36	firm	firm	NOUN
ihlr-28381	21	37	believes	believe	VERB
ihlr-28381	21	38	a	a	DET
ihlr-28381	21	39	patent	patent	NOUN
ihlr-28381	21	40	is	be	AUX
ihlr-28381	21	41	invalid	invalid	ADJ
ihlr-28381	21	42	—	—	PUNCT
ihlr-28381	21	43	a	a	DET
ihlr-28381	21	44	discounted	discount	VERB
ihlr-28381	21	45	,	,	PUNCT
ihlr-28381	21	46	interchangeable	interchangeable	ADJ
ihlr-28381	21	47	version	version	NOUN
ihlr-28381	21	48	of	of	ADP
ihlr-28381	21	49	the	the	DET
ihlr-28381	21	50	original	original	ADJ
ihlr-28381	21	51	drug	drug	NOUN
ihlr-28381	21	52	.	.	PUNCT
ihlr-28381	22	1	at	at	ADP
ihlr-28381	22	2	this	this	DET
ihlr-28381	22	3	stage	stage	NOUN
ihlr-28381	22	4	,	,	PUNCT
ihlr-28381	22	5	the	the	DET
ihlr-28381	22	6	hatch	hatch	NOUN
ihlr-28381	22	7	-	-	PUNCT
ihlr-28381	22	8	waxman	waxman	NOUN
ihlr-28381	22	9	process	process	NOUN
ihlr-28381	22	10	(	(	PUNCT
ihlr-28381	22	11	to	to	PART
ihlr-28381	22	12	be	be	AUX
ihlr-28381	22	13	discussed	discuss	VERB
ihlr-28381	22	14	)	)	PUNCT
ihlr-28381	22	15	for	for	ADP
ihlr-28381	22	16	generic	generic	ADJ
ihlr-28381	22	17	entry	entry	NOUN
ihlr-28381	22	18	draws	draw	VERB
ihlr-28381	22	19	the	the	DET
ihlr-28381	22	20	parties	party	NOUN
ihlr-28381	22	21	into	into	ADP
ihlr-28381	22	22	negotiations	negotiation	NOUN
ihlr-28381	22	23	.	.	PUNCT
ihlr-28381	23	1	sometimes	sometimes	ADV
ihlr-28381	23	2	,	,	PUNCT
ihlr-28381	23	3	and	and	CCONJ
ihlr-28381	23	4	particularly	particularly	ADV
ihlr-28381	23	5	beneficial	beneficial	ADJ
ihlr-28381	23	6	to	to	ADP
ihlr-28381	23	7	patients	patient	NOUN
ihlr-28381	23	8	struggling	struggle	VERB
ihlr-28381	23	9	with	with	ADP
ihlr-28381	23	10	affordability	affordability	NOUN
ihlr-28381	23	11	,	,	PUNCT
ihlr-28381	23	12	the	the	DET
ihlr-28381	23	13	parties	party	NOUN
ihlr-28381	23	14	enter	enter	VERB
ihlr-28381	23	15	a	a	DET
ihlr-28381	23	16	settlement	settlement	NOUN
ihlr-28381	23	17	to	to	PART
ihlr-28381	23	18	allow	allow	VERB
ihlr-28381	23	19	generic	generic	ADJ
ihlr-28381	23	20	entry	entry	NOUN
ihlr-28381	23	21	prior	prior	ADV
ihlr-28381	23	22	to	to	ADP
ihlr-28381	23	23	patent	patent	NOUN
ihlr-28381	23	24	expiration	expiration	NOUN
ihlr-28381	23	25	.	.	PUNCT
ihlr-28381	24	1	in	in	ADP
ihlr-28381	24	2	its	its	PRON
ihlr-28381	24	3	study	study	NOUN
ihlr-28381	24	4	of	of	ADP
ihlr-28381	24	5	generic	generic	ADJ
ihlr-28381	24	6	entry	entry	NOUN
ihlr-28381	24	7	prior	prior	ADV
ihlr-28381	24	8	to	to	ADP
ihlr-28381	24	9	patent	patent	NOUN
ihlr-28381	24	10	expiration	expiration	NOUN
ihlr-28381	24	11	,	,	PUNCT
ihlr-28381	24	12	the	the	DET
ihlr-28381	24	13	federal	federal	PROPN
ihlr-28381	24	14	trade	trade	PROPN
ihlr-28381	24	15	commission	commission	PROPN
ihlr-28381	24	16	(	(	PUNCT
ihlr-28381	24	17	“	"	PUNCT
ihlr-28381	24	18	ftc	ftc	PROPN
ihlr-28381	24	19	”	"	PUNCT
ihlr-28381	24	20	)	)	PUNCT
ihlr-28381	24	21	identified	identify	VERB
ihlr-28381	24	22	that	that	SCONJ
ihlr-28381	24	23	“	"	PUNCT
ihlr-28381	24	24	in	in	ADP
ihlr-28381	24	25	7	7	NUM
ihlr-28381	24	26	of	of	ADP
ihlr-28381	24	27	the	the	DET
ihlr-28381	24	28	20	20	NUM
ihlr-28381	24	29	final	final	ADJ
ihlr-28381	24	30	settlements	settlement	NOUN
ihlr-28381	24	31	,	,	PUNCT
ihlr-28381	24	32	the	the	DET
ihlr-28381	24	33	brandname	brandname	NOUN
ihlr-28381	24	34	company	company	NOUN
ihlr-28381	24	35	granted	grant	VERB
ihlr-28381	24	36	a	a	DET
ihlr-28381	24	37	license	license	NOUN
ihlr-28381	24	38	to	to	ADP
ihlr-28381	24	39	the	the	DET
ihlr-28381	24	40	generic	generic	ADJ
ihlr-28381	24	41	applicant	applicant	NOUN
ihlr-28381	24	42	to	to	PART
ihlr-28381	24	43	use	use	VERB
ihlr-28381	24	44	the	the	DET
ihlr-28381	24	45	patents	patent	NOUN
ihlr-28381	24	46	that	that	PRON
ihlr-28381	24	47	cover	cover	VERB
ihlr-28381	24	48	the	the	DET
ihlr-28381	24	49	brand	brand	NOUN
ihlr-28381	24	50	-	-	PUNCT
ihlr-28381	24	51	name	name	NOUN
ihlr-28381	24	52	drug	drug	NOUN
ihlr-28381	24	53	product	product	NOUN
ihlr-28381	24	54	prior	prior	ADV
ihlr-28381	24	55	to	to	ADP
ihlr-28381	24	56	patent	patent	NOUN
ihlr-28381	24	57	expiration	expiration	NOUN
ihlr-28381	24	58	so	so	SCONJ
ihlr-28381	24	59	that	that	SCONJ
ihlr-28381	24	60	the	the	DET
ihlr-28381	24	61	generic	generic	ADJ
ihlr-28381	24	62	applicant	applicant	NOUN
ihlr-28381	24	63	could	could	AUX
ihlr-28381	24	64	market	market	VERB
ihlr-28381	24	65	under	under	ADP
ihlr-28381	24	66	its	its	PRON
ihlr-28381	24	67	[	[	PUNCT
ihlr-28381	24	68	abbreviated	abbreviate	VERB
ihlr-28381	24	69	new	new	ADJ
ihlr-28381	24	70	drug	drug	NOUN
ihlr-28381	24	71	application	application	NOUN
ihlr-28381	24	72	]	]	PUNCT
ihlr-28381	24	73	”	"	PUNCT
ihlr-28381	24	74	(	(	PUNCT
ihlr-28381	24	75	“	"	PUNCT
ihlr-28381	24	76	anda”).2	anda”).2	PROPN
ihlr-28381	24	77	another	another	DET
ihlr-28381	24	78	ftc	ftc	PROPN
ihlr-28381	24	79	study	study	NOUN
ihlr-28381	24	80	showed	show	VERB
ihlr-28381	24	81	opposite	opposite	ADJ
ihlr-28381	24	82	outcomes	outcome	NOUN
ihlr-28381	24	83	,	,	PUNCT
ihlr-28381	24	84	where	where	SCONJ
ihlr-28381	24	85	among	among	ADP
ihlr-28381	24	86	218	218	NUM
ihlr-28381	24	87	settlement	settlement	NOUN
ihlr-28381	24	88	agreements	agreement	NOUN
ihlr-28381	24	89	,	,	PUNCT
ihlr-28381	24	90	“	"	PUNCT
ihlr-28381	24	91	66	66	NUM
ihlr-28381	24	92	final	final	ADJ
ihlr-28381	24	93	agreements	agreement	NOUN
ihlr-28381	24	94	involved	involve	VERB
ihlr-28381	24	95	some	some	DET
ihlr-28381	24	96	form	form	NOUN
ihlr-28381	24	97	of	of	ADP
ihlr-28381	24	98	compensation	compensation	NOUN
ihlr-28381	24	99	from	from	ADP
ihlr-28381	24	100	the	the	DET
ihlr-28381	24	101	brand	brand	NOUN
ihlr-28381	24	102	to	to	ADP
ihlr-28381	24	103	the	the	DET
ihlr-28381	24	104	generic	generic	NOUN
ihlr-28381	24	105	combined	combine	VERB
ihlr-28381	24	106	with	with	ADP
ihlr-28381	24	107	a	a	DET
ihlr-28381	24	108	delay	delay	NOUN
ihlr-28381	24	109	in	in	ADP
ihlr-28381	24	110	generic	generic	ADJ
ihlr-28381	24	111	entry	entry	NOUN
ihlr-28381	24	112	.	.	PUNCT
ihlr-28381	24	113	”3	”3	VERB
ihlr-28381	25	1	while	while	SCONJ
ihlr-28381	25	2	not	not	PART
ihlr-28381	25	3	in	in	ADP
ihlr-28381	25	4	the	the	DET
ihlr-28381	25	5	majority	majority	NOUN
ihlr-28381	25	6	,	,	PUNCT
ihlr-28381	25	7	these	these	DET
ihlr-28381	25	8	66	66	NUM
ihlr-28381	25	9	agreements	agreement	NOUN
ihlr-28381	25	10	represent	represent	VERB
ihlr-28381	25	11	“	"	PUNCT
ihlr-28381	25	12	pay	pay	VERB
ihlr-28381	25	13	-	-	PUNCT
ihlr-28381	25	14	for	for	ADP
ihlr-28381	25	15	-	-	PUNCT
ihlr-28381	25	16	delay”—a	delay”—a	NOUN
ihlr-28381	25	17	concerning	concern	VERB
ihlr-28381	25	18	tactic	tactic	NOUN
ihlr-28381	25	19	leveraged	leverage	VERB
ihlr-28381	25	20	by	by	ADP
ihlr-28381	25	21	some	some	DET
ihlr-28381	25	22	patent	patent	NOUN
ihlr-28381	25	23	holders	holder	NOUN
ihlr-28381	25	24	to	to	PART
ihlr-28381	25	25	delay	delay	VERB
ihlr-28381	25	26	generic	generic	ADJ
ihlr-28381	25	27	competition	competition	NOUN
ihlr-28381	25	28	and	and	CCONJ
ihlr-28381	25	29	prop	prop	VERB
ihlr-28381	25	30	up	up	ADP
ihlr-28381	25	31	monopolies.4	monopolies.4	PROPN
ihlr-28381	25	32	as	as	ADP
ihlr-28381	25	33	a	a	DET
ihlr-28381	25	34	result	result	NOUN
ihlr-28381	25	35	,	,	PUNCT
ihlr-28381	25	36	patients	patient	NOUN
ihlr-28381	25	37	“	"	PUNCT
ihlr-28381	25	38	miss	miss	VERB
ihlr-28381	25	39	out	out	ADP
ihlr-28381	25	40	on	on	ADP
ihlr-28381	25	41	generic	generic	ADJ
ihlr-28381	25	42	prices	price	NOUN
ihlr-28381	25	43	that	that	PRON
ihlr-28381	25	44	can	can	AUX
ihlr-28381	25	45	be	be	AUX
ihlr-28381	25	46	as	as	ADV
ihlr-28381	25	47	much	much	ADJ
ihlr-28381	25	48	as	as	ADP
ihlr-28381	25	49	90	90	NUM
ihlr-28381	25	50	%	%	NOUN
ihlr-28381	25	51	less	less	ADJ
ihlr-28381	25	52	than	than	ADP
ihlr-28381	25	53	brand	brand	NOUN
ihlr-28381	25	54	prices	price	NOUN
ihlr-28381	25	55	.	.	PUNCT
ihlr-28381	26	1	for	for	ADP
ihlr-28381	26	2	example	example	NOUN
ihlr-28381	26	3	,	,	PUNCT
ihlr-28381	26	4	brand	brand	NOUN
ihlr-28381	26	5	-	-	PUNCT
ihlr-28381	26	6	name	name	NOUN
ihlr-28381	26	7	medication	medication	NOUN
ihlr-28381	26	8	that	that	PRON
ihlr-28381	26	9	costs	cost	VERB
ihlr-28381	26	10	$	$	SYM
ihlr-28381	26	11	300	300	NUM
ihlr-28381	26	12	per	per	ADP
ihlr-28381	26	13	month	month	NOUN
ihlr-28381	26	14	might	might	AUX
ihlr-28381	26	15	be	be	AUX
ihlr-28381	26	16	sold	sell	VERB
ihlr-28381	26	17	as	as	ADP
ihlr-28381	26	18	a	a	DET
ihlr-28381	26	19	generic	generic	NOUN
ihlr-28381	26	20	for	for	ADP
ihlr-28381	26	21	as	as	ADV
ihlr-28381	26	22	little	little	ADJ
ihlr-28381	26	23	as	as	ADP
ihlr-28381	26	24	$	$	SYM
ihlr-28381	26	25	30	30	NUM
ihlr-28381	26	26	per	per	ADP
ihlr-28381	26	27	month	month	NOUN
ihlr-28381	26	28	.	.	PUNCT
ihlr-28381	26	29	”5	”5	PUNCT
ihlr-28381	27	1	regardless	regardless	ADV
ihlr-28381	27	2	of	of	ADP
ihlr-28381	27	3	who	who	PRON
ihlr-28381	27	4	(	(	PUNCT
ihlr-28381	27	5	e.g.	e.g.	ADV
ihlr-28381	27	6	,	,	PUNCT
ihlr-28381	27	7	patient	patient	ADJ
ihlr-28381	27	8	,	,	PUNCT
ihlr-28381	27	9	insurer	insurer	NOUN
ihlr-28381	27	10	,	,	PUNCT
ihlr-28381	27	11	taxpayer	taxpayer	NOUN
ihlr-28381	27	12	,	,	PUNCT
ihlr-28381	27	13	public	public	ADJ
ihlr-28381	27	14	program	program	NOUN
ihlr-28381	27	15	)	)	PUNCT
ihlr-28381	27	16	pays	pay	VERB
ihlr-28381	27	17	what	what	PRON
ihlr-28381	27	18	“	"	PUNCT
ihlr-28381	27	19	price	price	NOUN
ihlr-28381	27	20	”	"	PUNCT
ihlr-28381	27	21	(	(	PUNCT
ihlr-28381	27	22	e.g.	e.g.	ADV
ihlr-28381	27	23	,	,	PUNCT
ihlr-28381	27	24	copays	copay	NOUN
ihlr-28381	27	25	,	,	PUNCT
ihlr-28381	27	26	insurance	insurance	NOUN
ihlr-28381	27	27	premiums	premium	NOUN
ihlr-28381	27	28	,	,	PUNCT
ihlr-28381	27	29	list	list	NOUN
ihlr-28381	27	30	price	price	NOUN
ihlr-28381	27	31	)	)	PUNCT
ihlr-28381	27	32	,	,	PUNCT
ihlr-28381	27	33	the	the	DET
ihlr-28381	27	34	difference	difference	NOUN
ihlr-28381	27	35	between	between	ADP
ihlr-28381	27	36	brand	brand	NOUN
ihlr-28381	27	37	and	and	CCONJ
ihlr-28381	27	38	generic	generic	ADJ
ihlr-28381	27	39	price	price	NOUN
ihlr-28381	27	40	is	be	AUX
ihlr-28381	27	41	not	not	PART
ihlr-28381	27	42	small	small	ADJ
ihlr-28381	27	43	.	.	PUNCT
ihlr-28381	28	1	1	1	X
ihlr-28381	28	2	.	.	X
ihlr-28381	28	3	u.s	u.s	PROPN
ihlr-28381	28	4	.	.	PROPN
ihlr-28381	28	5	food	food	PROPN
ihlr-28381	28	6	&	&	CCONJ
ihlr-28381	28	7	drug	drug	PROPN
ihlr-28381	28	8	admin	admin	PROPN
ihlr-28381	28	9	.	.	PROPN
ihlr-28381	29	1	,	,	PUNCT
ihlr-28381	29	2	generic	generic	ADJ
ihlr-28381	29	3	drugs	drug	NOUN
ihlr-28381	29	4	:	:	PUNCT
ihlr-28381	29	5	overview	overview	NOUN
ihlr-28381	29	6	and	and	CCONJ
ihlr-28381	29	7	basics	basic	NOUN
ihlr-28381	29	8	(	(	PUNCT
ihlr-28381	29	9	2017	2017	NUM
ihlr-28381	29	10	)	)	PUNCT
ihlr-28381	29	11	,	,	PUNCT
ihlr-28381	29	12	https://www.fda.gov/drugs/generic-drugs/overview-basics	https://www.fda.gov/drugs/generic-drugs/overview-basics	PROPN
ihlr-28381	29	13	[	[	X
ihlr-28381	29	14	https://perma.cc/zf5n-n948	https://perma.cc/zf5n-n948	X
ihlr-28381	29	15	]	]	X
ihlr-28381	29	16	.	.	PUNCT
ihlr-28381	30	1	2	2	X
ihlr-28381	30	2	.	.	X
ihlr-28381	30	3	u.s	u.s	PROPN
ihlr-28381	30	4	.	.	PROPN
ihlr-28381	30	5	fed	fed	PROPN
ihlr-28381	30	6	.	.	PUNCT
ihlr-28381	31	1	trade	trade	NOUN
ihlr-28381	31	2	comm’n	comm’n	NOUN
ihlr-28381	31	3	,	,	PUNCT
ihlr-28381	31	4	generic	generic	ADJ
ihlr-28381	31	5	drug	drug	NOUN
ihlr-28381	31	6	entry	entry	NOUN
ihlr-28381	31	7	prior	prior	ADV
ihlr-28381	31	8	to	to	ADP
ihlr-28381	31	9	patent	patent	NOUN
ihlr-28381	31	10	expiration	expiration	NOUN
ihlr-28381	31	11	:	:	PUNCT
ihlr-28381	31	12	an	an	DET
ihlr-28381	31	13	ftc	ftc	PROPN
ihlr-28381	31	14	study	study	NOUN
ihlr-28381	31	15	,	,	PUNCT
ihlr-28381	31	16	25	25	NUM
ihlr-28381	31	17	(	(	PUNCT
ihlr-28381	31	18	2002	2002	NUM
ihlr-28381	31	19	)	)	PUNCT
ihlr-28381	31	20	,	,	PUNCT
ihlr-28381	31	21	https://www.ftc.gov/reports/generic-drug-entry-prior-patent-expiration-ftc-study	https://www.ftc.gov/reports/generic-drug-entry-prior-patent-expiration-ftc-study	PROPN
ihlr-28381	32	1	[	[	X
ihlr-28381	32	2	https://perma.cc/j5v9-9x8r	https://perma.cc/j5v9-9x8r	X
ihlr-28381	32	3	]	]	X
ihlr-28381	32	4	.	.	PUNCT
ihlr-28381	33	1	3	3	X
ihlr-28381	33	2	.	.	X
ihlr-28381	33	3	u.s	u.s	PROPN
ihlr-28381	33	4	.	.	PROPN
ihlr-28381	33	5	fed	fed	PROPN
ihlr-28381	33	6	.	.	PUNCT
ihlr-28381	34	1	trade	trade	NOUN
ihlr-28381	34	2	comm’n	comm’n	NOUN
ihlr-28381	34	3	,	,	PUNCT
ihlr-28381	34	4	pay	pay	NOUN
ihlr-28381	34	5	-	-	PUNCT
ihlr-28381	34	6	for	for	ADP
ihlr-28381	34	7	-	-	PUNCT
ihlr-28381	34	8	delay	delay	NOUN
ihlr-28381	34	9	:	:	PUNCT
ihlr-28381	34	10	how	how	SCONJ
ihlr-28381	34	11	drug	drug	NOUN
ihlr-28381	34	12	company	company	NOUN
ihlr-28381	34	13	pay	pay	NOUN
ihlr-28381	34	14	-	-	PUNCT
ihlr-28381	34	15	offs	off	NOUN
ihlr-28381	34	16	cost	cost	VERB
ihlr-28381	34	17	consumers	consumer	NOUN
ihlr-28381	34	18	billions	billion	NOUN
ihlr-28381	34	19	,	,	PUNCT
ihlr-28381	34	20	4	4	NUM
ihlr-28381	34	21	(	(	PUNCT
ihlr-28381	34	22	2010	2010	NUM
ihlr-28381	34	23	)	)	PUNCT
ihlr-28381	34	24	,	,	PUNCT
ihlr-28381	34	25	https://www.ftc.gov/reports/pay-delay-how-drug-company-pay-offs-costconsumers-billions-federal-trade-commission-staff-study	https://www.ftc.gov/reports/pay-delay-how-drug-company-pay-offs-costconsumers-billions-federal-trade-commission-staff-study	VERB
ihlr-28381	35	1	[	[	X
ihlr-28381	35	2	https://perma.cc/mz9e-dxr2	https://perma.cc/mz9e-dxr2	NOUN
ihlr-28381	35	3	]	]	PUNCT
ihlr-28381	35	4	.	.	PUNCT
ihlr-28381	36	1	4	4	X
ihlr-28381	36	2	.	.	X
ihlr-28381	37	1	i	i	PRON
ihlr-28381	37	2	d.	d.	PROPN
ihlr-28381	37	3	5	5	NUM
ihlr-28381	37	4	.	.	PUNCT
ihlr-28381	38	1	i	i	PRON
ihlr-28381	38	2	d.	d.	PROPN
ihlr-28381	38	3	at	at	ADP
ihlr-28381	38	4	1	1	NUM
ihlr-28381	38	5	.	.	PUNCT
ihlr-28381	38	6	2024	2024	NUM
ihlr-28381	38	7	]	]	PUNCT
ihlr-28381	38	8	incentivizing	incentivize	VERB
ihlr-28381	38	9	drug	drug	NOUN
ihlr-28381	38	10	affordability	affordability	NOUN
ihlr-28381	38	11	123	123	NUM
ihlr-28381	38	12	b.	b.	NOUN
ihlr-28381	38	13	the	the	DET
ihlr-28381	38	14	problem	problem	NOUN
ihlr-28381	38	15	:	:	PUNCT
ihlr-28381	38	16	price	price	NOUN
ihlr-28381	38	17	&	&	CCONJ
ihlr-28381	38	18	health	health	NOUN
ihlr-28381	38	19	outcomes	outcome	NOUN
ihlr-28381	38	20	the	the	DET
ihlr-28381	38	21	consequence	consequence	NOUN
ihlr-28381	38	22	of	of	ADP
ihlr-28381	38	23	poor	poor	ADJ
ihlr-28381	38	24	generic	generic	ADJ
ihlr-28381	38	25	access	access	NOUN
ihlr-28381	38	26	is	be	AUX
ihlr-28381	38	27	not	not	PART
ihlr-28381	38	28	just	just	ADV
ihlr-28381	38	29	monetary	monetary	ADJ
ihlr-28381	38	30	.	.	PUNCT
ihlr-28381	39	1	in	in	ADP
ihlr-28381	39	2	the	the	DET
ihlr-28381	39	3	u.s	u.s	PROPN
ihlr-28381	39	4	.	.	PROPN
ihlr-28381	39	5	,	,	PUNCT
ihlr-28381	39	6	8	8	NUM
ihlr-28381	39	7	%	%	NOUN
ihlr-28381	39	8	of	of	ADP
ihlr-28381	39	9	adults	adult	NOUN
ihlr-28381	39	10	report	report	VERB
ihlr-28381	39	11	worsening	worsen	VERB
ihlr-28381	39	12	health	health	NOUN
ihlr-28381	39	13	conditions	condition	NOUN
ihlr-28381	39	14	correlated	correlate	VERB
ihlr-28381	39	15	with	with	ADP
ihlr-28381	39	16	their	their	PRON
ihlr-28381	39	17	inability	inability	NOUN
ihlr-28381	39	18	to	to	PART
ihlr-28381	39	19	afford	afford	VERB
ihlr-28381	39	20	prescriptions.6	prescriptions.6	PROPN
ihlr-28381	39	21	according	accord	VERB
ihlr-28381	39	22	to	to	ADP
ihlr-28381	39	23	the	the	DET
ihlr-28381	39	24	kaiser	kaiser	PROPN
ihlr-28381	39	25	family	family	PROPN
ihlr-28381	39	26	foundation	foundation	PROPN
ihlr-28381	39	27	,	,	PUNCT
ihlr-28381	39	28	29	29	NUM
ihlr-28381	39	29	%	%	NOUN
ihlr-28381	39	30	of	of	ADP
ihlr-28381	39	31	u.s	u.s	PROPN
ihlr-28381	39	32	.	.	PROPN
ihlr-28381	39	33	adults	adult	NOUN
ihlr-28381	39	34	forego	forego	ADJ
ihlr-28381	39	35	medicine	medicine	NOUN
ihlr-28381	39	36	because	because	SCONJ
ihlr-28381	39	37	of	of	ADP
ihlr-28381	39	38	the	the	DET
ihlr-28381	39	39	cost	cost	NOUN
ihlr-28381	39	40	.	.	PUNCT
ihlr-28381	40	1	nearly	nearly	ADV
ihlr-28381	40	2	30	30	NUM
ihlr-28381	40	3	%	%	NOUN
ihlr-28381	40	4	of	of	ADP
ihlr-28381	40	5	americans	americans	PROPN
ihlr-28381	40	6	are	be	AUX
ihlr-28381	40	7	skipping	skip	VERB
ihlr-28381	40	8	doses	dose	NOUN
ihlr-28381	40	9	,	,	PUNCT
ihlr-28381	40	10	cutting	cut	VERB
ihlr-28381	40	11	pills	pill	NOUN
ihlr-28381	40	12	in	in	ADP
ihlr-28381	40	13	half	half	NOUN
ihlr-28381	40	14	,	,	PUNCT
ihlr-28381	40	15	or	or	CCONJ
ihlr-28381	40	16	not	not	PART
ihlr-28381	40	17	filling	fill	VERB
ihlr-28381	40	18	prescriptions	prescription	NOUN
ihlr-28381	40	19	because	because	SCONJ
ihlr-28381	40	20	of	of	ADP
ihlr-28381	40	21	the	the	DET
ihlr-28381	40	22	cost.7	cost.7	NOUN
ihlr-28381	40	23	approximately	approximately	ADV
ihlr-28381	40	24	8	8	NUM
ihlr-28381	40	25	%	%	NOUN
ihlr-28381	40	26	of	of	ADP
ihlr-28381	40	27	u.s	u.s	PROPN
ihlr-28381	40	28	.	.	PROPN
ihlr-28381	40	29	adults	adult	NOUN
ihlr-28381	40	30	reported	report	VERB
ihlr-28381	40	31	worsening	worsen	VERB
ihlr-28381	40	32	health	health	NOUN
ihlr-28381	40	33	after	after	ADP
ihlr-28381	40	34	skipping	skip	VERB
ihlr-28381	40	35	medication.8	medication.8	NOUN
ihlr-28381	40	36	the	the	DET
ihlr-28381	40	37	figure	figure	NOUN
ihlr-28381	40	38	below	below	ADP
ihlr-28381	40	39	illustrates	illustrate	VERB
ihlr-28381	40	40	where	where	SCONJ
ihlr-28381	40	41	affordability	affordability	NOUN
ihlr-28381	40	42	concerns	concern	NOUN
ihlr-28381	40	43	are	be	AUX
ihlr-28381	40	44	especially	especially	ADV
ihlr-28381	40	45	potent	potent	ADJ
ihlr-28381	40	46	.	.	PUNCT
ihlr-28381	41	1	figure	figure	NOUN
ihlr-28381	41	2	19	19	NUM
ihlr-28381	41	3	c.	c.	PROPN
ihlr-28381	41	4	roadmap	roadmap	NOUN
ihlr-28381	41	5	although	although	SCONJ
ihlr-28381	41	6	approaches	approach	NOUN
ihlr-28381	41	7	to	to	PART
ihlr-28381	41	8	delay	delay	VERB
ihlr-28381	41	9	generic	generic	ADJ
ihlr-28381	41	10	entry	entry	NOUN
ihlr-28381	41	11	vary	vary	NOUN
ihlr-28381	41	12	in	in	ADP
ihlr-28381	41	13	form	form	NOUN
ihlr-28381	41	14	,	,	PUNCT
ihlr-28381	41	15	this	this	DET
ihlr-28381	41	16	note	note	NOUN
ihlr-28381	41	17	uses	use	VERB
ihlr-28381	41	18	“	"	PUNCT
ihlr-28381	41	19	pay	pay	VERB
ihlr-28381	41	20	-	-	PUNCT
ihlr-28381	41	21	for	for	ADP
ihlr-28381	41	22	-	-	PUNCT
ihlr-28381	41	23	delay	delay	NOUN
ihlr-28381	41	24	”	"	PUNCT
ihlr-28381	41	25	to	to	PART
ihlr-28381	41	26	refer	refer	VERB
ihlr-28381	41	27	to	to	ADP
ihlr-28381	41	28	the	the	DET
ihlr-28381	41	29	various	various	ADJ
ihlr-28381	41	30	forms	form	NOUN
ihlr-28381	41	31	collectively	collectively	ADV
ihlr-28381	41	32	.	.	PUNCT
ihlr-28381	42	1	this	this	DET
ihlr-28381	42	2	note	note	NOUN
ihlr-28381	42	3	explains	explain	VERB
ihlr-28381	42	4	the	the	DET
ihlr-28381	42	5	problem	problem	NOUN
ihlr-28381	42	6	of	of	ADP
ihlr-28381	42	7	pay	pay	NOUN
ihlr-28381	42	8	-	-	PUNCT
ihlr-28381	42	9	for	for	ADP
ihlr-28381	42	10	-	-	PUNCT
ihlr-28381	42	11	delay	delay	NOUN
ihlr-28381	42	12	and	and	CCONJ
ihlr-28381	42	13	the	the	DET
ihlr-28381	42	14	difficulty	difficulty	NOUN
ihlr-28381	42	15	of	of	ADP
ihlr-28381	42	16	solving	solve	VERB
ihlr-28381	42	17	it	it	PRON
ihlr-28381	42	18	before	before	ADP
ihlr-28381	42	19	proposing	propose	VERB
ihlr-28381	42	20	a	a	DET
ihlr-28381	42	21	lowfriction	lowfriction	NOUN
ihlr-28381	42	22	incentive	incentive	NOUN
ihlr-28381	42	23	program	program	NOUN
ihlr-28381	42	24	as	as	ADP
ihlr-28381	42	25	a	a	DET
ihlr-28381	42	26	solution	solution	NOUN
ihlr-28381	42	27	.	.	PUNCT
ihlr-28381	43	1	by	by	ADP
ihlr-28381	43	2	presenting	present	VERB
ihlr-28381	43	3	attractive	attractive	ADJ
ihlr-28381	43	4	alternatives	alternative	NOUN
ihlr-28381	43	5	to	to	ADP
ihlr-28381	43	6	companies	company	NOUN
ihlr-28381	43	7	that	that	PRON
ihlr-28381	43	8	would	would	AUX
ihlr-28381	43	9	otherwise	otherwise	ADV
ihlr-28381	43	10	extend	extend	VERB
ihlr-28381	43	11	monopolies	monopoly	NOUN
ihlr-28381	43	12	,	,	PUNCT
ihlr-28381	43	13	a	a	DET
ihlr-28381	43	14	“	"	PUNCT
ihlr-28381	43	15	wildcard	wildcard	ADJ
ihlr-28381	43	16	exclusivity	exclusivity	NOUN
ihlr-28381	43	17	”	"	PUNCT
ihlr-28381	43	18	6	6	NUM
ihlr-28381	43	19	.	.	PUNCT
ihlr-28381	43	20	kaiser	kaiser	PROPN
ihlr-28381	43	21	fam	fam	PROPN
ihlr-28381	43	22	.	.	PROPN
ihlr-28381	43	23	found	find	VERB
ihlr-28381	43	24	.	.	PUNCT
ihlr-28381	44	1	,	,	PUNCT
ihlr-28381	44	2	poll	poll	NOUN
ihlr-28381	44	3	:	:	PUNCT
ihlr-28381	44	4	nearly	nearly	ADV
ihlr-28381	44	5	1	1	NUM
ihlr-28381	44	6	in	in	ADP
ihlr-28381	44	7	4	4	NUM
ihlr-28381	44	8	americans	americans	PROPN
ihlr-28381	44	9	taking	take	VERB
ihlr-28381	44	10	prescription	prescription	NOUN
ihlr-28381	44	11	drugs	drug	NOUN
ihlr-28381	44	12	say	say	VERB
ihlr-28381	44	13	it	it	PRON
ihlr-28381	44	14	’s	’	VERB
ihlr-28381	44	15	difficult	difficult	ADJ
ihlr-28381	44	16	to	to	PART
ihlr-28381	44	17	afford	afford	VERB
ihlr-28381	44	18	their	their	PRON
ihlr-28381	44	19	medicines	medicine	NOUN
ihlr-28381	44	20	,	,	PUNCT
ihlr-28381	44	21	including	include	VERB
ihlr-28381	44	22	larger	large	ADJ
ihlr-28381	44	23	shares	share	NOUN
ihlr-28381	44	24	among	among	ADP
ihlr-28381	44	25	those	those	PRON
ihlr-28381	44	26	with	with	ADP
ihlr-28381	44	27	health	health	NOUN
ihlr-28381	44	28	issues	issue	NOUN
ihlr-28381	44	29	,	,	PUNCT
ihlr-28381	44	30	with	with	ADP
ihlr-28381	44	31	low	low	ADJ
ihlr-28381	44	32	incomes	income	NOUN
ihlr-28381	44	33	and	and	CCONJ
ihlr-28381	44	34	nearing	near	VERB
ihlr-28381	44	35	medicare	medicare	PROPN
ihlr-28381	44	36	age	age	NOUN
ihlr-28381	44	37	(	(	PUNCT
ihlr-28381	44	38	mar	mar	PROPN
ihlr-28381	44	39	.	.	PROPN
ihlr-28381	44	40	2019	2019	NUM
ihlr-28381	44	41	)	)	PUNCT
ihlr-28381	44	42	,	,	PUNCT
ihlr-28381	44	43	https://www.kff.org/health-costs/pressrelease/poll-nearly-1-in-4-americans-taking-prescription-drugs-say-its-difficult-to-affordmedicines-including-larger-shares-with-low-incomes/	https://www.kff.org/health-costs/pressrelease/poll-nearly-1-in-4-americans-taking-prescription-drugs-say-its-difficult-to-affordmedicines-including-larger-shares-with-low-incomes/	PROPN
ihlr-28381	45	1	[	[	X
ihlr-28381	45	2	https://perma.cc/bsu2-a3rb	https://perma.cc/bsu2-a3rb	NOUN
ihlr-28381	45	3	]	]	X
ihlr-28381	45	4	.	.	PUNCT
ihlr-28381	46	1	7	7	X
ihlr-28381	46	2	.	.	X
ihlr-28381	47	1	i	i	PRON
ihlr-28381	47	2	d.	d.	PROPN
ihlr-28381	47	3	8	8	NUM
ihlr-28381	47	4	.	.	PUNCT
ihlr-28381	48	1	i	i	PRON
ihlr-28381	48	2	d.	d.	PROPN
ihlr-28381	48	3	9	9	NUM
ihlr-28381	48	4	.	.	PUNCT
ihlr-28381	49	1	i	i	PRON
ihlr-28381	49	2	d.	d.	PROPN
ihlr-28381	49	3	124	124	NUM
ihlr-28381	49	4	indiana	indiana	PROPN
ihlr-28381	49	5	health	health	PROPN
ihlr-28381	49	6	law	law	PROPN
ihlr-28381	49	7	review	review	NOUN
ihlr-28381	49	8	[	[	X
ihlr-28381	49	9	vol	vol	NOUN
ihlr-28381	49	10	.	.	NOUN
ihlr-28381	49	11	21:121	21:121	NUM
ihlr-28381	49	12	system	system	NOUN
ihlr-28381	49	13	would	would	AUX
ihlr-28381	49	14	simultaneously	simultaneously	ADV
ihlr-28381	49	15	reward	reward	VERB
ihlr-28381	49	16	companies	company	NOUN
ihlr-28381	49	17	that	that	PRON
ihlr-28381	49	18	facilitate	facilitate	VERB
ihlr-28381	49	19	drug	drug	NOUN
ihlr-28381	49	20	affordability	affordability	NOUN
ihlr-28381	49	21	,	,	PUNCT
ihlr-28381	49	22	save	save	VERB
ihlr-28381	49	23	patient	patient	NOUN
ihlr-28381	49	24	and	and	CCONJ
ihlr-28381	49	25	public	public	ADJ
ihlr-28381	49	26	dollars	dollar	NOUN
ihlr-28381	49	27	,	,	PUNCT
ihlr-28381	49	28	and	and	CCONJ
ihlr-28381	49	29	improve	improve	VERB
ihlr-28381	49	30	health	health	NOUN
ihlr-28381	49	31	outcomes	outcome	NOUN
ihlr-28381	49	32	.	.	PUNCT
ihlr-28381	50	1	this	this	DET
ihlr-28381	50	2	note	note	NOUN
ihlr-28381	50	3	embraces	embrace	VERB
ihlr-28381	50	4	one	one	NUM
ihlr-28381	50	5	promising	promising	ADJ
ihlr-28381	50	6	incentive	incentive	NOUN
ihlr-28381	50	7	,	,	PUNCT
ihlr-28381	50	8	but	but	CCONJ
ihlr-28381	50	9	other	other	ADJ
ihlr-28381	50	10	incentives	incentive	NOUN
ihlr-28381	50	11	outside	outside	ADP
ihlr-28381	50	12	the	the	DET
ihlr-28381	50	13	scope	scope	NOUN
ihlr-28381	50	14	of	of	ADP
ihlr-28381	50	15	this	this	DET
ihlr-28381	50	16	note	note	NOUN
ihlr-28381	50	17	—	—	PUNCT
ihlr-28381	50	18	such	such	ADJ
ihlr-28381	50	19	as	as	ADP
ihlr-28381	50	20	fda	fda	PROPN
ihlr-28381	50	21	user	user	NOUN
ihlr-28381	50	22	fee	fee	NOUN
ihlr-28381	50	23	waivers	waiver	NOUN
ihlr-28381	50	24	and	and	CCONJ
ihlr-28381	50	25	tax	tax	NOUN
ihlr-28381	50	26	credits	credit	NOUN
ihlr-28381	50	27	—	—	PUNCT
ihlr-28381	50	28	could	could	AUX
ihlr-28381	50	29	be	be	AUX
ihlr-28381	50	30	incorporated	incorporate	VERB
ihlr-28381	50	31	into	into	ADP
ihlr-28381	50	32	a	a	DET
ihlr-28381	50	33	more	more	ADV
ihlr-28381	50	34	dynamic	dynamic	ADJ
ihlr-28381	50	35	incentive	incentive	NOUN
ihlr-28381	50	36	package	package	NOUN
ihlr-28381	50	37	.	.	PUNCT
ihlr-28381	51	1	each	each	DET
ihlr-28381	51	2	year	year	NOUN
ihlr-28381	51	3	,	,	PUNCT
ihlr-28381	51	4	pay	pay	NOUN
ihlr-28381	51	5	-	-	PUNCT
ihlr-28381	51	6	for	for	ADP
ihlr-28381	51	7	-	-	PUNCT
ihlr-28381	51	8	delay	delay	NOUN
ihlr-28381	51	9	saddles	saddle	NOUN
ihlr-28381	51	10	the	the	DET
ihlr-28381	51	11	u.s	u.s	PROPN
ihlr-28381	51	12	.	.	PROPN
ihlr-28381	51	13	healthcare	healthcare	PROPN
ihlr-28381	51	14	system	system	NOUN
ihlr-28381	51	15	with	with	ADP
ihlr-28381	51	16	billions	billion	NOUN
ihlr-28381	51	17	of	of	ADP
ihlr-28381	51	18	dollars	dollar	NOUN
ihlr-28381	51	19	in	in	ADP
ihlr-28381	51	20	avoidable	avoidable	ADJ
ihlr-28381	51	21	cost.10	cost.10	VERB
ihlr-28381	51	22	the	the	DET
ihlr-28381	51	23	most	most	ADV
ihlr-28381	51	24	conservative	conservative	ADJ
ihlr-28381	51	25	estimated	estimate	VERB
ihlr-28381	51	26	annual	annual	ADJ
ihlr-28381	51	27	burden	burden	NOUN
ihlr-28381	51	28	is	be	AUX
ihlr-28381	51	29	$	$	SYM
ihlr-28381	51	30	3.5	3.5	NUM
ihlr-28381	51	31	billion	billion	NUM
ihlr-28381	51	32	while	while	SCONJ
ihlr-28381	51	33	more	more	ADJ
ihlr-28381	51	34	inclusive	inclusive	ADJ
ihlr-28381	51	35	estimates	estimate	NOUN
ihlr-28381	51	36	exceed	exceed	VERB
ihlr-28381	51	37	$	$	SYM
ihlr-28381	51	38	37	37	NUM
ihlr-28381	51	39	billion.11	billion.11	NOUN
ihlr-28381	51	40	based	base	VERB
ihlr-28381	51	41	on	on	ADP
ihlr-28381	51	42	six	six	NUM
ihlr-28381	51	43	different	different	ADJ
ihlr-28381	51	44	methodologies	methodology	NOUN
ihlr-28381	51	45	,	,	PUNCT
ihlr-28381	51	46	a	a	DET
ihlr-28381	51	47	study	study	NOUN
ihlr-28381	51	48	by	by	ADP
ihlr-28381	51	49	robin	robin	PROPN
ihlr-28381	51	50	feldman	feldman	PROPN
ihlr-28381	51	51	calculated	calculate	VERB
ihlr-28381	51	52	an	an	DET
ihlr-28381	51	53	average	average	ADJ
ihlr-28381	51	54	burden	burden	NOUN
ihlr-28381	51	55	of	of	ADP
ihlr-28381	51	56	$	$	SYM
ihlr-28381	51	57	19.2	19.2	NUM
ihlr-28381	51	58	billion	billion	NUM
ihlr-28381	51	59	,	,	PUNCT
ihlr-28381	51	60	or	or	CCONJ
ihlr-28381	51	61	about	about	ADV
ihlr-28381	51	62	7	7	NUM
ihlr-28381	51	63	%	%	NOUN
ihlr-28381	51	64	of	of	ADP
ihlr-28381	51	65	average	average	ADJ
ihlr-28381	51	66	annual	annual	ADJ
ihlr-28381	51	67	u.s	u.s	PROPN
ihlr-28381	51	68	.	.	PROPN
ihlr-28381	51	69	drug	drug	NOUN
ihlr-28381	51	70	spending.12	spending.12	PROPN
ihlr-28381	51	71	in	in	ADP
ihlr-28381	51	72	deriving	derive	VERB
ihlr-28381	51	73	these	these	DET
ihlr-28381	51	74	empirical	empirical	ADJ
ihlr-28381	51	75	estimates	estimate	NOUN
ihlr-28381	51	76	,	,	PUNCT
ihlr-28381	51	77	feldman	feldman	PROPN
ihlr-28381	51	78	analyzed	analyze	VERB
ihlr-28381	51	79	historical	historical	ADJ
ihlr-28381	51	80	pay	pay	NOUN
ihlr-28381	51	81	-	-	PUNCT
ihlr-28381	51	82	for	for	ADP
ihlr-28381	51	83	-	-	PUNCT
ihlr-28381	51	84	delay	delay	NOUN
ihlr-28381	51	85	settlements	settlement	NOUN
ihlr-28381	51	86	and	and	CCONJ
ihlr-28381	51	87	determined	determine	VERB
ihlr-28381	51	88	the	the	DET
ihlr-28381	51	89	length	length	NOUN
ihlr-28381	51	90	of	of	ADP
ihlr-28381	51	91	delay.13	delay.13	PRON
ihlr-28381	51	92	then	then	ADV
ihlr-28381	51	93	,	,	PUNCT
ihlr-28381	51	94	the	the	DET
ihlr-28381	51	95	eventual	eventual	ADJ
ihlr-28381	51	96	generic	generic	ADJ
ihlr-28381	51	97	price	price	NOUN
ihlr-28381	51	98	—	—	PUNCT
ihlr-28381	51	99	what	what	PRON
ihlr-28381	51	100	consumers	consumer	NOUN
ihlr-28381	51	101	would	would	AUX
ihlr-28381	51	102	have	have	AUX
ihlr-28381	51	103	paid	pay	VERB
ihlr-28381	51	104	but	but	CCONJ
ihlr-28381	51	105	for	for	ADP
ihlr-28381	51	106	the	the	DET
ihlr-28381	51	107	pay	pay	VERB
ihlr-28381	51	108	-	-	PUNCT
ihlr-28381	51	109	for	for	ADP
ihlr-28381	51	110	-	-	PUNCT
ihlr-28381	51	111	delay	delay	NOUN
ihlr-28381	51	112	settlement	settlement	NOUN
ihlr-28381	51	113	—	—	PUNCT
ihlr-28381	51	114	was	be	AUX
ihlr-28381	51	115	subtracted	subtract	VERB
ihlr-28381	51	116	from	from	ADP
ihlr-28381	51	117	the	the	DET
ihlr-28381	51	118	former	former	ADJ
ihlr-28381	51	119	monopoly	monopoly	NOUN
ihlr-28381	51	120	price.14	price.14	PROPN
ihlr-28381	51	121	“	"	PUNCT
ihlr-28381	51	122	this	this	PRON
ihlr-28381	51	123	revealed	reveal	VERB
ihlr-28381	51	124	the	the	DET
ihlr-28381	51	125	cost	cost	NOUN
ihlr-28381	51	126	incurred	incur	VERB
ihlr-28381	51	127	by	by	ADP
ihlr-28381	51	128	consumers	consumer	NOUN
ihlr-28381	51	129	as	as	ADP
ihlr-28381	51	130	a	a	DET
ihlr-28381	51	131	result	result	NOUN
ihlr-28381	51	132	of	of	ADP
ihlr-28381	51	133	the	the	DET
ihlr-28381	51	134	improper	improper	ADJ
ihlr-28381	51	135	extension	extension	NOUN
ihlr-28381	51	136	of	of	ADP
ihlr-28381	51	137	the	the	DET
ihlr-28381	51	138	brand	brand	NOUN
ihlr-28381	51	139	’s	’s	PART
ihlr-28381	51	140	monopoly	monopoly	NOUN
ihlr-28381	51	141	.	.	PUNCT
ihlr-28381	52	1	”15	”15	PROPN
ihlr-28381	52	2	essentially	essentially	ADV
ihlr-28381	52	3	,	,	PUNCT
ihlr-28381	52	4	the	the	DET
ihlr-28381	52	5	“	"	PUNCT
ihlr-28381	52	6	burden	burden	NOUN
ihlr-28381	52	7	”	"	PUNCT
ihlr-28381	52	8	refers	refer	VERB
ihlr-28381	52	9	to	to	ADP
ihlr-28381	52	10	the	the	DET
ihlr-28381	52	11	difference	difference	NOUN
ihlr-28381	52	12	between	between	ADP
ihlr-28381	52	13	an	an	DET
ihlr-28381	52	14	inappropriately	inappropriately	ADV
ihlr-28381	52	15	preserved	preserve	VERB
ihlr-28381	52	16	monopoly	monopoly	NOUN
ihlr-28381	52	17	price	price	NOUN
ihlr-28381	52	18	and	and	CCONJ
ihlr-28381	52	19	the	the	DET
ihlr-28381	52	20	discounted	discount	VERB
ihlr-28381	52	21	generic	generic	ADJ
ihlr-28381	52	22	price	price	NOUN
ihlr-28381	52	23	that	that	PRON
ihlr-28381	52	24	society	society	NOUN
ihlr-28381	52	25	would	would	AUX
ihlr-28381	52	26	enjoy	enjoy	VERB
ihlr-28381	52	27	but	but	CCONJ
ihlr-28381	52	28	for	for	ADP
ihlr-28381	52	29	pay	pay	NOUN
ihlr-28381	52	30	-	-	PUNCT
ihlr-28381	52	31	fordelay	fordelay	NOUN
ihlr-28381	52	32	.	.	PUNCT
ihlr-28381	53	1	the	the	DET
ihlr-28381	53	2	portfolio	portfolio	NOUN
ihlr-28381	53	3	of	of	ADP
ihlr-28381	53	4	attempts	attempt	NOUN
ihlr-28381	53	5	—	—	PUNCT
ihlr-28381	53	6	historic	historic	ADJ
ihlr-28381	53	7	and	and	CCONJ
ihlr-28381	53	8	proposed	propose	VERB
ihlr-28381	53	9	—	—	PUNCT
ihlr-28381	53	10	to	to	PART
ihlr-28381	53	11	reach	reach	VERB
ihlr-28381	53	12	the	the	DET
ihlr-28381	53	13	pay	pay	VERB
ihlr-28381	53	14	-	-	PUNCT
ihlr-28381	53	15	for	for	ADP
ihlr-28381	53	16	-	-	PUNCT
ihlr-28381	53	17	delay	delay	NOUN
ihlr-28381	53	18	angle	angle	NOUN
ihlr-28381	53	19	of	of	ADP
ihlr-28381	53	20	drug	drug	NOUN
ihlr-28381	53	21	affordability	affordability	NOUN
ihlr-28381	53	22	consists	consist	VERB
ihlr-28381	53	23	largely	largely	ADV
ihlr-28381	53	24	of	of	ADP
ihlr-28381	53	25	nominal	nominal	ADJ
ihlr-28381	53	26	progress	progress	NOUN
ihlr-28381	53	27	and	and	CCONJ
ihlr-28381	53	28	defeat	defeat	NOUN
ihlr-28381	53	29	.	.	PUNCT
ihlr-28381	54	1	in	in	ADP
ihlr-28381	54	2	part	part	NOUN
ihlr-28381	54	3	,	,	PUNCT
ihlr-28381	54	4	this	this	PRON
ihlr-28381	54	5	is	be	AUX
ihlr-28381	54	6	due	due	ADJ
ihlr-28381	54	7	to	to	ADP
ihlr-28381	54	8	a	a	DET
ihlr-28381	54	9	plethora	plethora	NOUN
ihlr-28381	54	10	of	of	ADP
ihlr-28381	54	11	legally	legally	ADV
ihlr-28381	54	12	defensible	defensible	ADJ
ihlr-28381	54	13	practices	practice	NOUN
ihlr-28381	54	14	that	that	PRON
ihlr-28381	54	15	,	,	PUNCT
ihlr-28381	54	16	with	with	ADP
ihlr-28381	54	17	the	the	DET
ihlr-28381	54	18	right	right	ADJ
ihlr-28381	54	19	spin	spin	NOUN
ihlr-28381	54	20	,	,	PUNCT
ihlr-28381	54	21	circumvent	circumvent	VERB
ihlr-28381	54	22	existing	exist	VERB
ihlr-28381	54	23	policy	policy	NOUN
ihlr-28381	54	24	.	.	PUNCT
ihlr-28381	55	1	owing	owe	VERB
ihlr-28381	55	2	to	to	ADP
ihlr-28381	55	3	this	this	DET
ihlr-28381	55	4	environment	environment	NOUN
ihlr-28381	55	5	and	and	CCONJ
ihlr-28381	55	6	respecting	respect	VERB
ihlr-28381	55	7	the	the	DET
ihlr-28381	55	8	objectives	objective	NOUN
ihlr-28381	55	9	of	of	ADP
ihlr-28381	55	10	all	all	DET
ihlr-28381	55	11	stakeholders	stakeholder	NOUN
ihlr-28381	55	12	,	,	PUNCT
ihlr-28381	55	13	this	this	DET
ihlr-28381	55	14	note	note	NOUN
ihlr-28381	55	15	explores	explore	VERB
ihlr-28381	55	16	two	two	NUM
ihlr-28381	55	17	low	low	ADJ
ihlr-28381	55	18	-	-	PUNCT
ihlr-28381	55	19	friction	friction	NOUN
ihlr-28381	55	20	,	,	PUNCT
ihlr-28381	55	21	nonpunitive	nonpunitive	ADJ
ihlr-28381	55	22	incentive	incentive	NOUN
ihlr-28381	55	23	structures	structure	NOUN
ihlr-28381	55	24	:	:	PUNCT
ihlr-28381	55	25	(	(	PUNCT
ihlr-28381	55	26	1	1	X
ihlr-28381	55	27	)	)	PUNCT
ihlr-28381	55	28	the	the	DET
ihlr-28381	55	29	fda	fda	PROPN
ihlr-28381	55	30	’s	’s	PART
ihlr-28381	55	31	priority	priority	PROPN
ihlr-28381	55	32	review	review	PROPN
ihlr-28381	55	33	voucher	voucher	ADJ
ihlr-28381	55	34	program	program	NOUN
ihlr-28381	55	35	(	(	PUNCT
ihlr-28381	55	36	“	"	PUNCT
ihlr-28381	55	37	prv	prv	PROPN
ihlr-28381	55	38	”	"	PUNCT
ihlr-28381	55	39	)	)	PUNCT
ihlr-28381	55	40	,	,	PUNCT
ihlr-28381	55	41	and	and	CCONJ
ihlr-28381	55	42	(	(	PUNCT
ihlr-28381	55	43	2	2	X
ihlr-28381	55	44	)	)	PUNCT
ihlr-28381	55	45	wildcard	wildcard	ADJ
ihlr-28381	55	46	exclusivity	exclusivity	NOUN
ihlr-28381	55	47	vouchers	voucher	NOUN
ihlr-28381	55	48	(	(	PUNCT
ihlr-28381	55	49	“	"	PUNCT
ihlr-28381	55	50	wildcard	wildcard	ADJ
ihlr-28381	55	51	”	"	PUNCT
ihlr-28381	55	52	)	)	PUNCT
ihlr-28381	55	53	.	.	PUNCT
ihlr-28381	56	1	the	the	DET
ihlr-28381	56	2	proposed	propose	VERB
ihlr-28381	56	3	prv	prv	PROPN
ihlr-28381	56	4	incentive	incentive	PROPN
ihlr-28381	56	5	would	would	AUX
ihlr-28381	56	6	reward	reward	VERB
ihlr-28381	56	7	innovator	innovator	NOUN
ihlr-28381	56	8	companies	company	NOUN
ihlr-28381	56	9	that	that	PRON
ihlr-28381	56	10	choose	choose	VERB
ihlr-28381	56	11	to	to	PART
ihlr-28381	56	12	facilitate	facilitate	VERB
ihlr-28381	56	13	price	price	NOUN
ihlr-28381	56	14	reductions	reduction	NOUN
ihlr-28381	56	15	rather	rather	ADV
ihlr-28381	56	16	than	than	ADP
ihlr-28381	56	17	delay	delay	VERB
ihlr-28381	56	18	generic	generic	ADJ
ihlr-28381	56	19	entry	entry	NOUN
ihlr-28381	56	20	.	.	PUNCT
ihlr-28381	57	1	specifically	specifically	ADV
ihlr-28381	57	2	,	,	PUNCT
ihlr-28381	57	3	the	the	DET
ihlr-28381	57	4	fda	fda	PROPN
ihlr-28381	57	5	would	would	AUX
ihlr-28381	57	6	issue	issue	VERB
ihlr-28381	57	7	prvs	prvs	NOUN
ihlr-28381	57	8	to	to	ADP
ihlr-28381	57	9	firms	firm	NOUN
ihlr-28381	57	10	that	that	PRON
ihlr-28381	57	11	facilitate	facilitate	VERB
ihlr-28381	57	12	generic	generic	ADJ
ihlr-28381	57	13	entry	entry	NOUN
ihlr-28381	57	14	or	or	CCONJ
ihlr-28381	57	15	otherwise	otherwise	ADV
ihlr-28381	57	16	facilitate	facilitate	VERB
ihlr-28381	57	17	price	price	NOUN
ihlr-28381	57	18	reductions	reduction	NOUN
ihlr-28381	57	19	.	.	PUNCT
ihlr-28381	58	1	such	such	DET
ihlr-28381	58	2	a	a	DET
ihlr-28381	58	3	program	program	NOUN
ihlr-28381	58	4	would	would	AUX
ihlr-28381	58	5	reduce	reduce	VERB
ihlr-28381	58	6	drug	drug	NOUN
ihlr-28381	58	7	prices	price	NOUN
ihlr-28381	58	8	,	,	PUNCT
ihlr-28381	58	9	improve	improve	VERB
ihlr-28381	58	10	patient	patient	ADJ
ihlr-28381	58	11	access	access	NOUN
ihlr-28381	58	12	to	to	ADP
ihlr-28381	58	13	medicine	medicine	NOUN
ihlr-28381	58	14	,	,	PUNCT
ihlr-28381	58	15	and	and	CCONJ
ihlr-28381	58	16	catalyze	catalyze	NOUN
ihlr-28381	58	17	competition	competition	NOUN
ihlr-28381	58	18	within	within	ADP
ihlr-28381	58	19	the	the	DET
ihlr-28381	58	20	pharmaceutical	pharmaceutical	ADJ
ihlr-28381	58	21	industry	industry	NOUN
ihlr-28381	58	22	,	,	PUNCT
ihlr-28381	58	23	all	all	PRON
ihlr-28381	58	24	while	while	SCONJ
ihlr-28381	58	25	respecting	respect	VERB
ihlr-28381	58	26	the	the	DET
ihlr-28381	58	27	economic	economic	ADJ
ihlr-28381	58	28	and	and	CCONJ
ihlr-28381	58	29	capitalistic	capitalistic	ADJ
ihlr-28381	58	30	interests	interest	NOUN
ihlr-28381	58	31	of	of	ADP
ihlr-28381	58	32	innovator	innovator	NOUN
ihlr-28381	58	33	companies	company	NOUN
ihlr-28381	58	34	.	.	PUNCT
ihlr-28381	59	1	unfortunately	unfortunately	ADV
ihlr-28381	59	2	,	,	PUNCT
ihlr-28381	59	3	the	the	DET
ihlr-28381	59	4	prv	prv	PROPN
ihlr-28381	59	5	proposal	proposal	NOUN
ihlr-28381	59	6	gives	give	VERB
ihlr-28381	59	7	way	way	NOUN
ihlr-28381	59	8	to	to	ADP
ihlr-28381	59	9	economic	economic	ADJ
ihlr-28381	59	10	and	and	CCONJ
ihlr-28381	59	11	efficiency	efficiency	NOUN
ihlr-28381	59	12	concerns	concern	NOUN
ihlr-28381	59	13	.	.	PUNCT
ihlr-28381	60	1	fortunately	fortunately	ADV
ihlr-28381	60	2	,	,	PUNCT
ihlr-28381	60	3	the	the	DET
ihlr-28381	60	4	wildcard	wildcard	ADJ
ihlr-28381	60	5	proposal	proposal	NOUN
ihlr-28381	60	6	is	be	AUX
ihlr-28381	60	7	unthreatened	unthreatene	VERB
ihlr-28381	60	8	by	by	ADP
ihlr-28381	60	9	those	those	DET
ihlr-28381	60	10	concerns	concern	NOUN
ihlr-28381	60	11	affecting	affect	VERB
ihlr-28381	60	12	the	the	DET
ihlr-28381	60	13	prv	prv	PROPN
ihlr-28381	60	14	proposal	proposal	NOUN
ihlr-28381	60	15	.	.	PUNCT
ihlr-28381	61	1	offering	offer	VERB
ihlr-28381	61	2	a	a	DET
ihlr-28381	61	3	transferable	transferable	ADJ
ihlr-28381	61	4	market	market	NOUN
ihlr-28381	61	5	exclusivity	exclusivity	NOUN
ihlr-28381	61	6	voucher	voucher	ADJ
ihlr-28381	61	7	—	—	PUNCT
ihlr-28381	61	8	a	a	DET
ihlr-28381	61	9	wildcard	wildcard	NOUN
ihlr-28381	61	10	—	—	PUNCT
ihlr-28381	61	11	to	to	ADP
ihlr-28381	61	12	firms	firm	NOUN
ihlr-28381	61	13	that	that	PRON
ihlr-28381	61	14	invite	invite	VERB
ihlr-28381	61	15	generic	generic	ADJ
ihlr-28381	61	16	competition	competition	NOUN
ihlr-28381	61	17	or	or	CCONJ
ihlr-28381	61	18	unilaterally	unilaterally	ADV
ihlr-28381	61	19	decrease	decrease	VERB
ihlr-28381	61	20	prices	price	NOUN
ihlr-28381	61	21	can	can	AUX
ihlr-28381	61	22	induce	induce	VERB
ihlr-28381	61	23	lower	low	ADJ
ihlr-28381	61	24	,	,	PUNCT
ihlr-28381	61	25	propatient	propatient	ADJ
ihlr-28381	61	26	pricing	pricing	NOUN
ihlr-28381	61	27	and	and	CCONJ
ihlr-28381	61	28	grow	grow	VERB
ihlr-28381	61	29	generic	generic	ADJ
ihlr-28381	61	30	competition	competition	NOUN
ihlr-28381	61	31	while	while	SCONJ
ihlr-28381	61	32	rewarding	reward	VERB
ihlr-28381	61	33	innovators	innovator	NOUN
ihlr-28381	61	34	.	.	PUNCT
ihlr-28381	62	1	this	this	DET
ihlr-28381	62	2	note	note	NOUN
ihlr-28381	62	3	proposes	propose	VERB
ihlr-28381	62	4	that	that	SCONJ
ihlr-28381	63	1	congress	congress	PROPN
ihlr-28381	63	2	,	,	PUNCT
ihlr-28381	63	3	through	through	ADP
ihlr-28381	63	4	an	an	DET
ihlr-28381	63	5	amendment	amendment	NOUN
ihlr-28381	63	6	to	to	ADP
ihlr-28381	63	7	the	the	DET
ihlr-28381	63	8	food	food	NOUN
ihlr-28381	63	9	drug	drug	NOUN
ihlr-28381	63	10	and	and	CCONJ
ihlr-28381	63	11	10	10	NUM
ihlr-28381	63	12	.	.	PUNCT
ihlr-28381	64	1	robin	robin	PROPN
ihlr-28381	64	2	c.	c.	PROPN
ihlr-28381	64	3	feldman	feldman	PROPN
ihlr-28381	64	4	,	,	PUNCT
ihlr-28381	64	5	the	the	DET
ihlr-28381	64	6	price	price	NOUN
ihlr-28381	64	7	tag	tag	NOUN
ihlr-28381	64	8	of	of	ADP
ihlr-28381	64	9	“	"	PUNCT
ihlr-28381	64	10	pay	pay	VERB
ihlr-28381	64	11	-	-	PUNCT
ihlr-28381	64	12	for	for	ADP
ihlr-28381	64	13	-	-	PUNCT
ihlr-28381	64	14	delay	delay	NOUN
ihlr-28381	64	15	”	"	PUNCT
ihlr-28381	64	16	,	,	PUNCT
ihlr-28381	64	17	23	23	NUM
ihlr-28381	64	18	colum	colum	NOUN
ihlr-28381	64	19	.	.	PUNCT
ihlr-28381	65	1	sci	sci	PROPN
ihlr-28381	65	2	.	.	PROPN
ihlr-28381	65	3	&	&	CCONJ
ihlr-28381	65	4	tech	tech	PROPN
ihlr-28381	65	5	.	.	PUNCT
ihlr-28381	66	1	l.	l.	PROPN
ihlr-28381	66	2	rev	rev	PROPN
ihlr-28381	66	3	.	.	PROPN
ihlr-28381	66	4	1	1	NUM
ihlr-28381	66	5	,	,	PUNCT
ihlr-28381	66	6	32	32	NUM
ihlr-28381	66	7	-	-	SYM
ihlr-28381	66	8	33	33	NUM
ihlr-28381	66	9	(	(	PUNCT
ihlr-28381	66	10	2022	2022	NUM
ihlr-28381	66	11	)	)	PUNCT
ihlr-28381	66	12	,	,	PUNCT
ihlr-28381	66	13	https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3846484	https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3846484	VERB
ihlr-28381	66	14	[	[	PUNCT
ihlr-28381	66	15	https://perma.cc/	https://perma.cc/	VERB
ihlr-28381	66	16	5ftm	5ftm	NUM
ihlr-28381	66	17	-	-	PUNCT
ihlr-28381	66	18	jdzq	jdzq	NOUN
ihlr-28381	66	19	]	]	PUNCT
ihlr-28381	66	20	.	.	PUNCT
ihlr-28381	67	1	11	11	NUM
ihlr-28381	67	2	.	.	PUNCT
ihlr-28381	68	1	i	i	PRON
ihlr-28381	68	2	d.	d.	PROPN
ihlr-28381	68	3	12	12	NUM
ihlr-28381	68	4	.	.	PUNCT
ihlr-28381	69	1	i	i	PRON
ihlr-28381	69	2	d.	d.	PROPN
ihlr-28381	69	3	13	13	NUM
ihlr-28381	69	4	.	.	PUNCT
ihlr-28381	70	1	i	i	PRON
ihlr-28381	70	2	d.	d.	PROPN
ihlr-28381	70	3	at	at	ADP
ihlr-28381	70	4	17	17	NUM
ihlr-28381	70	5	.	.	PUNCT
ihlr-28381	71	1	14	14	NUM
ihlr-28381	71	2	.	.	PUNCT
ihlr-28381	72	1	i	i	PRON
ihlr-28381	72	2	d.	d.	PROPN
ihlr-28381	72	3	15	15	NUM
ihlr-28381	72	4	.	.	PUNCT
ihlr-28381	73	1	i	i	PRON
ihlr-28381	73	2	d.	d.	PROPN
ihlr-28381	73	3	2024	2024	NUM
ihlr-28381	73	4	]	]	PUNCT
ihlr-28381	73	5	incentivizing	incentivize	VERB
ihlr-28381	73	6	drug	drug	NOUN
ihlr-28381	73	7	affordability	affordability	NOUN
ihlr-28381	73	8	125	125	NUM
ihlr-28381	73	9	cosmetic	cosmetic	ADJ
ihlr-28381	73	10	act	act	NOUN
ihlr-28381	73	11	(	(	PUNCT
ihlr-28381	73	12	“	"	PUNCT
ihlr-28381	73	13	fdca	fdca	NOUN
ihlr-28381	73	14	”	"	PUNCT
ihlr-28381	73	15	)	)	PUNCT
ihlr-28381	73	16	,	,	PUNCT
ihlr-28381	73	17	introduce	introduce	VERB
ihlr-28381	73	18	a	a	DET
ihlr-28381	73	19	carefully	carefully	ADV
ihlr-28381	73	20	tempered	temper	VERB
ihlr-28381	73	21	wildcard	wildcard	ADJ
ihlr-28381	73	22	exclusivity	exclusivity	NOUN
ihlr-28381	73	23	incentive	incentive	NOUN
ihlr-28381	73	24	program	program	NOUN
ihlr-28381	73	25	.	.	PUNCT
ihlr-28381	74	1	this	this	DET
ihlr-28381	74	2	note	note	NOUN
ihlr-28381	74	3	first	first	ADV
ihlr-28381	74	4	describes	describe	VERB
ihlr-28381	74	5	the	the	DET
ihlr-28381	74	6	characteristics	characteristic	NOUN
ihlr-28381	74	7	and	and	CCONJ
ihlr-28381	74	8	differences	difference	NOUN
ihlr-28381	74	9	between	between	ADP
ihlr-28381	74	10	two	two	NUM
ihlr-28381	74	11	important	important	ADJ
ihlr-28381	74	12	industry	industry	NOUN
ihlr-28381	74	13	participants	participant	NOUN
ihlr-28381	74	14	,	,	PUNCT
ihlr-28381	74	15	generic	generic	ADJ
ihlr-28381	74	16	companies	company	NOUN
ihlr-28381	74	17	and	and	CCONJ
ihlr-28381	74	18	innovator	innovator	NOUN
ihlr-28381	74	19	companies	company	NOUN
ihlr-28381	74	20	,	,	PUNCT
ihlr-28381	74	21	to	to	PART
ihlr-28381	74	22	reveal	reveal	VERB
ihlr-28381	74	23	the	the	DET
ihlr-28381	74	24	fundamental	fundamental	ADJ
ihlr-28381	74	25	conflict	conflict	NOUN
ihlr-28381	74	26	between	between	ADP
ihlr-28381	74	27	the	the	DET
ihlr-28381	74	28	two	two	NUM
ihlr-28381	74	29	groups	group	NOUN
ihlr-28381	74	30	.	.	PUNCT
ihlr-28381	75	1	next	next	ADV
ihlr-28381	75	2	,	,	PUNCT
ihlr-28381	75	3	the	the	DET
ihlr-28381	75	4	hatchwaxman	hatchwaxman	ADJ
ihlr-28381	75	5	act	act	NOUN
ihlr-28381	75	6	is	be	AUX
ihlr-28381	75	7	discussed	discuss	VERB
ihlr-28381	75	8	to	to	PART
ihlr-28381	75	9	illustrate	illustrate	VERB
ihlr-28381	75	10	the	the	DET
ihlr-28381	75	11	process	process	NOUN
ihlr-28381	75	12	of	of	ADP
ihlr-28381	75	13	bringing	bring	VERB
ihlr-28381	75	14	a	a	DET
ihlr-28381	75	15	generic	generic	ADJ
ihlr-28381	75	16	drug	drug	NOUN
ihlr-28381	75	17	to	to	ADP
ihlr-28381	75	18	market	market	NOUN
ihlr-28381	75	19	and	and	CCONJ
ihlr-28381	75	20	to	to	PART
ihlr-28381	75	21	introduce	introduce	VERB
ihlr-28381	75	22	the	the	DET
ihlr-28381	75	23	issue	issue	NOUN
ihlr-28381	75	24	of	of	ADP
ihlr-28381	75	25	delaying	delay	VERB
ihlr-28381	75	26	generic	generic	ADJ
ihlr-28381	75	27	entry	entry	NOUN
ihlr-28381	75	28	,	,	PUNCT
ihlr-28381	75	29	or	or	CCONJ
ihlr-28381	75	30	“	"	PUNCT
ihlr-28381	75	31	pay	pay	NOUN
ihlr-28381	75	32	-	-	PUNCT
ihlr-28381	75	33	fordelay	fordelay	NOUN
ihlr-28381	75	34	.	.	PUNCT
ihlr-28381	75	35	”	"	PUNCT
ihlr-28381	76	1	the	the	DET
ihlr-28381	76	2	classic	classic	ADJ
ihlr-28381	76	3	form	form	NOUN
ihlr-28381	76	4	of	of	ADP
ihlr-28381	76	5	pay	pay	NOUN
ihlr-28381	76	6	-	-	PUNCT
ihlr-28381	76	7	for	for	ADP
ihlr-28381	76	8	-	-	PUNCT
ihlr-28381	76	9	delay	delay	NOUN
ihlr-28381	76	10	—	—	PUNCT
ihlr-28381	76	11	the	the	DET
ihlr-28381	76	12	reverse	reverse	ADJ
ihlr-28381	76	13	payment	payment	NOUN
ihlr-28381	76	14	settlement	settlement	NOUN
ihlr-28381	76	15	agreement	agreement	NOUN
ihlr-28381	76	16	—	—	PUNCT
ihlr-28381	76	17	is	be	AUX
ihlr-28381	76	18	described	describe	VERB
ihlr-28381	76	19	and	and	CCONJ
ihlr-28381	76	20	later	later	ADV
ihlr-28381	76	21	expounded	expound	VERB
ihlr-28381	76	22	upon	upon	SCONJ
ihlr-28381	76	23	by	by	ADP
ihlr-28381	76	24	a	a	DET
ihlr-28381	76	25	discussion	discussion	NOUN
ihlr-28381	76	26	of	of	ADP
ihlr-28381	76	27	ftc	ftc	PROPN
ihlr-28381	76	28	v.	v.	ADP
ihlr-28381	76	29	actavis	actavis	PROPN
ihlr-28381	76	30	,	,	PUNCT
ihlr-28381	76	31	wherein	wherein	SCONJ
ihlr-28381	76	32	the	the	DET
ihlr-28381	76	33	supreme	supreme	PROPN
ihlr-28381	76	34	court	court	PROPN
ihlr-28381	76	35	addressed	address	VERB
ihlr-28381	76	36	reverse	reverse	ADJ
ihlr-28381	76	37	payment	payment	NOUN
ihlr-28381	76	38	settlement	settlement	NOUN
ihlr-28381	76	39	agreements	agreement	NOUN
ihlr-28381	76	40	.	.	PUNCT
ihlr-28381	77	1	the	the	DET
ihlr-28381	77	2	increasingly	increasingly	ADV
ihlr-28381	77	3	nuanced	nuanced	ADJ
ihlr-28381	77	4	forms	form	NOUN
ihlr-28381	77	5	of	of	ADP
ihlr-28381	77	6	delaying	delay	VERB
ihlr-28381	77	7	generic	generic	ADJ
ihlr-28381	77	8	entry	entry	NOUN
ihlr-28381	77	9	which	which	PRON
ihlr-28381	77	10	emerged	emerge	VERB
ihlr-28381	77	11	in	in	ADP
ihlr-28381	77	12	the	the	DET
ihlr-28381	77	13	wake	wake	NOUN
ihlr-28381	77	14	of	of	ADP
ihlr-28381	77	15	actavis	actavis	PROPN
ihlr-28381	77	16	are	be	AUX
ihlr-28381	77	17	then	then	ADV
ihlr-28381	77	18	described	describe	VERB
ihlr-28381	77	19	,	,	PUNCT
ihlr-28381	77	20	leading	lead	VERB
ihlr-28381	77	21	into	into	ADP
ihlr-28381	77	22	analysis	analysis	NOUN
ihlr-28381	77	23	of	of	ADP
ihlr-28381	77	24	existing	exist	VERB
ihlr-28381	77	25	and	and	CCONJ
ihlr-28381	77	26	proposed	proposed	ADJ
ihlr-28381	77	27	enforcement	enforcement	NOUN
ihlr-28381	77	28	mechanisms	mechanism	NOUN
ihlr-28381	77	29	and	and	CCONJ
ihlr-28381	77	30	why	why	SCONJ
ihlr-28381	77	31	these	these	PRON
ihlr-28381	77	32	often	often	ADV
ihlr-28381	77	33	fail	fail	VERB
ihlr-28381	77	34	.	.	PUNCT
ihlr-28381	78	1	the	the	DET
ihlr-28381	78	2	novel	novel	ADJ
ihlr-28381	78	3	incentive	incentive	NOUN
ihlr-28381	78	4	program	program	NOUN
ihlr-28381	78	5	at	at	ADP
ihlr-28381	78	6	the	the	DET
ihlr-28381	78	7	heart	heart	NOUN
ihlr-28381	78	8	of	of	ADP
ihlr-28381	78	9	this	this	DET
ihlr-28381	78	10	note	note	NOUN
ihlr-28381	78	11	is	be	AUX
ihlr-28381	78	12	then	then	ADV
ihlr-28381	78	13	introduced	introduce	VERB
ihlr-28381	78	14	and	and	CCONJ
ihlr-28381	78	15	analyzed	analyze	VERB
ihlr-28381	78	16	with	with	ADP
ihlr-28381	78	17	a	a	DET
ihlr-28381	78	18	discussion	discussion	NOUN
ihlr-28381	78	19	of	of	ADP
ihlr-28381	78	20	why	why	SCONJ
ihlr-28381	78	21	it	it	PRON
ihlr-28381	78	22	is	be	AUX
ihlr-28381	78	23	advantageous	advantageous	ADJ
ihlr-28381	78	24	relative	relative	ADJ
ihlr-28381	78	25	to	to	ADP
ihlr-28381	78	26	other	other	ADJ
ihlr-28381	78	27	proposals	proposal	NOUN
ihlr-28381	78	28	.	.	PUNCT
ihlr-28381	79	1	this	this	DET
ihlr-28381	79	2	note	note	NOUN
ihlr-28381	79	3	concludes	conclude	VERB
ihlr-28381	79	4	by	by	ADP
ihlr-28381	79	5	summarizing	summarize	VERB
ihlr-28381	79	6	the	the	DET
ihlr-28381	79	7	advantages	advantage	NOUN
ihlr-28381	79	8	of	of	ADP
ihlr-28381	79	9	the	the	DET
ihlr-28381	79	10	proposed	propose	VERB
ihlr-28381	79	11	wildcard	wildcard	ADJ
ihlr-28381	79	12	incentive	incentive	NOUN
ihlr-28381	79	13	,	,	PUNCT
ihlr-28381	79	14	and	and	CCONJ
ihlr-28381	79	15	how	how	SCONJ
ihlr-28381	79	16	patients	patient	NOUN
ihlr-28381	79	17	and	and	CCONJ
ihlr-28381	79	18	the	the	DET
ihlr-28381	79	19	u.s	u.s	PROPN
ihlr-28381	79	20	.	.	PROPN
ihlr-28381	79	21	healthcare	healthcare	PROPN
ihlr-28381	79	22	system	system	NOUN
ihlr-28381	79	23	can	can	AUX
ihlr-28381	79	24	benefit	benefit	VERB
ihlr-28381	79	25	through	through	ADP
ihlr-28381	79	26	its	its	PRON
ihlr-28381	79	27	adoption	adoption	NOUN
ihlr-28381	79	28	.	.	PUNCT
ihlr-28381	80	1	iii	iii	X
ihlr-28381	80	2	.	.	PUNCT
ihlr-28381	80	3	industry	industry	NOUN
ihlr-28381	80	4	participants	participant	NOUN
ihlr-28381	80	5	for	for	ADP
ihlr-28381	80	6	the	the	DET
ihlr-28381	80	7	purposes	purpose	NOUN
ihlr-28381	80	8	of	of	ADP
ihlr-28381	80	9	this	this	DET
ihlr-28381	80	10	note	note	NOUN
ihlr-28381	80	11	,	,	PUNCT
ihlr-28381	80	12	drug	drug	NOUN
ihlr-28381	80	13	industry	industry	NOUN
ihlr-28381	80	14	participants	participant	NOUN
ihlr-28381	80	15	can	can	AUX
ihlr-28381	80	16	be	be	AUX
ihlr-28381	80	17	divided	divide	VERB
ihlr-28381	80	18	into	into	ADP
ihlr-28381	80	19	innovator	innovator	NOUN
ihlr-28381	80	20	companies	company	NOUN
ihlr-28381	80	21	and	and	CCONJ
ihlr-28381	80	22	generic	generic	ADJ
ihlr-28381	80	23	companies	company	NOUN
ihlr-28381	80	24	.	.	PUNCT
ihlr-28381	81	1	both	both	PRON
ihlr-28381	81	2	create	create	VERB
ihlr-28381	81	3	value	value	NOUN
ihlr-28381	81	4	for	for	ADP
ihlr-28381	81	5	patients	patient	NOUN
ihlr-28381	81	6	and	and	CCONJ
ihlr-28381	81	7	the	the	DET
ihlr-28381	81	8	healthcare	healthcare	NOUN
ihlr-28381	81	9	system	system	NOUN
ihlr-28381	81	10	in	in	ADP
ihlr-28381	81	11	different	different	ADJ
ihlr-28381	81	12	ways	way	NOUN
ihlr-28381	81	13	.	.	PUNCT
ihlr-28381	82	1	despite	despite	SCONJ
ihlr-28381	82	2	sharing	share	VERB
ihlr-28381	82	3	a	a	DET
ihlr-28381	82	4	market	market	NOUN
ihlr-28381	82	5	and	and	CCONJ
ihlr-28381	82	6	selling	sell	VERB
ihlr-28381	82	7	an	an	DET
ihlr-28381	82	8	interchangeable	interchangeable	ADJ
ihlr-28381	82	9	product	product	NOUN
ihlr-28381	82	10	,	,	PUNCT
ihlr-28381	82	11	they	they	PRON
ihlr-28381	82	12	lack	lack	VERB
ihlr-28381	82	13	operational	operational	ADJ
ihlr-28381	82	14	and	and	CCONJ
ihlr-28381	82	15	strategic	strategic	ADJ
ihlr-28381	82	16	similarities	similarity	NOUN
ihlr-28381	82	17	and	and	CCONJ
ihlr-28381	82	18	face	face	VERB
ihlr-28381	82	19	different	different	ADJ
ihlr-28381	82	20	challenges	challenge	NOUN
ihlr-28381	82	21	.	.	PUNCT
ihlr-28381	83	1	in	in	ADP
ihlr-28381	83	2	the	the	DET
ihlr-28381	83	3	high	high	ADJ
ihlr-28381	83	4	-	-	PUNCT
ihlr-28381	83	5	stakes	stake	NOUN
ihlr-28381	83	6	world	world	NOUN
ihlr-28381	83	7	of	of	ADP
ihlr-28381	83	8	pharmaceuticals	pharmaceutical	NOUN
ihlr-28381	83	9	,	,	PUNCT
ihlr-28381	83	10	generics	generic	NOUN
ihlr-28381	83	11	and	and	CCONJ
ihlr-28381	83	12	innovators	innovator	NOUN
ihlr-28381	83	13	often	often	ADV
ihlr-28381	83	14	clash	clash	VERB
ihlr-28381	83	15	and	and	CCONJ
ihlr-28381	83	16	become	become	VERB
ihlr-28381	83	17	distracted	distracted	ADJ
ihlr-28381	83	18	from	from	ADP
ihlr-28381	83	19	their	their	PRON
ihlr-28381	83	20	societal	societal	ADJ
ihlr-28381	83	21	value	value	NOUN
ihlr-28381	83	22	propositions	proposition	NOUN
ihlr-28381	83	23	(	(	PUNCT
ihlr-28381	83	24	the	the	DET
ihlr-28381	83	25	value	value	NOUN
ihlr-28381	83	26	proposition	proposition	NOUN
ihlr-28381	83	27	of	of	ADP
ihlr-28381	83	28	an	an	DET
ihlr-28381	83	29	innovator	innovator	NOUN
ihlr-28381	83	30	could	could	AUX
ihlr-28381	83	31	be	be	AUX
ihlr-28381	83	32	inventing	invent	VERB
ihlr-28381	83	33	medicine	medicine	NOUN
ihlr-28381	83	34	,	,	PUNCT
ihlr-28381	83	35	while	while	SCONJ
ihlr-28381	83	36	that	that	PRON
ihlr-28381	83	37	of	of	ADP
ihlr-28381	83	38	a	a	DET
ihlr-28381	83	39	generic	generic	NOUN
ihlr-28381	83	40	could	could	AUX
ihlr-28381	83	41	be	be	AUX
ihlr-28381	83	42	lowering	lower	VERB
ihlr-28381	83	43	the	the	DET
ihlr-28381	83	44	price	price	NOUN
ihlr-28381	83	45	medicine	medicine	NOUN
ihlr-28381	83	46	)	)	PUNCT
ihlr-28381	83	47	.	.	PUNCT
ihlr-28381	84	1	when	when	SCONJ
ihlr-28381	84	2	innovators	innovator	NOUN
ihlr-28381	84	3	and	and	CCONJ
ihlr-28381	84	4	generics	generic	NOUN
ihlr-28381	84	5	clash	clash	VERB
ihlr-28381	84	6	and	and	CCONJ
ihlr-28381	84	7	stray	stray	VERB
ihlr-28381	84	8	far	far	ADV
ihlr-28381	84	9	from	from	ADP
ihlr-28381	84	10	their	their	PRON
ihlr-28381	84	11	purposes	purpose	NOUN
ihlr-28381	84	12	,	,	PUNCT
ihlr-28381	84	13	patients	patient	NOUN
ihlr-28381	84	14	and	and	CCONJ
ihlr-28381	84	15	payors	payor	NOUN
ihlr-28381	84	16	are	be	AUX
ihlr-28381	84	17	caught	catch	VERB
ihlr-28381	84	18	in	in	ADP
ihlr-28381	84	19	the	the	DET
ihlr-28381	84	20	crossfire	crossfire	NOUN
ihlr-28381	84	21	and	and	CCONJ
ihlr-28381	84	22	suffer	suffer	VERB
ihlr-28381	84	23	from	from	ADP
ihlr-28381	84	24	higher	high	ADJ
ihlr-28381	84	25	prices	price	NOUN
ihlr-28381	84	26	and	and	CCONJ
ihlr-28381	84	27	stifled	stifle	VERB
ihlr-28381	84	28	access	access	NOUN
ihlr-28381	84	29	.	.	PUNCT
ihlr-28381	85	1	a.	a.	NOUN
ihlr-28381	85	2	innovator	innovator	PROPN
ihlr-28381	85	3	companies	company	VERB
ihlr-28381	85	4	the	the	DET
ihlr-28381	85	5	first	first	ADJ
ihlr-28381	85	6	group	group	NOUN
ihlr-28381	85	7	to	to	PART
ihlr-28381	85	8	discuss	discuss	VERB
ihlr-28381	85	9	is	be	AUX
ihlr-28381	85	10	innovator	innovator	NOUN
ihlr-28381	85	11	companies	company	NOUN
ihlr-28381	85	12	,	,	PUNCT
ihlr-28381	85	13	or	or	CCONJ
ihlr-28381	85	14	companies	company	NOUN
ihlr-28381	85	15	that	that	PRON
ihlr-28381	85	16	invest	invest	VERB
ihlr-28381	85	17	in	in	ADP
ihlr-28381	85	18	research	research	NOUN
ihlr-28381	85	19	and	and	CCONJ
ihlr-28381	85	20	development	development	NOUN
ihlr-28381	85	21	to	to	PART
ihlr-28381	85	22	invent	invent	VERB
ihlr-28381	85	23	,	,	PUNCT
ihlr-28381	85	24	patent	patent	NOUN
ihlr-28381	85	25	,	,	PUNCT
ihlr-28381	85	26	and	and	CCONJ
ihlr-28381	85	27	bring	bring	VERB
ihlr-28381	85	28	to	to	PART
ihlr-28381	85	29	market	market	VERB
ihlr-28381	85	30	new	new	ADJ
ihlr-28381	85	31	medicines	medicine	NOUN
ihlr-28381	85	32	under	under	ADP
ihlr-28381	85	33	the	the	DET
ihlr-28381	85	34	company	company	NOUN
ihlr-28381	85	35	’s	’s	PART
ihlr-28381	85	36	brand	brand	NOUN
ihlr-28381	85	37	name	name	NOUN
ihlr-28381	85	38	.	.	PUNCT
ihlr-28381	86	1	familiar	familiar	ADJ
ihlr-28381	86	2	names	name	NOUN
ihlr-28381	86	3	falling	fall	VERB
ihlr-28381	86	4	into	into	ADP
ihlr-28381	86	5	this	this	DET
ihlr-28381	86	6	“	"	PUNCT
ihlr-28381	86	7	innovator	innovator	NOUN
ihlr-28381	86	8	”	"	PUNCT
ihlr-28381	86	9	category	category	NOUN
ihlr-28381	86	10	include	include	VERB
ihlr-28381	86	11	abbvie	abbvie	PROPN
ihlr-28381	86	12	,	,	PUNCT
ihlr-28381	86	13	merck	merck	PROPN
ihlr-28381	86	14	&	&	CCONJ
ihlr-28381	86	15	co.	co.	PROPN
ihlr-28381	86	16	,	,	PUNCT
ihlr-28381	86	17	bristol	bristol	PROPN
ihlr-28381	86	18	myers	myers	PROPN
ihlr-28381	86	19	squibb	squibb	PROPN
ihlr-28381	86	20	,	,	PUNCT
ihlr-28381	86	21	and	and	CCONJ
ihlr-28381	86	22	a	a	DET
ihlr-28381	86	23	host	host	NOUN
ihlr-28381	86	24	of	of	ADP
ihlr-28381	86	25	others	other	NOUN
ihlr-28381	86	26	.	.	PUNCT
ihlr-28381	87	1	although	although	SCONJ
ihlr-28381	87	2	this	this	DET
ihlr-28381	87	3	note	note	NOUN
ihlr-28381	87	4	concerns	concern	VERB
ihlr-28381	87	5	private	private	ADJ
ihlr-28381	87	6	innovators	innovator	NOUN
ihlr-28381	87	7	,	,	PUNCT
ihlr-28381	87	8	the	the	DET
ihlr-28381	87	9	indispensable	indispensable	ADJ
ihlr-28381	87	10	role	role	NOUN
ihlr-28381	87	11	of	of	ADP
ihlr-28381	87	12	public	public	ADJ
ihlr-28381	87	13	contributions	contribution	NOUN
ihlr-28381	87	14	can	can	AUX
ihlr-28381	87	15	not	not	PART
ihlr-28381	87	16	go	go	VERB
ihlr-28381	87	17	uncredited	uncredited	ADJ
ihlr-28381	87	18	.	.	PUNCT
ihlr-28381	88	1	the	the	DET
ihlr-28381	88	2	national	national	PROPN
ihlr-28381	88	3	institutes	institutes	PROPN
ihlr-28381	88	4	of	of	ADP
ihlr-28381	88	5	health	health	PROPN
ihlr-28381	88	6	(	(	PUNCT
ihlr-28381	88	7	“	"	PUNCT
ihlr-28381	88	8	nih	nih	NOUN
ihlr-28381	88	9	”	"	PUNCT
ihlr-28381	88	10	)	)	PUNCT
ihlr-28381	88	11	contributed	contribute	VERB
ihlr-28381	88	12	over	over	ADP
ihlr-28381	88	13	$	$	SYM
ihlr-28381	88	14	100	100	NUM
ihlr-28381	88	15	billion	billion	NUM
ihlr-28381	88	16	dollars	dollar	NOUN
ihlr-28381	88	17	in	in	ADP
ihlr-28381	88	18	grant	grant	NOUN
ihlr-28381	88	19	funding	funding	NOUN
ihlr-28381	88	20	to	to	ADP
ihlr-28381	88	21	research	research	NOUN
ihlr-28381	88	22	associated	associate	VERB
ihlr-28381	88	23	with	with	ADP
ihlr-28381	88	24	all	all	DET
ihlr-28381	88	25	210	210	NUM
ihlr-28381	88	26	drugs	drug	NOUN
ihlr-28381	88	27	approved	approve	VERB
ihlr-28381	88	28	by	by	ADP
ihlr-28381	88	29	the	the	DET
ihlr-28381	88	30	fda	fda	PROPN
ihlr-28381	88	31	between	between	ADP
ihlr-28381	88	32	2010–2016.16	2010–2016.16	PROPN
ihlr-28381	88	33	by	by	ADP
ihlr-28381	88	34	building	build	VERB
ihlr-28381	88	35	the	the	DET
ihlr-28381	88	36	early	early	ADJ
ihlr-28381	88	37	foundations	foundation	NOUN
ihlr-28381	88	38	in	in	ADP
ihlr-28381	88	39	various	various	ADJ
ihlr-28381	88	40	treatment	treatment	NOUN
ihlr-28381	88	41	areas	area	NOUN
ihlr-28381	88	42	,	,	PUNCT
ihlr-28381	88	43	publicly	publicly	ADV
ihlr-28381	88	44	funded	fund	VERB
ihlr-28381	88	45	16	16	NUM
ihlr-28381	88	46	.	.	PUNCT
ihlr-28381	89	1	ekaterina	ekaterina	PROPN
ihlr-28381	89	2	galkina	galkina	PROPN
ihlr-28381	89	3	cleary	cleary	PROPN
ihlr-28381	89	4	et	et	PROPN
ihlr-28381	89	5	al	al	PROPN
ihlr-28381	89	6	.	.	PROPN
ihlr-28381	89	7	,	,	PUNCT
ihlr-28381	89	8	contribution	contribution	NOUN
ihlr-28381	89	9	of	of	ADP
ihlr-28381	89	10	nih	nih	PROPN
ihlr-28381	89	11	funding	funding	PROPN
ihlr-28381	89	12	to	to	ADP
ihlr-28381	89	13	new	new	ADJ
ihlr-28381	89	14	drug	drug	NOUN
ihlr-28381	89	15	approvals	approval	NOUN
ihlr-28381	89	16	2010	2010	NUM
ihlr-28381	89	17	-	-	SYM
ihlr-28381	89	18	2016	2016	NUM
ihlr-28381	89	19	,	,	PUNCT
ihlr-28381	89	20	proceedings	proceeding	NOUN
ihlr-28381	89	21	of	of	ADP
ihlr-28381	89	22	the	the	DET
ihlr-28381	89	23	nat’l	nat’l	NOUN
ihlr-28381	89	24	acad	acad	NOUN
ihlr-28381	89	25	.	.	PUNCT
ihlr-28381	89	26	of	of	ADP
ihlr-28381	89	27	sci	sci	PROPN
ihlr-28381	89	28	.	.	PUNCT
ihlr-28381	90	1	(	(	PUNCT
ihlr-28381	90	2	2018	2018	NUM
ihlr-28381	90	3	)	)	PUNCT
ihlr-28381	90	4	,	,	PUNCT
ihlr-28381	90	5	https://pubmed.ncbi.nlm.nih	https://pubmed.ncbi.nlm.nih	PROPN
ihlr-28381	90	6	.	.	PUNCT
ihlr-28381	91	1	gov/29440428/	gov/29440428/	PROPN
ihlr-28381	91	2	[	[	X
ihlr-28381	91	3	https://perma.cc/6lps-rrx3	https://perma.cc/6lps-rrx3	PROPN
ihlr-28381	91	4	]	]	X
ihlr-28381	91	5	.	.	PUNCT
ihlr-28381	92	1	126	126	NUM
ihlr-28381	92	2	indiana	indiana	PROPN
ihlr-28381	92	3	health	health	PROPN
ihlr-28381	92	4	law	law	PROPN
ihlr-28381	92	5	review	review	NOUN
ihlr-28381	92	6	[	[	X
ihlr-28381	92	7	vol	vol	NOUN
ihlr-28381	92	8	.	.	NOUN
ihlr-28381	92	9	21:121	21:121	NUM
ihlr-28381	92	10	discoveries	discovery	NOUN
ihlr-28381	92	11	often	often	ADV
ihlr-28381	92	12	precede	precede	VERB
ihlr-28381	92	13	and	and	CCONJ
ihlr-28381	92	14	inspire	inspire	VERB
ihlr-28381	92	15	eventual	eventual	ADJ
ihlr-28381	92	16	private	private	ADJ
ihlr-28381	92	17	sponsorship	sponsorship	NOUN
ihlr-28381	92	18	of	of	ADP
ihlr-28381	92	19	related	related	ADJ
ihlr-28381	92	20	drug	drug	NOUN
ihlr-28381	92	21	development	development	NOUN
ihlr-28381	92	22	programs.17	programs.17	PROPN
ihlr-28381	92	23	in	in	ADP
ihlr-28381	92	24	the	the	DET
ihlr-28381	92	25	private	private	ADJ
ihlr-28381	92	26	sector	sector	NOUN
ihlr-28381	92	27	’s	’s	PART
ihlr-28381	92	28	quest	quest	NOUN
ihlr-28381	92	29	for	for	ADP
ihlr-28381	92	30	new	new	ADJ
ihlr-28381	92	31	medicine	medicine	NOUN
ihlr-28381	92	32	,	,	PUNCT
ihlr-28381	92	33	innovators	innovator	NOUN
ihlr-28381	92	34	attempt	attempt	VERB
ihlr-28381	92	35	to	to	PART
ihlr-28381	92	36	invent	invent	VERB
ihlr-28381	92	37	,	,	PUNCT
ihlr-28381	92	38	patent	patent	NOUN
ihlr-28381	92	39	,	,	PUNCT
ihlr-28381	92	40	and	and	CCONJ
ihlr-28381	92	41	steer	steer	VERB
ihlr-28381	92	42	new	new	ADJ
ihlr-28381	92	43	medicines	medicine	NOUN
ihlr-28381	92	44	from	from	ADP
ihlr-28381	92	45	labs	lab	NOUN
ihlr-28381	92	46	to	to	ADP
ihlr-28381	92	47	patients	patient	NOUN
ihlr-28381	92	48	.	.	PUNCT
ihlr-28381	93	1	with	with	ADP
ihlr-28381	93	2	fda	fda	PROPN
ihlr-28381	93	3	approval	approval	PROPN
ihlr-28381	93	4	,	,	PUNCT
ihlr-28381	93	5	innovators	innovator	NOUN
ihlr-28381	93	6	can	can	AUX
ihlr-28381	93	7	market	market	VERB
ihlr-28381	93	8	their	their	PRON
ihlr-28381	93	9	invention	invention	NOUN
ihlr-28381	93	10	as	as	ADP
ihlr-28381	93	11	a	a	DET
ihlr-28381	93	12	prescription	prescription	NOUN
ihlr-28381	93	13	drug	drug	NOUN
ihlr-28381	93	14	under	under	ADP
ihlr-28381	93	15	its	its	PRON
ihlr-28381	93	16	brand	brand	NOUN
ihlr-28381	93	17	name	name	NOUN
ihlr-28381	93	18	.	.	PUNCT
ihlr-28381	94	1	because	because	SCONJ
ihlr-28381	94	2	new	new	ADJ
ihlr-28381	94	3	drugs	drug	NOUN
ihlr-28381	94	4	are	be	AUX
ihlr-28381	94	5	protected	protect	VERB
ihlr-28381	94	6	by	by	ADP
ihlr-28381	94	7	patents	patent	NOUN
ihlr-28381	94	8	,	,	PUNCT
ihlr-28381	94	9	their	their	PRON
ihlr-28381	94	10	inventors	inventor	NOUN
ihlr-28381	94	11	are	be	AUX
ihlr-28381	94	12	entitled	entitle	VERB
ihlr-28381	94	13	to	to	ADP
ihlr-28381	94	14	a	a	DET
ihlr-28381	94	15	legal	legal	ADJ
ihlr-28381	94	16	monopoly	monopoly	NOUN
ihlr-28381	94	17	on	on	ADP
ihlr-28381	94	18	the	the	DET
ihlr-28381	94	19	drug.18	drug.18	PROPN
ihlr-28381	94	20	patents	patent	NOUN
ihlr-28381	94	21	are	be	AUX
ihlr-28381	94	22	usually	usually	ADV
ihlr-28381	94	23	filed	file	VERB
ihlr-28381	94	24	early	early	ADV
ihlr-28381	94	25	in	in	ADP
ihlr-28381	94	26	the	the	DET
ihlr-28381	94	27	development	development	NOUN
ihlr-28381	94	28	process	process	NOUN
ihlr-28381	94	29	,	,	PUNCT
ihlr-28381	94	30	allowing	allow	VERB
ihlr-28381	94	31	much	much	ADJ
ihlr-28381	94	32	of	of	ADP
ihlr-28381	94	33	the	the	DET
ihlr-28381	94	34	patent	patent	NOUN
ihlr-28381	94	35	’s	’s	PART
ihlr-28381	94	36	exclusivity	exclusivity	NOUN
ihlr-28381	94	37	period	period	NOUN
ihlr-28381	94	38	to	to	ADP
ihlr-28381	94	39	lapse	lapse	NOUN
ihlr-28381	94	40	while	while	SCONJ
ihlr-28381	94	41	the	the	DET
ihlr-28381	94	42	drug	drug	NOUN
ihlr-28381	94	43	is	be	AUX
ihlr-28381	94	44	still	still	ADV
ihlr-28381	94	45	in	in	ADP
ihlr-28381	94	46	the	the	DET
ihlr-28381	94	47	lab	lab	NOUN
ihlr-28381	94	48	,	,	PUNCT
ihlr-28381	94	49	clinical	clinical	ADJ
ihlr-28381	94	50	trials	trial	NOUN
ihlr-28381	94	51	,	,	PUNCT
ihlr-28381	94	52	or	or	CCONJ
ihlr-28381	94	53	fda	fda	PROPN
ihlr-28381	94	54	review	review	NOUN
ihlr-28381	94	55	processes	process	NOUN
ihlr-28381	94	56	.	.	PUNCT
ihlr-28381	95	1	therefore	therefore	ADV
ihlr-28381	95	2	,	,	PUNCT
ihlr-28381	95	3	despite	despite	SCONJ
ihlr-28381	95	4	patents	patent	NOUN
ihlr-28381	95	5	entitling	entitle	VERB
ihlr-28381	95	6	the	the	DET
ihlr-28381	95	7	inventor	inventor	NOUN
ihlr-28381	95	8	to	to	ADP
ihlr-28381	95	9	twenty	twenty	NUM
ihlr-28381	95	10	years	year	NOUN
ihlr-28381	95	11	of	of	ADP
ihlr-28381	95	12	protection	protection	NOUN
ihlr-28381	95	13	,	,	PUNCT
ihlr-28381	95	14	most	most	ADJ
ihlr-28381	95	15	drugs	drug	NOUN
ihlr-28381	95	16	reach	reach	VERB
ihlr-28381	95	17	the	the	DET
ihlr-28381	95	18	market	market	NOUN
ihlr-28381	95	19	with	with	ADP
ihlr-28381	95	20	only	only	ADV
ihlr-28381	95	21	seven	seven	NUM
ihlr-28381	95	22	to	to	PART
ihlr-28381	95	23	ten	ten	NUM
ihlr-28381	95	24	years	year	NOUN
ihlr-28381	95	25	of	of	ADP
ihlr-28381	95	26	patent	patent	NOUN
ihlr-28381	95	27	life	life	NOUN
ihlr-28381	95	28	remaining.19	remaining.19	NOUN
ihlr-28381	95	29	factoring	factor	VERB
ihlr-28381	95	30	in	in	ADP
ihlr-28381	95	31	capital	capital	NOUN
ihlr-28381	95	32	costs	cost	NOUN
ihlr-28381	95	33	and	and	CCONJ
ihlr-28381	95	34	expenditures	expenditure	NOUN
ihlr-28381	95	35	on	on	ADP
ihlr-28381	95	36	drugs	drug	NOUN
ihlr-28381	95	37	that	that	PRON
ihlr-28381	95	38	fail	fail	VERB
ihlr-28381	95	39	to	to	PART
ihlr-28381	95	40	reach	reach	VERB
ihlr-28381	95	41	the	the	DET
ihlr-28381	95	42	market	market	NOUN
ihlr-28381	95	43	—	—	PUNCT
ihlr-28381	95	44	only	only	ADV
ihlr-28381	95	45	12	12	NUM
ihlr-28381	95	46	%	%	NOUN
ihlr-28381	95	47	of	of	ADP
ihlr-28381	95	48	drugs	drug	NOUN
ihlr-28381	95	49	entering	enter	VERB
ihlr-28381	95	50	clinical	clinical	ADJ
ihlr-28381	95	51	trials	trial	NOUN
ihlr-28381	95	52	ultimately	ultimately	ADV
ihlr-28381	95	53	reach	reach	VERB
ihlr-28381	95	54	the	the	DET
ihlr-28381	95	55	market	market	NOUN
ihlr-28381	95	56	—	—	PUNCT
ihlr-28381	95	57	the	the	DET
ihlr-28381	95	58	cost	cost	NOUN
ihlr-28381	95	59	of	of	ADP
ihlr-28381	95	60	successfully	successfully	ADV
ihlr-28381	95	61	developing	develop	VERB
ihlr-28381	95	62	one	one	NUM
ihlr-28381	95	63	new	new	ADJ
ihlr-28381	95	64	drug	drug	NOUN
ihlr-28381	95	65	can	can	AUX
ihlr-28381	95	66	eclipse	eclipse	VERB
ihlr-28381	95	67	one	one	NUM
ihlr-28381	95	68	or	or	CCONJ
ihlr-28381	95	69	two	two	NUM
ihlr-28381	95	70	billion	billion	NUM
ihlr-28381	95	71	dollars.20	dollars.20	NOUN
ihlr-28381	95	72	once	once	ADV
ihlr-28381	95	73	costs	cost	NOUN
ihlr-28381	95	74	and	and	CCONJ
ihlr-28381	95	75	risks	risk	NOUN
ihlr-28381	95	76	are	be	AUX
ihlr-28381	95	77	overcome	overcome	VERB
ihlr-28381	95	78	and	and	CCONJ
ihlr-28381	95	79	a	a	DET
ihlr-28381	95	80	new	new	ADJ
ihlr-28381	95	81	drug	drug	NOUN
ihlr-28381	95	82	is	be	AUX
ihlr-28381	95	83	marketed	market	VERB
ihlr-28381	95	84	,	,	PUNCT
ihlr-28381	95	85	its	its	PRON
ihlr-28381	95	86	inventors	inventor	NOUN
ihlr-28381	95	87	benefit	benefit	VERB
ihlr-28381	95	88	from	from	ADP
ihlr-28381	95	89	a	a	DET
ihlr-28381	95	90	monopoly	monopoly	NOUN
ihlr-28381	95	91	for	for	ADP
ihlr-28381	95	92	the	the	DET
ihlr-28381	95	93	remainder	remainder	NOUN
ihlr-28381	95	94	of	of	ADP
ihlr-28381	95	95	the	the	DET
ihlr-28381	95	96	patent	patent	NOUN
ihlr-28381	95	97	life	life	NOUN
ihlr-28381	95	98	.	.	PUNCT
ihlr-28381	96	1	as	as	SCONJ
ihlr-28381	96	2	patents	patent	NOUN
ihlr-28381	96	3	approach	approach	VERB
ihlr-28381	96	4	expiration	expiration	NOUN
ihlr-28381	96	5	,	,	PUNCT
ihlr-28381	96	6	the	the	DET
ihlr-28381	96	7	other	other	ADJ
ihlr-28381	96	8	group	group	NOUN
ihlr-28381	96	9	of	of	ADP
ihlr-28381	96	10	industry	industry	NOUN
ihlr-28381	96	11	participants	participant	NOUN
ihlr-28381	96	12	relevant	relevant	ADJ
ihlr-28381	96	13	to	to	ADP
ihlr-28381	96	14	this	this	DET
ihlr-28381	96	15	note	note	NOUN
ihlr-28381	96	16	enters	enter	VERB
ihlr-28381	96	17	the	the	DET
ihlr-28381	96	18	equation	equation	NOUN
ihlr-28381	96	19	—	—	PUNCT
ihlr-28381	96	20	generic	generic	ADJ
ihlr-28381	96	21	companies	company	NOUN
ihlr-28381	96	22	.	.	PUNCT
ihlr-28381	97	1	b.	b.	PROPN
ihlr-28381	97	2	generic	generic	PROPN
ihlr-28381	97	3	companies	company	NOUN
ihlr-28381	97	4	rather	rather	ADV
ihlr-28381	97	5	than	than	ADP
ihlr-28381	97	6	inventing	invent	VERB
ihlr-28381	97	7	medicine	medicine	NOUN
ihlr-28381	97	8	,	,	PUNCT
ihlr-28381	97	9	generic	generic	ADJ
ihlr-28381	97	10	companies	company	NOUN
ihlr-28381	97	11	serve	serve	VERB
ihlr-28381	97	12	a	a	DET
ihlr-28381	97	13	different	different	ADJ
ihlr-28381	97	14	function	function	NOUN
ihlr-28381	97	15	—	—	PUNCT
ihlr-28381	97	16	price	price	NOUN
ihlr-28381	97	17	control	control	NOUN
ihlr-28381	97	18	through	through	ADP
ihlr-28381	97	19	competition	competition	NOUN
ihlr-28381	97	20	.	.	PUNCT
ihlr-28381	98	1	examples	example	NOUN
ihlr-28381	98	2	of	of	ADP
ihlr-28381	98	3	popular	popular	ADJ
ihlr-28381	98	4	generic	generic	ADJ
ihlr-28381	98	5	companies	company	NOUN
ihlr-28381	98	6	include	include	VERB
ihlr-28381	98	7	teva	teva	PROPN
ihlr-28381	98	8	,	,	PUNCT
ihlr-28381	98	9	viatris	viatris	PROPN
ihlr-28381	98	10	,	,	PUNCT
ihlr-28381	98	11	dr	dr	PROPN
ihlr-28381	98	12	.	.	PROPN
ihlr-28381	98	13	reddy	reddy	PROPN
ihlr-28381	98	14	’s	’s	PART
ihlr-28381	98	15	,	,	PUNCT
ihlr-28381	98	16	and	and	CCONJ
ihlr-28381	98	17	fresenius	fresenius	PROPN
ihlr-28381	98	18	kabi	kabi	PROPN
ihlr-28381	98	19	.	.	PUNCT
ihlr-28381	99	1	when	when	SCONJ
ihlr-28381	99	2	patents	patent	NOUN
ihlr-28381	99	3	on	on	ADP
ihlr-28381	99	4	the	the	DET
ihlr-28381	99	5	innovator	innovator	NOUN
ihlr-28381	99	6	’s	’s	PART
ihlr-28381	99	7	medicine	medicine	NOUN
ihlr-28381	99	8	expire	expire	NOUN
ihlr-28381	99	9	,	,	PUNCT
ihlr-28381	99	10	generic	generic	ADJ
ihlr-28381	99	11	companies	company	NOUN
ihlr-28381	99	12	replicate	replicate	VERB
ihlr-28381	99	13	the	the	DET
ihlr-28381	99	14	formula	formula	NOUN
ihlr-28381	99	15	,	,	PUNCT
ihlr-28381	99	16	seek	seek	VERB
ihlr-28381	99	17	fda	fda	PROPN
ihlr-28381	99	18	approval	approval	NOUN
ihlr-28381	99	19	,	,	PUNCT
ihlr-28381	99	20	and	and	CCONJ
ihlr-28381	99	21	sell	sell	VERB
ihlr-28381	99	22	approved	approve	VERB
ihlr-28381	99	23	generic	generic	ADJ
ihlr-28381	99	24	versions	version	NOUN
ihlr-28381	99	25	of	of	ADP
ihlr-28381	99	26	brand	brand	NOUN
ihlr-28381	99	27	-	-	PUNCT
ihlr-28381	99	28	name	name	NOUN
ihlr-28381	99	29	drugs	drug	NOUN
ihlr-28381	99	30	at	at	ADP
ihlr-28381	99	31	significant	significant	ADJ
ihlr-28381	99	32	discounts	discount	NOUN
ihlr-28381	99	33	.	.	PUNCT
ihlr-28381	100	1	unburdened	unburden	VERB
ihlr-28381	100	2	by	by	ADP
ihlr-28381	100	3	the	the	DET
ihlr-28381	100	4	level	level	NOUN
ihlr-28381	100	5	of	of	ADP
ihlr-28381	100	6	research	research	NOUN
ihlr-28381	100	7	and	and	CCONJ
ihlr-28381	100	8	development	development	NOUN
ihlr-28381	100	9	expense	expense	NOUN
ihlr-28381	100	10	shouldered	shoulder	VERB
ihlr-28381	100	11	by	by	ADP
ihlr-28381	100	12	innovator	innovator	NOUN
ihlr-28381	100	13	companies	company	NOUN
ihlr-28381	100	14	,	,	PUNCT
ihlr-28381	100	15	generic	generic	ADJ
ihlr-28381	100	16	companies	company	NOUN
ihlr-28381	100	17	can	can	AUX
ihlr-28381	100	18	survive	survive	VERB
ihlr-28381	100	19	on	on	ADP
ihlr-28381	100	20	small	small	ADJ
ihlr-28381	100	21	profit	profit	NOUN
ihlr-28381	100	22	margins	margin	NOUN
ihlr-28381	100	23	—	—	PUNCT
ihlr-28381	100	24	this	this	DET
ihlr-28381	100	25	dynamic	dynamic	NOUN
ihlr-28381	100	26	allows	allow	VERB
ihlr-28381	100	27	generic	generic	ADJ
ihlr-28381	100	28	companies	company	NOUN
ihlr-28381	100	29	to	to	PART
ihlr-28381	100	30	sell	sell	VERB
ihlr-28381	100	31	drugs	drug	NOUN
ihlr-28381	100	32	at	at	ADP
ihlr-28381	100	33	large	large	ADJ
ihlr-28381	100	34	discounts	discount	NOUN
ihlr-28381	100	35	.	.	PUNCT
ihlr-28381	101	1	the	the	DET
ihlr-28381	101	2	first	first	ADJ
ihlr-28381	101	3	generic	generic	PROPN
ihlr-28381	101	4	usually	usually	ADV
ihlr-28381	101	5	enters	enter	VERB
ihlr-28381	101	6	the	the	DET
ihlr-28381	101	7	brand	brand	NOUN
ihlr-28381	101	8	name	name	NOUN
ihlr-28381	101	9	product	product	NOUN
ihlr-28381	101	10	’s	’s	PART
ihlr-28381	101	11	market	market	NOUN
ihlr-28381	101	12	at	at	ADP
ihlr-28381	101	13	a	a	DET
ihlr-28381	101	14	discount	discount	NOUN
ihlr-28381	101	15	of	of	ADP
ihlr-28381	101	16	approximately	approximately	ADV
ihlr-28381	101	17	20%.21	20%.21	NUM
ihlr-28381	101	18	as	as	SCONJ
ihlr-28381	101	19	more	more	ADJ
ihlr-28381	101	20	competitors	competitor	NOUN
ihlr-28381	101	21	enter	enter	VERB
ihlr-28381	101	22	the	the	DET
ihlr-28381	101	23	post	post	ADJ
ihlr-28381	101	24	-	-	ADJ
ihlr-28381	101	25	patent	patent	ADJ
ihlr-28381	101	26	market	market	NOUN
ihlr-28381	101	27	,	,	PUNCT
ihlr-28381	101	28	the	the	DET
ihlr-28381	101	29	generic	generic	ADJ
ihlr-28381	101	30	discount	discount	NOUN
ihlr-28381	101	31	against	against	ADP
ihlr-28381	101	32	the	the	DET
ihlr-28381	101	33	brand	brand	NOUN
ihlr-28381	101	34	price	price	NOUN
ihlr-28381	101	35	grows	grow	VERB
ihlr-28381	101	36	to	to	ADP
ihlr-28381	101	37	85	85	NUM
ihlr-28381	101	38	%	%	NOUN
ihlr-28381	101	39	,	,	PUNCT
ihlr-28381	101	40	on	on	ADP
ihlr-28381	101	41	average.22	average.22	NOUN
ihlr-28381	101	42	by	by	ADP
ihlr-28381	101	43	offering	offer	VERB
ihlr-28381	101	44	17	17	NUM
ihlr-28381	101	45	.	.	PUNCT
ihlr-28381	102	1	i	i	PRON
ihlr-28381	102	2	d.	d.	PROPN
ihlr-28381	102	3	18	18	NUM
ihlr-28381	102	4	.	.	PUNCT
ihlr-28381	102	5	f.t.c	f.t.c	PROPN
ihlr-28381	102	6	.	.	PUNCT
ihlr-28381	103	1	v.	v.	ADP
ihlr-28381	103	2	actavis	actavis	PROPN
ihlr-28381	103	3	,	,	PUNCT
ihlr-28381	103	4	inc	inc	PROPN
ihlr-28381	103	5	.	.	PROPN
ihlr-28381	103	6	,	,	PUNCT
ihlr-28381	103	7	570	570	NUM
ihlr-28381	103	8	u.s	u.s	PROPN
ihlr-28381	103	9	.	.	PROPN
ihlr-28381	103	10	136	136	NUM
ihlr-28381	103	11	,	,	PUNCT
ihlr-28381	103	12	148	148	NUM
ihlr-28381	103	13	(	(	PUNCT
ihlr-28381	103	14	2013	2013	NUM
ihlr-28381	103	15	)	)	PUNCT
ihlr-28381	103	16	.	.	PUNCT
ihlr-28381	104	1	19	19	NUM
ihlr-28381	104	2	.	.	NOUN
ihlr-28381	104	3	jan	jan	PROPN
ihlr-28381	104	4	berger	berger	PROPN
ihlr-28381	104	5	et	et	PROPN
ihlr-28381	104	6	al	al	PROPN
ihlr-28381	104	7	.	.	PROPN
ihlr-28381	104	8	,	,	PUNCT
ihlr-28381	104	9	how	how	SCONJ
ihlr-28381	104	10	drug	drug	NOUN
ihlr-28381	104	11	life	life	NOUN
ihlr-28381	104	12	-	-	PUNCT
ihlr-28381	104	13	cycle	cycle	NOUN
ihlr-28381	104	14	management	management	NOUN
ihlr-28381	104	15	patent	patent	NOUN
ihlr-28381	104	16	strategies	strategy	NOUN
ihlr-28381	104	17	may	may	AUX
ihlr-28381	104	18	impact	impact	VERB
ihlr-28381	104	19	formulary	formulary	ADJ
ihlr-28381	104	20	management	management	NOUN
ihlr-28381	104	21	,	,	PUNCT
ihlr-28381	104	22	22	22	NUM
ihlr-28381	104	23	am	am	NOUN
ihlr-28381	104	24	.	.	PUNCT
ihlr-28381	105	1	j.	j.	PROPN
ihlr-28381	105	2	manag	manag	PROPN
ihlr-28381	105	3	.	.	PUNCT
ihlr-28381	105	4	care	care	PROPN
ihlr-28381	105	5	s487	s487	PROPN
ihlr-28381	105	6	,	,	PUNCT
ihlr-28381	105	7	s489	s489	PROPN
ihlr-28381	105	8	(	(	PUNCT
ihlr-28381	105	9	2016	2016	NUM
ihlr-28381	105	10	)	)	PUNCT
ihlr-28381	105	11	,	,	PUNCT
ihlr-28381	105	12	https://pubmed.ncbi.nlm	https://pubmed.ncbi.nlm	X
ihlr-28381	105	13	.	.	PUNCT
ihlr-28381	106	1	nih.gov/28719222/	nih.gov/28719222/	PROPN
ihlr-28381	107	1	[	[	X
ihlr-28381	107	2	https://perma.cc/2dbv-256p	https://perma.cc/2dbv-256p	NOUN
ihlr-28381	107	3	]	]	X
ihlr-28381	107	4	.	.	PUNCT
ihlr-28381	108	1	20	20	NUM
ihlr-28381	108	2	.	.	PUNCT
ihlr-28381	109	1	cong	cong	PROPN
ihlr-28381	109	2	.	.	PUNCT
ihlr-28381	110	1	budget	budget	NOUN
ihlr-28381	110	2	off	off	ADP
ihlr-28381	110	3	.	.	PUNCT
ihlr-28381	110	4	,	,	PUNCT
ihlr-28381	110	5	57025	57025	NUM
ihlr-28381	110	6	,	,	PUNCT
ihlr-28381	110	7	research	research	NOUN
ihlr-28381	110	8	and	and	CCONJ
ihlr-28381	110	9	development	development	NOUN
ihlr-28381	110	10	in	in	ADP
ihlr-28381	110	11	the	the	DET
ihlr-28381	110	12	pharmaceutical	pharmaceutical	ADJ
ihlr-28381	110	13	industry	industry	NOUN
ihlr-28381	110	14	2	2	NUM
ihlr-28381	110	15	,	,	PUNCT
ihlr-28381	110	16	14	14	NUM
ihlr-28381	110	17	,	,	PUNCT
ihlr-28381	110	18	17	17	NUM
ihlr-28381	110	19	(	(	PUNCT
ihlr-28381	110	20	apr	apr	PROPN
ihlr-28381	110	21	.	.	NOUN
ihlr-28381	110	22	2021	2021	NUM
ihlr-28381	110	23	)	)	PUNCT
ihlr-28381	110	24	,	,	PUNCT
ihlr-28381	110	25	https://www.cbo.gov/publication/57126	https://www.cbo.gov/publication/57126	NOUN
ihlr-28381	111	1	[	[	X
ihlr-28381	111	2	https://perma.cc/m4t3lt72	https://perma.cc/m4t3lt72	PROPN
ihlr-28381	111	3	]	]	X
ihlr-28381	111	4	.	.	PUNCT
ihlr-28381	112	1	21	21	NUM
ihlr-28381	112	2	.	.	PUNCT
ihlr-28381	113	1	robin	robin	PROPN
ihlr-28381	113	2	feldman	feldman	PROPN
ihlr-28381	113	3	&	&	CCONJ
ihlr-28381	113	4	evan	evan	PROPN
ihlr-28381	113	5	frondorf	frondorf	PROPN
ihlr-28381	113	6	,	,	PUNCT
ihlr-28381	113	7	drug	drug	NOUN
ihlr-28381	113	8	wars	war	NOUN
ihlr-28381	113	9	:	:	PUNCT
ihlr-28381	113	10	a	a	DET
ihlr-28381	113	11	new	new	ADJ
ihlr-28381	113	12	generation	generation	NOUN
ihlr-28381	113	13	of	of	ADP
ihlr-28381	113	14	generic	generic	ADJ
ihlr-28381	113	15	pharmaceutical	pharmaceutical	ADJ
ihlr-28381	113	16	delay	delay	NOUN
ihlr-28381	113	17	,	,	PUNCT
ihlr-28381	113	18	53	53	NUM
ihlr-28381	113	19	harv	harv	NOUN
ihlr-28381	113	20	.	.	PUNCT
ihlr-28381	114	1	j.	j.	PROPN
ihlr-28381	114	2	legis	legis	PROPN
ihlr-28381	114	3	.	.	PUNCT
ihlr-28381	115	1	499	499	NUM
ihlr-28381	115	2	,	,	PUNCT
ihlr-28381	115	3	500	500	NUM
ihlr-28381	115	4	-	-	SYM
ihlr-28381	115	5	501	501	NUM
ihlr-28381	115	6	(	(	PUNCT
ihlr-28381	115	7	2016	2016	NUM
ihlr-28381	115	8	)	)	PUNCT
ihlr-28381	115	9	,	,	PUNCT
ihlr-28381	115	10	https://papers.ssrn.com/sol3/	https://papers.ssrn.com/sol3/	X
ihlr-28381	116	1	papers.cfm?abstract_id=2659308	papers.cfm?abstract_id=2659308	NOUN
ihlr-28381	116	2	#	#	NOUN
ihlr-28381	117	1	[	[	X
ihlr-28381	117	2	https://perma.cc/5d83-agth	https://perma.cc/5d83-agth	NOUN
ihlr-28381	117	3	]	]	PUNCT
ihlr-28381	117	4	.	.	PUNCT
ihlr-28381	118	1	22	22	NUM
ihlr-28381	118	2	.	.	PUNCT
ihlr-28381	119	1	u.s	u.s	PROPN
ihlr-28381	119	2	.	.	PROPN
ihlr-28381	119	3	food	food	PROPN
ihlr-28381	119	4	&	&	CCONJ
ihlr-28381	119	5	drug	drug	PROPN
ihlr-28381	119	6	admin	admin	PROPN
ihlr-28381	119	7	.	.	PROPN
ihlr-28381	119	8	,	,	PUNCT
ihlr-28381	119	9	generic	generic	ADJ
ihlr-28381	119	10	drug	drug	NOUN
ihlr-28381	119	11	facts	fact	NOUN
ihlr-28381	119	12	,	,	PUNCT
ihlr-28381	119	13	https://www.fda.gov/drugs/generic2024	https://www.fda.gov/drugs/generic2024	PROPN
ihlr-28381	119	14	]	]	PUNCT
ihlr-28381	119	15	incentivizing	incentivize	VERB
ihlr-28381	119	16	drug	drug	NOUN
ihlr-28381	119	17	affordability	affordability	NOUN
ihlr-28381	119	18	127	127	NUM
ihlr-28381	119	19	lower	low	ADJ
ihlr-28381	119	20	prices	price	NOUN
ihlr-28381	119	21	and	and	CCONJ
ihlr-28381	119	22	making	make	VERB
ihlr-28381	119	23	medicine	medicine	NOUN
ihlr-28381	119	24	more	more	ADV
ihlr-28381	119	25	affordable	affordable	ADJ
ihlr-28381	119	26	,	,	PUNCT
ihlr-28381	119	27	generic	generic	ADJ
ihlr-28381	119	28	drug	drug	NOUN
ihlr-28381	119	29	makers	maker	NOUN
ihlr-28381	119	30	create	create	VERB
ihlr-28381	119	31	savings	saving	NOUN
ihlr-28381	119	32	and	and	CCONJ
ihlr-28381	119	33	increase	increase	VERB
ihlr-28381	119	34	access	access	NOUN
ihlr-28381	119	35	to	to	ADP
ihlr-28381	119	36	medicine	medicine	NOUN
ihlr-28381	119	37	.	.	PUNCT
ihlr-28381	120	1	more	more	ADJ
ihlr-28381	120	2	than	than	ADP
ihlr-28381	120	3	10,000	10,000	NUM
ihlr-28381	120	4	generic	generic	ADJ
ihlr-28381	120	5	drugs	drug	NOUN
ihlr-28381	120	6	have	have	AUX
ihlr-28381	120	7	been	be	AUX
ihlr-28381	120	8	approved	approve	VERB
ihlr-28381	120	9	,	,	PUNCT
ihlr-28381	120	10	accounting	account	VERB
ihlr-28381	120	11	for	for	ADP
ihlr-28381	120	12	90	90	NUM
ihlr-28381	120	13	%	%	NOUN
ihlr-28381	120	14	of	of	ADP
ihlr-28381	120	15	prescriptions	prescription	NOUN
ihlr-28381	120	16	filled	fill	VERB
ihlr-28381	120	17	in	in	ADP
ihlr-28381	120	18	the	the	DET
ihlr-28381	120	19	united	united	PROPN
ihlr-28381	120	20	states.23	states.23	PROPN
ihlr-28381	120	21	despite	despite	SCONJ
ihlr-28381	120	22	nine	nine	NUM
ihlr-28381	120	23	out	out	ADP
ihlr-28381	120	24	of	of	ADP
ihlr-28381	120	25	ten	ten	NUM
ihlr-28381	120	26	prescriptions	prescription	NOUN
ihlr-28381	120	27	being	be	AUX
ihlr-28381	120	28	filled	fill	VERB
ihlr-28381	120	29	by	by	ADP
ihlr-28381	120	30	generic	generic	ADJ
ihlr-28381	120	31	drugs	drug	NOUN
ihlr-28381	120	32	,	,	PUNCT
ihlr-28381	120	33	generics	generic	NOUN
ihlr-28381	120	34	are	be	AUX
ihlr-28381	120	35	only	only	ADV
ihlr-28381	120	36	responsible	responsible	ADJ
ihlr-28381	120	37	for	for	ADP
ihlr-28381	120	38	18	18	NUM
ihlr-28381	120	39	%	%	NOUN
ihlr-28381	120	40	of	of	ADP
ihlr-28381	120	41	drug	drug	NOUN
ihlr-28381	120	42	spending	spending	NOUN
ihlr-28381	120	43	—	—	PUNCT
ihlr-28381	120	44	a	a	DET
ihlr-28381	120	45	testament	testament	NOUN
ihlr-28381	120	46	to	to	ADP
ihlr-28381	120	47	the	the	DET
ihlr-28381	120	48	ability	ability	NOUN
ihlr-28381	120	49	of	of	ADP
ihlr-28381	120	50	generics	generic	NOUN
ihlr-28381	120	51	to	to	PART
ihlr-28381	120	52	save	save	VERB
ihlr-28381	120	53	money	money	NOUN
ihlr-28381	120	54	(	(	PUNCT
ihlr-28381	120	55	i.e.	i.e.	X
ihlr-28381	120	56	,	,	PUNCT
ihlr-28381	120	57	90	90	NUM
ihlr-28381	120	58	%	%	NOUN
ihlr-28381	120	59	of	of	ADP
ihlr-28381	120	60	volume	volume	NOUN
ihlr-28381	120	61	,	,	PUNCT
ihlr-28381	120	62	but	but	CCONJ
ihlr-28381	120	63	only	only	ADV
ihlr-28381	120	64	18	18	NUM
ihlr-28381	120	65	%	%	NOUN
ihlr-28381	120	66	of	of	ADP
ihlr-28381	120	67	cost).24	cost).24	NOUN
ihlr-28381	120	68	in	in	ADP
ihlr-28381	120	69	2020	2020	NUM
ihlr-28381	120	70	,	,	PUNCT
ihlr-28381	120	71	generics	generic	NOUN
ihlr-28381	120	72	were	be	AUX
ihlr-28381	120	73	responsible	responsible	ADJ
ihlr-28381	120	74	for	for	ADP
ihlr-28381	120	75	$	$	SYM
ihlr-28381	120	76	338	338	NUM
ihlr-28381	120	77	billion	billion	NUM
ihlr-28381	120	78	in	in	ADP
ihlr-28381	120	79	savings.25	savings.25	NOUN
ihlr-28381	120	80	by	by	ADP
ihlr-28381	120	81	avoiding	avoid	VERB
ihlr-28381	120	82	the	the	DET
ihlr-28381	120	83	risk	risk	NOUN
ihlr-28381	120	84	and	and	CCONJ
ihlr-28381	120	85	cost	cost	NOUN
ihlr-28381	120	86	of	of	ADP
ihlr-28381	120	87	developing	develop	VERB
ihlr-28381	120	88	new	new	ADJ
ihlr-28381	120	89	medicine	medicine	NOUN
ihlr-28381	120	90	,	,	PUNCT
ihlr-28381	120	91	generics	generic	NOUN
ihlr-28381	120	92	offer	offer	VERB
ihlr-28381	120	93	the	the	DET
ihlr-28381	120	94	same	same	ADJ
ihlr-28381	120	95	benefit	benefit	NOUN
ihlr-28381	120	96	at	at	ADP
ihlr-28381	120	97	a	a	DET
ihlr-28381	120	98	reduced	reduce	VERB
ihlr-28381	120	99	priced	price	VERB
ihlr-28381	120	100	,	,	PUNCT
ihlr-28381	120	101	saving	save	VERB
ihlr-28381	120	102	the	the	DET
ihlr-28381	120	103	healthcare	healthcare	NOUN
ihlr-28381	120	104	system	system	NOUN
ihlr-28381	120	105	billions	billion	NOUN
ihlr-28381	120	106	of	of	ADP
ihlr-28381	120	107	dollars	dollar	NOUN
ihlr-28381	120	108	annually	annually	ADV
ihlr-28381	120	109	.	.	PUNCT
ihlr-28381	121	1	c.	c.	NOUN
ihlr-28381	121	2	recap	recap	PROPN
ihlr-28381	121	3	:	:	PUNCT
ihlr-28381	121	4	innovators	innovator	NOUN
ihlr-28381	121	5	&	&	CCONJ
ihlr-28381	121	6	generics	generics	PROPN
ihlr-28381	121	7	innovator	innovator	NOUN
ihlr-28381	121	8	and	and	CCONJ
ihlr-28381	121	9	generic	generic	ADJ
ihlr-28381	121	10	companies	company	NOUN
ihlr-28381	121	11	each	each	PRON
ihlr-28381	121	12	create	create	VERB
ihlr-28381	121	13	essential	essential	ADJ
ihlr-28381	121	14	value	value	NOUN
ihlr-28381	121	15	in	in	ADP
ihlr-28381	121	16	different	different	ADJ
ihlr-28381	121	17	ways	way	NOUN
ihlr-28381	121	18	.	.	PUNCT
ihlr-28381	122	1	innovators	innovator	NOUN
ihlr-28381	122	2	create	create	VERB
ihlr-28381	122	3	new	new	ADJ
ihlr-28381	122	4	medicines	medicine	NOUN
ihlr-28381	122	5	,	,	PUNCT
ihlr-28381	122	6	while	while	SCONJ
ihlr-28381	122	7	generic	generic	ADJ
ihlr-28381	122	8	companies	company	NOUN
ihlr-28381	122	9	make	make	VERB
ihlr-28381	122	10	those	those	DET
ihlr-28381	122	11	medicines	medicine	NOUN
ihlr-28381	122	12	cheaper	cheap	ADJ
ihlr-28381	122	13	and	and	CCONJ
ihlr-28381	122	14	more	more	ADV
ihlr-28381	122	15	accessible	accessible	ADJ
ihlr-28381	122	16	.	.	PUNCT
ihlr-28381	123	1	when	when	SCONJ
ihlr-28381	123	2	generics	generic	NOUN
ihlr-28381	123	3	enter	enter	VERB
ihlr-28381	123	4	the	the	DET
ihlr-28381	123	5	market	market	NOUN
ihlr-28381	123	6	,	,	PUNCT
ihlr-28381	123	7	innovators	innovator	NOUN
ihlr-28381	123	8	lose	lose	VERB
ihlr-28381	123	9	pricing	pricing	NOUN
ihlr-28381	123	10	power	power	NOUN
ihlr-28381	123	11	and	and	CCONJ
ihlr-28381	123	12	sales	sale	NOUN
ihlr-28381	123	13	volume	volume	NOUN
ihlr-28381	123	14	.	.	PUNCT
ihlr-28381	124	1	therefore	therefore	ADV
ihlr-28381	124	2	,	,	PUNCT
ihlr-28381	124	3	it	it	PRON
ihlr-28381	124	4	is	be	AUX
ihlr-28381	124	5	often	often	ADV
ihlr-28381	124	6	in	in	ADP
ihlr-28381	124	7	the	the	DET
ihlr-28381	124	8	innovator	innovator	NOUN
ihlr-28381	124	9	’s	’s	PART
ihlr-28381	124	10	best	good	ADJ
ihlr-28381	124	11	interest	interest	NOUN
ihlr-28381	124	12	to	to	PART
ihlr-28381	124	13	delay	delay	VERB
ihlr-28381	124	14	generic	generic	ADJ
ihlr-28381	124	15	competition	competition	NOUN
ihlr-28381	124	16	.	.	PUNCT
ihlr-28381	125	1	delaying	delay	VERB
ihlr-28381	125	2	generic	generic	ADJ
ihlr-28381	125	3	entry	entry	NOUN
ihlr-28381	125	4	is	be	AUX
ihlr-28381	125	5	a	a	DET
ihlr-28381	125	6	way	way	NOUN
ihlr-28381	125	7	to	to	PART
ihlr-28381	125	8	maximize	maximize	VERB
ihlr-28381	125	9	profits	profit	NOUN
ihlr-28381	125	10	and	and	CCONJ
ihlr-28381	125	11	fund	fund	VERB
ihlr-28381	125	12	new	new	ADJ
ihlr-28381	125	13	inventions	invention	NOUN
ihlr-28381	125	14	.	.	PUNCT
ihlr-28381	126	1	sometimes	sometimes	ADV
ihlr-28381	126	2	delaying	delay	VERB
ihlr-28381	126	3	generic	generic	ADJ
ihlr-28381	126	4	entry	entry	NOUN
ihlr-28381	126	5	is	be	AUX
ihlr-28381	126	6	the	the	DET
ihlr-28381	126	7	difference	difference	NOUN
ihlr-28381	126	8	between	between	ADP
ihlr-28381	126	9	solvency	solvency	NOUN
ihlr-28381	126	10	and	and	CCONJ
ihlr-28381	126	11	bankruptcy	bankruptcy	NOUN
ihlr-28381	126	12	for	for	ADP
ihlr-28381	126	13	a	a	DET
ihlr-28381	126	14	firm	firm	NOUN
ihlr-28381	126	15	with	with	ADP
ihlr-28381	126	16	one	one	NUM
ihlr-28381	126	17	or	or	CCONJ
ihlr-28381	126	18	few	few	ADJ
ihlr-28381	126	19	marketable	marketable	ADJ
ihlr-28381	126	20	products	product	NOUN
ihlr-28381	126	21	.	.	PUNCT
ihlr-28381	127	1	however	however	ADV
ihlr-28381	127	2	,	,	PUNCT
ihlr-28381	127	3	if	if	SCONJ
ihlr-28381	127	4	financial	financial	ADJ
ihlr-28381	127	5	health	health	NOUN
ihlr-28381	127	6	is	be	AUX
ihlr-28381	127	7	achievable	achievable	ADJ
ihlr-28381	127	8	through	through	ADP
ihlr-28381	127	9	more	more	ADV
ihlr-28381	127	10	certain	certain	ADJ
ihlr-28381	127	11	means	mean	NOUN
ihlr-28381	127	12	,	,	PUNCT
ihlr-28381	127	13	the	the	DET
ihlr-28381	127	14	utility	utility	NOUN
ihlr-28381	127	15	of	of	ADP
ihlr-28381	127	16	pay	pay	NOUN
ihlr-28381	127	17	-	-	PUNCT
ihlr-28381	127	18	for	for	ADP
ihlr-28381	127	19	-	-	PUNCT
ihlr-28381	127	20	delay	delay	NOUN
ihlr-28381	127	21	as	as	SCONJ
ihlr-28381	127	22	a	a	DET
ihlr-28381	127	23	business	business	NOUN
ihlr-28381	127	24	strategy	strategy	NOUN
ihlr-28381	127	25	is	be	AUX
ihlr-28381	127	26	reduced	reduce	VERB
ihlr-28381	127	27	.	.	PUNCT
ihlr-28381	128	1	much	much	ADV
ihlr-28381	128	2	like	like	ADP
ihlr-28381	128	3	a	a	DET
ihlr-28381	128	4	bird	bird	NOUN
ihlr-28381	128	5	in	in	ADP
ihlr-28381	128	6	the	the	DET
ihlr-28381	128	7	hand	hand	NOUN
ihlr-28381	128	8	that	that	PRON
ihlr-28381	128	9	is	be	AUX
ihlr-28381	128	10	worth	worth	ADJ
ihlr-28381	128	11	more	more	ADJ
ihlr-28381	128	12	than	than	ADP
ihlr-28381	128	13	two	two	NUM
ihlr-28381	128	14	in	in	ADP
ihlr-28381	128	15	the	the	DET
ihlr-28381	128	16	bush	bush	NOUN
ihlr-28381	128	17	,	,	PUNCT
ihlr-28381	128	18	the	the	DET
ihlr-28381	128	19	certainty	certainty	NOUN
ihlr-28381	128	20	of	of	ADP
ihlr-28381	128	21	a	a	DET
ihlr-28381	128	22	valuable	valuable	ADJ
ihlr-28381	128	23	wildcard	wildcard	NOUN
ihlr-28381	128	24	on	on	ADP
ihlr-28381	128	25	the	the	DET
ihlr-28381	128	26	balance	balance	NOUN
ihlr-28381	128	27	sheet	sheet	NOUN
ihlr-28381	128	28	can	can	AUX
ihlr-28381	128	29	outweigh	outweigh	VERB
ihlr-28381	128	30	the	the	DET
ihlr-28381	128	31	pursuit	pursuit	NOUN
ihlr-28381	128	32	of	of	ADP
ihlr-28381	128	33	future	future	ADJ
ihlr-28381	128	34	monopoly	monopoly	NOUN
ihlr-28381	128	35	sales	sale	NOUN
ihlr-28381	128	36	,	,	PUNCT
ihlr-28381	128	37	the	the	DET
ihlr-28381	128	38	value	value	NOUN
ihlr-28381	128	39	of	of	ADP
ihlr-28381	128	40	which	which	PRON
ihlr-28381	128	41	must	must	AUX
ihlr-28381	128	42	be	be	AUX
ihlr-28381	128	43	discounted	discount	VERB
ihlr-28381	128	44	by	by	ADP
ihlr-28381	128	45	the	the	DET
ihlr-28381	128	46	uncertainty	uncertainty	NOUN
ihlr-28381	128	47	,	,	PUNCT
ihlr-28381	128	48	cost	cost	NOUN
ihlr-28381	128	49	of	of	ADP
ihlr-28381	128	50	litigation	litigation	NOUN
ihlr-28381	128	51	,	,	PUNCT
ihlr-28381	128	52	and	and	CCONJ
ihlr-28381	128	53	potential	potential	NOUN
ihlr-28381	128	54	for	for	ADP
ihlr-28381	128	55	antitrust	antitrust	ADJ
ihlr-28381	128	56	liability	liability	NOUN
ihlr-28381	128	57	.	.	PUNCT
ihlr-28381	129	1	iv	iv	X
ihlr-28381	129	2	.	.	PUNCT
ihlr-28381	129	3	hatch	hatch	PROPN
ihlr-28381	129	4	-	-	PUNCT
ihlr-28381	129	5	waxman	waxman	PROPN
ihlr-28381	129	6	&	&	CCONJ
ihlr-28381	129	7	pay	pay	PROPN
ihlr-28381	129	8	-	-	PUNCT
ihlr-28381	129	9	for	for	ADP
ihlr-28381	129	10	-	-	PUNCT
ihlr-28381	129	11	delay	delay	NOUN
ihlr-28381	129	12	in	in	ADP
ihlr-28381	129	13	1984	1984	NUM
ihlr-28381	129	14	,	,	PUNCT
ihlr-28381	129	15	congress	congress	PROPN
ihlr-28381	129	16	enacted	enact	VERB
ihlr-28381	129	17	the	the	DET
ihlr-28381	129	18	drug	drug	NOUN
ihlr-28381	129	19	price	price	NOUN
ihlr-28381	129	20	competition	competition	NOUN
ihlr-28381	129	21	and	and	CCONJ
ihlr-28381	129	22	patent	patent	NOUN
ihlr-28381	129	23	term	term	NOUN
ihlr-28381	129	24	restoration	restoration	NOUN
ihlr-28381	129	25	act	act	NOUN
ihlr-28381	129	26	,	,	PUNCT
ihlr-28381	129	27	better	well	ADV
ihlr-28381	129	28	known	know	VERB
ihlr-28381	129	29	as	as	ADP
ihlr-28381	129	30	the	the	DET
ihlr-28381	129	31	hatch	hatch	NOUN
ihlr-28381	129	32	-	-	PUNCT
ihlr-28381	129	33	waxman	waxman	NOUN
ihlr-28381	129	34	act.26	act.26	PROPN
ihlr-28381	129	35	hatch	hatch	PROPN
ihlr-28381	129	36	-	-	PUNCT
ihlr-28381	129	37	waxman	waxman	NOUN
ihlr-28381	129	38	increased	increase	VERB
ihlr-28381	129	39	drug	drug	NOUN
ihlr-28381	129	40	affordability	affordability	NOUN
ihlr-28381	129	41	by	by	ADP
ihlr-28381	129	42	adding	add	VERB
ihlr-28381	129	43	efficiency	efficiency	NOUN
ihlr-28381	129	44	to	to	ADP
ihlr-28381	129	45	the	the	DET
ihlr-28381	129	46	process	process	NOUN
ihlr-28381	129	47	by	by	ADP
ihlr-28381	129	48	which	which	PRON
ihlr-28381	129	49	generic	generic	ADJ
ihlr-28381	129	50	drugs	drug	NOUN
ihlr-28381	129	51	enter	enter	VERB
ihlr-28381	129	52	the	the	DET
ihlr-28381	129	53	market.27	market.27	PROPN
ihlr-28381	129	54	prior	prior	ADV
ihlr-28381	129	55	to	to	ADP
ihlr-28381	129	56	hatch	hatch	NOUN
ihlr-28381	129	57	-	-	PUNCT
ihlr-28381	129	58	waxman	waxman	NOUN
ihlr-28381	129	59	,	,	PUNCT
ihlr-28381	129	60	19	19	NUM
ihlr-28381	129	61	%	%	NOUN
ihlr-28381	129	62	of	of	ADP
ihlr-28381	129	63	prescriptions	prescription	NOUN
ihlr-28381	129	64	were	be	AUX
ihlr-28381	129	65	filled	fill	VERB
ihlr-28381	129	66	with	with	ADP
ihlr-28381	129	67	generic	generic	ADJ
ihlr-28381	129	68	drugs	drug	NOUN
ihlr-28381	129	69	and	and	CCONJ
ihlr-28381	129	70	35	35	NUM
ihlr-28381	129	71	%	%	NOUN
ihlr-28381	129	72	of	of	ADP
ihlr-28381	129	73	top	top	ADJ
ihlr-28381	129	74	-	-	PUNCT
ihlr-28381	129	75	selling	sell	VERB
ihlr-28381	129	76	drugs	drug	NOUN
ihlr-28381	129	77	faced	face	VERB
ihlr-28381	129	78	generic	generic	ADJ
ihlr-28381	129	79	competition	competition	NOUN
ihlr-28381	129	80	following	follow	VERB
ihlr-28381	129	81	patent	patent	NOUN
ihlr-28381	129	82	expirations.28	expirations.28	PROPN
ihlr-28381	129	83	today	today	NOUN
ihlr-28381	129	84	,	,	PUNCT
ihlr-28381	129	85	90	90	NUM
ihlr-28381	129	86	%	%	NOUN
ihlr-28381	129	87	of	of	ADP
ihlr-28381	129	88	prescriptions	prescription	NOUN
ihlr-28381	129	89	are	be	AUX
ihlr-28381	129	90	filled	fill	VERB
ihlr-28381	129	91	with	with	ADP
ihlr-28381	129	92	generic	generic	ADJ
ihlr-28381	129	93	drugs	drug	NOUN
ihlr-28381	129	94	/	/	SYM
ihlr-28381	129	95	generic	generic	ADJ
ihlr-28381	129	96	-	-	PUNCT
ihlr-28381	129	97	drug	drug	NOUN
ihlr-28381	129	98	-	-	PUNCT
ihlr-28381	129	99	facts	fact	NOUN
ihlr-28381	129	100	[	[	X
ihlr-28381	129	101	https://perma.cc/2xna-7wtz	https://perma.cc/2xna-7wtz	X
ihlr-28381	129	102	]	]	X
ihlr-28381	129	103	(	(	PUNCT
ihlr-28381	129	104	last	last	ADV
ihlr-28381	129	105	updated	update	VERB
ihlr-28381	129	106	nov	nov	PROPN
ihlr-28381	129	107	.	.	PROPN
ihlr-28381	129	108	2021	2021	NUM
ihlr-28381	129	109	)	)	PUNCT
ihlr-28381	129	110	.	.	PUNCT
ihlr-28381	130	1	23	23	NUM
ihlr-28381	130	2	.	.	PUNCT
ihlr-28381	131	1	u.s	u.s	PROPN
ihlr-28381	131	2	.	.	PROPN
ihlr-28381	131	3	food	food	PROPN
ihlr-28381	131	4	&	&	CCONJ
ihlr-28381	131	5	drug	drug	PROPN
ihlr-28381	131	6	admin	admin	PROPN
ihlr-28381	131	7	.	.	PROPN
ihlr-28381	131	8	,	,	PUNCT
ihlr-28381	131	9	office	office	NOUN
ihlr-28381	131	10	of	of	ADP
ihlr-28381	131	11	generic	generic	ADJ
ihlr-28381	131	12	drugs	drug	NOUN
ihlr-28381	131	13	:	:	PUNCT
ihlr-28381	131	14	2021	2021	NUM
ihlr-28381	131	15	annual	annual	ADJ
ihlr-28381	131	16	report	report	NOUN
ihlr-28381	131	17	2	2	NUM
ihlr-28381	131	18	,	,	PUNCT
ihlr-28381	131	19	9	9	NUM
ihlr-28381	131	20	(	(	PUNCT
ihlr-28381	131	21	2022	2022	NUM
ihlr-28381	131	22	)	)	PUNCT
ihlr-28381	131	23	,	,	PUNCT
ihlr-28381	131	24	https://www.fda.gov/drugs/generic-drugs/office-generic-drugs-2021-annual-report	https://www.fda.gov/drugs/generic-drugs/office-generic-drugs-2021-annual-report	PROPN
ihlr-28381	132	1	[	[	X
ihlr-28381	132	2	https://perma.cc/7wkg-4byc	https://perma.cc/7wkg-4byc	X
ihlr-28381	132	3	]	]	X
ihlr-28381	132	4	.	.	PUNCT
ihlr-28381	133	1	24	24	NUM
ihlr-28381	133	2	.	.	PUNCT
ihlr-28381	134	1	i	i	PRON
ihlr-28381	134	2	d.	d.	PROPN
ihlr-28381	134	3	at	at	ADP
ihlr-28381	134	4	2	2	NUM
ihlr-28381	134	5	.	.	NUM
ihlr-28381	134	6	25	25	NUM
ihlr-28381	134	7	.	.	PUNCT
ihlr-28381	135	1	i	i	PRON
ihlr-28381	135	2	d.	d.	PROPN
ihlr-28381	135	3	26	26	NUM
ihlr-28381	135	4	.	.	PUNCT
ihlr-28381	135	5	21	21	NUM
ihlr-28381	135	6	u.s.c	u.s.c	NOUN
ihlr-28381	135	7	.	.	PUNCT
ihlr-28381	136	1	§	§	PROPN
ihlr-28381	136	2	355	355	NUM
ihlr-28381	136	3	(	(	PUNCT
ihlr-28381	136	4	2022	2022	NUM
ihlr-28381	136	5	)	)	PUNCT
ihlr-28381	136	6	.	.	PUNCT
ihlr-28381	137	1	27	27	NUM
ihlr-28381	137	2	.	.	PUNCT
ihlr-28381	138	1	what	what	PRON
ihlr-28381	138	2	is	be	AUX
ihlr-28381	138	3	hatch	hatch	NOUN
ihlr-28381	138	4	-	-	PUNCT
ihlr-28381	138	5	waxman	waxman	NOUN
ihlr-28381	138	6	,	,	PUNCT
ihlr-28381	138	7	phrma	phrma	NOUN
ihlr-28381	138	8	(	(	PUNCT
ihlr-28381	138	9	2018	2018	NUM
ihlr-28381	138	10	)	)	PUNCT
ihlr-28381	138	11	,	,	PUNCT
ihlr-28381	138	12	https://phrma.org/resource-center/topics/costand-value/what-is-hatch-waxman	https://phrma.org/resource-center/topics/costand-value/what-is-hatch-waxman	NOUN
ihlr-28381	139	1	[	[	X
ihlr-28381	139	2	https://perma.cc/u7lh-5gsj	https://perma.cc/u7lh-5gsj	X
ihlr-28381	139	3	]	]	X
ihlr-28381	139	4	.	.	PUNCT
ihlr-28381	140	1	28	28	NUM
ihlr-28381	140	2	.	.	PUNCT
ihlr-28381	141	1	i	i	PRON
ihlr-28381	141	2	d.	d.	PROPN
ihlr-28381	141	3	https://perma.cc/u7lh-5gsj	https://perma.cc/u7lh-5gsj	PROPN
ihlr-28381	141	4	128	128	NUM
ihlr-28381	141	5	indiana	indiana	PROPN
ihlr-28381	141	6	health	health	PROPN
ihlr-28381	141	7	law	law	PROPN
ihlr-28381	141	8	review	review	NOUN
ihlr-28381	142	1	[	[	X
ihlr-28381	142	2	vol	vol	NOUN
ihlr-28381	142	3	.	.	NOUN
ihlr-28381	142	4	21:121	21:121	NUM
ihlr-28381	142	5	drugs	drug	NOUN
ihlr-28381	142	6	and	and	CCONJ
ihlr-28381	142	7	over	over	ADP
ihlr-28381	142	8	80	80	NUM
ihlr-28381	142	9	%	%	NOUN
ihlr-28381	142	10	of	of	ADP
ihlr-28381	142	11	brand	brand	NOUN
ihlr-28381	142	12	drugs	drug	NOUN
ihlr-28381	142	13	face	face	VERB
ihlr-28381	142	14	generic	generic	ADJ
ihlr-28381	142	15	competition.29	competition.29	PROPN
ihlr-28381	142	16	hatch	hatch	PROPN
ihlr-28381	142	17	-	-	PUNCT
ihlr-28381	142	18	waxman	waxman	NOUN
ihlr-28381	142	19	achieved	achieve	VERB
ihlr-28381	142	20	these	these	DET
ihlr-28381	142	21	improvements	improvement	NOUN
ihlr-28381	142	22	by	by	ADP
ihlr-28381	142	23	increasing	increase	VERB
ihlr-28381	142	24	the	the	DET
ihlr-28381	142	25	efficiency	efficiency	NOUN
ihlr-28381	142	26	and	and	CCONJ
ihlr-28381	142	27	profitability	profitability	NOUN
ihlr-28381	142	28	of	of	ADP
ihlr-28381	142	29	bringing	bring	VERB
ihlr-28381	142	30	a	a	DET
ihlr-28381	142	31	generic	generic	NOUN
ihlr-28381	142	32	to	to	ADP
ihlr-28381	142	33	market	market	NOUN
ihlr-28381	142	34	.	.	PUNCT
ihlr-28381	143	1	previously	previously	ADV
ihlr-28381	143	2	,	,	PUNCT
ihlr-28381	143	3	the	the	DET
ihlr-28381	143	4	use	use	NOUN
ihlr-28381	143	5	of	of	ADP
ihlr-28381	143	6	patented	patented	ADJ
ihlr-28381	143	7	inventions	invention	NOUN
ihlr-28381	143	8	to	to	PART
ihlr-28381	143	9	develop	develop	VERB
ihlr-28381	143	10	drugs	drug	NOUN
ihlr-28381	143	11	,	,	PUNCT
ihlr-28381	143	12	even	even	ADV
ihlr-28381	143	13	if	if	SCONJ
ihlr-28381	143	14	not	not	PART
ihlr-28381	143	15	marketed	market	VERB
ihlr-28381	143	16	,	,	PUNCT
ihlr-28381	143	17	constituted	constitute	VERB
ihlr-28381	143	18	infringement.30	infringement.30	PROPN
ihlr-28381	143	19	because	because	SCONJ
ihlr-28381	143	20	generic	generic	ADJ
ihlr-28381	143	21	development	development	NOUN
ihlr-28381	143	22	and	and	CCONJ
ihlr-28381	143	23	approval	approval	NOUN
ihlr-28381	143	24	processes	process	NOUN
ihlr-28381	143	25	require	require	VERB
ihlr-28381	143	26	years	year	NOUN
ihlr-28381	143	27	of	of	ADP
ihlr-28381	143	28	work	work	NOUN
ihlr-28381	143	29	,	,	PUNCT
ihlr-28381	143	30	this	this	DET
ihlr-28381	143	31	outdated	outdated	ADJ
ihlr-28381	143	32	treatment	treatment	NOUN
ihlr-28381	143	33	of	of	ADP
ihlr-28381	143	34	generic	generic	ADJ
ihlr-28381	143	35	development	development	NOUN
ihlr-28381	143	36	effectively	effectively	ADV
ihlr-28381	143	37	extended	extend	VERB
ihlr-28381	143	38	patent	patent	NOUN
ihlr-28381	143	39	protections	protection	NOUN
ihlr-28381	143	40	.	.	PUNCT
ihlr-28381	144	1	hatch	hatch	NOUN
ihlr-28381	144	2	-	-	PUNCT
ihlr-28381	144	3	waxman	waxman	NOUN
ihlr-28381	144	4	changed	change	VERB
ihlr-28381	144	5	this	this	PRON
ihlr-28381	144	6	,	,	PUNCT
ihlr-28381	144	7	stating	state	VERB
ihlr-28381	144	8	“	"	PUNCT
ihlr-28381	144	9	it	it	PRON
ihlr-28381	144	10	shall	shall	AUX
ihlr-28381	144	11	not	not	PART
ihlr-28381	144	12	be	be	AUX
ihlr-28381	144	13	an	an	DET
ihlr-28381	144	14	act	act	NOUN
ihlr-28381	144	15	of	of	ADP
ihlr-28381	144	16	infringement	infringement	NOUN
ihlr-28381	144	17	”	"	PUNCT
ihlr-28381	144	18	to	to	PART
ihlr-28381	144	19	use	use	VERB
ihlr-28381	144	20	a	a	DET
ihlr-28381	144	21	patented	patented	ADJ
ihlr-28381	144	22	invention	invention	NOUN
ihlr-28381	144	23	in	in	ADP
ihlr-28381	144	24	the	the	DET
ihlr-28381	144	25	development	development	NOUN
ihlr-28381	144	26	and	and	CCONJ
ihlr-28381	144	27	submission	submission	NOUN
ihlr-28381	144	28	of	of	ADP
ihlr-28381	144	29	information	information	NOUN
ihlr-28381	144	30	under	under	ADP
ihlr-28381	144	31	federal	federal	ADJ
ihlr-28381	144	32	drug	drug	NOUN
ihlr-28381	144	33	law	law	NOUN
ihlr-28381	144	34	.	.	PUNCT
ihlr-28381	145	1	31	31	NUM
ihlr-28381	145	2	this	this	DET
ihlr-28381	145	3	efficiency	efficiency	NOUN
ihlr-28381	145	4	,	,	PUNCT
ihlr-28381	145	5	with	with	ADP
ihlr-28381	145	6	others	other	NOUN
ihlr-28381	145	7	including	include	VERB
ihlr-28381	145	8	the	the	DET
ihlr-28381	145	9	abbreviated	abbreviate	VERB
ihlr-28381	145	10	new	new	ADJ
ihlr-28381	145	11	drug	drug	NOUN
ihlr-28381	145	12	application,32	application,32	VERB
ihlr-28381	145	13	ease	ease	NOUN
ihlr-28381	145	14	and	and	CCONJ
ihlr-28381	145	15	expedite	expedite	ADJ
ihlr-28381	145	16	generic	generic	ADJ
ihlr-28381	145	17	competition	competition	NOUN
ihlr-28381	145	18	.	.	PUNCT
ihlr-28381	146	1	regarding	regard	VERB
ihlr-28381	146	2	profitability	profitability	NOUN
ihlr-28381	146	3	,	,	PUNCT
ihlr-28381	146	4	hatch	hatch	NOUN
ihlr-28381	146	5	-	-	PUNCT
ihlr-28381	146	6	waxman	waxman	NOUN
ihlr-28381	146	7	incentivizes	incentivize	VERB
ihlr-28381	146	8	generic	generic	ADJ
ihlr-28381	146	9	competition	competition	NOUN
ihlr-28381	146	10	by	by	ADP
ihlr-28381	146	11	rewarding	reward	VERB
ihlr-28381	146	12	the	the	DET
ihlr-28381	146	13	first	first	ADJ
ihlr-28381	146	14	company	company	NOUN
ihlr-28381	146	15	to	to	PART
ihlr-28381	146	16	offer	offer	VERB
ihlr-28381	146	17	a	a	DET
ihlr-28381	146	18	generic	generic	ADJ
ihlr-28381	146	19	alternative	alternative	NOUN
ihlr-28381	146	20	to	to	ADP
ihlr-28381	146	21	an	an	DET
ihlr-28381	146	22	existing	exist	VERB
ihlr-28381	146	23	drug	drug	NOUN
ihlr-28381	146	24	with	with	ADP
ihlr-28381	146	25	a	a	DET
ihlr-28381	146	26	180	180	NUM
ihlr-28381	146	27	-	-	PUNCT
ihlr-28381	146	28	day	day	NOUN
ihlr-28381	146	29	exclusivity	exclusivity	NOUN
ihlr-28381	146	30	period.33	period.33	NOUN
ihlr-28381	146	31	this	this	DET
ihlr-28381	146	32	exclusivity	exclusivity	NOUN
ihlr-28381	146	33	period	period	NOUN
ihlr-28381	146	34	increases	increase	VERB
ihlr-28381	146	35	generic	generic	ADJ
ihlr-28381	146	36	profitability	profitability	NOUN
ihlr-28381	146	37	by	by	ADP
ihlr-28381	146	38	allowing	allow	VERB
ihlr-28381	146	39	the	the	DET
ihlr-28381	146	40	generic	generic	ADJ
ihlr-28381	146	41	to	to	PART
ihlr-28381	146	42	compete	compete	VERB
ihlr-28381	146	43	with	with	ADP
ihlr-28381	146	44	the	the	DET
ihlr-28381	146	45	brand	brand	NOUN
ihlr-28381	146	46	company	company	NOUN
ihlr-28381	146	47	alone	alone	ADJ
ihlr-28381	146	48	for	for	ADP
ihlr-28381	146	49	180	180	NUM
ihlr-28381	146	50	days	day	NOUN
ihlr-28381	146	51	,	,	PUNCT
ihlr-28381	146	52	rather	rather	ADV
ihlr-28381	146	53	than	than	ADP
ihlr-28381	146	54	competing	compete	VERB
ihlr-28381	146	55	with	with	ADP
ihlr-28381	146	56	other	other	ADJ
ihlr-28381	146	57	generic	generic	ADJ
ihlr-28381	146	58	competitors	competitor	NOUN
ihlr-28381	146	59	in	in	ADP
ihlr-28381	146	60	addition	addition	NOUN
ihlr-28381	146	61	to	to	ADP
ihlr-28381	146	62	the	the	DET
ihlr-28381	146	63	brand	brand	NOUN
ihlr-28381	146	64	company	company	NOUN
ihlr-28381	146	65	.	.	PUNCT
ihlr-28381	147	1	in	in	ADP
ihlr-28381	147	2	other	other	ADJ
ihlr-28381	147	3	words	word	NOUN
ihlr-28381	147	4	,	,	PUNCT
ihlr-28381	147	5	the	the	DET
ihlr-28381	147	6	fastest	fast	ADJ
ihlr-28381	147	7	generic	generic	ADJ
ihlr-28381	147	8	company	company	NOUN
ihlr-28381	147	9	gets	get	VERB
ihlr-28381	147	10	to	to	PART
ihlr-28381	147	11	go	go	VERB
ihlr-28381	147	12	oneon	oneon	NOUN
ihlr-28381	147	13	-	-	PUNCT
ihlr-28381	147	14	one	one	NUM
ihlr-28381	147	15	with	with	ADP
ihlr-28381	147	16	the	the	DET
ihlr-28381	147	17	brand	brand	NOUN
ihlr-28381	147	18	company	company	NOUN
ihlr-28381	147	19	for	for	ADP
ihlr-28381	147	20	six	six	NUM
ihlr-28381	147	21	months	month	NOUN
ihlr-28381	147	22	before	before	SCONJ
ihlr-28381	147	23	more	more	ADJ
ihlr-28381	147	24	generic	generic	ADJ
ihlr-28381	147	25	competition	competition	NOUN
ihlr-28381	147	26	enters	enter	VERB
ihlr-28381	147	27	the	the	DET
ihlr-28381	147	28	market	market	NOUN
ihlr-28381	147	29	.	.	PUNCT
ihlr-28381	148	1	acutely	acutely	ADV
ihlr-28381	148	2	designed	design	VERB
ihlr-28381	148	3	to	to	PART
ihlr-28381	148	4	affect	affect	VERB
ihlr-28381	148	5	pressure	pressure	NOUN
ihlr-28381	148	6	points	point	NOUN
ihlr-28381	148	7	within	within	ADP
ihlr-28381	148	8	the	the	DET
ihlr-28381	148	9	market	market	NOUN
ihlr-28381	148	10	,	,	PUNCT
ihlr-28381	148	11	hatch	hatch	NOUN
ihlr-28381	148	12	-	-	PUNCT
ihlr-28381	148	13	waxman	waxman	NOUN
ihlr-28381	148	14	brought	bring	VERB
ihlr-28381	148	15	about	about	ADP
ihlr-28381	148	16	greater	great	ADJ
ihlr-28381	148	17	savings	saving	NOUN
ihlr-28381	148	18	and	and	CCONJ
ihlr-28381	148	19	greater	great	ADJ
ihlr-28381	148	20	access	access	NOUN
ihlr-28381	148	21	for	for	ADP
ihlr-28381	148	22	patients	patient	NOUN
ihlr-28381	148	23	.	.	PUNCT
ihlr-28381	149	1	competition	competition	NOUN
ihlr-28381	149	2	increased	increase	VERB
ihlr-28381	149	3	while	while	SCONJ
ihlr-28381	149	4	prices	price	NOUN
ihlr-28381	149	5	fell.34	fell.34	VERB
ihlr-28381	149	6	between	between	ADP
ihlr-28381	149	7	2009	2009	NUM
ihlr-28381	149	8	and	and	CCONJ
ihlr-28381	149	9	2019	2019	NUM
ihlr-28381	149	10	,	,	PUNCT
ihlr-28381	149	11	generic	generic	ADJ
ihlr-28381	149	12	drugs	drug	NOUN
ihlr-28381	149	13	were	be	AUX
ihlr-28381	149	14	estimated	estimate	VERB
ihlr-28381	149	15	to	to	PART
ihlr-28381	149	16	save	save	VERB
ihlr-28381	149	17	the	the	DET
ihlr-28381	149	18	u.s	u.s	PROPN
ihlr-28381	149	19	.	.	PROPN
ihlr-28381	149	20	healthcare	healthcare	PROPN
ihlr-28381	149	21	system	system	NOUN
ihlr-28381	149	22	over	over	ADP
ihlr-28381	149	23	two	two	NUM
ihlr-28381	149	24	trillion	trillion	NUM
ihlr-28381	149	25	dollars.35	dollars.35	NOUN
ihlr-28381	149	26	nevertheless	nevertheless	ADV
ihlr-28381	149	27	,	,	PUNCT
ihlr-28381	149	28	billions	billion	NOUN
ihlr-28381	149	29	in	in	ADP
ihlr-28381	149	30	would	would	AUX
ihlr-28381	149	31	-	-	PUNCT
ihlr-28381	149	32	be	be	AUX
ihlr-28381	149	33	hatch	hatch	NOUN
ihlr-28381	149	34	-	-	PUNCT
ihlr-28381	149	35	waxman	waxman	NOUN
ihlr-28381	149	36	savings	saving	NOUN
ihlr-28381	149	37	go	go	VERB
ihlr-28381	149	38	unrealized	unrealized	ADJ
ihlr-28381	149	39	as	as	SCONJ
ihlr-28381	149	40	some	some	DET
ihlr-28381	149	41	companies	company	NOUN
ihlr-28381	149	42	avoid	avoid	VERB
ihlr-28381	149	43	generic	generic	ADJ
ihlr-28381	149	44	pressure	pressure	NOUN
ihlr-28381	149	45	and	and	CCONJ
ihlr-28381	149	46	maintain	maintain	VERB
ihlr-28381	149	47	monopoly	monopoly	NOUN
ihlr-28381	149	48	-	-	PUNCT
ihlr-28381	149	49	level	level	NOUN
ihlr-28381	149	50	prices.36	prices.36	NOUN
ihlr-28381	149	51	patentees	patentee	NOUN
ihlr-28381	149	52	(	(	PUNCT
ihlr-28381	149	53	patent	patent	NOUN
ihlr-28381	149	54	holders	holder	NOUN
ihlr-28381	149	55	)	)	PUNCT
ihlr-28381	149	56	may	may	AUX
ihlr-28381	149	57	anticipate	anticipate	VERB
ihlr-28381	149	58	the	the	DET
ihlr-28381	149	59	impending	impending	ADJ
ihlr-28381	149	60	consequences	consequence	NOUN
ihlr-28381	149	61	of	of	ADP
ihlr-28381	149	62	patent	patent	NOUN
ihlr-28381	149	63	expiration	expiration	NOUN
ihlr-28381	149	64	and	and	CCONJ
ihlr-28381	149	65	stall	stall	VERB
ihlr-28381	149	66	generic	generic	ADJ
ihlr-28381	149	67	entry	entry	NOUN
ihlr-28381	149	68	with	with	ADP
ihlr-28381	149	69	a	a	DET
ihlr-28381	149	70	variety	variety	NOUN
ihlr-28381	149	71	of	of	ADP
ihlr-28381	149	72	legal	legal	ADJ
ihlr-28381	149	73	maneuvers	maneuver	NOUN
ihlr-28381	149	74	.	.	PUNCT
ihlr-28381	150	1	the	the	DET
ihlr-28381	150	2	“	"	PUNCT
ihlr-28381	150	3	reverse	reverse	ADJ
ihlr-28381	150	4	payment	payment	NOUN
ihlr-28381	150	5	settlement	settlement	NOUN
ihlr-28381	150	6	agreement”—under	agreement”—under	PUNCT
ihlr-28381	150	7	anti	anti	ADJ
ihlr-28381	150	8	-	-	ADJ
ihlr-28381	150	9	competitive	competitive	ADJ
ihlr-28381	150	10	circumstances	circumstance	NOUN
ihlr-28381	150	11	—	—	PUNCT
ihlr-28381	150	12	is	be	AUX
ihlr-28381	150	13	the	the	DET
ihlr-28381	150	14	original	original	ADJ
ihlr-28381	150	15	form	form	NOUN
ihlr-28381	150	16	of	of	ADP
ihlr-28381	150	17	pay	pay	NOUN
ihlr-28381	150	18	-	-	PUNCT
ihlr-28381	150	19	for	for	ADP
ihlr-28381	150	20	-	-	PUNCT
ihlr-28381	150	21	delay	delay	NOUN
ihlr-28381	150	22	and	and	CCONJ
ihlr-28381	150	23	an	an	DET
ihlr-28381	150	24	unintended	unintended	ADJ
ihlr-28381	150	25	byproduct	byproduct	NOUN
ihlr-28381	150	26	of	of	ADP
ihlr-28381	150	27	the	the	DET
ihlr-28381	150	28	hatchwaxman	hatchwaxman	PROPN
ihlr-28381	150	29	model	model	NOUN
ihlr-28381	150	30	.	.	PUNCT
ihlr-28381	151	1	anti	anti	ADJ
ihlr-28381	151	2	-	-	ADJ
ihlr-28381	151	3	competitive	competitive	ADJ
ihlr-28381	151	4	reverse	reverse	ADJ
ihlr-28381	151	5	payment	payment	NOUN
ihlr-28381	151	6	settlement	settlement	NOUN
ihlr-28381	151	7	agreements	agreement	NOUN
ihlr-28381	151	8	remain	remain	VERB
ihlr-28381	151	9	emblematic	emblematic	ADJ
ihlr-28381	151	10	of	of	ADP
ihlr-28381	151	11	“	"	PUNCT
ihlr-28381	151	12	pay	pay	VERB
ihlr-28381	151	13	-	-	PUNCT
ihlr-28381	151	14	for	for	ADP
ihlr-28381	151	15	-	-	PUNCT
ihlr-28381	151	16	delay	delay	NOUN
ihlr-28381	151	17	,	,	PUNCT
ihlr-28381	151	18	”	"	PUNCT
ihlr-28381	151	19	but	but	CCONJ
ihlr-28381	151	20	the	the	DET
ihlr-28381	151	21	phrase	phrase	NOUN
ihlr-28381	151	22	has	have	AUX
ihlr-28381	151	23	evolved	evolve	VERB
ihlr-28381	151	24	into	into	ADP
ihlr-28381	151	25	a	a	DET
ihlr-28381	151	26	more	more	ADV
ihlr-28381	151	27	general	general	ADJ
ihlr-28381	151	28	reference	reference	NOUN
ihlr-28381	151	29	to	to	ADP
ihlr-28381	151	30	the	the	DET
ihlr-28381	151	31	tactical	tactical	ADJ
ihlr-28381	151	32	delay	delay	NOUN
ihlr-28381	151	33	of	of	ADP
ihlr-28381	151	34	competition	competition	NOUN
ihlr-28381	151	35	.	.	PUNCT
ihlr-28381	152	1	a.	a.	NOUN
ihlr-28381	152	2	hatch	hatch	PROPN
ihlr-28381	152	3	-	-	PUNCT
ihlr-28381	152	4	waxman	waxman	NOUN
ihlr-28381	152	5	’s	’s	PART
ihlr-28381	152	6	abbreviated	abbreviate	VERB
ihlr-28381	152	7	new	new	ADJ
ihlr-28381	152	8	drug	drug	NOUN
ihlr-28381	152	9	application	application	NOUN
ihlr-28381	152	10	pathway	pathway	NOUN
ihlr-28381	152	11	hatch	hatch	PROPN
ihlr-28381	152	12	-	-	PUNCT
ihlr-28381	152	13	waxman	waxman	NOUN
ihlr-28381	152	14	promotes	promote	VERB
ihlr-28381	152	15	competition	competition	NOUN
ihlr-28381	152	16	by	by	ADP
ihlr-28381	152	17	helping	help	VERB
ihlr-28381	152	18	generic	generic	ADJ
ihlr-28381	152	19	manufacturers	manufacturer	NOUN
ihlr-28381	152	20	reach	reach	VERB
ihlr-28381	152	21	the	the	DET
ihlr-28381	152	22	market	market	NOUN
ihlr-28381	152	23	faster	fast	ADV
ihlr-28381	152	24	through	through	ADP
ihlr-28381	152	25	abbreviated	abbreviate	VERB
ihlr-28381	152	26	new	new	ADJ
ihlr-28381	152	27	drug	drug	NOUN
ihlr-28381	152	28	applications	application	NOUN
ihlr-28381	152	29	29	29	NUM
ihlr-28381	152	30	.	.	PUNCT
ihlr-28381	153	1	i	i	PRON
ihlr-28381	153	2	d.	d.	PROPN
ihlr-28381	153	3	30	30	NUM
ihlr-28381	153	4	.	.	PUNCT
ihlr-28381	154	1	roche	roche	PROPN
ihlr-28381	154	2	prod	prod	PROPN
ihlr-28381	154	3	.	.	PROPN
ihlr-28381	154	4	,	,	PUNCT
ihlr-28381	154	5	inc	inc	PROPN
ihlr-28381	154	6	.	.	PROPN
ihlr-28381	154	7	v.	v.	ADP
ihlr-28381	154	8	bolar	bolar	PROPN
ihlr-28381	154	9	pharm	pharm	PROPN
ihlr-28381	154	10	.	.	PUNCT
ihlr-28381	155	1	co.	co.	PROPN
ihlr-28381	155	2	,	,	PUNCT
ihlr-28381	155	3	733	733	NUM
ihlr-28381	155	4	f.2d	f.2d	ADP
ihlr-28381	155	5	858	858	NUM
ihlr-28381	155	6	(	(	PUNCT
ihlr-28381	155	7	fed	fed	PROPN
ihlr-28381	155	8	.	.	PUNCT
ihlr-28381	155	9	cir	cir	PROPN
ihlr-28381	155	10	.	.	PUNCT
ihlr-28381	155	11	1984	1984	NUM
ihlr-28381	155	12	)	)	PUNCT
ihlr-28381	155	13	.	.	PUNCT
ihlr-28381	156	1	31	31	NUM
ihlr-28381	156	2	.	.	SYM
ihlr-28381	156	3	35	35	NUM
ihlr-28381	156	4	u.s.c	u.s.c	NOUN
ihlr-28381	156	5	.	.	PUNCT
ihlr-28381	157	1	§	§	PROPN
ihlr-28381	157	2	271(e)(1	271(e)(1	PROPN
ihlr-28381	157	3	)	)	PUNCT
ihlr-28381	157	4	.	.	PUNCT
ihlr-28381	158	1	32	32	NUM
ihlr-28381	158	2	.	.	X
ihlr-28381	158	3	21	21	NUM
ihlr-28381	158	4	u.s.c	u.s.c	NOUN
ihlr-28381	158	5	.	.	PUNCT
ihlr-28381	159	1	§	§	PROPN
ihlr-28381	159	2	355(j	355(j	PROPN
ihlr-28381	159	3	)	)	PUNCT
ihlr-28381	159	4	(	(	PUNCT
ihlr-28381	159	5	2022	2022	NUM
ihlr-28381	159	6	)	)	PUNCT
ihlr-28381	159	7	.	.	PUNCT
ihlr-28381	160	1	33	33	NUM
ihlr-28381	160	2	.	.	PUNCT
ihlr-28381	161	1	i	i	PRON
ihlr-28381	161	2	d.	d.	PROPN
ihlr-28381	161	3	34	34	NUM
ihlr-28381	161	4	.	.	PUNCT
ihlr-28381	162	1	feldman	feldman	PROPN
ihlr-28381	162	2	&	&	CCONJ
ihlr-28381	162	3	frondorf	frondorf	PROPN
ihlr-28381	162	4	,	,	PUNCT
ihlr-28381	162	5	supra	supra	PROPN
ihlr-28381	162	6	note	note	PROPN
ihlr-28381	162	7	21	21	NUM
ihlr-28381	162	8	,	,	PUNCT
ihlr-28381	162	9	at	at	ADP
ihlr-28381	162	10	500	500	NUM
ihlr-28381	162	11	-	-	SYM
ihlr-28381	162	12	03	03	NUM
ihlr-28381	162	13	.	.	PUNCT
ihlr-28381	163	1	35	35	NUM
ihlr-28381	163	2	.	.	PUNCT
ihlr-28381	164	1	generic	generic	ADJ
ihlr-28381	164	2	drug	drug	NOUN
ihlr-28381	164	3	facts	fact	NOUN
ihlr-28381	164	4	,	,	PUNCT
ihlr-28381	164	5	supra	supra	PROPN
ihlr-28381	164	6	note	note	NOUN
ihlr-28381	164	7	22	22	NUM
ihlr-28381	164	8	.	.	PUNCT
ihlr-28381	165	1	36	36	NUM
ihlr-28381	165	2	.	.	PUNCT
ihlr-28381	166	1	feldman	feldman	PROPN
ihlr-28381	166	2	,	,	PUNCT
ihlr-28381	166	3	supra	supra	PROPN
ihlr-28381	166	4	note	note	PROPN
ihlr-28381	166	5	10	10	NUM
ihlr-28381	166	6	,	,	PUNCT
ihlr-28381	166	7	at	at	ADP
ihlr-28381	166	8	32	32	NUM
ihlr-28381	166	9	.	.	PUNCT
ihlr-28381	166	10	2024	2024	NUM
ihlr-28381	166	11	]	]	PUNCT
ihlr-28381	166	12	incentivizing	incentivize	VERB
ihlr-28381	166	13	drug	drug	NOUN
ihlr-28381	166	14	affordability	affordability	NOUN
ihlr-28381	166	15	129	129	NUM
ihlr-28381	166	16	(	(	PUNCT
ihlr-28381	166	17	“	"	PUNCT
ihlr-28381	166	18	anda”).37	anda”).37	PROPN
ihlr-28381	166	19	andas	anda	NOUN
ihlr-28381	166	20	may	may	AUX
ihlr-28381	166	21	be	be	AUX
ihlr-28381	166	22	submitted	submit	VERB
ihlr-28381	166	23	by	by	ADP
ihlr-28381	166	24	a	a	DET
ihlr-28381	166	25	generic	generic	ADJ
ihlr-28381	166	26	regardless	regardless	ADV
ihlr-28381	166	27	of	of	ADP
ihlr-28381	166	28	an	an	DET
ihlr-28381	166	29	innovator	innovator	NOUN
ihlr-28381	166	30	’s	’s	PART
ihlr-28381	166	31	patent	patent	NOUN
ihlr-28381	166	32	protection	protection	NOUN
ihlr-28381	166	33	through	through	ADP
ihlr-28381	166	34	a	a	DET
ihlr-28381	166	35	“	"	PUNCT
ihlr-28381	166	36	paragraph	paragraph	NOUN
ihlr-28381	166	37	iv	iv	NUM
ihlr-28381	166	38	certification	certification	NOUN
ihlr-28381	166	39	”	"	PUNCT
ihlr-28381	166	40	in	in	ADP
ihlr-28381	166	41	which	which	PRON
ihlr-28381	166	42	the	the	DET
ihlr-28381	166	43	generic	generic	NOUN
ihlr-28381	166	44	asserts	assert	VERB
ihlr-28381	166	45	that	that	SCONJ
ihlr-28381	166	46	existing	exist	VERB
ihlr-28381	166	47	patents	patent	NOUN
ihlr-28381	166	48	are	be	AUX
ihlr-28381	166	49	either	either	ADV
ihlr-28381	166	50	invalid	invalid	ADJ
ihlr-28381	166	51	or	or	CCONJ
ihlr-28381	166	52	would	would	AUX
ihlr-28381	166	53	not	not	PART
ihlr-28381	166	54	be	be	AUX
ihlr-28381	166	55	infringed	infringe	VERB
ihlr-28381	166	56	by	by	ADP
ihlr-28381	166	57	the	the	DET
ihlr-28381	166	58	generic	generic	ADJ
ihlr-28381	166	59	product.38	product.38	NOUN
ihlr-28381	166	60	this	this	PRON
ihlr-28381	166	61	allows	allow	VERB
ihlr-28381	166	62	generic	generic	ADJ
ihlr-28381	166	63	companies	company	NOUN
ihlr-28381	166	64	to	to	PART
ihlr-28381	166	65	begin	begin	VERB
ihlr-28381	166	66	developing	develop	VERB
ihlr-28381	166	67	generic	generic	ADJ
ihlr-28381	166	68	alternatives	alternative	NOUN
ihlr-28381	166	69	before	before	SCONJ
ihlr-28381	166	70	the	the	DET
ihlr-28381	166	71	innovator	innovator	NOUN
ihlr-28381	166	72	’s	’s	PART
ihlr-28381	166	73	patents	patent	NOUN
ihlr-28381	166	74	expire	expire	VERB
ihlr-28381	166	75	.	.	PUNCT
ihlr-28381	167	1	when	when	SCONJ
ihlr-28381	167	2	a	a	DET
ihlr-28381	167	3	paragraph	paragraph	NOUN
ihlr-28381	167	4	iv	iv	NUM
ihlr-28381	167	5	certification	certification	NOUN
ihlr-28381	167	6	is	be	AUX
ihlr-28381	167	7	filed	file	VERB
ihlr-28381	167	8	,	,	PUNCT
ihlr-28381	167	9	the	the	DET
ihlr-28381	167	10	certifying	certify	VERB
ihlr-28381	167	11	generic	generic	ADJ
ihlr-28381	167	12	company	company	NOUN
ihlr-28381	167	13	must	must	AUX
ihlr-28381	167	14	notify	notify	VERB
ihlr-28381	167	15	the	the	DET
ihlr-28381	167	16	implicated	implicated	ADJ
ihlr-28381	167	17	brand	brand	NOUN
ihlr-28381	167	18	-	-	PUNCT
ihlr-28381	167	19	name	name	NOUN
ihlr-28381	167	20	company	company	NOUN
ihlr-28381	167	21	within	within	ADP
ihlr-28381	167	22	20	20	NUM
ihlr-28381	167	23	days	day	NOUN
ihlr-28381	167	24	of	of	ADP
ihlr-28381	167	25	filing	file	VERB
ihlr-28381	167	26	the	the	DET
ihlr-28381	167	27	certification.39	certification.39	NOUN
ihlr-28381	167	28	after	after	ADP
ihlr-28381	167	29	receiving	receive	VERB
ihlr-28381	167	30	notice	notice	NOUN
ihlr-28381	167	31	of	of	ADP
ihlr-28381	167	32	the	the	DET
ihlr-28381	167	33	paragraph	paragraph	NOUN
ihlr-28381	167	34	iv	iv	NUM
ihlr-28381	167	35	certification	certification	NOUN
ihlr-28381	167	36	asserting	assert	VERB
ihlr-28381	167	37	the	the	DET
ihlr-28381	167	38	invalidity	invalidity	NOUN
ihlr-28381	167	39	or	or	CCONJ
ihlr-28381	167	40	non	non	NOUN
ihlr-28381	167	41	-	-	NOUN
ihlr-28381	167	42	infringement	infringement	NOUN
ihlr-28381	167	43	of	of	ADP
ihlr-28381	167	44	the	the	DET
ihlr-28381	167	45	patent	patent	NOUN
ihlr-28381	167	46	-	-	PUNCT
ihlr-28381	167	47	holding	holding	NOUN
ihlr-28381	167	48	,	,	PUNCT
ihlr-28381	167	49	brand	brand	NOUN
ihlr-28381	167	50	-	-	PUNCT
ihlr-28381	167	51	name	name	NOUN
ihlr-28381	167	52	company	company	NOUN
ihlr-28381	167	53	’s	’s	PART
ihlr-28381	167	54	patent(s	patent(s	PROPN
ihlr-28381	167	55	)	)	PUNCT
ihlr-28381	167	56	,	,	PUNCT
ihlr-28381	167	57	the	the	DET
ihlr-28381	167	58	brand	brand	NOUN
ihlr-28381	167	59	-	-	PUNCT
ihlr-28381	167	60	name	name	NOUN
ihlr-28381	167	61	company	company	NOUN
ihlr-28381	167	62	initiates	initiate	VERB
ihlr-28381	167	63	a	a	DET
ihlr-28381	167	64	lawsuit	lawsuit	NOUN
ihlr-28381	167	65	against	against	ADP
ihlr-28381	167	66	the	the	DET
ihlr-28381	167	67	generic	generic	ADJ
ihlr-28381	167	68	company	company	NOUN
ihlr-28381	167	69	for	for	ADP
ihlr-28381	167	70	patent	patent	NOUN
ihlr-28381	167	71	infringement	infringement	NOUN
ihlr-28381	167	72	.	.	PUNCT
ihlr-28381	168	1	this	this	DET
ihlr-28381	168	2	infringement	infringement	NOUN
ihlr-28381	168	3	right	right	NOUN
ihlr-28381	168	4	of	of	ADP
ihlr-28381	168	5	action	action	NOUN
ihlr-28381	168	6	is	be	AUX
ihlr-28381	168	7	preemptive	preemptive	ADJ
ihlr-28381	168	8	in	in	ADP
ihlr-28381	168	9	nature	nature	NOUN
ihlr-28381	168	10	,	,	PUNCT
ihlr-28381	168	11	granted	grant	VERB
ihlr-28381	168	12	to	to	ADP
ihlr-28381	168	13	brand	brand	NOUN
ihlr-28381	168	14	-	-	PUNCT
ihlr-28381	168	15	name	name	NOUN
ihlr-28381	168	16	companies	company	NOUN
ihlr-28381	168	17	even	even	ADV
ihlr-28381	168	18	though	though	SCONJ
ihlr-28381	168	19	the	the	DET
ihlr-28381	168	20	alleged	allege	VERB
ihlr-28381	168	21	infringement	infringement	NOUN
ihlr-28381	168	22	is	be	AUX
ihlr-28381	168	23	yet	yet	ADV
ihlr-28381	168	24	to	to	PART
ihlr-28381	168	25	occur	occur	VERB
ihlr-28381	168	26	,	,	PUNCT
ihlr-28381	168	27	and	and	CCONJ
ihlr-28381	168	28	damages	damage	NOUN
ihlr-28381	168	29	are	be	AUX
ihlr-28381	168	30	still	still	ADV
ihlr-28381	168	31	prospective.40	prospective.40	ADJ
ihlr-28381	168	32	by	by	ADP
ihlr-28381	168	33	allowing	allow	VERB
ihlr-28381	168	34	the	the	DET
ihlr-28381	168	35	generic	generic	ADJ
ihlr-28381	168	36	firm	firm	NOUN
ihlr-28381	168	37	to	to	PART
ihlr-28381	168	38	provoke	provoke	VERB
ihlr-28381	168	39	the	the	DET
ihlr-28381	168	40	brand	brand	NOUN
ihlr-28381	168	41	firm	firm	NOUN
ihlr-28381	168	42	into	into	ADP
ihlr-28381	168	43	litigation	litigation	NOUN
ihlr-28381	168	44	before	before	SCONJ
ihlr-28381	168	45	the	the	DET
ihlr-28381	168	46	generic	generic	PROPN
ihlr-28381	168	47	actually	actually	ADV
ihlr-28381	168	48	commits	commit	VERB
ihlr-28381	168	49	any	any	DET
ihlr-28381	168	50	alleged	allege	VERB
ihlr-28381	168	51	infringement	infringement	NOUN
ihlr-28381	168	52	,	,	PUNCT
ihlr-28381	168	53	both	both	DET
ihlr-28381	168	54	parties	party	NOUN
ihlr-28381	168	55	benefit	benefit	VERB
ihlr-28381	168	56	from	from	ADP
ihlr-28381	168	57	greater	great	ADJ
ihlr-28381	168	58	efficiency	efficiency	NOUN
ihlr-28381	168	59	and	and	CCONJ
ihlr-28381	168	60	predictability	predictability	NOUN
ihlr-28381	168	61	.	.	PUNCT
ihlr-28381	169	1	the	the	DET
ihlr-28381	169	2	filing	filing	NOUN
ihlr-28381	169	3	of	of	ADP
ihlr-28381	169	4	the	the	DET
ihlr-28381	169	5	lawsuit	lawsuit	NOUN
ihlr-28381	169	6	by	by	ADP
ihlr-28381	169	7	the	the	DET
ihlr-28381	169	8	plaintiff	plaintiff	NOUN
ihlr-28381	169	9	-	-	PUNCT
ihlr-28381	169	10	innovator	innovator	NOUN
ihlr-28381	169	11	against	against	ADP
ihlr-28381	169	12	the	the	DET
ihlr-28381	169	13	defendantgeneric	defendantgeneric	NOUN
ihlr-28381	169	14	in	in	ADP
ihlr-28381	169	15	response	response	NOUN
ihlr-28381	169	16	to	to	ADP
ihlr-28381	169	17	the	the	DET
ihlr-28381	169	18	paragraph	paragraph	NOUN
ihlr-28381	169	19	iv	iv	NUM
ihlr-28381	169	20	certification	certification	NOUN
ihlr-28381	169	21	triggers	trigger	VERB
ihlr-28381	169	22	a	a	DET
ihlr-28381	169	23	“	"	PUNCT
ihlr-28381	169	24	stay	stay	NOUN
ihlr-28381	169	25	period	period	NOUN
ihlr-28381	169	26	,	,	PUNCT
ihlr-28381	169	27	”	"	PUNCT
ihlr-28381	169	28	during	during	ADP
ihlr-28381	169	29	which	which	DET
ihlr-28381	169	30	time	time	NOUN
ihlr-28381	169	31	the	the	DET
ihlr-28381	169	32	fda	fda	PROPN
ihlr-28381	169	33	will	will	AUX
ihlr-28381	169	34	suspend	suspend	VERB
ihlr-28381	169	35	review	review	NOUN
ihlr-28381	169	36	of	of	ADP
ihlr-28381	169	37	the	the	DET
ihlr-28381	169	38	anda	anda	PROPN
ihlr-28381	169	39	for	for	ADP
ihlr-28381	169	40	30	30	NUM
ihlr-28381	169	41	months	month	NOUN
ihlr-28381	169	42	or	or	CCONJ
ihlr-28381	169	43	until	until	SCONJ
ihlr-28381	169	44	litigation	litigation	NOUN
ihlr-28381	169	45	is	be	AUX
ihlr-28381	169	46	resolved.41	resolved.41	ADJ
ihlr-28381	169	47	at	at	ADP
ihlr-28381	169	48	this	this	DET
ihlr-28381	169	49	juncture	juncture	NOUN
ihlr-28381	169	50	,	,	PUNCT
ihlr-28381	169	51	the	the	DET
ihlr-28381	169	52	innovator	innovator	NOUN
ihlr-28381	169	53	can	can	AUX
ihlr-28381	169	54	either	either	CCONJ
ihlr-28381	169	55	(	(	PUNCT
ihlr-28381	169	56	1	1	X
ihlr-28381	169	57	)	)	PUNCT
ihlr-28381	169	58	litigate	litigate	NOUN
ihlr-28381	169	59	and	and	CCONJ
ihlr-28381	169	60	attempt	attempt	VERB
ihlr-28381	169	61	to	to	PART
ihlr-28381	169	62	uphold	uphold	VERB
ihlr-28381	169	63	the	the	DET
ihlr-28381	169	64	patent	patent	NOUN
ihlr-28381	169	65	in	in	ADP
ihlr-28381	169	66	court	court	NOUN
ihlr-28381	169	67	,	,	PUNCT
ihlr-28381	169	68	or	or	CCONJ
ihlr-28381	169	69	(	(	PUNCT
ihlr-28381	169	70	2	2	X
ihlr-28381	169	71	)	)	PUNCT
ihlr-28381	169	72	settle	settle	VERB
ihlr-28381	169	73	the	the	DET
ihlr-28381	169	74	lawsuit	lawsuit	NOUN
ihlr-28381	169	75	by	by	ADP
ihlr-28381	169	76	paying	pay	VERB
ihlr-28381	169	77	(	(	PUNCT
ihlr-28381	169	78	or	or	CCONJ
ihlr-28381	169	79	otherwise	otherwise	ADV
ihlr-28381	169	80	compensating	compensating	NOUN
ihlr-28381	169	81	)	)	PUNCT
ihlr-28381	169	82	the	the	DET
ihlr-28381	169	83	generic	generic	ADJ
ihlr-28381	169	84	to	to	PART
ihlr-28381	169	85	delay	delay	VERB
ihlr-28381	169	86	launching	launch	VERB
ihlr-28381	169	87	its	its	PRON
ihlr-28381	169	88	product	product	NOUN
ihlr-28381	169	89	until	until	ADP
ihlr-28381	169	90	a	a	DET
ihlr-28381	169	91	later	later	ADV
ihlr-28381	169	92	specified	specify	VERB
ihlr-28381	169	93	date	date	NOUN
ihlr-28381	169	94	.	.	PUNCT
ihlr-28381	170	1	the	the	DET
ihlr-28381	170	2	second	second	ADJ
ihlr-28381	170	3	option	option	NOUN
ihlr-28381	170	4	is	be	AUX
ihlr-28381	170	5	a	a	DET
ihlr-28381	170	6	“	"	PUNCT
ihlr-28381	170	7	reverse	reverse	ADJ
ihlr-28381	170	8	payment	payment	NOUN
ihlr-28381	170	9	settlement	settlement	NOUN
ihlr-28381	170	10	agreement	agreement	NOUN
ihlr-28381	170	11	.	.	PUNCT
ihlr-28381	170	12	”	"	PUNCT
ihlr-28381	171	1	many	many	ADJ
ihlr-28381	171	2	reverse	reverse	ADJ
ihlr-28381	171	3	payment	payment	NOUN
ihlr-28381	171	4	settlements	settlement	NOUN
ihlr-28381	171	5	are	be	AUX
ihlr-28381	171	6	entered	enter	VERB
ihlr-28381	171	7	in	in	ADP
ihlr-28381	171	8	good	good	ADJ
ihlr-28381	171	9	faith	faith	NOUN
ihlr-28381	171	10	and	and	CCONJ
ihlr-28381	171	11	produce	produce	VERB
ihlr-28381	171	12	positive	positive	ADJ
ihlr-28381	171	13	effects	effect	NOUN
ihlr-28381	171	14	(	(	PUNCT
ihlr-28381	171	15	e.g.	e.g.	ADV
ihlr-28381	171	16	,	,	PUNCT
ihlr-28381	171	17	a	a	DET
ihlr-28381	171	18	date	date	NOUN
ihlr-28381	171	19	certain	certain	ADJ
ihlr-28381	171	20	for	for	ADP
ihlr-28381	171	21	generic	generic	ADJ
ihlr-28381	171	22	entry	entry	NOUN
ihlr-28381	171	23	,	,	PUNCT
ihlr-28381	171	24	eliminated	eliminate	VERB
ihlr-28381	171	25	litigation	litigation	NOUN
ihlr-28381	171	26	costs	cost	NOUN
ihlr-28381	171	27	,	,	PUNCT
ihlr-28381	171	28	reduced	reduce	VERB
ihlr-28381	171	29	uncertainty	uncertainty	NOUN
ihlr-28381	171	30	)	)	PUNCT
ihlr-28381	171	31	.	.	PUNCT
ihlr-28381	172	1	unfortunately	unfortunately	ADV
ihlr-28381	172	2	,	,	PUNCT
ihlr-28381	172	3	reverse	reverse	ADJ
ihlr-28381	172	4	payment	payment	NOUN
ihlr-28381	172	5	settlements	settlement	NOUN
ihlr-28381	172	6	are	be	AUX
ihlr-28381	172	7	also	also	ADV
ihlr-28381	172	8	ripe	ripe	ADJ
ihlr-28381	172	9	for	for	ADP
ihlr-28381	172	10	anticompetitive	anticompetitive	ADJ
ihlr-28381	172	11	abuse	abuse	NOUN
ihlr-28381	172	12	.	.	PUNCT
ihlr-28381	173	1	the	the	DET
ihlr-28381	173	2	complicated	complicated	ADJ
ihlr-28381	173	3	nature	nature	NOUN
ihlr-28381	173	4	of	of	ADP
ihlr-28381	173	5	pay	pay	NOUN
ihlr-28381	173	6	-	-	PUNCT
ihlr-28381	173	7	for	for	ADP
ihlr-28381	173	8	-	-	PUNCT
ihlr-28381	173	9	delay	delay	NOUN
ihlr-28381	173	10	and	and	CCONJ
ihlr-28381	173	11	the	the	DET
ihlr-28381	173	12	diversity	diversity	NOUN
ihlr-28381	173	13	of	of	ADP
ihlr-28381	173	14	approaches	approach	NOUN
ihlr-28381	173	15	make	make	VERB
ihlr-28381	173	16	it	it	PRON
ihlr-28381	173	17	difficult	difficult	ADJ
ihlr-28381	173	18	for	for	SCONJ
ihlr-28381	173	19	the	the	DET
ihlr-28381	173	20	ftc	ftc	PROPN
ihlr-28381	173	21	—	—	PUNCT
ihlr-28381	173	22	the	the	DET
ihlr-28381	173	23	agency	agency	NOUN
ihlr-28381	173	24	tasked	task	VERB
ihlr-28381	173	25	with	with	ADP
ihlr-28381	173	26	rooting	root	VERB
ihlr-28381	173	27	out	out	ADP
ihlr-28381	173	28	anti	anti	ADJ
ihlr-28381	173	29	-	-	ADJ
ihlr-28381	173	30	competitive	competitive	ADJ
ihlr-28381	173	31	conduct	conduct	NOUN
ihlr-28381	173	32	—	—	PUNCT
ihlr-28381	173	33	to	to	PART
ihlr-28381	173	34	identify	identify	VERB
ihlr-28381	173	35	,	,	PUNCT
ihlr-28381	173	36	let	let	VERB
ihlr-28381	173	37	alone	alone	ADV
ihlr-28381	173	38	prove	prove	VERB
ihlr-28381	173	39	,	,	PUNCT
ihlr-28381	173	40	true	true	ADJ
ihlr-28381	173	41	pay	pay	VERB
ihlr-28381	173	42	-	-	PUNCT
ihlr-28381	173	43	for	for	ADP
ihlr-28381	173	44	-	-	PUNCT
ihlr-28381	173	45	delay	delay	NOUN
ihlr-28381	173	46	schemes	scheme	NOUN
ihlr-28381	173	47	.	.	PUNCT
ihlr-28381	174	1	b.	b.	PROPN
ihlr-28381	174	2	secondary	secondary	ADJ
ihlr-28381	174	3	patents	patent	NOUN
ihlr-28381	174	4	secondary	secondary	ADJ
ihlr-28381	174	5	patents	patent	NOUN
ihlr-28381	174	6	rather	rather	ADV
ihlr-28381	174	7	than	than	ADP
ihlr-28381	174	8	primary	primary	ADJ
ihlr-28381	174	9	patents	patent	NOUN
ihlr-28381	174	10	are	be	AUX
ihlr-28381	174	11	the	the	DET
ihlr-28381	174	12	usual	usual	ADJ
ihlr-28381	174	13	subject	subject	NOUN
ihlr-28381	174	14	of	of	ADP
ihlr-28381	174	15	paragraph	paragraph	NOUN
ihlr-28381	174	16	iv	iv	NUM
ihlr-28381	174	17	certifications	certification	NOUN
ihlr-28381	174	18	.	.	PUNCT
ihlr-28381	175	1	further	far	ADV
ihlr-28381	175	2	,	,	PUNCT
ihlr-28381	175	3	many	many	ADJ
ihlr-28381	175	4	pharmaceuticals	pharmaceutical	NOUN
ihlr-28381	175	5	are	be	AUX
ihlr-28381	175	6	protected	protect	VERB
ihlr-28381	175	7	by	by	ADP
ihlr-28381	175	8	multiple	multiple	ADJ
ihlr-28381	175	9	patents	patent	NOUN
ihlr-28381	175	10	.	.	PUNCT
ihlr-28381	176	1	when	when	SCONJ
ihlr-28381	176	2	multiple	multiple	ADJ
ihlr-28381	176	3	patents	patent	NOUN
ihlr-28381	176	4	concern	concern	VERB
ihlr-28381	176	5	the	the	DET
ihlr-28381	176	6	same	same	ADJ
ihlr-28381	176	7	drug	drug	NOUN
ihlr-28381	176	8	,	,	PUNCT
ihlr-28381	176	9	the	the	DET
ihlr-28381	176	10	patents	patent	NOUN
ihlr-28381	176	11	are	be	AUX
ihlr-28381	176	12	often	often	ADV
ihlr-28381	176	13	differentiated	differentiate	VERB
ihlr-28381	176	14	as	as	ADP
ihlr-28381	176	15	“	"	PUNCT
ihlr-28381	176	16	primary	primary	ADJ
ihlr-28381	176	17	”	"	PUNCT
ihlr-28381	176	18	or	or	CCONJ
ihlr-28381	176	19	“	"	PUNCT
ihlr-28381	176	20	secondary	secondary	ADJ
ihlr-28381	176	21	.	.	PUNCT
ihlr-28381	176	22	”	"	PUNCT
ihlr-28381	177	1	primary	primary	ADJ
ihlr-28381	177	2	patents	patent	NOUN
ihlr-28381	177	3	protect	protect	VERB
ihlr-28381	177	4	the	the	DET
ihlr-28381	177	5	“	"	PUNCT
ihlr-28381	177	6	active	active	ADJ
ihlr-28381	177	7	ingredient	ingredient	NOUN
ihlr-28381	177	8	,	,	PUNCT
ihlr-28381	177	9	”	"	PUNCT
ihlr-28381	177	10	or	or	CCONJ
ihlr-28381	177	11	the	the	DET
ihlr-28381	177	12	invented	invent	VERB
ihlr-28381	177	13	chemical	chemical	NOUN
ihlr-28381	177	14	that	that	PRON
ihlr-28381	177	15	is	be	AUX
ihlr-28381	177	16	primarily	primarily	ADV
ihlr-28381	177	17	responsible	responsible	ADJ
ihlr-28381	177	18	for	for	ADP
ihlr-28381	177	19	a	a	DET
ihlr-28381	177	20	medication	medication	NOUN
ihlr-28381	177	21	’s	’s	PART
ihlr-28381	177	22	effect.42	effect.42	ADP
ihlr-28381	177	23	primary	primary	ADJ
ihlr-28381	177	24	patents	patent	NOUN
ihlr-28381	177	25	are	be	AUX
ihlr-28381	177	26	usually	usually	ADV
ihlr-28381	177	27	37	37	NUM
ihlr-28381	177	28	.	.	NOUN
ihlr-28381	177	29	21	21	NUM
ihlr-28381	177	30	u.s.c	u.s.c	NOUN
ihlr-28381	177	31	.	.	PUNCT
ihlr-28381	178	1	§	§	PROPN
ihlr-28381	178	2	355	355	NUM
ihlr-28381	178	3	(	(	PUNCT
ihlr-28381	178	4	j	j	NOUN
ihlr-28381	178	5	)	)	PUNCT
ihlr-28381	178	6	(	(	PUNCT
ihlr-28381	178	7	2022	2022	NUM
ihlr-28381	178	8	)	)	PUNCT
ihlr-28381	178	9	.	.	PUNCT
ihlr-28381	179	1	38	38	NUM
ihlr-28381	179	2	.	.	PUNCT
ihlr-28381	180	1	i	i	PRON
ihlr-28381	180	2	d.	d.	PROPN
ihlr-28381	180	3	§	§	PROPN
ihlr-28381	180	4	§	§	PROPN
ihlr-28381	180	5	355(j)(2)(a)(vii)(iv	355(j)(2)(a)(vii)(iv	NUM
ihlr-28381	180	6	)	)	PUNCT
ihlr-28381	180	7	.	.	PUNCT
ihlr-28381	181	1	39	39	NUM
ihlr-28381	181	2	.	.	PUNCT
ihlr-28381	182	1	i	i	PRON
ihlr-28381	182	2	d.	d.	PROPN
ihlr-28381	182	3	§	§	PROPN
ihlr-28381	182	4	§	§	PROPN
ihlr-28381	182	5	355(j)(2)(b)(ii	355(j)(2)(b)(ii	NUM
ihlr-28381	182	6	)	)	PUNCT
ihlr-28381	182	7	.	.	PUNCT
ihlr-28381	183	1	40	40	NUM
ihlr-28381	183	2	.	.	PUNCT
ihlr-28381	184	1	i	i	PRON
ihlr-28381	184	2	d.	d.	PROPN
ihlr-28381	184	3	§	§	PROPN
ihlr-28381	184	4	§	§	PROPN
ihlr-28381	184	5	355	355	NUM
ihlr-28381	184	6	(	(	PUNCT
ihlr-28381	184	7	j)(5)(b)(iii	j)(5)(b)(iii	PROPN
ihlr-28381	184	8	)	)	PUNCT
ihlr-28381	184	9	.	.	PUNCT
ihlr-28381	185	1	41	41	NUM
ihlr-28381	185	2	.	.	PUNCT
ihlr-28381	186	1	feldman	feldman	PROPN
ihlr-28381	186	2	&	&	CCONJ
ihlr-28381	186	3	frondorf	frondorf	PROPN
ihlr-28381	186	4	,	,	PUNCT
ihlr-28381	186	5	supra	supra	PROPN
ihlr-28381	186	6	note	note	NOUN
ihlr-28381	186	7	21	21	NUM
ihlr-28381	186	8	,	,	PUNCT
ihlr-28381	186	9	at	at	ADP
ihlr-28381	186	10	509	509	NUM
ihlr-28381	186	11	.	.	PUNCT
ihlr-28381	187	1	42	42	NUM
ihlr-28381	187	2	.	.	PUNCT
ihlr-28381	188	1	kevin	kevin	PROPN
ihlr-28381	188	2	t.	t.	PROPN
ihlr-28381	188	3	richards	richards	PROPN
ihlr-28381	188	4	et	et	PROPN
ihlr-28381	188	5	al	al	PROPN
ihlr-28381	188	6	.	.	PROPN
ihlr-28381	188	7	,	,	PUNCT
ihlr-28381	188	8	cong	cong	PROPN
ihlr-28381	188	9	.	.	PUNCT
ihlr-28381	189	1	rsch	rsch	PROPN
ihlr-28381	189	2	.	.	PUNCT
ihlr-28381	190	1	serv	serv	PROPN
ihlr-28381	190	2	.	.	PROPN
ihlr-28381	190	3	,	,	PUNCT
ihlr-28381	190	4	r46221	r46221	NOUN
ihlr-28381	190	5	,	,	PUNCT
ihlr-28381	190	6	drug	drug	NOUN
ihlr-28381	190	7	pricing	pricing	NOUN
ihlr-28381	190	8	and	and	CCONJ
ihlr-28381	190	9	130	130	NUM
ihlr-28381	190	10	indiana	indiana	PROPN
ihlr-28381	190	11	health	health	NOUN
ihlr-28381	190	12	law	law	NOUN
ihlr-28381	190	13	review	review	NOUN
ihlr-28381	191	1	[	[	X
ihlr-28381	191	2	vol	vol	NOUN
ihlr-28381	191	3	.	.	NOUN
ihlr-28381	191	4	21:121	21:121	NUM
ihlr-28381	191	5	stronger	strong	ADJ
ihlr-28381	191	6	and	and	CCONJ
ihlr-28381	191	7	therefore	therefore	ADV
ihlr-28381	191	8	not	not	PART
ihlr-28381	191	9	implicated	implicate	VERB
ihlr-28381	191	10	in	in	ADP
ihlr-28381	191	11	paragraph	paragraph	NOUN
ihlr-28381	191	12	iv	iv	NUM
ihlr-28381	191	13	certifications	certification	NOUN
ihlr-28381	191	14	.	.	PUNCT
ihlr-28381	192	1	secondary	secondary	ADJ
ihlr-28381	192	2	patents	patent	NOUN
ihlr-28381	192	3	do	do	AUX
ihlr-28381	192	4	not	not	PART
ihlr-28381	192	5	protect	protect	VERB
ihlr-28381	192	6	the	the	DET
ihlr-28381	192	7	main	main	ADJ
ihlr-28381	192	8	invention	invention	NOUN
ihlr-28381	192	9	but	but	CCONJ
ihlr-28381	192	10	protect	protect	VERB
ihlr-28381	192	11	other	other	ADJ
ihlr-28381	192	12	aspects	aspect	NOUN
ihlr-28381	192	13	of	of	ADP
ihlr-28381	192	14	the	the	DET
ihlr-28381	192	15	medicine	medicine	NOUN
ihlr-28381	192	16	including	include	VERB
ihlr-28381	192	17	dosage	dosage	NOUN
ihlr-28381	192	18	(	(	PUNCT
ihlr-28381	192	19	e.g.	e.g.	ADV
ihlr-28381	192	20	,	,	PUNCT
ihlr-28381	192	21	five	five	NUM
ihlr-28381	192	22	milligrams	milligram	NOUN
ihlr-28381	192	23	per	per	ADP
ihlr-28381	192	24	kilogram	kilogram	NOUN
ihlr-28381	192	25	of	of	ADP
ihlr-28381	192	26	body	body	NOUN
ihlr-28381	192	27	weight	weight	NOUN
ihlr-28381	192	28	)	)	PUNCT
ihlr-28381	192	29	,	,	PUNCT
ihlr-28381	192	30	form	form	NOUN
ihlr-28381	192	31	of	of	ADP
ihlr-28381	192	32	administration	administration	NOUN
ihlr-28381	192	33	(	(	PUNCT
ihlr-28381	192	34	e.g.	e.g.	ADV
ihlr-28381	192	35	,	,	PUNCT
ihlr-28381	192	36	intravenous	intravenous	ADJ
ihlr-28381	192	37	or	or	CCONJ
ihlr-28381	192	38	“	"	PUNCT
ihlr-28381	192	39	iv	iv	NUM
ihlr-28381	192	40	,	,	PUNCT
ihlr-28381	192	41	”	"	PUNCT
ihlr-28381	192	42	pill	pill	NOUN
ihlr-28381	192	43	form	form	NOUN
ihlr-28381	192	44	,	,	PUNCT
ihlr-28381	192	45	capsule	capsule	NOUN
ihlr-28381	192	46	)	)	PUNCT
ihlr-28381	192	47	,	,	PUNCT
ihlr-28381	192	48	method	method	NOUN
ihlr-28381	192	49	of	of	ADP
ihlr-28381	192	50	use	use	NOUN
ihlr-28381	192	51	(	(	PUNCT
ihlr-28381	192	52	e.g.	e.g.	ADV
ihlr-28381	192	53	,	,	PUNCT
ihlr-28381	192	54	used	use	VERB
ihlr-28381	192	55	to	to	PART
ihlr-28381	192	56	treat	treat	VERB
ihlr-28381	192	57	a	a	DET
ihlr-28381	192	58	specific	specific	ADJ
ihlr-28381	192	59	form	form	NOUN
ihlr-28381	192	60	of	of	ADP
ihlr-28381	192	61	cancer	cancer	NOUN
ihlr-28381	192	62	)	)	PUNCT
ihlr-28381	192	63	,	,	PUNCT
ihlr-28381	192	64	manufacturing	manufacturing	NOUN
ihlr-28381	192	65	processes	process	NOUN
ihlr-28381	192	66	,	,	PUNCT
ihlr-28381	192	67	or	or	CCONJ
ihlr-28381	192	68	other	other	ADJ
ihlr-28381	192	69	nonprimary	nonprimary	ADJ
ihlr-28381	192	70	characteristics	characteristic	NOUN
ihlr-28381	192	71	.	.	PUNCT
ihlr-28381	193	1	for	for	ADP
ihlr-28381	193	2	example	example	NOUN
ihlr-28381	193	3	,	,	PUNCT
ihlr-28381	193	4	assume	assume	VERB
ihlr-28381	193	5	chemical	chemical	NOUN
ihlr-28381	193	6	x	x	PUNCT
ihlr-28381	193	7	is	be	AUX
ihlr-28381	193	8	the	the	DET
ihlr-28381	193	9	active	active	ADJ
ihlr-28381	193	10	ingredient	ingredient	NOUN
ihlr-28381	193	11	in	in	ADP
ihlr-28381	193	12	drug	drug	NOUN
ihlr-28381	193	13	a	a	NOUN
ihlr-28381	193	14	,	,	PUNCT
ihlr-28381	193	15	which	which	PRON
ihlr-28381	193	16	effectively	effectively	ADV
ihlr-28381	193	17	treats	treat	VERB
ihlr-28381	193	18	breast	breast	NOUN
ihlr-28381	193	19	cancer	cancer	NOUN
ihlr-28381	193	20	when	when	SCONJ
ihlr-28381	193	21	administered	administer	VERB
ihlr-28381	193	22	intravenously	intravenously	ADV
ihlr-28381	193	23	at	at	ADP
ihlr-28381	193	24	five	five	NUM
ihlr-28381	193	25	mg	mg	PROPN
ihlr-28381	193	26	/	/	SYM
ihlr-28381	193	27	kg	kg	PROPN
ihlr-28381	193	28	.	.	PUNCT
ihlr-28381	194	1	the	the	DET
ihlr-28381	194	2	inventor	inventor	NOUN
ihlr-28381	194	3	invented	invent	VERB
ihlr-28381	194	4	chemical	chemical	NOUN
ihlr-28381	194	5	x	x	NOUN
ihlr-28381	194	6	,	,	PUNCT
ihlr-28381	194	7	but	but	CCONJ
ihlr-28381	194	8	also	also	ADV
ihlr-28381	194	9	discovered	discover	VERB
ihlr-28381	194	10	that	that	SCONJ
ihlr-28381	194	11	chemical	chemical	NOUN
ihlr-28381	194	12	x	x	PUNCT
ihlr-28381	194	13	has	have	VERB
ihlr-28381	194	14	a	a	DET
ihlr-28381	194	15	therapeutic	therapeutic	ADJ
ihlr-28381	194	16	effect	effect	NOUN
ihlr-28381	194	17	on	on	ADP
ihlr-28381	194	18	breast	breast	NOUN
ihlr-28381	194	19	cancer	cancer	NOUN
ihlr-28381	194	20	,	,	PUNCT
ihlr-28381	194	21	can	can	AUX
ihlr-28381	194	22	be	be	AUX
ihlr-28381	194	23	administered	administer	VERB
ihlr-28381	194	24	effectively	effectively	ADV
ihlr-28381	194	25	through	through	ADP
ihlr-28381	194	26	an	an	DET
ihlr-28381	194	27	intravenous	intravenous	ADJ
ihlr-28381	194	28	solution	solution	NOUN
ihlr-28381	194	29	,	,	PUNCT
ihlr-28381	194	30	and	and	CCONJ
ihlr-28381	194	31	is	be	AUX
ihlr-28381	194	32	effective	effective	ADJ
ihlr-28381	194	33	therapeutically	therapeutically	ADV
ihlr-28381	194	34	at	at	ADP
ihlr-28381	194	35	a	a	DET
ihlr-28381	194	36	five	five	NUM
ihlr-28381	194	37	mg	mg	NUM
ihlr-28381	194	38	/	/	SYM
ihlr-28381	194	39	kg	kg	PROPN
ihlr-28381	194	40	dose	dose	NOUN
ihlr-28381	194	41	.	.	PUNCT
ihlr-28381	195	1	chemical	chemical	PROPN
ihlr-28381	195	2	x	x	PUNCT
ihlr-28381	195	3	is	be	AUX
ihlr-28381	195	4	protected	protect	VERB
ihlr-28381	195	5	by	by	ADP
ihlr-28381	195	6	a	a	DET
ihlr-28381	195	7	primary	primary	ADJ
ihlr-28381	195	8	patent	patent	NOUN
ihlr-28381	195	9	,	,	PUNCT
ihlr-28381	195	10	while	while	SCONJ
ihlr-28381	195	11	drug	drug	NOUN
ihlr-28381	195	12	a	a	DET
ihlr-28381	195	13	’s	’s	NOUN
ihlr-28381	195	14	application	application	NOUN
ihlr-28381	195	15	to	to	ADP
ihlr-28381	195	16	breast	breast	NOUN
ihlr-28381	195	17	cancer	cancer	NOUN
ihlr-28381	195	18	,	,	PUNCT
ihlr-28381	195	19	intravenous	intravenous	ADJ
ihlr-28381	195	20	administration	administration	NOUN
ihlr-28381	195	21	technique	technique	NOUN
ihlr-28381	195	22	,	,	PUNCT
ihlr-28381	195	23	and	and	CCONJ
ihlr-28381	195	24	effective	effective	ADJ
ihlr-28381	195	25	dosage	dosage	NOUN
ihlr-28381	195	26	of	of	ADP
ihlr-28381	195	27	five	five	NUM
ihlr-28381	195	28	mg	mg	NOUN
ihlr-28381	195	29	/	/	SYM
ihlr-28381	195	30	kg	kg	NOUN
ihlr-28381	195	31	are	be	AUX
ihlr-28381	195	32	protected	protect	VERB
ihlr-28381	195	33	by	by	ADP
ihlr-28381	195	34	secondary	secondary	ADJ
ihlr-28381	195	35	patents	patent	NOUN
ihlr-28381	195	36	.	.	PUNCT
ihlr-28381	196	1	the	the	DET
ihlr-28381	196	2	primary	primary	ADJ
ihlr-28381	196	3	and	and	CCONJ
ihlr-28381	196	4	secondary	secondary	ADJ
ihlr-28381	196	5	patents	patent	NOUN
ihlr-28381	196	6	protect	protect	VERB
ihlr-28381	196	7	different	different	ADJ
ihlr-28381	196	8	features	feature	NOUN
ihlr-28381	196	9	of	of	ADP
ihlr-28381	196	10	the	the	DET
ihlr-28381	196	11	same	same	ADJ
ihlr-28381	196	12	drug	drug	NOUN
ihlr-28381	196	13	and	and	CCONJ
ihlr-28381	196	14	are	be	AUX
ihlr-28381	196	15	usually	usually	ADV
ihlr-28381	196	16	filed	file	VERB
ihlr-28381	196	17	at	at	ADP
ihlr-28381	196	18	different	different	ADJ
ihlr-28381	196	19	times	time	NOUN
ihlr-28381	196	20	,	,	PUNCT
ihlr-28381	196	21	creating	create	VERB
ihlr-28381	196	22	multiple	multiple	ADJ
ihlr-28381	196	23	,	,	PUNCT
ihlr-28381	196	24	staggered	staggered	ADJ
ihlr-28381	196	25	layers	layer	NOUN
ihlr-28381	196	26	of	of	ADP
ihlr-28381	196	27	patent	patent	NOUN
ihlr-28381	196	28	protection	protection	NOUN
ihlr-28381	196	29	.	.	PUNCT
ihlr-28381	197	1	according	accord	VERB
ihlr-28381	197	2	to	to	ADP
ihlr-28381	197	3	an	an	DET
ihlr-28381	197	4	ftc	ftc	PROPN
ihlr-28381	197	5	study	study	NOUN
ihlr-28381	197	6	,	,	PUNCT
ihlr-28381	197	7	generic	generic	ADJ
ihlr-28381	197	8	challengers	challenger	NOUN
ihlr-28381	197	9	win	win	VERB
ihlr-28381	197	10	73	73	NUM
ihlr-28381	197	11	%	%	NOUN
ihlr-28381	197	12	of	of	ADP
ihlr-28381	197	13	paragraph	paragraph	NOUN
ihlr-28381	197	14	iv	iv	NUM
ihlr-28381	197	15	cases	case	NOUN
ihlr-28381	197	16	that	that	PRON
ihlr-28381	197	17	are	be	AUX
ihlr-28381	197	18	litigated	litigate	VERB
ihlr-28381	197	19	to	to	PART
ihlr-28381	197	20	completion.43	completion.43	VERB
ihlr-28381	197	21	however	however	ADV
ihlr-28381	197	22	,	,	PUNCT
ihlr-28381	197	23	the	the	DET
ihlr-28381	197	24	majority	majority	NOUN
ihlr-28381	197	25	of	of	ADP
ihlr-28381	197	26	paragraph	paragraph	NOUN
ihlr-28381	197	27	iv	iv	NUM
ihlr-28381	197	28	cases	case	NOUN
ihlr-28381	197	29	settle	settle	VERB
ihlr-28381	197	30	with	with	ADP
ihlr-28381	197	31	no	no	DET
ihlr-28381	197	32	conclusion	conclusion	NOUN
ihlr-28381	197	33	regarding	regard	VERB
ihlr-28381	197	34	the	the	DET
ihlr-28381	197	35	patent	patent	NOUN
ihlr-28381	197	36	’s	’s	PART
ihlr-28381	197	37	true	true	ADJ
ihlr-28381	197	38	validity.44	validity.44	NOUN
ihlr-28381	197	39	patents	patent	NOUN
ihlr-28381	197	40	implicated	implicate	VERB
ihlr-28381	197	41	by	by	ADP
ihlr-28381	197	42	paragraph	paragraph	NOUN
ihlr-28381	197	43	iv	iv	NUM
ihlr-28381	197	44	certifications	certification	NOUN
ihlr-28381	197	45	tend	tend	VERB
ihlr-28381	197	46	to	to	PART
ihlr-28381	197	47	be	be	AUX
ihlr-28381	197	48	secondary	secondary	ADJ
ihlr-28381	197	49	patents,45	patents,45	NOUN
ihlr-28381	197	50	often	often	ADV
ihlr-28381	197	51	vulnerable	vulnerable	ADJ
ihlr-28381	197	52	to	to	ADP
ihlr-28381	197	53	invalidation.46	invalidation.46	PROPN
ihlr-28381	197	54	innovators	innovator	NOUN
ihlr-28381	197	55	/	/	SYM
ihlr-28381	197	56	patentees	patentee	NOUN
ihlr-28381	197	57	recognize	recognize	VERB
ihlr-28381	197	58	this	this	DET
ihlr-28381	197	59	risk	risk	NOUN
ihlr-28381	197	60	and	and	CCONJ
ihlr-28381	197	61	prospective	prospective	ADJ
ihlr-28381	197	62	loss	loss	NOUN
ihlr-28381	197	63	of	of	ADP
ihlr-28381	197	64	monopoly	monopoly	NOUN
ihlr-28381	197	65	power	power	NOUN
ihlr-28381	197	66	.	.	PUNCT
ihlr-28381	198	1	as	as	ADP
ihlr-28381	198	2	a	a	DET
ihlr-28381	198	3	solution	solution	NOUN
ihlr-28381	198	4	,	,	PUNCT
ihlr-28381	198	5	patentees	patentee	NOUN
ihlr-28381	198	6	defending	defend	VERB
ihlr-28381	198	7	a	a	DET
ihlr-28381	198	8	weak	weak	ADJ
ihlr-28381	198	9	secondary	secondary	ADJ
ihlr-28381	198	10	patent	patent	NOUN
ihlr-28381	198	11	may	may	AUX
ihlr-28381	198	12	wish	wish	VERB
ihlr-28381	198	13	to	to	PART
ihlr-28381	198	14	settle	settle	VERB
ihlr-28381	198	15	.	.	PUNCT
ihlr-28381	199	1	by	by	ADP
ihlr-28381	199	2	settling	settle	VERB
ihlr-28381	199	3	,	,	PUNCT
ihlr-28381	199	4	the	the	DET
ihlr-28381	199	5	inventor	inventor	NOUN
ihlr-28381	199	6	seals	seal	VERB
ihlr-28381	199	7	off	off	ADP
ihlr-28381	199	8	the	the	DET
ihlr-28381	199	9	dispute	dispute	NOUN
ihlr-28381	199	10	and	and	CCONJ
ihlr-28381	199	11	saves	save	VERB
ihlr-28381	199	12	its	its	PRON
ihlr-28381	199	13	patent	patent	NOUN
ihlr-28381	199	14	from	from	ADP
ihlr-28381	199	15	potential	potential	ADJ
ihlr-28381	199	16	invalidation	invalidation	NOUN
ihlr-28381	199	17	.	.	PUNCT
ihlr-28381	200	1	c.	c.	NOUN
ihlr-28381	200	2	reverse	reverse	PROPN
ihlr-28381	200	3	payment	payment	NOUN
ihlr-28381	200	4	settlement	settlement	NOUN
ihlr-28381	200	5	agreements	agreement	NOUN
ihlr-28381	200	6	rather	rather	ADV
ihlr-28381	200	7	than	than	ADP
ihlr-28381	200	8	engage	engage	VERB
ihlr-28381	200	9	in	in	ADP
ihlr-28381	200	10	drawn	draw	VERB
ihlr-28381	200	11	-	-	PUNCT
ihlr-28381	200	12	out	out	ADP
ihlr-28381	200	13	,	,	PUNCT
ihlr-28381	200	14	expensive	expensive	ADJ
ihlr-28381	200	15	litigation	litigation	NOUN
ihlr-28381	200	16	with	with	ADP
ihlr-28381	200	17	a	a	DET
ihlr-28381	200	18	fair	fair	ADJ
ihlr-28381	200	19	chance	chance	NOUN
ihlr-28381	200	20	of	of	ADP
ihlr-28381	200	21	patent	patent	NOUN
ihlr-28381	200	22	invalidation	invalidation	NOUN
ihlr-28381	200	23	and	and	CCONJ
ihlr-28381	200	24	loss	loss	NOUN
ihlr-28381	200	25	of	of	ADP
ihlr-28381	200	26	market	market	NOUN
ihlr-28381	200	27	exclusivity	exclusivity	NOUN
ihlr-28381	200	28	,	,	PUNCT
ihlr-28381	200	29	the	the	DET
ihlr-28381	200	30	plaintiff	plaintiff	NOUN
ihlr-28381	200	31	-	-	PUNCT
ihlr-28381	200	32	innovator	innovator	NOUN
ihlr-28381	200	33	/	/	SYM
ihlr-28381	200	34	patentee	patentee	NOUN
ihlr-28381	200	35	may	may	AUX
ihlr-28381	200	36	propose	propose	VERB
ihlr-28381	200	37	a	a	DET
ihlr-28381	200	38	mutually	mutually	ADV
ihlr-28381	200	39	beneficial	beneficial	ADJ
ihlr-28381	200	40	settlement	settlement	NOUN
ihlr-28381	200	41	in	in	ADP
ihlr-28381	200	42	the	the	DET
ihlr-28381	200	43	form	form	NOUN
ihlr-28381	200	44	of	of	ADP
ihlr-28381	200	45	a	a	DET
ihlr-28381	200	46	reverse	reverse	ADJ
ihlr-28381	200	47	payment	payment	NOUN
ihlr-28381	200	48	settlement	settlement	NOUN
ihlr-28381	200	49	agreement	agreement	NOUN
ihlr-28381	200	50	.	.	PUNCT
ihlr-28381	201	1	as	as	SCONJ
ihlr-28381	201	2	previously	previously	ADV
ihlr-28381	201	3	mentioned	mention	VERB
ihlr-28381	201	4	,	,	PUNCT
ihlr-28381	201	5	a	a	DET
ihlr-28381	201	6	reverse	reverse	ADJ
ihlr-28381	201	7	payment	payment	NOUN
ihlr-28381	201	8	settlement	settlement	NOUN
ihlr-28381	201	9	essentially	essentially	ADV
ihlr-28381	201	10	involves	involve	VERB
ihlr-28381	201	11	the	the	DET
ihlr-28381	201	12	plaintiff	plaintiff	NOUN
ihlr-28381	201	13	-	-	PUNCT
ihlr-28381	201	14	innovator	innovator	NOUN
ihlr-28381	201	15	offering	offer	VERB
ihlr-28381	201	16	the	the	DET
ihlr-28381	201	17	defendant	defendant	NOUN
ihlr-28381	201	18	-	-	PUNCT
ihlr-28381	201	19	generic	generic	ADJ
ihlr-28381	201	20	some	some	DET
ihlr-28381	201	21	value	value	NOUN
ihlr-28381	201	22	greater	great	ADJ
ihlr-28381	201	23	than	than	ADP
ihlr-28381	201	24	the	the	DET
ihlr-28381	201	25	generic	generic	ADJ
ihlr-28381	201	26	company	company	NOUN
ihlr-28381	201	27	’s	’s	PART
ihlr-28381	201	28	prospective	prospective	ADJ
ihlr-28381	201	29	profits	profit	NOUN
ihlr-28381	201	30	,	,	PUNCT
ihlr-28381	201	31	but	but	CCONJ
ihlr-28381	201	32	less	less	ADJ
ihlr-28381	201	33	than	than	ADP
ihlr-28381	201	34	the	the	DET
ihlr-28381	201	35	innovator	innovator	NOUN
ihlr-28381	201	36	company	company	NOUN
ihlr-28381	201	37	’s	’s	PART
ihlr-28381	201	38	prospective	prospective	ADJ
ihlr-28381	201	39	loss	loss	NOUN
ihlr-28381	201	40	.	.	PUNCT
ihlr-28381	202	1	in	in	ADP
ihlr-28381	202	2	exchange	exchange	NOUN
ihlr-28381	202	3	for	for	ADP
ihlr-28381	202	4	the	the	DET
ihlr-28381	202	5	value	value	NOUN
ihlr-28381	202	6	received	receive	VERB
ihlr-28381	202	7	,	,	PUNCT
ihlr-28381	202	8	the	the	DET
ihlr-28381	202	9	generic	generic	ADJ
ihlr-28381	202	10	company	company	NOUN
ihlr-28381	202	11	foregoes	forego	VERB
ihlr-28381	202	12	or	or	CCONJ
ihlr-28381	202	13	delays	delay	VERB
ihlr-28381	202	14	market	market	NOUN
ihlr-28381	202	15	entry	entry	NOUN
ihlr-28381	202	16	,	,	PUNCT
ihlr-28381	202	17	and	and	CCONJ
ihlr-28381	202	18	thus	thus	ADV
ihlr-28381	202	19	the	the	DET
ihlr-28381	202	20	innovator	innovator	NOUN
ihlr-28381	202	21	pharmaceutical	pharmaceutical	NOUN
ihlr-28381	202	22	patenting	patenting	NOUN
ihlr-28381	202	23	practices	practice	NOUN
ihlr-28381	202	24	8	8	NUM
ihlr-28381	202	25	(	(	PUNCT
ihlr-28381	202	26	2020	2020	NUM
ihlr-28381	202	27	)	)	PUNCT
ihlr-28381	202	28	,	,	PUNCT
ihlr-28381	202	29	https://crsreports.congress.gov/product/pdf/	https://crsreports.congress.gov/product/pdf/	PROPN
ihlr-28381	202	30	r	r	PROPN
ihlr-28381	202	31	/	/	SYM
ihlr-28381	202	32	r46679	r46679	PROPN
ihlr-28381	203	1	[	[	X
ihlr-28381	203	2	https://perma.cc/yfd8-p5z3	https://perma.cc/yfd8-p5z3	PROPN
ihlr-28381	203	3	]	]	X
ihlr-28381	203	4	.	.	PUNCT
ihlr-28381	204	1	43	43	NUM
ihlr-28381	204	2	.	.	PUNCT
ihlr-28381	205	1	u.s	u.s	PROPN
ihlr-28381	205	2	.	.	PROPN
ihlr-28381	205	3	fed	fed	PROPN
ihlr-28381	205	4	.	.	PUNCT
ihlr-28381	206	1	trade	trade	NOUN
ihlr-28381	206	2	comm’n	comm’n	NOUN
ihlr-28381	206	3	,	,	PUNCT
ihlr-28381	206	4	generic	generic	ADJ
ihlr-28381	206	5	drug	drug	NOUN
ihlr-28381	206	6	entry	entry	NOUN
ihlr-28381	206	7	prior	prior	ADV
ihlr-28381	206	8	to	to	ADP
ihlr-28381	206	9	patent	patent	NOUN
ihlr-28381	206	10	expiration	expiration	NOUN
ihlr-28381	206	11	:	:	PUNCT
ihlr-28381	206	12	an	an	DET
ihlr-28381	206	13	ftc	ftc	PROPN
ihlr-28381	206	14	study	study	NOUN
ihlr-28381	206	15	,	,	PUNCT
ihlr-28381	206	16	13	13	NUM
ihlr-28381	206	17	(	(	PUNCT
ihlr-28381	206	18	2002	2002	NUM
ihlr-28381	206	19	)	)	PUNCT
ihlr-28381	206	20	,	,	PUNCT
ihlr-28381	206	21	https://www.ftc.gov/reports/generic-drug-entry-prior-patent-expiration-ftc-study	https://www.ftc.gov/reports/generic-drug-entry-prior-patent-expiration-ftc-study	PROPN
ihlr-28381	207	1	[	[	X
ihlr-28381	207	2	https://perma.cc/j5v9-9x8r	https://perma.cc/j5v9-9x8r	NOUN
ihlr-28381	207	3	]	]	X
ihlr-28381	207	4	.	.	PUNCT
ihlr-28381	208	1	44	44	NUM
ihlr-28381	208	2	.	.	PUNCT
ihlr-28381	209	1	brian	brian	PROPN
ihlr-28381	209	2	c.	c.	PROPN
ihlr-28381	209	3	howard	howard	PROPN
ihlr-28381	209	4	,	,	PUNCT
ihlr-28381	209	5	hatch	hatch	NOUN
ihlr-28381	209	6	-	-	PUNCT
ihlr-28381	209	7	waxman	waxman	PROPN
ihlr-28381	209	8	/	/	SYM
ihlr-28381	209	9	anda	anda	PROPN
ihlr-28381	209	10	litigation	litigation	PROPN
ihlr-28381	209	11	report	report	PROPN
ihlr-28381	209	12	2017	2017	NUM
ihlr-28381	209	13	,	,	PUNCT
ihlr-28381	209	14	global	global	ADJ
ihlr-28381	209	15	patent	patent	NOUN
ihlr-28381	209	16	group	group	NOUN
ihlr-28381	209	17	,	,	PUNCT
ihlr-28381	209	18	iii	iii	X
ihlr-28381	209	19	(	(	PUNCT
ihlr-28381	209	20	april	april	PROPN
ihlr-28381	209	21	2017	2017	NUM
ihlr-28381	209	22	)	)	PUNCT
ihlr-28381	209	23	,	,	PUNCT
ihlr-28381	209	24	https://pages.lexmachina.com/email_andareport2017_lprequests.html	https://pages.lexmachina.com/email_andareport2017_lprequests.html	VERB
ihlr-28381	209	25	[	[	PUNCT
ihlr-28381	209	26	https://perma.cc/l9zg-8w4	https://perma.cc/l9zg-8w4	NOUN
ihlr-28381	209	27	m	m	NOUN
ihlr-28381	209	28	]	]	X
ihlr-28381	209	29	.	.	PUNCT
ihlr-28381	210	1	45	45	NUM
ihlr-28381	210	2	.	.	X
ihlr-28381	210	3	feldman	feldman	PROPN
ihlr-28381	210	4	&	&	CCONJ
ihlr-28381	210	5	frondorf	frondorf	PROPN
ihlr-28381	210	6	,	,	PUNCT
ihlr-28381	210	7	supra	supra	PROPN
ihlr-28381	210	8	note	note	NOUN
ihlr-28381	210	9	21	21	NUM
ihlr-28381	210	10	,	,	PUNCT
ihlr-28381	210	11	at	at	ADP
ihlr-28381	210	12	511	511	NUM
ihlr-28381	210	13	.	.	PUNCT
ihlr-28381	211	1	46	46	NUM
ihlr-28381	211	2	.	.	PUNCT
ihlr-28381	211	3	feldman	feldman	PROPN
ihlr-28381	211	4	,	,	PUNCT
ihlr-28381	211	5	supra	supra	PROPN
ihlr-28381	211	6	note	note	PROPN
ihlr-28381	211	7	10	10	NUM
ihlr-28381	211	8	,	,	PUNCT
ihlr-28381	211	9	at	at	ADP
ihlr-28381	211	10	22	22	NUM
ihlr-28381	211	11	,	,	PUNCT
ihlr-28381	211	12	25	25	NUM
ihlr-28381	211	13	.	.	NOUN
ihlr-28381	211	14	2024	2024	NUM
ihlr-28381	211	15	]	]	PUNCT
ihlr-28381	211	16	incentivizing	incentivize	VERB
ihlr-28381	211	17	drug	drug	NOUN
ihlr-28381	211	18	affordability	affordability	NOUN
ihlr-28381	211	19	131	131	NUM
ihlr-28381	211	20	preserves	preserve	VERB
ihlr-28381	211	21	its	its	PRON
ihlr-28381	211	22	monopoly.47	monopoly.47	NOUN
ihlr-28381	211	23	the	the	DET
ihlr-28381	211	24	reverse	reverse	ADJ
ihlr-28381	211	25	payment	payment	NOUN
ihlr-28381	211	26	settlement	settlement	NOUN
ihlr-28381	211	27	results	result	NOUN
ihlr-28381	211	28	in	in	ADP
ihlr-28381	211	29	mutual	mutual	ADJ
ihlr-28381	211	30	economic	economic	ADJ
ihlr-28381	211	31	benefit	benefit	NOUN
ihlr-28381	211	32	,	,	PUNCT
ihlr-28381	211	33	and	and	CCONJ
ihlr-28381	211	34	mutual	mutual	ADJ
ihlr-28381	211	35	avoidance	avoidance	NOUN
ihlr-28381	211	36	of	of	ADP
ihlr-28381	211	37	the	the	DET
ihlr-28381	211	38	risk	risk	NOUN
ihlr-28381	211	39	of	of	ADP
ihlr-28381	211	40	losing	lose	VERB
ihlr-28381	211	41	at	at	ADP
ihlr-28381	211	42	trial	trial	NOUN
ihlr-28381	211	43	.	.	PUNCT
ihlr-28381	212	1	“	"	PUNCT
ihlr-28381	212	2	reverse	reverse	VERB
ihlr-28381	212	3	payment	payment	NOUN
ihlr-28381	212	4	settlement	settlement	NOUN
ihlr-28381	212	5	agreement	agreement	NOUN
ihlr-28381	212	6	”	"	PUNCT
ihlr-28381	212	7	reflects	reflect	VERB
ihlr-28381	212	8	the	the	DET
ihlr-28381	212	9	counterintuitive	counterintuitive	ADJ
ihlr-28381	212	10	nature	nature	NOUN
ihlr-28381	212	11	of	of	ADP
ihlr-28381	212	12	these	these	DET
ihlr-28381	212	13	agreements	agreement	NOUN
ihlr-28381	212	14	.	.	PUNCT
ihlr-28381	213	1	“	"	PUNCT
ihlr-28381	213	2	reverse	reverse	NOUN
ihlr-28381	213	3	”	"	PUNCT
ihlr-28381	213	4	communicates	communicate	VERB
ihlr-28381	213	5	that	that	SCONJ
ihlr-28381	213	6	in	in	ADP
ihlr-28381	213	7	the	the	DET
ihlr-28381	213	8	paragraph	paragraph	NOUN
ihlr-28381	213	9	iv	iv	NUM
ihlr-28381	213	10	context	context	NOUN
ihlr-28381	213	11	,	,	PUNCT
ihlr-28381	213	12	the	the	DET
ihlr-28381	213	13	plaintiff	plaintiff	NOUN
ihlr-28381	213	14	(	(	PUNCT
ihlr-28381	213	15	patent	patent	NOUN
ihlr-28381	213	16	-	-	PUNCT
ihlr-28381	213	17	holding	hold	VERB
ihlr-28381	213	18	innovator	innovator	NOUN
ihlr-28381	213	19	)	)	PUNCT
ihlr-28381	213	20	actually	actually	ADV
ihlr-28381	213	21	compensates	compensate	VERB
ihlr-28381	213	22	the	the	DET
ihlr-28381	213	23	defendant	defendant	NOUN
ihlr-28381	213	24	,	,	PUNCT
ihlr-28381	213	25	rather	rather	ADV
ihlr-28381	213	26	than	than	ADP
ihlr-28381	213	27	the	the	DET
ihlr-28381	213	28	defendant	defendant	NOUN
ihlr-28381	213	29	settling	settle	VERB
ihlr-28381	213	30	the	the	DET
ihlr-28381	213	31	dispute	dispute	NOUN
ihlr-28381	213	32	by	by	ADP
ihlr-28381	213	33	compensating	compensate	VERB
ihlr-28381	213	34	the	the	DET
ihlr-28381	213	35	plaintiff	plaintiff	NOUN
ihlr-28381	213	36	.	.	PUNCT
ihlr-28381	214	1	this	this	PRON
ihlr-28381	214	2	is	be	AUX
ihlr-28381	214	3	the	the	DET
ihlr-28381	214	4	reverse	reverse	NOUN
ihlr-28381	214	5	of	of	ADP
ihlr-28381	214	6	the	the	DET
ihlr-28381	214	7	usual	usual	ADJ
ihlr-28381	214	8	dynamic	dynamic	NOUN
ihlr-28381	214	9	,	,	PUNCT
ihlr-28381	214	10	in	in	ADP
ihlr-28381	214	11	which	which	PRON
ihlr-28381	214	12	a	a	DET
ihlr-28381	214	13	plaintiff	plaintiff	NOUN
ihlr-28381	214	14	suffers	suffer	VERB
ihlr-28381	214	15	damages	damage	NOUN
ihlr-28381	214	16	caused	cause	VERB
ihlr-28381	214	17	by	by	ADP
ihlr-28381	214	18	a	a	DET
ihlr-28381	214	19	defendant	defendant	NOUN
ihlr-28381	214	20	,	,	PUNCT
ihlr-28381	214	21	and	and	CCONJ
ihlr-28381	214	22	the	the	DET
ihlr-28381	214	23	defendant	defendant	NOUN
ihlr-28381	214	24	settles	settle	VERB
ihlr-28381	214	25	the	the	DET
ihlr-28381	214	26	case	case	NOUN
ihlr-28381	214	27	by	by	ADP
ihlr-28381	214	28	compensating	compensate	VERB
ihlr-28381	214	29	the	the	DET
ihlr-28381	214	30	plaintiff	plaintiff	NOUN
ihlr-28381	214	31	.	.	PUNCT
ihlr-28381	215	1	as	as	SCONJ
ihlr-28381	215	2	the	the	DET
ihlr-28381	215	3	name	name	NOUN
ihlr-28381	215	4	suggests	suggest	VERB
ihlr-28381	215	5	,	,	PUNCT
ihlr-28381	215	6	the	the	DET
ihlr-28381	215	7	roles	role	NOUN
ihlr-28381	215	8	are	be	AUX
ihlr-28381	215	9	reversed	reverse	VERB
ihlr-28381	215	10	,	,	PUNCT
ihlr-28381	215	11	with	with	ADP
ihlr-28381	215	12	the	the	DET
ihlr-28381	215	13	plaintiff	plaintiff	NOUN
ihlr-28381	215	14	ironically	ironically	ADV
ihlr-28381	215	15	compensating	compensate	VERB
ihlr-28381	215	16	the	the	DET
ihlr-28381	215	17	defendant	defendant	NOUN
ihlr-28381	215	18	to	to	PART
ihlr-28381	215	19	resolve	resolve	VERB
ihlr-28381	215	20	the	the	DET
ihlr-28381	215	21	dispute	dispute	NOUN
ihlr-28381	215	22	.	.	PUNCT
ihlr-28381	216	1	while	while	SCONJ
ihlr-28381	216	2	this	this	PRON
ihlr-28381	216	3	is	be	AUX
ihlr-28381	216	4	somewhat	somewhat	ADV
ihlr-28381	216	5	suspicious	suspicious	ADJ
ihlr-28381	216	6	,	,	PUNCT
ihlr-28381	216	7	the	the	DET
ihlr-28381	216	8	reversed	reverse	VERB
ihlr-28381	216	9	flow	flow	NOUN
ihlr-28381	216	10	of	of	ADP
ihlr-28381	216	11	the	the	DET
ihlr-28381	216	12	settlement	settlement	NOUN
ihlr-28381	216	13	payment	payment	NOUN
ihlr-28381	216	14	can	can	AUX
ihlr-28381	216	15	somewhat	somewhat	ADV
ihlr-28381	216	16	be	be	AUX
ihlr-28381	216	17	attributed	attribute	VERB
ihlr-28381	216	18	to	to	ADP
ihlr-28381	216	19	the	the	DET
ihlr-28381	216	20	unique	unique	ADJ
ihlr-28381	216	21	nature	nature	NOUN
ihlr-28381	216	22	of	of	ADP
ihlr-28381	216	23	the	the	DET
ihlr-28381	216	24	paragraph	paragraph	NOUN
ihlr-28381	216	25	iv	iv	NUM
ihlr-28381	216	26	proves	prove	VERB
ihlr-28381	216	27	.	.	PUNCT
ihlr-28381	217	1	while	while	SCONJ
ihlr-28381	217	2	the	the	DET
ihlr-28381	217	3	patent	patent	NOUN
ihlr-28381	217	4	-	-	PUNCT
ihlr-28381	217	5	holder	holder	NOUN
ihlr-28381	217	6	is	be	AUX
ihlr-28381	217	7	indeed	indeed	ADV
ihlr-28381	217	8	the	the	DET
ihlr-28381	217	9	plaintiff	plaintiff	NOUN
ihlr-28381	217	10	,	,	PUNCT
ihlr-28381	217	11	the	the	DET
ihlr-28381	217	12	generic	generic	ADJ
ihlr-28381	217	13	challenger	challenger	NOUN
ihlr-28381	217	14	is	be	AUX
ihlr-28381	217	15	the	the	DET
ihlr-28381	217	16	true	true	ADJ
ihlr-28381	217	17	provocateur	provocateur	NOUN
ihlr-28381	217	18	via	via	ADP
ihlr-28381	217	19	its	its	PRON
ihlr-28381	217	20	paragraph	paragraph	NOUN
ihlr-28381	217	21	iv	iv	NUM
ihlr-28381	217	22	certification	certification	NOUN
ihlr-28381	217	23	stating	state	VERB
ihlr-28381	217	24	that	that	SCONJ
ihlr-28381	217	25	the	the	DET
ihlr-28381	217	26	innovator	innovator	NOUN
ihlr-28381	217	27	’s	’s	PART
ihlr-28381	217	28	patent	patent	NOUN
ihlr-28381	217	29	is	be	AUX
ihlr-28381	217	30	invalid	invalid	ADJ
ihlr-28381	217	31	or	or	CCONJ
ihlr-28381	217	32	would	would	AUX
ihlr-28381	217	33	not	not	PART
ihlr-28381	217	34	be	be	AUX
ihlr-28381	217	35	infringed	infringe	VERB
ihlr-28381	217	36	.	.	PUNCT
ihlr-28381	218	1	the	the	DET
ihlr-28381	218	2	substance	substance	NOUN
ihlr-28381	218	3	of	of	ADP
ihlr-28381	218	4	modern	modern	ADJ
ihlr-28381	218	5	pay	pay	NOUN
ihlr-28381	218	6	-	-	PUNCT
ihlr-28381	218	7	for	for	ADP
ihlr-28381	218	8	-	-	PUNCT
ihlr-28381	218	9	delay	delay	NOUN
ihlr-28381	218	10	agreements	agreement	NOUN
ihlr-28381	218	11	exhibit	exhibit	VERB
ihlr-28381	218	12	an	an	DET
ihlr-28381	218	13	impressive	impressive	ADJ
ihlr-28381	218	14	level	level	NOUN
ihlr-28381	218	15	of	of	ADP
ihlr-28381	218	16	complexity	complexity	NOUN
ihlr-28381	218	17	,	,	PUNCT
ihlr-28381	218	18	as	as	ADP
ihlr-28381	218	19	a	a	DET
ihlr-28381	218	20	straight	straight	ADJ
ihlr-28381	218	21	-	-	PUNCT
ihlr-28381	218	22	forward	forward	NOUN
ihlr-28381	218	23	quid	quid	ADJ
ihlr-28381	218	24	pro	pro	X
ihlr-28381	218	25	quo	quo	NOUN
ihlr-28381	218	26	—	—	PUNCT
ihlr-28381	218	27	cash	cash	NOUN
ihlr-28381	218	28	for	for	ADP
ihlr-28381	218	29	exiting	exit	VERB
ihlr-28381	218	30	,	,	PUNCT
ihlr-28381	218	31	or	or	CCONJ
ihlr-28381	218	32	not	not	PART
ihlr-28381	218	33	entering	enter	VERB
ihlr-28381	218	34	,	,	PUNCT
ihlr-28381	218	35	the	the	DET
ihlr-28381	218	36	market	market	NOUN
ihlr-28381	218	37	—	—	PUNCT
ihlr-28381	218	38	would	would	AUX
ihlr-28381	218	39	be	be	AUX
ihlr-28381	218	40	considered	consider	VERB
ihlr-28381	218	41	antitrust	antitrust	ADJ
ihlr-28381	218	42	on	on	ADP
ihlr-28381	218	43	its	its	PRON
ihlr-28381	218	44	face	face	NOUN
ihlr-28381	218	45	following	follow	VERB
ihlr-28381	218	46	the	the	DET
ihlr-28381	218	47	2013	2013	NUM
ihlr-28381	218	48	case	case	NOUN
ihlr-28381	218	49	of	of	ADP
ihlr-28381	218	50	ftc	ftc	PROPN
ihlr-28381	218	51	v.	v.	ADP
ihlr-28381	218	52	actavis	actavis	PROPN
ihlr-28381	218	53	(	(	PUNCT
ihlr-28381	218	54	as	as	SCONJ
ihlr-28381	218	55	discussed	discuss	VERB
ihlr-28381	218	56	later	later	ADV
ihlr-28381	218	57	in	in	ADP
ihlr-28381	218	58	this	this	DET
ihlr-28381	218	59	note).48	note).48	PROPN
ihlr-28381	218	60	contemporary	contemporary	ADJ
ihlr-28381	218	61	reverse	reverse	ADJ
ihlr-28381	218	62	payment	payment	NOUN
ihlr-28381	218	63	settlements	settlement	NOUN
ihlr-28381	218	64	often	often	ADV
ihlr-28381	218	65	avoid	avoid	VERB
ihlr-28381	218	66	cash	cash	NOUN
ihlr-28381	218	67	payments	payment	NOUN
ihlr-28381	218	68	but	but	CCONJ
ihlr-28381	218	69	include	include	VERB
ihlr-28381	218	70	non	non	ADJ
ihlr-28381	218	71	-	-	ADJ
ihlr-28381	218	72	cash	cash	ADJ
ihlr-28381	218	73	consideration	consideration	NOUN
ihlr-28381	218	74	to	to	PART
ihlr-28381	218	75	achieve	achieve	VERB
ihlr-28381	218	76	the	the	DET
ihlr-28381	218	77	same	same	ADJ
ihlr-28381	218	78	result	result	NOUN
ihlr-28381	218	79	.	.	PUNCT
ihlr-28381	219	1	the	the	DET
ihlr-28381	219	2	modern	modern	ADJ
ihlr-28381	219	3	complexity	complexity	NOUN
ihlr-28381	219	4	is	be	AUX
ihlr-28381	219	5	illustrated	illustrate	VERB
ihlr-28381	219	6	by	by	ADP
ihlr-28381	219	7	the	the	DET
ihlr-28381	219	8	ftc	ftc	PROPN
ihlr-28381	219	9	’s	’s	PART
ihlr-28381	219	10	analysis	analysis	NOUN
ihlr-28381	219	11	of	of	ADP
ihlr-28381	219	12	these	these	DET
ihlr-28381	219	13	agreements	agreement	NOUN
ihlr-28381	219	14	,	,	PUNCT
ihlr-28381	219	15	in	in	ADP
ihlr-28381	219	16	which	which	PRON
ihlr-28381	219	17	the	the	DET
ihlr-28381	219	18	agency	agency	NOUN
ihlr-28381	219	19	may	may	AUX
ihlr-28381	219	20	label	label	VERB
ihlr-28381	219	21	an	an	DET
ihlr-28381	219	22	agreement	agreement	NOUN
ihlr-28381	219	23	as	as	ADP
ihlr-28381	219	24	involving	involve	VERB
ihlr-28381	219	25	“	"	PUNCT
ihlr-28381	219	26	possible	possible	ADJ
ihlr-28381	219	27	compensation	compensation	NOUN
ihlr-28381	219	28	.	.	PUNCT
ihlr-28381	220	1	”49	”49	ADP
ihlr-28381	220	2	regardless	regardless	ADV
ihlr-28381	220	3	of	of	ADP
ihlr-28381	220	4	the	the	DET
ihlr-28381	220	5	complexity	complexity	NOUN
ihlr-28381	220	6	and	and	CCONJ
ihlr-28381	220	7	specific	specific	ADJ
ihlr-28381	220	8	terms	term	NOUN
ihlr-28381	220	9	of	of	ADP
ihlr-28381	220	10	a	a	DET
ihlr-28381	220	11	reverse	reverse	ADJ
ihlr-28381	220	12	payment	payment	NOUN
ihlr-28381	220	13	settlement	settlement	NOUN
ihlr-28381	220	14	,	,	PUNCT
ihlr-28381	220	15	an	an	DET
ihlr-28381	220	16	anti	anti	ADJ
ihlr-28381	220	17	-	-	ADJ
ihlr-28381	220	18	competitive	competitive	ADJ
ihlr-28381	220	19	reverse	reverse	ADJ
ihlr-28381	220	20	payment	payment	NOUN
ihlr-28381	220	21	settlement	settlement	NOUN
ihlr-28381	220	22	boils	boil	VERB
ihlr-28381	220	23	down	down	ADP
ihlr-28381	220	24	to	to	ADP
ihlr-28381	220	25	a	a	DET
ihlr-28381	220	26	patentee	patentee	NOUN
ihlr-28381	220	27	compensating	compensate	VERB
ihlr-28381	220	28	a	a	DET
ihlr-28381	220	29	would	would	AUX
ihlr-28381	220	30	-	-	PUNCT
ihlr-28381	220	31	be	be	AUX
ihlr-28381	220	32	competitor	competitor	NOUN
ihlr-28381	220	33	to	to	PART
ihlr-28381	220	34	stay	stay	VERB
ihlr-28381	220	35	out	out	ADP
ihlr-28381	220	36	of	of	ADP
ihlr-28381	220	37	its	its	PRON
ihlr-28381	220	38	market	market	NOUN
ihlr-28381	220	39	.	.	PUNCT
ihlr-28381	221	1	although	although	SCONJ
ihlr-28381	221	2	this	this	DET
ihlr-28381	221	3	note	note	NOUN
ihlr-28381	221	4	focuses	focus	VERB
ihlr-28381	221	5	on	on	ADP
ihlr-28381	221	6	instances	instance	NOUN
ihlr-28381	221	7	of	of	ADP
ihlr-28381	221	8	abuse	abuse	NOUN
ihlr-28381	221	9	,	,	PUNCT
ihlr-28381	221	10	many	many	ADJ
ihlr-28381	221	11	reverse	reverse	ADJ
ihlr-28381	221	12	payment	payment	NOUN
ihlr-28381	221	13	settlements	settlement	NOUN
ihlr-28381	221	14	are	be	AUX
ihlr-28381	221	15	pro	pro	ADJ
ihlr-28381	221	16	-	-	ADJ
ihlr-28381	221	17	competitive	competitive	ADJ
ihlr-28381	221	18	and	and	CCONJ
ihlr-28381	221	19	accelerate	accelerate	VERB
ihlr-28381	221	20	competition	competition	NOUN
ihlr-28381	221	21	.	.	PUNCT
ihlr-28381	222	1	when	when	SCONJ
ihlr-28381	222	2	a	a	DET
ihlr-28381	222	3	patent	patent	NOUN
ihlr-28381	222	4	is	be	AUX
ihlr-28381	222	5	strong	strong	ADJ
ihlr-28381	222	6	and	and	CCONJ
ihlr-28381	222	7	likely	likely	ADJ
ihlr-28381	222	8	to	to	PART
ihlr-28381	222	9	be	be	AUX
ihlr-28381	222	10	upheld	uphold	VERB
ihlr-28381	222	11	in	in	ADP
ihlr-28381	222	12	court	court	NOUN
ihlr-28381	222	13	,	,	PUNCT
ihlr-28381	222	14	a	a	DET
ihlr-28381	222	15	reverse	reverse	ADJ
ihlr-28381	222	16	payment	payment	NOUN
ihlr-28381	222	17	settlement	settlement	NOUN
ihlr-28381	222	18	may	may	AUX
ihlr-28381	222	19	actually	actually	ADV
ihlr-28381	222	20	bring	bring	VERB
ihlr-28381	222	21	the	the	DET
ihlr-28381	222	22	generic	generic	NOUN
ihlr-28381	222	23	to	to	ADP
ihlr-28381	222	24	market	market	NOUN
ihlr-28381	222	25	before	before	SCONJ
ihlr-28381	222	26	the	the	DET
ihlr-28381	222	27	patent	patent	NOUN
ihlr-28381	222	28	expires	expire	VERB
ihlr-28381	222	29	.	.	PUNCT
ihlr-28381	223	1	even	even	ADV
ihlr-28381	223	2	though	though	SCONJ
ihlr-28381	223	3	the	the	DET
ihlr-28381	223	4	patent	patent	NOUN
ihlr-28381	223	5	is	be	AUX
ihlr-28381	223	6	probably	probably	ADV
ihlr-28381	223	7	valid	valid	ADJ
ihlr-28381	223	8	and	and	CCONJ
ihlr-28381	223	9	if	if	SCONJ
ihlr-28381	223	10	so	so	ADV
ihlr-28381	223	11	would	would	AUX
ihlr-28381	223	12	be	be	AUX
ihlr-28381	223	13	infringed	infringe	VERB
ihlr-28381	223	14	,	,	PUNCT
ihlr-28381	223	15	a	a	DET
ihlr-28381	223	16	risk	risk	NOUN
ihlr-28381	223	17	-	-	PUNCT
ihlr-28381	223	18	averse	averse	ADJ
ihlr-28381	223	19	innovator	innovator	NOUN
ihlr-28381	223	20	might	might	AUX
ihlr-28381	223	21	pursue	pursue	VERB
ihlr-28381	223	22	a	a	DET
ihlr-28381	223	23	reverse	reverse	ADJ
ihlr-28381	223	24	payment	payment	NOUN
ihlr-28381	223	25	settlement	settlement	NOUN
ihlr-28381	223	26	to	to	PART
ihlr-28381	223	27	eliminate	eliminate	VERB
ihlr-28381	223	28	the	the	DET
ihlr-28381	223	29	threat	threat	NOUN
ihlr-28381	223	30	of	of	ADP
ihlr-28381	223	31	an	an	DET
ihlr-28381	223	32	unlikely	unlikely	ADJ
ihlr-28381	223	33	but	but	CCONJ
ihlr-28381	223	34	extremely	extremely	ADV
ihlr-28381	223	35	damaging	damaging	ADJ
ihlr-28381	223	36	trial	trial	NOUN
ihlr-28381	223	37	outcome	outcome	NOUN
ihlr-28381	223	38	.	.	PUNCT
ihlr-28381	224	1	in	in	ADP
ihlr-28381	224	2	such	such	ADJ
ihlr-28381	224	3	situations	situation	NOUN
ihlr-28381	224	4	,	,	PUNCT
ihlr-28381	224	5	the	the	DET
ihlr-28381	224	6	parties	party	NOUN
ihlr-28381	224	7	compromise	compromise	VERB
ihlr-28381	224	8	for	for	ADP
ihlr-28381	224	9	a	a	DET
ihlr-28381	224	10	date	date	NOUN
ihlr-28381	224	11	of	of	ADP
ihlr-28381	224	12	generic	generic	ADJ
ihlr-28381	224	13	entry	entry	NOUN
ihlr-28381	224	14	later	later	ADV
ihlr-28381	224	15	than	than	SCONJ
ihlr-28381	224	16	the	the	DET
ihlr-28381	224	17	generic	generic	ADJ
ihlr-28381	224	18	company	company	NOUN
ihlr-28381	224	19	would	would	AUX
ihlr-28381	224	20	prefer	prefer	VERB
ihlr-28381	224	21	,	,	PUNCT
ihlr-28381	224	22	but	but	CCONJ
ihlr-28381	224	23	earlier	early	ADV
ihlr-28381	224	24	than	than	ADP
ihlr-28381	224	25	the	the	DET
ihlr-28381	224	26	date	date	NOUN
ihlr-28381	224	27	of	of	ADP
ihlr-28381	224	28	the	the	DET
ihlr-28381	224	29	valid	valid	ADJ
ihlr-28381	224	30	patent	patent	NOUN
ihlr-28381	224	31	’s	’s	NOUN
ihlr-28381	224	32	expiration.50	expiration.50	VERB
ihlr-28381	224	33	most	most	ADV
ihlr-28381	224	34	reverse	reverse	ADJ
ihlr-28381	224	35	payment	payment	NOUN
ihlr-28381	224	36	settlements	settlement	NOUN
ihlr-28381	224	37	are	be	AUX
ihlr-28381	224	38	of	of	ADP
ihlr-28381	224	39	this	this	DET
ihlr-28381	224	40	pro	pro	ADJ
ihlr-28381	224	41	-	-	ADJ
ihlr-28381	224	42	competitive	competitive	ADJ
ihlr-28381	224	43	character	character	NOUN
ihlr-28381	224	44	and	and	CCONJ
ihlr-28381	224	45	induce	induce	VERB
ihlr-28381	224	46	generic	generic	ADJ
ihlr-28381	224	47	entry	entry	NOUN
ihlr-28381	224	48	and	and	CCONJ
ihlr-28381	224	49	associated	associate	VERB
ihlr-28381	224	50	discounts	discount	NOUN
ihlr-28381	224	51	before	before	ADP
ihlr-28381	224	52	the	the	DET
ihlr-28381	224	53	disputed	dispute	VERB
ihlr-28381	224	54	patent	patent	NOUN
ihlr-28381	224	55	would	would	AUX
ihlr-28381	224	56	otherwise	otherwise	ADV
ihlr-28381	224	57	allow.51	allow.51	NOUN
ihlr-28381	224	58	47	47	NUM
ihlr-28381	224	59	.	.	PUNCT
ihlr-28381	225	1	feldman	feldman	PROPN
ihlr-28381	225	2	&	&	CCONJ
ihlr-28381	225	3	frondorf	frondorf	PROPN
ihlr-28381	225	4	,	,	PUNCT
ihlr-28381	225	5	supra	supra	PROPN
ihlr-28381	225	6	note	note	NOUN
ihlr-28381	225	7	21	21	NUM
ihlr-28381	225	8	,	,	PUNCT
ihlr-28381	225	9	at	at	ADP
ihlr-28381	225	10	511	511	NUM
ihlr-28381	225	11	.	.	PUNCT
ihlr-28381	226	1	48	48	NUM
ihlr-28381	226	2	.	.	PUNCT
ihlr-28381	227	1	i	i	PRON
ihlr-28381	227	2	d.	d.	PROPN
ihlr-28381	227	3	at	at	ADP
ihlr-28381	227	4	516	516	NUM
ihlr-28381	227	5	.	.	PUNCT
ihlr-28381	227	6	49	49	NUM
ihlr-28381	227	7	.	.	PUNCT
ihlr-28381	228	1	jamie	jamie	PROPN
ihlr-28381	228	2	towey	towey	PROPN
ihlr-28381	228	3	&	&	CCONJ
ihlr-28381	228	4	brad	brad	PROPN
ihlr-28381	228	5	albert	albert	PROPN
ihlr-28381	228	6	,	,	PUNCT
ihlr-28381	228	7	then	then	ADV
ihlr-28381	228	8	,	,	PUNCT
ihlr-28381	228	9	now	now	ADV
ihlr-28381	228	10	,	,	PUNCT
ihlr-28381	228	11	and	and	CCONJ
ihlr-28381	228	12	down	down	ADP
ihlr-28381	228	13	the	the	DET
ihlr-28381	228	14	road	road	NOUN
ihlr-28381	228	15	:	:	PUNCT
ihlr-28381	228	16	trends	trend	NOUN
ihlr-28381	228	17	in	in	ADP
ihlr-28381	228	18	pharmaceutical	pharmaceutical	NOUN
ihlr-28381	228	19	patent	patent	NOUN
ihlr-28381	228	20	settlements	settlement	NOUN
ihlr-28381	228	21	after	after	ADP
ihlr-28381	228	22	ftc	ftc	PROPN
ihlr-28381	228	23	v.	v.	CCONJ
ihlr-28381	228	24	actavis	actavis	PROPN
ihlr-28381	228	25	,	,	PUNCT
ihlr-28381	228	26	competition	competition	NOUN
ihlr-28381	228	27	matters	matter	NOUN
ihlr-28381	228	28	(	(	PUNCT
ihlr-28381	228	29	may	may	PROPN
ihlr-28381	228	30	28	28	NUM
ihlr-28381	228	31	,	,	PUNCT
ihlr-28381	228	32	2019	2019	NUM
ihlr-28381	228	33	)	)	PUNCT
ihlr-28381	228	34	,	,	PUNCT
ihlr-28381	228	35	https://www.ftc	https://www.ftc	PROPN
ihlr-28381	228	36	.	.	PUNCT
ihlr-28381	229	1	gov	gov	NOUN
ihlr-28381	229	2	/	/	SYM
ihlr-28381	229	3	enforcement	enforcement	NOUN
ihlr-28381	229	4	/	/	SYM
ihlr-28381	229	5	competition	competition	NOUN
ihlr-28381	229	6	-	-	PUNCT
ihlr-28381	229	7	matters/2019/05	matters/2019/05	NOUN
ihlr-28381	229	8	/	/	SYM
ihlr-28381	229	9	then	then	ADV
ihlr-28381	229	10	-	-	PUNCT
ihlr-28381	229	11	now	now	ADV
ihlr-28381	229	12	-	-	PUNCT
ihlr-28381	229	13	down	down	ADP
ihlr-28381	229	14	-	-	PUNCT
ihlr-28381	229	15	road	road	NOUN
ihlr-28381	229	16	-	-	PUNCT
ihlr-28381	229	17	trends	trend	NOUN
ihlr-28381	229	18	-	-	PUNCT
ihlr-28381	229	19	pharmaceutical	pharmaceutical	NOUN
ihlr-28381	229	20	-	-	PUNCT
ihlr-28381	229	21	patentsettlements	patentsettlement	NOUN
ihlr-28381	229	22	-	-	PUNCT
ihlr-28381	229	23	after	after	ADP
ihlr-28381	229	24	-	-	PUNCT
ihlr-28381	229	25	ftc	ftc	NOUN
ihlr-28381	229	26	-	-	PUNCT
ihlr-28381	229	27	v	v	NOUN
ihlr-28381	229	28	-	-	PUNCT
ihlr-28381	229	29	actavis	actavis	NOUN
ihlr-28381	230	1	[	[	X
ihlr-28381	230	2	https://perma.cc/g5lg-aen8	https://perma.cc/g5lg-aen8	X
ihlr-28381	230	3	]	]	X
ihlr-28381	230	4	.	.	PUNCT
ihlr-28381	231	1	50	50	NUM
ihlr-28381	231	2	.	.	PUNCT
ihlr-28381	232	1	impax	impax	PROPN
ihlr-28381	232	2	labs	labs	PROPN
ihlr-28381	232	3	.	.	PUNCT
ihlr-28381	232	4	,	,	PUNCT
ihlr-28381	232	5	inc	inc	PROPN
ihlr-28381	232	6	.	.	PROPN
ihlr-28381	232	7	v.	v.	PROPN
ihlr-28381	232	8	ftc	ftc	PROPN
ihlr-28381	232	9	,	,	PUNCT
ihlr-28381	232	10	994	994	NUM
ihlr-28381	232	11	f.3d	f.3d	NUM
ihlr-28381	232	12	484	484	NUM
ihlr-28381	232	13	,	,	PUNCT
ihlr-28381	232	14	493	493	NUM
ihlr-28381	232	15	(	(	PUNCT
ihlr-28381	232	16	5th	5th	ADJ
ihlr-28381	232	17	cir	cir	NOUN
ihlr-28381	232	18	.	.	PROPN
ihlr-28381	232	19	2021	2021	NUM
ihlr-28381	232	20	)	)	PUNCT
ihlr-28381	232	21	.	.	PUNCT
ihlr-28381	233	1	51	51	NUM
ihlr-28381	233	2	.	.	X
ihlr-28381	234	1	laura	laura	PROPN
ihlr-28381	234	2	karas	karas	PROPN
ihlr-28381	234	3	et	et	PROPN
ihlr-28381	234	4	al	al	PROPN
ihlr-28381	234	5	.	.	PROPN
ihlr-28381	234	6	,	,	PUNCT
ihlr-28381	234	7	pharmaceutical	pharmaceutical	NOUN
ihlr-28381	234	8	“	"	PUNCT
ihlr-28381	234	9	pay	pay	VERB
ihlr-28381	234	10	-	-	PUNCT
ihlr-28381	234	11	for	for	ADP
ihlr-28381	234	12	-	-	PUNCT
ihlr-28381	234	13	delay	delay	NOUN
ihlr-28381	234	14	”	"	PUNCT
ihlr-28381	234	15	reexamined	reexamine	VERB
ihlr-28381	234	16	:	:	PUNCT
ihlr-28381	234	17	a	a	DET
ihlr-28381	234	18	dwindling	dwindle	VERB
ihlr-28381	234	19	practice	practice	NOUN
ihlr-28381	234	20	or	or	CCONJ
ihlr-28381	234	21	a	a	DET
ihlr-28381	234	22	persistent	persistent	ADJ
ihlr-28381	234	23	problem	problem	NOUN
ihlr-28381	234	24	?	?	PUNCT
ihlr-28381	234	25	,	,	PUNCT
ihlr-28381	234	26	71	71	NUM
ihlr-28381	234	27	hastings	hastings	PROPN
ihlr-28381	234	28	l.j	l.j	PROPN
ihlr-28381	234	29	.	.	PROPN
ihlr-28381	234	30	959	959	NUM
ihlr-28381	234	31	,	,	PUNCT
ihlr-28381	234	32	967	967	NUM
ihlr-28381	234	33	-	-	SYM
ihlr-28381	234	34	68	68	NUM
ihlr-28381	234	35	(	(	PUNCT
ihlr-28381	234	36	may	may	NOUN
ihlr-28381	234	37	2020	2020	NUM
ihlr-28381	234	38	)	)	PUNCT
ihlr-28381	234	39	,	,	PUNCT
ihlr-28381	234	40	https://papers.ssrn.com/sol3/	https://papers.ssrn.com/sol3/	PROPN
ihlr-28381	234	41	132	132	NUM
ihlr-28381	234	42	indiana	indiana	PROPN
ihlr-28381	234	43	health	health	PROPN
ihlr-28381	234	44	law	law	PROPN
ihlr-28381	234	45	review	review	NOUN
ihlr-28381	234	46	[	[	X
ihlr-28381	234	47	vol	vol	NOUN
ihlr-28381	234	48	.	.	NOUN
ihlr-28381	234	49	21:121	21:121	NUM
ihlr-28381	235	1	even	even	ADV
ihlr-28381	235	2	if	if	SCONJ
ihlr-28381	235	3	they	they	PRON
ihlr-28381	235	4	do	do	AUX
ihlr-28381	235	5	not	not	PART
ihlr-28381	235	6	produce	produce	VERB
ihlr-28381	235	7	the	the	DET
ihlr-28381	235	8	pro	pro	ADJ
ihlr-28381	235	9	-	-	ADJ
ihlr-28381	235	10	competitive	competitive	ADJ
ihlr-28381	235	11	effects	effect	NOUN
ihlr-28381	235	12	of	of	ADP
ihlr-28381	235	13	the	the	DET
ihlr-28381	235	14	previous	previous	ADJ
ihlr-28381	235	15	example	example	NOUN
ihlr-28381	235	16	,	,	PUNCT
ihlr-28381	235	17	reverse	reverse	ADJ
ihlr-28381	235	18	payment	payment	NOUN
ihlr-28381	235	19	settlement	settlement	NOUN
ihlr-28381	235	20	agreements	agreement	NOUN
ihlr-28381	235	21	can	can	AUX
ihlr-28381	235	22	be	be	AUX
ihlr-28381	235	23	commercially	commercially	ADV
ihlr-28381	235	24	reasonable	reasonable	ADJ
ihlr-28381	235	25	and	and	CCONJ
ihlr-28381	235	26	legally	legally	ADV
ihlr-28381	235	27	justifiable	justifiable	ADJ
ihlr-28381	235	28	.	.	PUNCT
ihlr-28381	236	1	consider	consider	VERB
ihlr-28381	236	2	that	that	SCONJ
ihlr-28381	236	3	the	the	DET
ihlr-28381	236	4	180	180	NUM
ihlr-28381	236	5	-	-	PUNCT
ihlr-28381	236	6	day	day	NOUN
ihlr-28381	236	7	generic	generic	ADJ
ihlr-28381	236	8	exclusivity	exclusivity	NOUN
ihlr-28381	236	9	period	period	NOUN
ihlr-28381	236	10	begins	begin	VERB
ihlr-28381	236	11	running	run	VERB
ihlr-28381	236	12	the	the	DET
ihlr-28381	236	13	day	day	NOUN
ihlr-28381	236	14	the	the	DET
ihlr-28381	236	15	first	first	ADJ
ihlr-28381	236	16	generic	generic	ADJ
ihlr-28381	236	17	filer	filer	NOUN
ihlr-28381	236	18	markets	market	VERB
ihlr-28381	236	19	the	the	DET
ihlr-28381	236	20	drug	drug	NOUN
ihlr-28381	236	21	.	.	PUNCT
ihlr-28381	237	1	in	in	SCONJ
ihlr-28381	237	2	the	the	DET
ihlr-28381	237	3	race	race	NOUN
ihlr-28381	237	4	to	to	PART
ihlr-28381	237	5	file	file	VERB
ihlr-28381	237	6	first	first	ADV
ihlr-28381	237	7	and	and	CCONJ
ihlr-28381	237	8	win	win	VERB
ihlr-28381	237	9	the	the	DET
ihlr-28381	237	10	180	180	NUM
ihlr-28381	237	11	-	-	PUNCT
ihlr-28381	237	12	day	day	NOUN
ihlr-28381	237	13	exclusivity	exclusivity	NOUN
ihlr-28381	237	14	period	period	NOUN
ihlr-28381	237	15	as	as	ADP
ihlr-28381	237	16	the	the	DET
ihlr-28381	237	17	first	first	ADJ
ihlr-28381	237	18	generic	generic	ADJ
ihlr-28381	237	19	filer	filer	NOUN
ihlr-28381	237	20	,	,	PUNCT
ihlr-28381	237	21	the	the	DET
ihlr-28381	237	22	generic	generic	ADJ
ihlr-28381	237	23	company	company	NOUN
ihlr-28381	237	24	’s	’s	PART
ihlr-28381	237	25	challenge	challenge	NOUN
ihlr-28381	237	26	may	may	AUX
ihlr-28381	237	27	be	be	AUX
ihlr-28381	237	28	weak	weak	ADJ
ihlr-28381	237	29	,	,	PUNCT
ihlr-28381	237	30	or	or	CCONJ
ihlr-28381	237	31	the	the	DET
ihlr-28381	237	32	innovator	innovator	NOUN
ihlr-28381	237	33	’s	’s	PART
ihlr-28381	237	34	patent	patent	NOUN
ihlr-28381	237	35	strong	strong	ADJ
ihlr-28381	237	36	.	.	PUNCT
ihlr-28381	238	1	further	far	ADV
ihlr-28381	238	2	,	,	PUNCT
ihlr-28381	238	3	and	and	CCONJ
ihlr-28381	238	4	not	not	PART
ihlr-28381	238	5	uncommon	uncommon	ADJ
ihlr-28381	238	6	for	for	ADP
ihlr-28381	238	7	small	small	ADJ
ihlr-28381	238	8	innovators	innovator	NOUN
ihlr-28381	238	9	with	with	ADP
ihlr-28381	238	10	one	one	NUM
ihlr-28381	238	11	or	or	CCONJ
ihlr-28381	238	12	few	few	ADJ
ihlr-28381	238	13	drugs	drug	NOUN
ihlr-28381	238	14	,	,	PUNCT
ihlr-28381	238	15	the	the	DET
ihlr-28381	238	16	innovator	innovator	NOUN
ihlr-28381	238	17	’s	’s	PART
ihlr-28381	238	18	survival	survival	NOUN
ihlr-28381	238	19	might	might	AUX
ihlr-28381	238	20	depend	depend	VERB
ihlr-28381	238	21	upon	upon	SCONJ
ihlr-28381	238	22	the	the	DET
ihlr-28381	238	23	revenues	revenue	NOUN
ihlr-28381	238	24	currently	currently	ADV
ihlr-28381	238	25	protected	protect	VERB
ihlr-28381	238	26	by	by	ADP
ihlr-28381	238	27	the	the	DET
ihlr-28381	238	28	challenged	challenge	VERB
ihlr-28381	238	29	patent	patent	NOUN
ihlr-28381	238	30	—	—	PUNCT
ihlr-28381	238	31	the	the	DET
ihlr-28381	238	32	innovator	innovator	NOUN
ihlr-28381	238	33	’s	’s	PART
ihlr-28381	238	34	risk	risk	NOUN
ihlr-28381	238	35	tolerance	tolerance	NOUN
ihlr-28381	238	36	might	might	AUX
ihlr-28381	238	37	require	require	VERB
ihlr-28381	238	38	the	the	DET
ihlr-28381	238	39	innovator	innovator	NOUN
ihlr-28381	238	40	to	to	PART
ihlr-28381	238	41	leave	leave	VERB
ihlr-28381	238	42	nothing	nothing	PRON
ihlr-28381	238	43	to	to	PART
ihlr-28381	238	44	chance	chance	VERB
ihlr-28381	238	45	,	,	PUNCT
ihlr-28381	238	46	even	even	ADV
ihlr-28381	238	47	if	if	SCONJ
ihlr-28381	238	48	a	a	DET
ihlr-28381	238	49	patent	patent	NOUN
ihlr-28381	238	50	is	be	AUX
ihlr-28381	238	51	strong	strong	ADJ
ihlr-28381	238	52	.	.	PUNCT
ihlr-28381	239	1	both	both	DET
ihlr-28381	239	2	parties	party	NOUN
ihlr-28381	239	3	want	want	VERB
ihlr-28381	239	4	to	to	PART
ihlr-28381	239	5	avoid	avoid	VERB
ihlr-28381	239	6	the	the	DET
ihlr-28381	239	7	binary	binary	ADJ
ihlr-28381	239	8	risk	risk	NOUN
ihlr-28381	239	9	of	of	ADP
ihlr-28381	239	10	litigation	litigation	NOUN
ihlr-28381	239	11	for	for	ADP
ihlr-28381	239	12	reasons	reason	NOUN
ihlr-28381	239	13	beyond	beyond	ADP
ihlr-28381	239	14	minimizing	minimize	VERB
ihlr-28381	239	15	legal	legal	ADJ
ihlr-28381	239	16	fees	fee	NOUN
ihlr-28381	239	17	;	;	PUNCT
ihlr-28381	239	18	the	the	DET
ihlr-28381	239	19	innovator	innovator	NOUN
ihlr-28381	239	20	expects	expect	VERB
ihlr-28381	239	21	to	to	PART
ihlr-28381	239	22	win	win	VERB
ihlr-28381	239	23	but	but	CCONJ
ihlr-28381	239	24	can	can	AUX
ihlr-28381	239	25	not	not	PART
ihlr-28381	239	26	afford	afford	VERB
ihlr-28381	239	27	to	to	PART
ihlr-28381	239	28	lose	lose	VERB
ihlr-28381	239	29	,	,	PUNCT
ihlr-28381	239	30	and	and	CCONJ
ihlr-28381	239	31	the	the	DET
ihlr-28381	239	32	generic	generic	PROPN
ihlr-28381	239	33	expects	expect	VERB
ihlr-28381	239	34	to	to	PART
ihlr-28381	239	35	lose	lose	VERB
ihlr-28381	239	36	.	.	PUNCT
ihlr-28381	240	1	to	to	PART
ihlr-28381	240	2	protect	protect	VERB
ihlr-28381	240	3	its	its	PRON
ihlr-28381	240	4	patent	patent	NOUN
ihlr-28381	240	5	,	,	PUNCT
ihlr-28381	240	6	the	the	DET
ihlr-28381	240	7	innovator	innovator	NOUN
ihlr-28381	240	8	may	may	AUX
ihlr-28381	240	9	offer	offer	VERB
ihlr-28381	240	10	to	to	PART
ihlr-28381	240	11	license	license	VERB
ihlr-28381	240	12	marketing	marketing	NOUN
ihlr-28381	240	13	rights	right	NOUN
ihlr-28381	240	14	to	to	ADP
ihlr-28381	240	15	the	the	DET
ihlr-28381	240	16	generic	generic	ADJ
ihlr-28381	240	17	firm	firm	NOUN
ihlr-28381	240	18	or	or	CCONJ
ihlr-28381	240	19	commit	commit	VERB
ihlr-28381	240	20	to	to	PART
ihlr-28381	240	21	not	not	PART
ihlr-28381	240	22	launching	launch	VERB
ihlr-28381	240	23	its	its	PRON
ihlr-28381	240	24	own	own	ADJ
ihlr-28381	240	25	authorized	authorize	VERB
ihlr-28381	240	26	generic	generic	ADJ
ihlr-28381	240	27	during	during	ADP
ihlr-28381	240	28	the	the	DET
ihlr-28381	240	29	180	180	NUM
ihlr-28381	240	30	-	-	PUNCT
ihlr-28381	240	31	day	day	NOUN
ihlr-28381	240	32	exclusivity	exclusivity	NOUN
ihlr-28381	240	33	period	period	NOUN
ihlr-28381	240	34	,	,	PUNCT
ihlr-28381	240	35	which	which	PRON
ihlr-28381	240	36	does	do	AUX
ihlr-28381	240	37	not	not	PART
ihlr-28381	240	38	prohibit	prohibit	VERB
ihlr-28381	240	39	a	a	DET
ihlr-28381	240	40	company	company	NOUN
ihlr-28381	240	41	from	from	ADP
ihlr-28381	240	42	selling	sell	VERB
ihlr-28381	240	43	its	its	PRON
ihlr-28381	240	44	own	own	ADJ
ihlr-28381	240	45	fdaapproved	fdaapprove	VERB
ihlr-28381	240	46	product	product	NOUN
ihlr-28381	240	47	,	,	PUNCT
ihlr-28381	240	48	repackaged	repackage	VERB
ihlr-28381	240	49	and	and	CCONJ
ihlr-28381	240	50	sold	sell	VERB
ihlr-28381	240	51	at	at	ADP
ihlr-28381	240	52	a	a	DET
ihlr-28381	240	53	lower	low	ADJ
ihlr-28381	240	54	price	price	NOUN
ihlr-28381	240	55	.	.	PUNCT
ihlr-28381	241	1	in	in	ADP
ihlr-28381	241	2	exchange	exchange	NOUN
ihlr-28381	241	3	,	,	PUNCT
ihlr-28381	241	4	the	the	DET
ihlr-28381	241	5	generic	generic	ADJ
ihlr-28381	241	6	firm	firm	NOUN
ihlr-28381	241	7	agrees	agree	VERB
ihlr-28381	241	8	not	not	PART
ihlr-28381	241	9	to	to	PART
ihlr-28381	241	10	launch	launch	VERB
ihlr-28381	241	11	its	its	PRON
ihlr-28381	241	12	competing	compete	VERB
ihlr-28381	241	13	drug	drug	NOUN
ihlr-28381	241	14	until	until	SCONJ
ihlr-28381	241	15	the	the	DET
ihlr-28381	241	16	disputed	dispute	VERB
ihlr-28381	241	17	patent	patent	NOUN
ihlr-28381	241	18	expires	expire	VERB
ihlr-28381	241	19	.	.	PUNCT
ihlr-28381	242	1	because	because	SCONJ
ihlr-28381	242	2	losing	lose	VERB
ihlr-28381	242	3	at	at	ADP
ihlr-28381	242	4	trial	trial	NOUN
ihlr-28381	242	5	would	would	AUX
ihlr-28381	242	6	negate	negate	VERB
ihlr-28381	242	7	the	the	DET
ihlr-28381	242	8	180	180	NUM
ihlr-28381	242	9	-	-	PUNCT
ihlr-28381	242	10	day	day	NOUN
ihlr-28381	242	11	exclusivity	exclusivity	NOUN
ihlr-28381	242	12	right	right	NOUN
ihlr-28381	242	13	,	,	PUNCT
ihlr-28381	242	14	the	the	DET
ihlr-28381	242	15	generic	generic	ADJ
ihlr-28381	242	16	firm	firm	NOUN
ihlr-28381	242	17	accepts	accept	VERB
ihlr-28381	242	18	these	these	DET
ihlr-28381	242	19	terms	term	NOUN
ihlr-28381	242	20	.	.	PUNCT
ihlr-28381	243	1	the	the	DET
ihlr-28381	243	2	innovator	innovator	NOUN
ihlr-28381	243	3	is	be	AUX
ihlr-28381	243	4	satisfied	satisfied	ADJ
ihlr-28381	243	5	with	with	ADP
ihlr-28381	243	6	the	the	DET
ihlr-28381	243	7	preservation	preservation	NOUN
ihlr-28381	243	8	of	of	ADP
ihlr-28381	243	9	its	its	PRON
ihlr-28381	243	10	likely	likely	ADJ
ihlr-28381	243	11	-	-	PUNCT
ihlr-28381	243	12	valid	valid	ADJ
ihlr-28381	243	13	but	but	CCONJ
ihlr-28381	243	14	life	life	NOUN
ihlr-28381	243	15	-	-	PUNCT
ihlr-28381	243	16	giving	give	VERB
ihlr-28381	243	17	patent	patent	NOUN
ihlr-28381	243	18	,	,	PUNCT
ihlr-28381	243	19	and	and	CCONJ
ihlr-28381	243	20	the	the	DET
ihlr-28381	243	21	generic	generic	ADJ
ihlr-28381	243	22	firm	firm	NOUN
ihlr-28381	243	23	is	be	AUX
ihlr-28381	243	24	satisfied	satisfied	ADJ
ihlr-28381	243	25	with	with	ADP
ihlr-28381	243	26	the	the	DET
ihlr-28381	243	27	preservation	preservation	NOUN
ihlr-28381	243	28	of	of	ADP
ihlr-28381	243	29	its	its	PRON
ihlr-28381	243	30	180	180	NUM
ihlr-28381	243	31	-	-	PUNCT
ihlr-28381	243	32	day	day	NOUN
ihlr-28381	243	33	exclusivity	exclusivity	NOUN
ihlr-28381	243	34	right	right	NOUN
ihlr-28381	243	35	.	.	PUNCT
ihlr-28381	244	1	however	however	ADV
ihlr-28381	244	2	,	,	PUNCT
ihlr-28381	244	3	the	the	DET
ihlr-28381	244	4	patient	patient	NOUN
ihlr-28381	244	5	remains	remain	VERB
ihlr-28381	244	6	the	the	DET
ihlr-28381	244	7	source	source	NOUN
ihlr-28381	244	8	of	of	ADP
ihlr-28381	244	9	inelastic	inelastic	ADJ
ihlr-28381	244	10	demand	demand	NOUN
ihlr-28381	244	11	in	in	ADP
ihlr-28381	244	12	this	this	DET
ihlr-28381	244	13	market	market	NOUN
ihlr-28381	244	14	made	make	VERB
ihlr-28381	244	15	less	less	ADV
ihlr-28381	244	16	competitive	competitive	ADJ
ihlr-28381	244	17	by	by	ADP
ihlr-28381	244	18	the	the	DET
ihlr-28381	244	19	reverse	reverse	ADJ
ihlr-28381	244	20	payment	payment	NOUN
ihlr-28381	244	21	settlement	settlement	NOUN
ihlr-28381	244	22	.	.	PUNCT
ihlr-28381	245	1	as	as	SCONJ
ihlr-28381	245	2	illustrated	illustrate	VERB
ihlr-28381	245	3	,	,	PUNCT
ihlr-28381	245	4	reverse	reverse	ADJ
ihlr-28381	245	5	payment	payment	NOUN
ihlr-28381	245	6	settlement	settlement	NOUN
ihlr-28381	245	7	agreements	agreement	NOUN
ihlr-28381	245	8	can	can	AUX
ihlr-28381	245	9	be	be	AUX
ihlr-28381	245	10	pro	pro	ADJ
ihlr-28381	245	11	-	-	ADJ
ihlr-28381	245	12	competitive	competitive	ADJ
ihlr-28381	245	13	and	and	CCONJ
ihlr-28381	245	14	beneficial	beneficial	ADJ
ihlr-28381	245	15	to	to	ADP
ihlr-28381	245	16	patients	patient	NOUN
ihlr-28381	245	17	,	,	PUNCT
ihlr-28381	245	18	or	or	CCONJ
ihlr-28381	245	19	simply	simply	ADV
ihlr-28381	245	20	within	within	ADP
ihlr-28381	245	21	the	the	DET
ihlr-28381	245	22	boundaries	boundary	NOUN
ihlr-28381	245	23	of	of	ADP
ihlr-28381	245	24	capitalism	capitalism	NOUN
ihlr-28381	245	25	and	and	CCONJ
ihlr-28381	245	26	antitrust	antitrust	ADJ
ihlr-28381	245	27	and	and	CCONJ
ihlr-28381	245	28	intellectual	intellectual	ADJ
ihlr-28381	245	29	property	property	NOUN
ihlr-28381	245	30	law	law	NOUN
ihlr-28381	245	31	.	.	PUNCT
ihlr-28381	246	1	while	while	SCONJ
ihlr-28381	246	2	the	the	DET
ihlr-28381	246	3	good	good	ADJ
ihlr-28381	246	4	-	-	PUNCT
ihlr-28381	246	5	faith	faith	NOUN
ihlr-28381	246	6	nature	nature	NOUN
ihlr-28381	246	7	of	of	ADP
ihlr-28381	246	8	many	many	ADJ
ihlr-28381	246	9	reverse	reverse	ADJ
ihlr-28381	246	10	payment	payment	NOUN
ihlr-28381	246	11	settlements	settlement	NOUN
ihlr-28381	246	12	must	must	AUX
ihlr-28381	246	13	be	be	AUX
ihlr-28381	246	14	recognized	recognize	VERB
ihlr-28381	246	15	,	,	PUNCT
ihlr-28381	246	16	this	this	PRON
ihlr-28381	246	17	does	do	AUX
ihlr-28381	246	18	not	not	PART
ihlr-28381	246	19	make	make	VERB
ihlr-28381	246	20	anticompetitive	anticompetitive	ADJ
ihlr-28381	246	21	reverse	reverse	ADJ
ihlr-28381	246	22	payment	payment	NOUN
ihlr-28381	246	23	settlements	settlement	NOUN
ihlr-28381	246	24	any	any	PRON
ihlr-28381	246	25	less	less	ADV
ihlr-28381	246	26	expensive	expensive	ADJ
ihlr-28381	246	27	or	or	CCONJ
ihlr-28381	246	28	any	any	PRON
ihlr-28381	246	29	less	less	ADV
ihlr-28381	246	30	detrimental	detrimental	ADJ
ihlr-28381	246	31	to	to	ADP
ihlr-28381	246	32	patients	patient	NOUN
ihlr-28381	246	33	.	.	PUNCT
ihlr-28381	247	1	originally	originally	ADV
ihlr-28381	247	2	characterized	characterize	VERB
ihlr-28381	247	3	by	by	ADP
ihlr-28381	247	4	undisguised	undisguised	ADJ
ihlr-28381	247	5	quid	quid	ADJ
ihlr-28381	247	6	pro	pro	X
ihlr-28381	247	7	quos	quo	NOUN
ihlr-28381	247	8	,	,	PUNCT
ihlr-28381	247	9	the	the	DET
ihlr-28381	247	10	classic	classic	ADJ
ihlr-28381	247	11	version	version	NOUN
ihlr-28381	247	12	of	of	ADP
ihlr-28381	247	13	anti	anti	ADJ
ihlr-28381	247	14	-	-	ADJ
ihlr-28381	247	15	competitive	competitive	ADJ
ihlr-28381	247	16	reverse	reverse	ADJ
ihlr-28381	247	17	payment	payment	NOUN
ihlr-28381	247	18	settlements	settlement	NOUN
ihlr-28381	247	19	eventually	eventually	ADV
ihlr-28381	247	20	earned	earn	VERB
ihlr-28381	247	21	supreme	supreme	PROPN
ihlr-28381	247	22	court	court	PROPN
ihlr-28381	247	23	disapproval.52	disapproval.52	NOUN
ihlr-28381	247	24	before	before	ADP
ihlr-28381	247	25	discussing	discuss	VERB
ihlr-28381	247	26	the	the	DET
ihlr-28381	247	27	court	court	NOUN
ihlr-28381	247	28	’s	’s	PART
ihlr-28381	247	29	decision	decision	NOUN
ihlr-28381	247	30	,	,	PUNCT
ihlr-28381	247	31	however	however	ADV
ihlr-28381	247	32	,	,	PUNCT
ihlr-28381	247	33	an	an	DET
ihlr-28381	247	34	analysis	analysis	NOUN
ihlr-28381	247	35	of	of	ADP
ihlr-28381	247	36	other	other	ADJ
ihlr-28381	247	37	pay	pay	VERB
ihlr-28381	247	38	-	-	PUNCT
ihlr-28381	247	39	for	for	ADP
ihlr-28381	247	40	-	-	PUNCT
ihlr-28381	247	41	delay	delay	NOUN
ihlr-28381	247	42	strategies	strategy	NOUN
ihlr-28381	247	43	is	be	AUX
ihlr-28381	247	44	warranted	warrant	VERB
ihlr-28381	247	45	.	.	PUNCT
ihlr-28381	248	1	v.	v.	ADP
ihlr-28381	248	2	analysis	analysis	NOUN
ihlr-28381	248	3	:	:	PUNCT
ihlr-28381	248	4	diversifying	diversify	VERB
ihlr-28381	248	5	delay	delay	NOUN
ihlr-28381	248	6	the	the	DET
ihlr-28381	248	7	variation	variation	NOUN
ihlr-28381	248	8	and	and	CCONJ
ihlr-28381	248	9	depth	depth	NOUN
ihlr-28381	248	10	of	of	ADP
ihlr-28381	248	11	pay	pay	NOUN
ihlr-28381	248	12	-	-	PUNCT
ihlr-28381	248	13	for	for	ADP
ihlr-28381	248	14	-	-	PUNCT
ihlr-28381	248	15	delay	delay	NOUN
ihlr-28381	248	16	—	—	PUNCT
ihlr-28381	248	17	including	include	VERB
ihlr-28381	248	18	well	well	ADV
ihlr-28381	248	19	-	-	PUNCT
ihlr-28381	248	20	disguised	disguise	VERB
ihlr-28381	248	21	anticompetitive	anticompetitive	ADJ
ihlr-28381	248	22	reverse	reverse	ADJ
ihlr-28381	248	23	payment	payment	NOUN
ihlr-28381	248	24	settlements	settlement	NOUN
ihlr-28381	248	25	—	—	PUNCT
ihlr-28381	248	26	is	be	AUX
ihlr-28381	248	27	indefinite	indefinite	ADJ
ihlr-28381	248	28	.	.	PUNCT
ihlr-28381	249	1	although	although	SCONJ
ihlr-28381	249	2	congress	congress	PROPN
ihlr-28381	249	3	periodically	periodically	ADV
ihlr-28381	249	4	attempts	attempt	VERB
ihlr-28381	249	5	to	to	PART
ihlr-28381	249	6	define	define	VERB
ihlr-28381	249	7	and	and	CCONJ
ihlr-28381	249	8	outlaw	outlaw	VERB
ihlr-28381	249	9	specific	specific	ADJ
ihlr-28381	249	10	manifestations	manifestation	NOUN
ihlr-28381	249	11	of	of	ADP
ihlr-28381	249	12	pay	pay	NOUN
ihlr-28381	249	13	-	-	PUNCT
ihlr-28381	249	14	fordelay	fordelay	NOUN
ihlr-28381	249	15	,	,	PUNCT
ihlr-28381	249	16	the	the	DET
ihlr-28381	249	17	menu	menu	NOUN
ihlr-28381	249	18	of	of	ADP
ihlr-28381	249	19	substitutes	substitute	NOUN
ihlr-28381	249	20	greatly	greatly	ADV
ihlr-28381	249	21	mutes	mute	VERB
ihlr-28381	249	22	the	the	DET
ihlr-28381	249	23	intended	intend	VERB
ihlr-28381	249	24	effect	effect	NOUN
ihlr-28381	249	25	of	of	ADP
ihlr-28381	249	26	congressional	congressional	ADJ
ihlr-28381	249	27	efforts	effort	NOUN
ihlr-28381	249	28	.	.	PUNCT
ihlr-28381	250	1	“	"	PUNCT
ihlr-28381	250	2	anti	anti	ADJ
ihlr-28381	250	3	-	-	ADJ
ihlr-28381	250	4	competitive	competitive	ADJ
ihlr-28381	250	5	conduct	conduct	NOUN
ihlr-28381	250	6	can	can	AUX
ihlr-28381	250	7	come	come	VERB
ihlr-28381	250	8	in	in	ADP
ihlr-28381	250	9	too	too	ADV
ihlr-28381	250	10	many	many	ADJ
ihlr-28381	250	11	different	different	ADJ
ihlr-28381	250	12	forms	form	NOUN
ihlr-28381	250	13	,	,	PUNCT
ihlr-28381	250	14	and	and	CCONJ
ihlr-28381	250	15	is	be	AUX
ihlr-28381	250	16	too	too	ADV
ihlr-28381	250	17	dependent	dependent	ADJ
ihlr-28381	250	18	upon	upon	SCONJ
ihlr-28381	250	19	context	context	NOUN
ihlr-28381	250	20	,	,	PUNCT
ihlr-28381	250	21	for	for	SCONJ
ihlr-28381	250	22	any	any	DET
ihlr-28381	250	23	court	court	NOUN
ihlr-28381	250	24	or	or	CCONJ
ihlr-28381	250	25	commentator	commentator	NOUN
ihlr-28381	250	26	ever	ever	ADV
ihlr-28381	250	27	to	to	PART
ihlr-28381	250	28	have	have	AUX
ihlr-28381	250	29	enumerated	enumerate	VERB
ihlr-28381	250	30	all	all	DET
ihlr-28381	250	31	the	the	DET
ihlr-28381	250	32	varieties	variety	NOUN
ihlr-28381	250	33	.	.	PUNCT
ihlr-28381	251	1	”53	”53	ADJ
ihlr-28381	251	2	notwithstanding	notwithstanding	ADV
ihlr-28381	251	3	,	,	PUNCT
ihlr-28381	251	4	this	this	DET
ihlr-28381	251	5	note	note	NOUN
ihlr-28381	251	6	attempts	attempt	VERB
ihlr-28381	251	7	to	to	PART
ihlr-28381	251	8	describe	describe	VERB
ihlr-28381	251	9	papers.cfm?abstract_id=3458552	papers.cfm?abstract_id=3458552	PUNCT
ihlr-28381	251	10	[	[	X
ihlr-28381	251	11	https://perma.cc/pq2j-lqna	https://perma.cc/pq2j-lqna	X
ihlr-28381	251	12	]	]	X
ihlr-28381	251	13	.	.	PUNCT
ihlr-28381	252	1	52	52	NUM
ihlr-28381	252	2	.	.	PUNCT
ihlr-28381	253	1	ftc	ftc	PROPN
ihlr-28381	253	2	v.	v.	ADP
ihlr-28381	253	3	actavis	actavis	PROPN
ihlr-28381	253	4	,	,	PUNCT
ihlr-28381	253	5	inc	inc	PROPN
ihlr-28381	253	6	.	.	PROPN
ihlr-28381	253	7	,	,	PUNCT
ihlr-28381	253	8	570	570	NUM
ihlr-28381	253	9	u.s	u.s	PROPN
ihlr-28381	253	10	.	.	PROPN
ihlr-28381	253	11	136	136	NUM
ihlr-28381	253	12	,	,	PUNCT
ihlr-28381	253	13	141	141	NUM
ihlr-28381	253	14	(	(	PUNCT
ihlr-28381	253	15	2013	2013	NUM
ihlr-28381	253	16	)	)	PUNCT
ihlr-28381	253	17	.	.	PUNCT
ihlr-28381	254	1	53	53	NUM
ihlr-28381	254	2	.	.	PUNCT
ihlr-28381	255	1	in	in	ADP
ihlr-28381	255	2	re	re	PROPN
ihlr-28381	255	3	suboxone	suboxone	NOUN
ihlr-28381	255	4	(	(	PUNCT
ihlr-28381	255	5	buprenorphine	buprenorphine	NOUN
ihlr-28381	255	6	hydrochloride	hydrochloride	NOUN
ihlr-28381	255	7	&	&	CCONJ
ihlr-28381	255	8	naloxone	naloxone	NOUN
ihlr-28381	255	9	)	)	PUNCT
ihlr-28381	255	10	antitrust	antitrust	ADJ
ihlr-28381	255	11	litig	litig	NOUN
ihlr-28381	255	12	.	.	PUNCT
ihlr-28381	256	1	,	,	PUNCT
ihlr-28381	256	2	64	64	NUM
ihlr-28381	256	3	f.	f.	PROPN
ihlr-28381	256	4	supp	supp	PROPN
ihlr-28381	256	5	.	.	PUNCT
ihlr-28381	257	1	2024	2024	NUM
ihlr-28381	257	2	]	]	PUNCT
ihlr-28381	257	3	incentivizing	incentivize	VERB
ihlr-28381	257	4	drug	drug	NOUN
ihlr-28381	257	5	affordability	affordability	NOUN
ihlr-28381	257	6	133	133	NUM
ihlr-28381	257	7	several	several	ADJ
ihlr-28381	257	8	variations	variation	NOUN
ihlr-28381	257	9	of	of	ADP
ihlr-28381	257	10	pay	pay	NOUN
ihlr-28381	257	11	-	-	PUNCT
ihlr-28381	257	12	for	for	ADP
ihlr-28381	257	13	-	-	PUNCT
ihlr-28381	257	14	delay	delay	NOUN
ihlr-28381	257	15	beyond	beyond	ADP
ihlr-28381	257	16	reverse	reverse	ADJ
ihlr-28381	257	17	payment	payment	NOUN
ihlr-28381	257	18	settlement	settlement	NOUN
ihlr-28381	257	19	agreements	agreement	NOUN
ihlr-28381	257	20	.	.	PUNCT
ihlr-28381	258	1	a.	a.	PROPN
ihlr-28381	258	2	citizen	citizen	PROPN
ihlr-28381	258	3	petitions	petition	VERB
ihlr-28381	258	4	the	the	DET
ihlr-28381	258	5	code	code	NOUN
ihlr-28381	258	6	of	of	ADP
ihlr-28381	258	7	federal	federal	ADJ
ihlr-28381	258	8	regulations—21	regulations—21	X
ihlr-28381	258	9	cfr	cfr	NOUN
ihlr-28381	258	10	§	§	NOUN
ihlr-28381	258	11	10.20	10.20	NUM
ihlr-28381	258	12	-	-	SYM
ihlr-28381	258	13	30	30	NUM
ihlr-28381	258	14	—	—	PUNCT
ihlr-28381	258	15	allows	allow	VERB
ihlr-28381	258	16	interested	interested	ADJ
ihlr-28381	258	17	persons	person	NOUN
ihlr-28381	258	18	to	to	PART
ihlr-28381	258	19	submit	submit	VERB
ihlr-28381	258	20	“	"	PUNCT
ihlr-28381	258	21	citizen	citizen	NOUN
ihlr-28381	258	22	petitions	petition	NOUN
ihlr-28381	258	23	”	"	PUNCT
ihlr-28381	258	24	to	to	ADP
ihlr-28381	258	25	the	the	DET
ihlr-28381	258	26	fda	fda	PROPN
ihlr-28381	258	27	whereby	whereby	SCONJ
ihlr-28381	258	28	the	the	DET
ihlr-28381	258	29	interested	interested	ADJ
ihlr-28381	258	30	person	person	NOUN
ihlr-28381	258	31	advises	advise	VERB
ihlr-28381	258	32	the	the	DET
ihlr-28381	258	33	agency	agency	NOUN
ihlr-28381	258	34	to	to	PART
ihlr-28381	258	35	take	take	VERB
ihlr-28381	258	36	,	,	PUNCT
ihlr-28381	258	37	or	or	CCONJ
ihlr-28381	258	38	refrain	refrain	VERB
ihlr-28381	258	39	from	from	ADP
ihlr-28381	258	40	taking	take	VERB
ihlr-28381	258	41	,	,	PUNCT
ihlr-28381	258	42	an	an	DET
ihlr-28381	258	43	action.54	action.54	NOUN
ihlr-28381	258	44	sometimes	sometimes	ADV
ihlr-28381	258	45	these	these	DET
ihlr-28381	258	46	concerned	concerned	ADJ
ihlr-28381	258	47	citizens	citizen	NOUN
ihlr-28381	258	48	are	be	AUX
ihlr-28381	258	49	pharmaceutical	pharmaceutical	ADJ
ihlr-28381	258	50	companies	company	NOUN
ihlr-28381	258	51	advising	advise	VERB
ihlr-28381	258	52	the	the	DET
ihlr-28381	258	53	agency	agency	NOUN
ihlr-28381	258	54	to	to	PART
ihlr-28381	258	55	reject	reject	VERB
ihlr-28381	258	56	generic	generic	ADJ
ihlr-28381	258	57	drug	drug	NOUN
ihlr-28381	258	58	applications	application	NOUN
ihlr-28381	258	59	poised	poise	VERB
ihlr-28381	258	60	to	to	PART
ihlr-28381	258	61	compete	compete	VERB
ihlr-28381	258	62	with	with	ADP
ihlr-28381	258	63	the	the	DET
ihlr-28381	258	64	brand	brand	NOUN
ihlr-28381	258	65	name	name	NOUN
ihlr-28381	258	66	product	product	NOUN
ihlr-28381	258	67	.	.	PUNCT
ihlr-28381	259	1	logically	logically	ADV
ihlr-28381	259	2	,	,	PUNCT
ihlr-28381	259	3	the	the	DET
ihlr-28381	259	4	inventor	inventor	NOUN
ihlr-28381	259	5	of	of	ADP
ihlr-28381	259	6	a	a	DET
ihlr-28381	259	7	drug	drug	NOUN
ihlr-28381	259	8	is	be	AUX
ihlr-28381	259	9	in	in	ADP
ihlr-28381	259	10	an	an	DET
ihlr-28381	259	11	ideal	ideal	ADJ
ihlr-28381	259	12	position	position	NOUN
ihlr-28381	259	13	to	to	PART
ihlr-28381	259	14	identify	identify	VERB
ihlr-28381	259	15	risks	risk	NOUN
ihlr-28381	259	16	or	or	CCONJ
ihlr-28381	259	17	deficiencies	deficiency	NOUN
ihlr-28381	259	18	associated	associate	VERB
ihlr-28381	259	19	with	with	ADP
ihlr-28381	259	20	copying	copy	VERB
ihlr-28381	259	21	the	the	DET
ihlr-28381	259	22	invention	invention	NOUN
ihlr-28381	259	23	.	.	PUNCT
ihlr-28381	260	1	thus	thus	ADV
ihlr-28381	260	2	,	,	PUNCT
ihlr-28381	260	3	it	it	PRON
ihlr-28381	260	4	is	be	AUX
ihlr-28381	260	5	understandable	understandable	ADJ
ihlr-28381	260	6	that	that	SCONJ
ihlr-28381	260	7	petitions	petition	NOUN
ihlr-28381	260	8	to	to	PART
ihlr-28381	260	9	block	block	VERB
ihlr-28381	260	10	generics	generic	NOUN
ihlr-28381	260	11	are	be	AUX
ihlr-28381	260	12	frequently	frequently	ADV
ihlr-28381	260	13	sourced	source	VERB
ihlr-28381	260	14	by	by	ADP
ihlr-28381	260	15	innovators	innovator	NOUN
ihlr-28381	260	16	with	with	ADP
ihlr-28381	260	17	much	much	ADV
ihlr-28381	260	18	to	to	PART
ihlr-28381	260	19	lose	lose	VERB
ihlr-28381	260	20	.	.	PUNCT
ihlr-28381	261	1	nevertheless	nevertheless	ADV
ihlr-28381	261	2	,	,	PUNCT
ihlr-28381	261	3	the	the	DET
ihlr-28381	261	4	conflict	conflict	NOUN
ihlr-28381	261	5	of	of	ADP
ihlr-28381	261	6	interest	interest	NOUN
ihlr-28381	261	7	is	be	AUX
ihlr-28381	261	8	obvious	obvious	ADJ
ihlr-28381	261	9	.	.	PUNCT
ihlr-28381	262	1	citizen	citizen	NOUN
ihlr-28381	262	2	petitions	petition	NOUN
ihlr-28381	262	3	raise	raise	VERB
ihlr-28381	262	4	various	various	ADJ
ihlr-28381	262	5	concerns	concern	NOUN
ihlr-28381	262	6	with	with	ADP
ihlr-28381	262	7	a	a	DET
ihlr-28381	262	8	drug	drug	NOUN
ihlr-28381	262	9	’s	’s	PART
ihlr-28381	262	10	safety	safety	NOUN
ihlr-28381	262	11	profile	profile	NOUN
ihlr-28381	262	12	,	,	PUNCT
ihlr-28381	262	13	and	and	CCONJ
ihlr-28381	262	14	are	be	AUX
ihlr-28381	262	15	usually	usually	ADV
ihlr-28381	262	16	found	find	VERB
ihlr-28381	262	17	immaterial	immaterial	ADJ
ihlr-28381	262	18	.	.	PUNCT
ihlr-28381	263	1	from	from	ADP
ihlr-28381	263	2	2008	2008	NUM
ihlr-28381	263	3	to	to	ADP
ihlr-28381	263	4	2013	2013	NUM
ihlr-28381	263	5	,	,	PUNCT
ihlr-28381	263	6	124	124	NUM
ihlr-28381	263	7	petitions	petition	NOUN
ihlr-28381	263	8	to	to	PART
ihlr-28381	263	9	delay	delay	VERB
ihlr-28381	263	10	generic	generic	ADJ
ihlr-28381	263	11	approvals	approval	NOUN
ihlr-28381	263	12	were	be	AUX
ihlr-28381	263	13	filed	file	VERB
ihlr-28381	263	14	,	,	PUNCT
ihlr-28381	263	15	with	with	ADP
ihlr-28381	263	16	only	only	ADV
ihlr-28381	263	17	eight	eight	NUM
ihlr-28381	263	18	granted	grant	VERB
ihlr-28381	263	19	;	;	PUNCT
ihlr-28381	263	20	a	a	DET
ihlr-28381	263	21	mere	mere	ADJ
ihlr-28381	263	22	6	6	NUM
ihlr-28381	263	23	%	%	NOUN
ihlr-28381	263	24	of	of	ADP
ihlr-28381	263	25	petitions	petition	NOUN
ihlr-28381	263	26	opposing	oppose	VERB
ihlr-28381	263	27	generic	generic	ADJ
ihlr-28381	263	28	approvals	approval	NOUN
ihlr-28381	263	29	raised	raise	VERB
ihlr-28381	263	30	credible	credible	ADJ
ihlr-28381	263	31	issues.55	issues.55	NOUN
ihlr-28381	263	32	however	however	ADV
ihlr-28381	263	33	,	,	PUNCT
ihlr-28381	263	34	a	a	DET
ihlr-28381	263	35	citizen	citizen	NOUN
ihlr-28381	263	36	petition	petition	NOUN
ihlr-28381	263	37	can	can	AUX
ihlr-28381	263	38	delay	delay	VERB
ihlr-28381	263	39	generic	generic	ADJ
ihlr-28381	263	40	competition	competition	NOUN
ihlr-28381	263	41	without	without	ADP
ihlr-28381	263	42	being	be	AUX
ihlr-28381	263	43	granted	grant	VERB
ihlr-28381	263	44	.	.	PUNCT
ihlr-28381	264	1	after	after	SCONJ
ihlr-28381	264	2	the	the	DET
ihlr-28381	264	3	fda	fda	PROPN
ihlr-28381	264	4	receives	receive	VERB
ihlr-28381	264	5	a	a	DET
ihlr-28381	264	6	citizen	citizen	NOUN
ihlr-28381	264	7	petition	petition	NOUN
ihlr-28381	264	8	advising	advise	VERB
ihlr-28381	264	9	against	against	ADP
ihlr-28381	264	10	an	an	DET
ihlr-28381	264	11	anda	anda	PROPN
ihlr-28381	264	12	approval	approval	NOUN
ihlr-28381	264	13	,	,	PUNCT
ihlr-28381	264	14	the	the	DET
ihlr-28381	264	15	fda	fda	PROPN
ihlr-28381	264	16	has	have	VERB
ihlr-28381	264	17	150	150	NUM
ihlr-28381	264	18	days	day	NOUN
ihlr-28381	264	19	to	to	PART
ihlr-28381	264	20	review	review	VERB
ihlr-28381	264	21	the	the	DET
ihlr-28381	264	22	petition	petition	NOUN
ihlr-28381	264	23	.	.	PUNCT
ihlr-28381	265	1	during	during	ADP
ihlr-28381	265	2	that	that	DET
ihlr-28381	265	3	150	150	NUM
ihlr-28381	265	4	-	-	PUNCT
ihlr-28381	265	5	day	day	NOUN
ihlr-28381	265	6	period	period	NOUN
ihlr-28381	265	7	,	,	PUNCT
ihlr-28381	265	8	the	the	DET
ihlr-28381	265	9	review	review	NOUN
ihlr-28381	265	10	of	of	ADP
ihlr-28381	265	11	the	the	DET
ihlr-28381	265	12	anda	anda	PROPN
ihlr-28381	265	13	for	for	ADP
ihlr-28381	265	14	the	the	DET
ihlr-28381	265	15	respective	respective	ADJ
ihlr-28381	265	16	generic	generic	ADJ
ihlr-28381	265	17	drug	drug	NOUN
ihlr-28381	265	18	is	be	AUX
ihlr-28381	265	19	placed	place	VERB
ihlr-28381	265	20	on	on	ADP
ihlr-28381	265	21	hold.56	hold.56	NOUN
ihlr-28381	265	22	extending	extend	VERB
ihlr-28381	265	23	brand	brand	NOUN
ihlr-28381	265	24	exclusivity	exclusivity	NOUN
ihlr-28381	265	25	—	—	PUNCT
ihlr-28381	265	26	and	and	CCONJ
ihlr-28381	265	27	therefore	therefore	ADV
ihlr-28381	265	28	monopoly	monopoly	NOUN
ihlr-28381	265	29	price	price	NOUN
ihlr-28381	265	30	—	—	PUNCT
ihlr-28381	265	31	for	for	ADP
ihlr-28381	265	32	150	150	NUM
ihlr-28381	265	33	days	day	NOUN
ihlr-28381	265	34	can	can	AUX
ihlr-28381	265	35	translate	translate	VERB
ihlr-28381	265	36	to	to	ADP
ihlr-28381	265	37	hundreds	hundred	NOUN
ihlr-28381	265	38	of	of	ADP
ihlr-28381	265	39	millions	million	NOUN
ihlr-28381	265	40	of	of	ADP
ihlr-28381	265	41	dollars	dollar	NOUN
ihlr-28381	265	42	in	in	ADP
ihlr-28381	265	43	sales	sale	NOUN
ihlr-28381	265	44	for	for	ADP
ihlr-28381	265	45	the	the	DET
ihlr-28381	265	46	company	company	NOUN
ihlr-28381	265	47	,	,	PUNCT
ihlr-28381	265	48	and	and	CCONJ
ihlr-28381	265	49	consequently	consequently	ADV
ihlr-28381	265	50	hundreds	hundred	NOUN
ihlr-28381	265	51	of	of	ADP
ihlr-28381	265	52	millions	million	NOUN
ihlr-28381	265	53	of	of	ADP
ihlr-28381	265	54	dollars	dollar	NOUN
ihlr-28381	265	55	in	in	ADP
ihlr-28381	265	56	cost	cost	NOUN
ihlr-28381	265	57	to	to	ADP
ihlr-28381	265	58	the	the	DET
ihlr-28381	265	59	healthcare	healthcare	NOUN
ihlr-28381	265	60	system.57	system.57	PROPN
ihlr-28381	265	61	exacerbating	exacerbate	VERB
ihlr-28381	265	62	the	the	DET
ihlr-28381	265	63	problem	problem	NOUN
ihlr-28381	265	64	,	,	PUNCT
ihlr-28381	265	65	citizen	citizen	NOUN
ihlr-28381	265	66	petitions	petition	NOUN
ihlr-28381	265	67	can	can	AUX
ihlr-28381	265	68	be	be	AUX
ihlr-28381	265	69	creatively	creatively	ADV
ihlr-28381	265	70	deployed	deploy	VERB
ihlr-28381	265	71	to	to	PART
ihlr-28381	265	72	maximize	maximize	VERB
ihlr-28381	265	73	anti	anti	ADJ
ihlr-28381	265	74	-	-	ADJ
ihlr-28381	265	75	competitive	competitive	ADJ
ihlr-28381	265	76	effect	effect	NOUN
ihlr-28381	265	77	.	.	PUNCT
ihlr-28381	266	1	for	for	ADP
ihlr-28381	266	2	example	example	NOUN
ihlr-28381	266	3	,	,	PUNCT
ihlr-28381	266	4	innovators	innovator	NOUN
ihlr-28381	266	5	can	can	AUX
ihlr-28381	266	6	file	file	VERB
ihlr-28381	266	7	numerous	numerous	ADJ
ihlr-28381	266	8	petitions	petition	NOUN
ihlr-28381	266	9	targeted	target	VERB
ihlr-28381	266	10	at	at	ADP
ihlr-28381	266	11	a	a	DET
ihlr-28381	266	12	single	single	ADJ
ihlr-28381	266	13	generic	generic	ADJ
ihlr-28381	266	14	applicant	applicant	NOUN
ihlr-28381	266	15	to	to	PART
ihlr-28381	266	16	amplify	amplify	VERB
ihlr-28381	266	17	the	the	DET
ihlr-28381	266	18	redirection	redirection	NOUN
ihlr-28381	266	19	of	of	ADP
ihlr-28381	266	20	fda	fda	PROPN
ihlr-28381	266	21	resources	resource	NOUN
ihlr-28381	266	22	.	.	PUNCT
ihlr-28381	267	1	in	in	ADP
ihlr-28381	267	2	2018	2018	NUM
ihlr-28381	267	3	,	,	PUNCT
ihlr-28381	267	4	a	a	DET
ihlr-28381	267	5	delaware	delaware	PROPN
ihlr-28381	267	6	district	district	PROPN
ihlr-28381	267	7	court	court	PROPN
ihlr-28381	267	8	dismissed	dismiss	VERB
ihlr-28381	267	9	an	an	DET
ihlr-28381	267	10	ftc	ftc	PROPN
ihlr-28381	267	11	complaint	complaint	NOUN
ihlr-28381	267	12	against	against	ADP
ihlr-28381	267	13	shire	shire	PROPN
ihlr-28381	267	14	viropharma.58	viropharma.58	PROPN
ihlr-28381	267	15	the	the	DET
ihlr-28381	267	16	ftc	ftc	PROPN
ihlr-28381	267	17	’s	’s	PART
ihlr-28381	267	18	complaint	complaint	NOUN
ihlr-28381	267	19	alleged	allege	VERB
ihlr-28381	267	20	that	that	SCONJ
ihlr-28381	267	21	viropharma	viropharma	NOUN
ihlr-28381	267	22	“	"	PUNCT
ihlr-28381	267	23	inundated	inundate	VERB
ihlr-28381	267	24	the	the	DET
ihlr-28381	267	25	fda	fda	PROPN
ihlr-28381	267	26	”	"	PUNCT
ihlr-28381	267	27	with	with	ADP
ihlr-28381	267	28	numerous	numerous	ADJ
ihlr-28381	267	29	filings	filing	NOUN
ihlr-28381	267	30	,	,	PUNCT
ihlr-28381	267	31	including	include	VERB
ihlr-28381	267	32	24	24	NUM
ihlr-28381	267	33	citizen	citizen	NOUN
ihlr-28381	267	34	petitions	petition	NOUN
ihlr-28381	267	35	,	,	PUNCT
ihlr-28381	267	36	intended	intend	VERB
ihlr-28381	267	37	to	to	PART
ihlr-28381	267	38	“	"	PUNCT
ihlr-28381	267	39	maintain	maintain	VERB
ihlr-28381	267	40	its	its	PRON
ihlr-28381	267	41	monopoly	monopoly	NOUN
ihlr-28381	267	42	on	on	ADP
ihlr-28381	267	43	vancocin	vancocin	NOUN
ihlr-28381	267	44	capsules	capsule	NOUN
ihlr-28381	267	45	.	.	PUNCT
ihlr-28381	268	1	”59	”59	ADJ
ihlr-28381	268	2	another	another	DET
ihlr-28381	268	3	way	way	NOUN
ihlr-28381	268	4	to	to	PART
ihlr-28381	268	5	maximize	maximize	VERB
ihlr-28381	268	6	delay	delay	NOUN
ihlr-28381	268	7	is	be	AUX
ihlr-28381	268	8	to	to	PART
ihlr-28381	268	9	wait	wait	VERB
ihlr-28381	268	10	until	until	ADP
ihlr-28381	268	11	the	the	DET
ihlr-28381	268	12	11th	11th	ADJ
ihlr-28381	268	13	hour	hour	NOUN
ihlr-28381	268	14	to	to	PART
ihlr-28381	268	15	file	file	VERB
ihlr-28381	268	16	a	a	DET
ihlr-28381	268	17	petition	petition	NOUN
ihlr-28381	268	18	.	.	PUNCT
ihlr-28381	269	1	in	in	ADP
ihlr-28381	269	2	2015	2015	NUM
ihlr-28381	269	3	,	,	PUNCT
ihlr-28381	269	4	bayer	bayer	PROPN
ihlr-28381	269	5	healthcare	healthcare	PROPN
ihlr-28381	269	6	3d	3d	NUM
ihlr-28381	269	7	665	665	NUM
ihlr-28381	269	8	,	,	PUNCT
ihlr-28381	269	9	679	679	NUM
ihlr-28381	269	10	(	(	PUNCT
ihlr-28381	269	11	e.d	e.d	PROPN
ihlr-28381	269	12	.	.	PROPN
ihlr-28381	269	13	pa	pa	PROPN
ihlr-28381	269	14	.	.	PROPN
ihlr-28381	269	15	2014	2014	NUM
ihlr-28381	269	16	)	)	PUNCT
ihlr-28381	269	17	(	(	PUNCT
ihlr-28381	269	18	quoting	quote	VERB
ihlr-28381	269	19	west	west	PROPN
ihlr-28381	269	20	penn	penn	PROPN
ihlr-28381	269	21	allegheny	allegheny	PROPN
ihlr-28381	269	22	health	health	PROPN
ihlr-28381	269	23	sys	sys	PROPN
ihlr-28381	269	24	.	.	PROPN
ihlr-28381	269	25	,	,	PUNCT
ihlr-28381	269	26	inc	inc	PROPN
ihlr-28381	269	27	.	.	PROPN
ihlr-28381	270	1	v.	v.	PROPN
ihlr-28381	270	2	upmc	upmc	PROPN
ihlr-28381	270	3	,	,	PUNCT
ihlr-28381	270	4	627	627	NUM
ihlr-28381	270	5	f.3d	f.3d	NUM
ihlr-28381	270	6	85	85	NUM
ihlr-28381	270	7	,	,	PUNCT
ihlr-28381	270	8	109	109	NUM
ihlr-28381	270	9	(	(	PUNCT
ihlr-28381	270	10	3rd	3rd	ADJ
ihlr-28381	270	11	cir	cir	NOUN
ihlr-28381	270	12	.	.	PUNCT
ihlr-28381	270	13	2010	2010	NUM
ihlr-28381	270	14	)	)	PUNCT
ihlr-28381	270	15	)	)	PUNCT
ihlr-28381	270	16	.	.	PUNCT
ihlr-28381	271	1	54	54	NUM
ihlr-28381	271	2	.	.	SYM
ihlr-28381	271	3	21	21	NUM
ihlr-28381	271	4	c.f.r	c.f.r	NOUN
ihlr-28381	271	5	.	.	PUNCT
ihlr-28381	272	1	§	§	PROPN
ihlr-28381	272	2	§	§	PROPN
ihlr-28381	272	3	10.20	10.20	NUM
ihlr-28381	272	4	,	,	PUNCT
ihlr-28381	272	5	10.30	10.30	NUM
ihlr-28381	272	6	(	(	PUNCT
ihlr-28381	272	7	2022	2022	NUM
ihlr-28381	272	8	)	)	PUNCT
ihlr-28381	272	9	.	.	PUNCT
ihlr-28381	273	1	55	55	NUM
ihlr-28381	273	2	.	.	X
ihlr-28381	274	1	feldman	feldman	PROPN
ihlr-28381	274	2	&	&	CCONJ
ihlr-28381	274	3	frondorf	frondorf	PROPN
ihlr-28381	274	4	,	,	PUNCT
ihlr-28381	274	5	supra	supra	PROPN
ihlr-28381	274	6	note	note	PROPN
ihlr-28381	274	7	21	21	NUM
ihlr-28381	274	8	,	,	PUNCT
ihlr-28381	274	9	at	at	ADP
ihlr-28381	274	10	546	546	NUM
ihlr-28381	274	11	-	-	SYM
ihlr-28381	274	12	47	47	NUM
ihlr-28381	274	13	.	.	PUNCT
ihlr-28381	275	1	56	56	NUM
ihlr-28381	275	2	.	.	NOUN
ihlr-28381	275	3	21	21	NUM
ihlr-28381	275	4	c.f.r	c.f.r	NOUN
ihlr-28381	275	5	.	.	PUNCT
ihlr-28381	276	1	§	§	PROPN
ihlr-28381	276	2	10.30	10.30	NUM
ihlr-28381	276	3	(	(	PUNCT
ihlr-28381	276	4	2022	2022	NUM
ihlr-28381	276	5	)	)	PUNCT
ihlr-28381	276	6	.	.	PUNCT
ihlr-28381	277	1	57	57	NUM
ihlr-28381	277	2	.	.	PUNCT
ihlr-28381	278	1	robin	robin	PROPN
ihlr-28381	278	2	feldman	feldman	PROPN
ihlr-28381	278	3	&	&	CCONJ
ihlr-28381	278	4	connie	connie	PROPN
ihlr-28381	278	5	wang	wang	PROPN
ihlr-28381	278	6	,	,	PUNCT
ihlr-28381	278	7	a	a	DET
ihlr-28381	278	8	citizen	citizen	NOUN
ihlr-28381	278	9	’s	’s	PART
ihlr-28381	278	10	pathway	pathway	NOUN
ihlr-28381	278	11	gone	go	VERB
ihlr-28381	278	12	astray	astray	ADV
ihlr-28381	278	13	—	—	PUNCT
ihlr-28381	278	14	delaying	delay	VERB
ihlr-28381	278	15	competition	competition	NOUN
ihlr-28381	278	16	from	from	ADP
ihlr-28381	278	17	generic	generic	ADJ
ihlr-28381	278	18	drugs	drug	NOUN
ihlr-28381	278	19	,	,	PUNCT
ihlr-28381	278	20	376	376	NUM
ihlr-28381	278	21	new	new	ADJ
ihlr-28381	278	22	eng	eng	PROPN
ihlr-28381	278	23	.	.	PUNCT
ihlr-28381	278	24	j.	j.	PROPN
ihlr-28381	278	25	med	med	PROPN
ihlr-28381	278	26	.	.	PROPN
ihlr-28381	279	1	1499	1499	NUM
ihlr-28381	279	2	,	,	PUNCT
ihlr-28381	279	3	1501	1501	NUM
ihlr-28381	279	4	(	(	PUNCT
ihlr-28381	279	5	apr	apr	NOUN
ihlr-28381	279	6	.	.	PROPN
ihlr-28381	279	7	20	20	NUM
ihlr-28381	279	8	,	,	PUNCT
ihlr-28381	279	9	2017	2017	NUM
ihlr-28381	279	10	)	)	PUNCT
ihlr-28381	279	11	,	,	PUNCT
ihlr-28381	279	12	https://repository.uclawsf.edu/cgi/viewcontent.cgi?article=2557&context=faculty_scholarship	https://repository.uclawsf.edu/cgi/viewcontent.cgi?article=2557&context=faculty_scholarship	VERB
ihlr-28381	279	13	[	[	X
ihlr-28381	279	14	https://perma.cc/7kqy-yycj	https://perma.cc/7kqy-yycj	X
ihlr-28381	279	15	]	]	X
ihlr-28381	279	16	.	.	PUNCT
ihlr-28381	280	1	58	58	NUM
ihlr-28381	280	2	.	.	PUNCT
ihlr-28381	281	1	ftc	ftc	PROPN
ihlr-28381	281	2	v.	v.	PROPN
ihlr-28381	281	3	shire	shire	PROPN
ihlr-28381	281	4	viropharma	viropharma	PROPN
ihlr-28381	281	5	inc	inc	PROPN
ihlr-28381	281	6	.	.	PROPN
ihlr-28381	281	7	,	,	PUNCT
ihlr-28381	281	8	no	no	INTJ
ihlr-28381	281	9	.	.	PUNCT
ihlr-28381	282	1	cv	cv	PROPN
ihlr-28381	282	2	17	17	NUM
ihlr-28381	282	3	-	-	SYM
ihlr-28381	282	4	131	131	NUM
ihlr-28381	282	5	-	-	PUNCT
ihlr-28381	282	6	rga	rga	NOUN
ihlr-28381	282	7	,	,	PUNCT
ihlr-28381	282	8	2018	2018	NUM
ihlr-28381	282	9	wl	wl	NOUN
ihlr-28381	282	10	1401329	1401329	NUM
ihlr-28381	282	11	,	,	PUNCT
ihlr-28381	282	12	at	at	ADP
ihlr-28381	282	13	*	*	NOUN
ihlr-28381	282	14	1	1	NUM
ihlr-28381	282	15	(	(	PUNCT
ihlr-28381	282	16	d.	d.	PROPN
ihlr-28381	282	17	del	del	PROPN
ihlr-28381	282	18	.	.	PROPN
ihlr-28381	282	19	mar	mar	PROPN
ihlr-28381	282	20	.	.	PROPN
ihlr-28381	282	21	20	20	NUM
ihlr-28381	282	22	,	,	PUNCT
ihlr-28381	282	23	2018	2018	NUM
ihlr-28381	282	24	)	)	PUNCT
ihlr-28381	282	25	,	,	PUNCT
ihlr-28381	282	26	aff'd	aff'd	NOUN
ihlr-28381	282	27	,	,	PUNCT
ihlr-28381	282	28	917	917	NUM
ihlr-28381	282	29	f.3d	f.3d	NUM
ihlr-28381	282	30	147	147	NUM
ihlr-28381	282	31	(	(	PUNCT
ihlr-28381	282	32	3d	3d	PROPN
ihlr-28381	282	33	cir	cir	NOUN
ihlr-28381	282	34	.	.	PROPN
ihlr-28381	282	35	2019	2019	NUM
ihlr-28381	282	36	)	)	PUNCT
ihlr-28381	282	37	.	.	PUNCT
ihlr-28381	283	1	59	59	NUM
ihlr-28381	283	2	.	.	PUNCT
ihlr-28381	284	1	i	i	PRON
ihlr-28381	284	2	d.	d.	PROPN
ihlr-28381	284	3	134	134	NUM
ihlr-28381	284	4	indiana	indiana	PROPN
ihlr-28381	284	5	health	health	PROPN
ihlr-28381	284	6	law	law	PROPN
ihlr-28381	284	7	review	review	NOUN
ihlr-28381	284	8	[	[	X
ihlr-28381	284	9	vol	vol	NOUN
ihlr-28381	284	10	.	.	NOUN
ihlr-28381	284	11	21:121	21:121	NUM
ihlr-28381	284	12	filed	file	VERB
ihlr-28381	284	13	its	its	PRON
ihlr-28381	284	14	citizen	citizen	NOUN
ihlr-28381	284	15	petition	petition	NOUN
ihlr-28381	284	16	one	one	NUM
ihlr-28381	284	17	day	day	NOUN
ihlr-28381	284	18	before	before	ADP
ihlr-28381	284	19	the	the	DET
ihlr-28381	284	20	expiration	expiration	NOUN
ihlr-28381	284	21	of	of	ADP
ihlr-28381	284	22	its	its	PRON
ihlr-28381	284	23	patent.60	patent.60	NOUN
ihlr-28381	284	24	such	such	ADJ
ihlr-28381	284	25	timing	timing	NOUN
ihlr-28381	284	26	effectively	effectively	ADV
ihlr-28381	284	27	extends	extend	VERB
ihlr-28381	284	28	a	a	DET
ihlr-28381	284	29	patent	patent	NOUN
ihlr-28381	284	30	by	by	ADP
ihlr-28381	284	31	150	150	NUM
ihlr-28381	284	32	days	day	NOUN
ihlr-28381	284	33	.	.	PUNCT
ihlr-28381	285	1	antitrust	antitrust	ADJ
ihlr-28381	285	2	recourse	recourse	NOUN
ihlr-28381	285	3	exists	exist	VERB
ihlr-28381	285	4	for	for	ADP
ihlr-28381	285	5	severe	severe	ADJ
ihlr-28381	285	6	abuse	abuse	NOUN
ihlr-28381	285	7	of	of	ADP
ihlr-28381	285	8	citizen	citizen	NOUN
ihlr-28381	285	9	petitions	petition	NOUN
ihlr-28381	285	10	but	but	CCONJ
ihlr-28381	285	11	,	,	PUNCT
ihlr-28381	285	12	as	as	SCONJ
ihlr-28381	285	13	is	be	AUX
ihlr-28381	285	14	thematic	thematic	ADJ
ihlr-28381	285	15	of	of	ADP
ihlr-28381	285	16	all	all	DET
ihlr-28381	285	17	attempts	attempt	NOUN
ihlr-28381	285	18	to	to	PART
ihlr-28381	285	19	reign	reign	VERB
ihlr-28381	285	20	in	in	ADP
ihlr-28381	285	21	pay	pay	NOUN
ihlr-28381	285	22	-	-	PUNCT
ihlr-28381	285	23	for	for	ADP
ihlr-28381	285	24	-	-	PUNCT
ihlr-28381	285	25	delay	delay	NOUN
ihlr-28381	285	26	,	,	PUNCT
ihlr-28381	285	27	high	high	ADJ
ihlr-28381	285	28	burdens	burden	NOUN
ihlr-28381	285	29	of	of	ADP
ihlr-28381	285	30	proof	proof	NOUN
ihlr-28381	285	31	and	and	CCONJ
ihlr-28381	285	32	vast	vast	ADJ
ihlr-28381	285	33	grey	grey	ADJ
ihlr-28381	285	34	areas	area	NOUN
ihlr-28381	285	35	allow	allow	VERB
ihlr-28381	285	36	careful	careful	ADJ
ihlr-28381	285	37	players	player	NOUN
ihlr-28381	285	38	to	to	PART
ihlr-28381	285	39	leverage	leverage	VERB
ihlr-28381	285	40	citizen	citizen	NOUN
ihlr-28381	285	41	petitions	petition	NOUN
ihlr-28381	285	42	without	without	ADP
ihlr-28381	285	43	becoming	become	VERB
ihlr-28381	285	44	realistic	realistic	ADJ
ihlr-28381	285	45	targets	target	NOUN
ihlr-28381	285	46	for	for	ADP
ihlr-28381	285	47	the	the	DET
ihlr-28381	285	48	ftc.61	ftc.61	NOUN
ihlr-28381	285	49	citizen	citizen	NOUN
ihlr-28381	285	50	petitions	petition	NOUN
ihlr-28381	285	51	remain	remain	VERB
ihlr-28381	285	52	a	a	DET
ihlr-28381	285	53	highly	highly	ADV
ihlr-28381	285	54	effective	effective	ADJ
ihlr-28381	285	55	means	mean	NOUN
ihlr-28381	285	56	of	of	ADP
ihlr-28381	285	57	delaying	delay	VERB
ihlr-28381	285	58	generic	generic	ADJ
ihlr-28381	285	59	competition	competition	NOUN
ihlr-28381	285	60	.	.	PUNCT
ihlr-28381	286	1	with	with	ADP
ihlr-28381	286	2	additional	additional	ADJ
ihlr-28381	286	3	planning	planning	NOUN
ihlr-28381	286	4	and	and	CCONJ
ihlr-28381	286	5	attention	attention	NOUN
ihlr-28381	286	6	to	to	ADP
ihlr-28381	286	7	detail	detail	NOUN
ihlr-28381	286	8	,	,	PUNCT
ihlr-28381	286	9	patentees	patentee	NOUN
ihlr-28381	286	10	can	can	AUX
ihlr-28381	286	11	maximize	maximize	VERB
ihlr-28381	286	12	the	the	DET
ihlr-28381	286	13	impact	impact	NOUN
ihlr-28381	286	14	of	of	ADP
ihlr-28381	286	15	a	a	DET
ihlr-28381	286	16	citizen	citizen	NOUN
ihlr-28381	286	17	petition	petition	NOUN
ihlr-28381	286	18	by	by	ADP
ihlr-28381	286	19	filing	file	VERB
ihlr-28381	286	20	several	several	ADJ
ihlr-28381	286	21	petitions	petition	NOUN
ihlr-28381	286	22	or	or	CCONJ
ihlr-28381	286	23	by	by	ADP
ihlr-28381	286	24	waiting	wait	VERB
ihlr-28381	286	25	until	until	ADP
ihlr-28381	286	26	the	the	DET
ihlr-28381	286	27	eve	eve	NOUN
ihlr-28381	286	28	of	of	ADP
ihlr-28381	286	29	patent	patent	NOUN
ihlr-28381	286	30	expiration	expiration	NOUN
ihlr-28381	286	31	to	to	PART
ihlr-28381	286	32	submit	submit	VERB
ihlr-28381	286	33	the	the	DET
ihlr-28381	286	34	petition	petition	NOUN
ihlr-28381	286	35	.	.	PUNCT
ihlr-28381	287	1	b.	b.	PROPN
ihlr-28381	287	2	evergreening	evergreening	PROPN
ihlr-28381	287	3	&	&	CCONJ
ihlr-28381	287	4	product	product	NOUN
ihlr-28381	287	5	hopping	hop	VERB
ihlr-28381	287	6	“	"	PUNCT
ihlr-28381	287	7	evergreening	evergreene	VERB
ihlr-28381	287	8	”	"	PUNCT
ihlr-28381	287	9	informally	informally	ADV
ihlr-28381	287	10	refers	refer	VERB
ihlr-28381	287	11	to	to	ADP
ihlr-28381	287	12	the	the	DET
ihlr-28381	287	13	practice	practice	NOUN
ihlr-28381	287	14	of	of	ADP
ihlr-28381	287	15	insulating	insulate	VERB
ihlr-28381	287	16	a	a	DET
ihlr-28381	287	17	brand	brand	NOUN
ihlr-28381	287	18	-	-	PUNCT
ihlr-28381	287	19	name	name	NOUN
ihlr-28381	287	20	drug	drug	NOUN
ihlr-28381	287	21	from	from	ADP
ihlr-28381	287	22	competition	competition	NOUN
ihlr-28381	287	23	by	by	ADP
ihlr-28381	287	24	tacking	tack	VERB
ihlr-28381	287	25	on	on	ADP
ihlr-28381	287	26	secondary	secondary	ADJ
ihlr-28381	287	27	patents	patent	NOUN
ihlr-28381	287	28	for	for	ADP
ihlr-28381	287	29	slight	slight	ADJ
ihlr-28381	287	30	modifications	modification	NOUN
ihlr-28381	287	31	made	make	VERB
ihlr-28381	287	32	to	to	ADP
ihlr-28381	287	33	the	the	DET
ihlr-28381	287	34	drug.62	drug.62	NOUN
ihlr-28381	287	35	these	these	DET
ihlr-28381	287	36	secondary	secondary	ADJ
ihlr-28381	287	37	patents	patent	NOUN
ihlr-28381	287	38	extend	extend	VERB
ihlr-28381	287	39	market	market	NOUN
ihlr-28381	287	40	exclusivity	exclusivity	NOUN
ihlr-28381	287	41	beyond	beyond	ADP
ihlr-28381	287	42	the	the	DET
ihlr-28381	287	43	life	life	NOUN
ihlr-28381	287	44	of	of	ADP
ihlr-28381	287	45	the	the	DET
ihlr-28381	287	46	primary	primary	ADJ
ihlr-28381	287	47	patent.63	patent.63	NOUN
ihlr-28381	287	48	when	when	SCONJ
ihlr-28381	287	49	litigated	litigate	VERB
ihlr-28381	287	50	to	to	ADP
ihlr-28381	287	51	completion	completion	NOUN
ihlr-28381	287	52	,	,	PUNCT
ihlr-28381	287	53	the	the	DET
ihlr-28381	287	54	secondary	secondary	ADJ
ihlr-28381	287	55	patents	patent	NOUN
ihlr-28381	287	56	are	be	AUX
ihlr-28381	287	57	invalidated—68	invalidated—68	PRON
ihlr-28381	287	58	%	%	NOUN
ihlr-28381	287	59	of	of	ADP
ihlr-28381	287	60	the	the	DET
ihlr-28381	287	61	time	time	NOUN
ihlr-28381	287	62	according	accord	VERB
ihlr-28381	287	63	to	to	ADP
ihlr-28381	287	64	one	one	NUM
ihlr-28381	287	65	study	study	NOUN
ihlr-28381	287	66	—	—	PUNCT
ihlr-28381	287	67	more	more	ADJ
ihlr-28381	287	68	than	than	SCONJ
ihlr-28381	287	69	upheld.64	upheld.64	ADJ
ihlr-28381	287	70	evergreening	evergreening	NOUN
ihlr-28381	287	71	is	be	AUX
ihlr-28381	287	72	sometimes	sometimes	ADV
ihlr-28381	287	73	interchangeable	interchangeable	ADJ
ihlr-28381	287	74	with	with	ADP
ihlr-28381	287	75	“	"	PUNCT
ihlr-28381	287	76	product	product	NOUN
ihlr-28381	287	77	hopping	hopping	NOUN
ihlr-28381	287	78	”	"	PUNCT
ihlr-28381	287	79	due	due	ADP
ihlr-28381	287	80	to	to	ADP
ihlr-28381	287	81	the	the	DET
ihlr-28381	287	82	appearance	appearance	NOUN
ihlr-28381	287	83	of	of	ADP
ihlr-28381	287	84	“	"	PUNCT
ihlr-28381	287	85	hopping	hop	VERB
ihlr-28381	287	86	”	"	PUNCT
ihlr-28381	287	87	to	to	ADP
ihlr-28381	287	88	a	a	DET
ihlr-28381	287	89	slightly	slightly	ADV
ihlr-28381	287	90	different	different	ADJ
ihlr-28381	287	91	product	product	NOUN
ihlr-28381	287	92	with	with	ADP
ihlr-28381	287	93	a	a	DET
ihlr-28381	287	94	later	late	ADJ
ihlr-28381	287	95	patent	patent	NOUN
ihlr-28381	287	96	expiration.65	expiration.65	ADV
ihlr-28381	287	97	however	however	ADV
ihlr-28381	287	98	,	,	PUNCT
ihlr-28381	287	99	product	product	NOUN
ihlr-28381	287	100	hopping	hopping	NOUN
ihlr-28381	287	101	usually	usually	ADV
ihlr-28381	287	102	includes	include	VERB
ihlr-28381	287	103	a	a	DET
ihlr-28381	287	104	marketing	marketing	NOUN
ihlr-28381	287	105	pivot	pivot	NOUN
ihlr-28381	287	106	.	.	PUNCT
ihlr-28381	288	1	although	although	SCONJ
ihlr-28381	288	2	not	not	PART
ihlr-28381	288	3	consistently	consistently	ADV
ihlr-28381	288	4	defined	define	VERB
ihlr-28381	288	5	,	,	PUNCT
ihlr-28381	288	6	product	product	NOUN
ihlr-28381	288	7	hopping	hopping	NOUN
ihlr-28381	288	8	is	be	AUX
ihlr-28381	288	9	generally	generally	ADV
ihlr-28381	288	10	“	"	PUNCT
ihlr-28381	288	11	the	the	DET
ihlr-28381	288	12	switching	switching	NOUN
ihlr-28381	288	13	of	of	ADP
ihlr-28381	288	14	the	the	DET
ihlr-28381	288	15	market	market	NOUN
ihlr-28381	288	16	in	in	ADP
ihlr-28381	288	17	order	order	NOUN
ihlr-28381	288	18	to	to	PART
ihlr-28381	288	19	stifle	stifle	VERB
ihlr-28381	288	20	generic	generic	ADJ
ihlr-28381	288	21	competition	competition	NOUN
ihlr-28381	288	22	.	.	PUNCT
ihlr-28381	289	1	”66	”66	NOUN
ihlr-28381	289	2	in	in	ADP
ihlr-28381	289	3	practice	practice	NOUN
ihlr-28381	289	4	,	,	PUNCT
ihlr-28381	289	5	product	product	NOUN
ihlr-28381	289	6	hopping	hopping	NOUN
ihlr-28381	289	7	is	be	AUX
ihlr-28381	289	8	often	often	ADV
ihlr-28381	289	9	achieved	achieve	VERB
ihlr-28381	289	10	by	by	ADP
ihlr-28381	289	11	reformulating	reformulate	VERB
ihlr-28381	289	12	a	a	DET
ihlr-28381	289	13	drug	drug	NOUN
ihlr-28381	289	14	to	to	ADP
ihlr-28381	289	15	the	the	DET
ihlr-28381	289	16	point	point	NOUN
ihlr-28381	289	17	where	where	SCONJ
ihlr-28381	289	18	a	a	DET
ihlr-28381	289	19	pending	pende	VERB
ihlr-28381	289	20	generic	generic	NOUN
ihlr-28381	289	21	is	be	AUX
ihlr-28381	289	22	no	no	ADV
ihlr-28381	289	23	longer	long	ADV
ihlr-28381	289	24	substitutable	substitutable	ADJ
ihlr-28381	289	25	,	,	PUNCT
ihlr-28381	289	26	and	and	CCONJ
ihlr-28381	289	27	then	then	ADV
ihlr-28381	289	28	encouraging	encourage	VERB
ihlr-28381	289	29	doctors	doctor	NOUN
ihlr-28381	289	30	to	to	PART
ihlr-28381	289	31	prescribe	prescribe	VERB
ihlr-28381	289	32	the	the	DET
ihlr-28381	289	33	reformulated	reformulate	VERB
ihlr-28381	289	34	version	version	NOUN
ihlr-28381	289	35	instead	instead	ADV
ihlr-28381	289	36	of	of	ADP
ihlr-28381	289	37	the	the	DET
ihlr-28381	289	38	original	original	ADJ
ihlr-28381	289	39	version	version	NOUN
ihlr-28381	289	40	which	which	PRON
ihlr-28381	289	41	is	be	AUX
ihlr-28381	289	42	the	the	DET
ihlr-28381	289	43	focus	focus	NOUN
ihlr-28381	289	44	of	of	ADP
ihlr-28381	289	45	generic	generic	ADJ
ihlr-28381	289	46	developers.67	developers.67	PROPN
ihlr-28381	289	47	if	if	SCONJ
ihlr-28381	289	48	effective	effective	ADJ
ihlr-28381	289	49	,	,	PUNCT
ihlr-28381	289	50	there	there	PRON
ihlr-28381	289	51	will	will	AUX
ihlr-28381	289	52	be	be	AUX
ihlr-28381	289	53	no	no	DET
ihlr-28381	289	54	market	market	NOUN
ihlr-28381	289	55	for	for	ADP
ihlr-28381	289	56	the	the	DET
ihlr-28381	289	57	generic	generic	ADJ
ihlr-28381	289	58	drug	drug	NOUN
ihlr-28381	289	59	because	because	SCONJ
ihlr-28381	289	60	doctors	doctor	NOUN
ihlr-28381	289	61	and	and	CCONJ
ihlr-28381	289	62	patients	patient	NOUN
ihlr-28381	289	63	have	have	AUX
ihlr-28381	289	64	“	"	PUNCT
ihlr-28381	289	65	hopped	hop	VERB
ihlr-28381	289	66	”	"	PUNCT
ihlr-28381	289	67	to	to	ADP
ihlr-28381	289	68	the	the	DET
ihlr-28381	289	69	reformulated	reformulate	VERB
ihlr-28381	289	70	version	version	NOUN
ihlr-28381	289	71	.	.	PUNCT
ihlr-28381	290	1	astrazeneca	astrazeneca	PROPN
ihlr-28381	290	2	’s	’s	PART
ihlr-28381	290	3	handling	handling	NOUN
ihlr-28381	290	4	of	of	ADP
ihlr-28381	290	5	prilosec	prilosec	NOUN
ihlr-28381	290	6	—	—	PUNCT
ihlr-28381	290	7	a	a	DET
ihlr-28381	290	8	multi	multi	ADJ
ihlr-28381	290	9	-	-	ADJ
ihlr-28381	290	10	billion	billion	NUM
ihlr-28381	290	11	dollar	dollar	NOUN
ihlr-28381	290	12	per	per	ADP
ihlr-28381	290	13	year	year	NOUN
ihlr-28381	290	14	earner	earner	NOUN
ihlr-28381	290	15	for	for	ADP
ihlr-28381	290	16	the	the	DET
ihlr-28381	290	17	company	company	NOUN
ihlr-28381	290	18	—	—	PUNCT
ihlr-28381	290	19	is	be	AUX
ihlr-28381	290	20	often	often	ADV
ihlr-28381	290	21	cited	cite	VERB
ihlr-28381	290	22	as	as	ADP
ihlr-28381	290	23	a	a	DET
ihlr-28381	290	24	product	product	NOUN
ihlr-28381	290	25	hopping	hop	VERB
ihlr-28381	290	26	example.68	example.68	PROPN
ihlr-28381	290	27	as	as	ADP
ihlr-28381	290	28	prilosec	prilosec	NOUN
ihlr-28381	290	29	’s	’s	PART
ihlr-28381	290	30	primary	primary	ADJ
ihlr-28381	290	31	patent	patent	NOUN
ihlr-28381	290	32	approached	approach	VERB
ihlr-28381	290	33	expiration	expiration	NOUN
ihlr-28381	290	34	,	,	PUNCT
ihlr-28381	290	35	astrazeneca	astrazeneca	PROPN
ihlr-28381	290	36	introduced	introduce	VERB
ihlr-28381	290	37	nexium	nexium	NOUN
ihlr-28381	290	38	—	—	PUNCT
ihlr-28381	290	39	a	a	DET
ihlr-28381	290	40	60	60	NUM
ihlr-28381	290	41	.	.	PUNCT
ihlr-28381	291	1	michael	michael	PROPN
ihlr-28381	291	2	a.	a.	PROPN
ihlr-28381	291	3	carrier	carrier	PROPN
ihlr-28381	291	4	&	&	CCONJ
ihlr-28381	291	5	carl	carl	PROPN
ihlr-28381	291	6	minniti	minniti	PROPN
ihlr-28381	291	7	,	,	PUNCT
ihlr-28381	291	8	citizen	citizen	NOUN
ihlr-28381	291	9	petitions	petition	NOUN
ihlr-28381	291	10	:	:	PUNCT
ihlr-28381	291	11	long	long	ADJ
ihlr-28381	291	12	,	,	PUNCT
ihlr-28381	291	13	late	late	ADV
ihlr-28381	291	14	-	-	PUNCT
ihlr-28381	291	15	filed	file	VERB
ihlr-28381	291	16	,	,	PUNCT
ihlr-28381	291	17	and	and	CCONJ
ihlr-28381	291	18	at	at	ADP
ihlr-28381	291	19	-	-	PUNCT
ihlr-28381	291	20	last	last	NOUN
ihlr-28381	291	21	denied	deny	VERB
ihlr-28381	291	22	,	,	PUNCT
ihlr-28381	291	23	66	66	NUM
ihlr-28381	291	24	am	am	NOUN
ihlr-28381	291	25	.	.	PUNCT
ihlr-28381	292	1	u.	u.	PROPN
ihlr-28381	292	2	l.	l.	PROPN
ihlr-28381	292	3	rev	rev	PROPN
ihlr-28381	292	4	.	.	PROPN
ihlr-28381	292	5	305	305	NUM
ihlr-28381	292	6	,	,	PUNCT
ihlr-28381	292	7	309	309	NUM
ihlr-28381	292	8	,	,	PUNCT
ihlr-28381	292	9	346	346	NUM
ihlr-28381	292	10	-	-	SYM
ihlr-28381	292	11	47	47	NUM
ihlr-28381	292	12	(	(	PUNCT
ihlr-28381	292	13	2017	2017	NUM
ihlr-28381	292	14	)	)	PUNCT
ihlr-28381	292	15	,	,	PUNCT
ihlr-28381	292	16	https://digitalcommons.wcl.american.edu/cgi/	https://digitalcommons.wcl.american.edu/cgi/	NOUN
ihlr-28381	292	17	viewcontent.cgi?article=1956&context=aulr	viewcontent.cgi?article=1956&context=aulr	ADJ
ihlr-28381	292	18	[	[	X
ihlr-28381	292	19	https://perma.cc/8cer-gu6a	https://perma.cc/8cer-gu6a	X
ihlr-28381	292	20	]	]	X
ihlr-28381	292	21	.	.	PUNCT
ihlr-28381	293	1	61	61	NUM
ihlr-28381	293	2	.	.	X
ihlr-28381	293	3	feldman	feldman	PROPN
ihlr-28381	293	4	&	&	CCONJ
ihlr-28381	293	5	wang	wang	PROPN
ihlr-28381	293	6	,	,	PUNCT
ihlr-28381	293	7	supra	supra	PROPN
ihlr-28381	293	8	note	note	PROPN
ihlr-28381	293	9	56	56	NUM
ihlr-28381	293	10	,	,	PUNCT
ihlr-28381	293	11	at	at	ADP
ihlr-28381	293	12	1501	1501	NUM
ihlr-28381	293	13	;	;	PUNCT
ihlr-28381	293	14	feldman	feldman	PROPN
ihlr-28381	293	15	&	&	CCONJ
ihlr-28381	293	16	frondorf	frondorf	PROPN
ihlr-28381	293	17	,	,	PUNCT
ihlr-28381	293	18	supra	supra	PROPN
ihlr-28381	293	19	note	note	PROPN
ihlr-28381	293	20	21	21	NUM
ihlr-28381	293	21	,	,	PUNCT
ihlr-28381	293	22	at	at	ADP
ihlr-28381	293	23	547	547	NUM
ihlr-28381	293	24	.	.	PUNCT
ihlr-28381	293	25	62	62	NUM
ihlr-28381	293	26	.	.	PUNCT
ihlr-28381	294	1	richards	richard	NOUN
ihlr-28381	294	2	et	et	PROPN
ihlr-28381	294	3	al	al	PROPN
ihlr-28381	294	4	.	.	PROPN
ihlr-28381	294	5	,	,	PUNCT
ihlr-28381	294	6	supra	supra	PROPN
ihlr-28381	294	7	note	note	VERB
ihlr-28381	294	8	41	41	NUM
ihlr-28381	294	9	.	.	PUNCT
ihlr-28381	294	10	63	63	NUM
ihlr-28381	294	11	.	.	PUNCT
ihlr-28381	295	1	i	i	PRON
ihlr-28381	295	2	d.	d.	PROPN
ihlr-28381	295	3	64	64	NUM
ihlr-28381	295	4	.	.	PUNCT
ihlr-28381	296	1	feldman	feldman	PROPN
ihlr-28381	296	2	,	,	PUNCT
ihlr-28381	296	3	supra	supra	PROPN
ihlr-28381	296	4	note	note	PROPN
ihlr-28381	296	5	10	10	NUM
ihlr-28381	296	6	,	,	PUNCT
ihlr-28381	296	7	at	at	ADP
ihlr-28381	296	8	21	21	NUM
ihlr-28381	296	9	.	.	PUNCT
ihlr-28381	296	10	65	65	NUM
ihlr-28381	296	11	.	.	PUNCT
ihlr-28381	297	1	richards	richard	NOUN
ihlr-28381	297	2	et	et	PROPN
ihlr-28381	297	3	al	al	PROPN
ihlr-28381	297	4	.	.	PROPN
ihlr-28381	297	5	,	,	PUNCT
ihlr-28381	297	6	supra	supra	PROPN
ihlr-28381	297	7	note	note	VERB
ihlr-28381	297	8	41	41	NUM
ihlr-28381	297	9	.	.	PUNCT
ihlr-28381	298	1	66	66	NUM
ihlr-28381	298	2	.	.	PUNCT
ihlr-28381	299	1	michael	michael	PROPN
ihlr-28381	299	2	a.	a.	PROPN
ihlr-28381	299	3	carrier	carrier	PROPN
ihlr-28381	299	4	&	&	CCONJ
ihlr-28381	299	5	steve	steve	PROPN
ihlr-28381	299	6	d.	d.	PROPN
ihlr-28381	299	7	shadowen	shadowen	PROPN
ihlr-28381	299	8	,	,	PUNCT
ihlr-28381	299	9	product	product	NOUN
ihlr-28381	299	10	hopping	hop	VERB
ihlr-28381	299	11	:	:	PUNCT
ihlr-28381	299	12	a	a	DET
ihlr-28381	299	13	new	new	ADJ
ihlr-28381	299	14	framework	framework	NOUN
ihlr-28381	299	15	,	,	PUNCT
ihlr-28381	299	16	92	92	NUM
ihlr-28381	299	17	notre	notre	PROPN
ihlr-28381	299	18	dame	dame	PROPN
ihlr-28381	299	19	l.	l.	PROPN
ihlr-28381	299	20	rev	rev	PROPN
ihlr-28381	299	21	.	.	PROPN
ihlr-28381	299	22	167	167	NUM
ihlr-28381	299	23	,	,	PUNCT
ihlr-28381	299	24	169	169	NUM
ihlr-28381	299	25	(	(	PUNCT
ihlr-28381	299	26	2017	2017	NUM
ihlr-28381	299	27	)	)	PUNCT
ihlr-28381	299	28	,	,	PUNCT
ihlr-28381	299	29	https://papers.ssrn.com/sol3/papers.cfm?abstract	https://papers.ssrn.com/sol3/papers.cfm?abstract	VERB
ihlr-28381	299	30	_	_	PRON
ihlr-28381	299	31	id=2747526	id=2747526	PROPN
ihlr-28381	300	1	[	[	X
ihlr-28381	300	2	https://perma.cc/ekv8-agka	https://perma.cc/ekv8-agka	PROPN
ihlr-28381	300	3	]	]	X
ihlr-28381	300	4	.	.	PUNCT
ihlr-28381	301	1	67	67	NUM
ihlr-28381	301	2	.	.	PUNCT
ihlr-28381	302	1	i	i	PRON
ihlr-28381	302	2	d.	d.	PROPN
ihlr-28381	302	3	at	at	ADP
ihlr-28381	302	4	168	168	NUM
ihlr-28381	302	5	-	-	SYM
ihlr-28381	302	6	69	69	NUM
ihlr-28381	302	7	.	.	PUNCT
ihlr-28381	303	1	68	68	NUM
ihlr-28381	303	2	.	.	PUNCT
ihlr-28381	304	1	alex	alex	PROPN
ihlr-28381	304	2	brill	brill	PROPN
ihlr-28381	304	3	,	,	PUNCT
ihlr-28381	304	4	the	the	DET
ihlr-28381	304	5	cost	cost	NOUN
ihlr-28381	304	6	of	of	ADP
ihlr-28381	304	7	brand	brand	NOUN
ihlr-28381	304	8	drug	drug	NOUN
ihlr-28381	304	9	product	product	NOUN
ihlr-28381	304	10	hopping	hopping	NOUN
ihlr-28381	304	11	,	,	PUNCT
ihlr-28381	304	12	matrix	matrix	NOUN
ihlr-28381	304	13	global	global	ADJ
ihlr-28381	304	14	advisors	advisor	NOUN
ihlr-28381	304	15	,	,	PUNCT
ihlr-28381	304	16	at	at	ADP
ihlr-28381	304	17	4	4	NUM
ihlr-28381	304	18	(	(	PUNCT
ihlr-28381	304	19	sep	sep	PROPN
ihlr-28381	304	20	.	.	PROPN
ihlr-28381	304	21	2020	2020	NUM
ihlr-28381	304	22	)	)	PUNCT
ihlr-28381	304	23	,	,	PUNCT
ihlr-28381	304	24	https://www.affordableprescriptiondrugs.org/app/uploads/2020/09/	https://www.affordableprescriptiondrugs.org/app/uploads/2020/09/	PROPN
ihlr-28381	305	1	costofproducthoppingsept2020-1.pdf	costofproducthoppingsept2020-1.pdf	PROPN
ihlr-28381	306	1	[	[	X
ihlr-28381	306	2	https://perma.cc/2yeu-37jc	https://perma.cc/2yeu-37jc	X
ihlr-28381	306	3	]	]	X
ihlr-28381	306	4	.	.	PUNCT
ihlr-28381	307	1	2024	2024	NUM
ihlr-28381	307	2	]	]	PUNCT
ihlr-28381	307	3	incentivizing	incentivize	VERB
ihlr-28381	307	4	drug	drug	NOUN
ihlr-28381	307	5	affordability	affordability	NOUN
ihlr-28381	307	6	135	135	NUM
ihlr-28381	307	7	slightly	slightly	ADV
ihlr-28381	307	8	modified	modify	VERB
ihlr-28381	307	9	version	version	NOUN
ihlr-28381	307	10	of	of	ADP
ihlr-28381	307	11	prilosec	prilosec	NOUN
ihlr-28381	307	12	with	with	ADP
ihlr-28381	307	13	a	a	DET
ihlr-28381	307	14	largely	largely	ADV
ihlr-28381	307	15	equivalent	equivalent	ADJ
ihlr-28381	307	16	therapeutic	therapeutic	ADJ
ihlr-28381	307	17	effect.69	effect.69	NOUN
ihlr-28381	307	18	unlike	unlike	ADP
ihlr-28381	307	19	prilosec	prilosec	NOUN
ihlr-28381	307	20	,	,	PUNCT
ihlr-28381	307	21	nexium	nexium	NOUN
ihlr-28381	307	22	boasted	boast	VERB
ihlr-28381	307	23	13	13	NUM
ihlr-28381	307	24	remaining	remain	VERB
ihlr-28381	307	25	years	year	NOUN
ihlr-28381	307	26	of	of	ADP
ihlr-28381	307	27	patent	patent	NOUN
ihlr-28381	307	28	protection.70	protection.70	ADP
ihlr-28381	307	29	the	the	DET
ihlr-28381	307	30	launch	launch	NOUN
ihlr-28381	307	31	of	of	ADP
ihlr-28381	307	32	nexium	nexium	NOUN
ihlr-28381	307	33	was	be	AUX
ihlr-28381	307	34	accompanied	accompany	VERB
ihlr-28381	307	35	by	by	ADP
ihlr-28381	307	36	a	a	DET
ihlr-28381	307	37	marketing	marketing	NOUN
ihlr-28381	307	38	campaign	campaign	NOUN
ihlr-28381	307	39	to	to	PART
ihlr-28381	307	40	switch	switch	VERB
ihlr-28381	307	41	prescribers	prescriber	NOUN
ihlr-28381	307	42	from	from	ADP
ihlr-28381	307	43	prilosec	prilosec	NOUN
ihlr-28381	307	44	to	to	ADP
ihlr-28381	307	45	nexium.71	nexium.71	VERB
ihlr-28381	307	46	beyond	beyond	ADP
ihlr-28381	307	47	prilosec	prilosec	NOUN
ihlr-28381	307	48	,	,	PUNCT
ihlr-28381	307	49	product	product	NOUN
ihlr-28381	307	50	hopping	hop	VERB
ihlr-28381	307	51	strategies	strategy	NOUN
ihlr-28381	307	52	often	often	ADV
ihlr-28381	307	53	leverage	leverage	VERB
ihlr-28381	307	54	secondary	secondary	ADJ
ihlr-28381	307	55	patents	patent	NOUN
ihlr-28381	307	56	to	to	PART
ihlr-28381	307	57	extend	extend	VERB
ihlr-28381	307	58	exclusivity	exclusivity	NOUN
ihlr-28381	307	59	.	.	PUNCT
ihlr-28381	308	1	for	for	ADP
ihlr-28381	308	2	example	example	NOUN
ihlr-28381	308	3	,	,	PUNCT
ihlr-28381	308	4	an	an	DET
ihlr-28381	308	5	innovator	innovator	NOUN
ihlr-28381	308	6	can	can	AUX
ihlr-28381	308	7	switch	switch	VERB
ihlr-28381	308	8	a	a	DET
ihlr-28381	308	9	product	product	NOUN
ihlr-28381	308	10	nearing	near	VERB
ihlr-28381	308	11	patent	patent	NOUN
ihlr-28381	308	12	expiration	expiration	NOUN
ihlr-28381	308	13	from	from	ADP
ihlr-28381	308	14	a	a	DET
ihlr-28381	308	15	tablet	tablet	NOUN
ihlr-28381	308	16	to	to	ADP
ihlr-28381	308	17	a	a	DET
ihlr-28381	308	18	capsule	capsule	NOUN
ihlr-28381	308	19	and	and	CCONJ
ihlr-28381	308	20	enjoy	enjoy	VERB
ihlr-28381	308	21	fresh	fresh	ADJ
ihlr-28381	308	22	exclusivity	exclusivity	NOUN
ihlr-28381	308	23	afforded	afford	VERB
ihlr-28381	308	24	by	by	ADP
ihlr-28381	308	25	the	the	DET
ihlr-28381	308	26	secondary	secondary	ADJ
ihlr-28381	308	27	patent	patent	NOUN
ihlr-28381	308	28	associated	associate	VERB
ihlr-28381	308	29	with	with	ADP
ihlr-28381	308	30	the	the	DET
ihlr-28381	308	31	capsule	capsule	ADJ
ihlr-28381	308	32	form.72	form.72	NOUN
ihlr-28381	308	33	by	by	ADP
ihlr-28381	308	34	product	product	NOUN
ihlr-28381	308	35	hopping	hopping	NOUN
ihlr-28381	308	36	,	,	PUNCT
ihlr-28381	308	37	brand	brand	NOUN
ihlr-28381	308	38	companies	company	NOUN
ihlr-28381	308	39	make	make	VERB
ihlr-28381	308	40	subtle	subtle	ADJ
ihlr-28381	308	41	changes	change	NOUN
ihlr-28381	308	42	or	or	CCONJ
ihlr-28381	308	43	improvements	improvement	NOUN
ihlr-28381	308	44	to	to	ADP
ihlr-28381	308	45	existing	exist	VERB
ihlr-28381	308	46	drugs	drug	NOUN
ihlr-28381	308	47	and	and	CCONJ
ihlr-28381	308	48	encourage	encourage	VERB
ihlr-28381	308	49	prescribers	prescriber	NOUN
ihlr-28381	308	50	and	and	CCONJ
ihlr-28381	308	51	patients	patient	NOUN
ihlr-28381	308	52	to	to	PART
ihlr-28381	308	53	adopt	adopt	VERB
ihlr-28381	308	54	this	this	DET
ihlr-28381	308	55	new	new	ADJ
ihlr-28381	308	56	and	and	CCONJ
ihlr-28381	308	57	improved	improved	ADJ
ihlr-28381	308	58	version	version	NOUN
ihlr-28381	308	59	.	.	PUNCT
ihlr-28381	309	1	if	if	SCONJ
ihlr-28381	309	2	successful	successful	ADJ
ihlr-28381	309	3	,	,	PUNCT
ihlr-28381	309	4	a	a	DET
ihlr-28381	309	5	company	company	NOUN
ihlr-28381	309	6	that	that	PRON
ihlr-28381	309	7	developed	develop	VERB
ihlr-28381	309	8	a	a	DET
ihlr-28381	309	9	generic	generic	NOUN
ihlr-28381	309	10	to	to	ADP
ihlr-28381	309	11	the	the	DET
ihlr-28381	309	12	now	now	ADV
ihlr-28381	309	13	outdated	outdated	ADJ
ihlr-28381	309	14	product	product	NOUN
ihlr-28381	309	15	is	be	AUX
ihlr-28381	309	16	left	leave	VERB
ihlr-28381	309	17	with	with	ADP
ihlr-28381	309	18	no	no	DET
ihlr-28381	309	19	market	market	NOUN
ihlr-28381	309	20	.	.	PUNCT
ihlr-28381	310	1	the	the	DET
ihlr-28381	310	2	result	result	NOUN
ihlr-28381	310	3	is	be	AUX
ihlr-28381	310	4	a	a	DET
ihlr-28381	310	5	sustained	sustained	ADJ
ihlr-28381	310	6	monopoly	monopoly	NOUN
ihlr-28381	310	7	for	for	ADP
ihlr-28381	310	8	the	the	DET
ihlr-28381	310	9	innovator	innovator	NOUN
ihlr-28381	310	10	’s	’s	PART
ihlr-28381	310	11	branded	brand	VERB
ihlr-28381	310	12	product	product	NOUN
ihlr-28381	310	13	.	.	PUNCT
ihlr-28381	311	1	while	while	SCONJ
ihlr-28381	311	2	somewhat	somewhat	ADV
ihlr-28381	311	3	interchangeable	interchangeable	ADJ
ihlr-28381	311	4	,	,	PUNCT
ihlr-28381	311	5	evergreening	evergreene	VERB
ihlr-28381	311	6	refers	refer	NOUN
ihlr-28381	311	7	to	to	ADP
ihlr-28381	311	8	layering	layer	VERB
ihlr-28381	311	9	patents	patent	NOUN
ihlr-28381	311	10	onto	onto	ADP
ihlr-28381	311	11	an	an	DET
ihlr-28381	311	12	existing	exist	VERB
ihlr-28381	311	13	drug	drug	NOUN
ihlr-28381	311	14	to	to	PART
ihlr-28381	311	15	prolong	prolong	VERB
ihlr-28381	311	16	the	the	DET
ihlr-28381	311	17	monopoly	monopoly	NOUN
ihlr-28381	311	18	environment	environment	NOUN
ihlr-28381	311	19	,	,	PUNCT
ihlr-28381	311	20	while	while	SCONJ
ihlr-28381	311	21	product	product	NOUN
ihlr-28381	311	22	hopping	hopping	NOUN
ihlr-28381	311	23	usually	usually	ADV
ihlr-28381	311	24	suggests	suggest	VERB
ihlr-28381	311	25	a	a	DET
ihlr-28381	311	26	marketing	marketing	NOUN
ihlr-28381	311	27	effort	effort	NOUN
ihlr-28381	311	28	aimed	aim	VERB
ihlr-28381	311	29	at	at	ADP
ihlr-28381	311	30	reducing	reduce	VERB
ihlr-28381	311	31	demand	demand	NOUN
ihlr-28381	311	32	for	for	ADP
ihlr-28381	311	33	a	a	DET
ihlr-28381	311	34	previous	previous	ADJ
ihlr-28381	311	35	iteration	iteration	NOUN
ihlr-28381	311	36	of	of	ADP
ihlr-28381	311	37	a	a	DET
ihlr-28381	311	38	new	new	ADJ
ihlr-28381	311	39	but	but	CCONJ
ihlr-28381	311	40	largely	largely	ADV
ihlr-28381	311	41	interchangeable	interchangeable	ADJ
ihlr-28381	311	42	product	product	NOUN
ihlr-28381	311	43	.	.	PUNCT
ihlr-28381	312	1	firms	firm	NOUN
ihlr-28381	312	2	evergreen	evergreen	VERB
ihlr-28381	312	3	a	a	DET
ihlr-28381	312	4	specific	specific	ADJ
ihlr-28381	312	5	drug	drug	NOUN
ihlr-28381	312	6	by	by	ADP
ihlr-28381	312	7	layering	layer	VERB
ihlr-28381	312	8	on	on	ADP
ihlr-28381	312	9	secondary	secondary	ADJ
ihlr-28381	312	10	patents	patent	NOUN
ihlr-28381	312	11	,	,	PUNCT
ihlr-28381	312	12	while	while	SCONJ
ihlr-28381	312	13	product	product	NOUN
ihlr-28381	312	14	hoppers	hopper	NOUN
ihlr-28381	312	15	are	be	AUX
ihlr-28381	312	16	less	less	ADV
ihlr-28381	312	17	concerned	concerned	ADJ
ihlr-28381	312	18	with	with	ADP
ihlr-28381	312	19	a	a	DET
ihlr-28381	312	20	specific	specific	ADJ
ihlr-28381	312	21	drug	drug	NOUN
ihlr-28381	312	22	’s	’s	PART
ihlr-28381	312	23	primary	primary	ADJ
ihlr-28381	312	24	patent	patent	NOUN
ihlr-28381	312	25	expiration	expiration	NOUN
ihlr-28381	312	26	because	because	SCONJ
ihlr-28381	312	27	demand	demand	NOUN
ihlr-28381	312	28	has	have	AUX
ihlr-28381	312	29	hopped	hop	VERB
ihlr-28381	312	30	to	to	ADP
ihlr-28381	312	31	a	a	DET
ihlr-28381	312	32	new	new	ADJ
ihlr-28381	312	33	product	product	NOUN
ihlr-28381	312	34	.	.	PUNCT
ihlr-28381	313	1	overcoming	overcome	VERB
ihlr-28381	313	2	the	the	DET
ihlr-28381	313	3	numerous	numerous	ADJ
ihlr-28381	313	4	secondary	secondary	ADJ
ihlr-28381	313	5	patents	patent	NOUN
ihlr-28381	313	6	guarding	guard	VERB
ihlr-28381	313	7	an	an	DET
ihlr-28381	313	8	evergreened	evergreened	ADJ
ihlr-28381	313	9	product	product	NOUN
ihlr-28381	313	10	demands	demand	VERB
ihlr-28381	313	11	time	time	NOUN
ihlr-28381	313	12	and	and	CCONJ
ihlr-28381	313	13	resources	resource	NOUN
ihlr-28381	313	14	from	from	ADP
ihlr-28381	313	15	generic	generic	ADJ
ihlr-28381	313	16	challengers	challenger	NOUN
ihlr-28381	313	17	,	,	PUNCT
ihlr-28381	313	18	which	which	PRON
ihlr-28381	313	19	may	may	AUX
ihlr-28381	313	20	ultimately	ultimately	ADV
ihlr-28381	313	21	gain	gain	VERB
ihlr-28381	313	22	approval	approval	NOUN
ihlr-28381	313	23	only	only	ADV
ihlr-28381	313	24	to	to	PART
ihlr-28381	313	25	enter	enter	VERB
ihlr-28381	313	26	a	a	DET
ihlr-28381	313	27	dead	dead	ADJ
ihlr-28381	313	28	market	market	NOUN
ihlr-28381	313	29	due	due	ADP
ihlr-28381	313	30	to	to	ADP
ihlr-28381	313	31	product	product	NOUN
ihlr-28381	313	32	hopping.73	hopping.73	NOUN
ihlr-28381	313	33	in	in	ADP
ihlr-28381	313	34	either	either	DET
ihlr-28381	313	35	case	case	NOUN
ihlr-28381	313	36	,	,	PUNCT
ihlr-28381	313	37	generic	generic	ADJ
ihlr-28381	313	38	competition	competition	NOUN
ihlr-28381	313	39	is	be	AUX
ihlr-28381	313	40	delayed	delay	VERB
ihlr-28381	313	41	.	.	PUNCT
ihlr-28381	314	1	c.	c.	NOUN
ihlr-28381	314	2	constricting	constrict	VERB
ihlr-28381	314	3	supply	supply	NOUN
ihlr-28381	314	4	in	in	ADP
ihlr-28381	314	5	addition	addition	NOUN
ihlr-28381	314	6	to	to	ADP
ihlr-28381	314	7	patent	patent	NOUN
ihlr-28381	314	8	-	-	PUNCT
ihlr-28381	314	9	based	base	VERB
ihlr-28381	314	10	methods	method	NOUN
ihlr-28381	314	11	of	of	ADP
ihlr-28381	314	12	delaying	delay	VERB
ihlr-28381	314	13	generic	generic	ADJ
ihlr-28381	314	14	competition	competition	NOUN
ihlr-28381	314	15	,	,	PUNCT
ihlr-28381	314	16	the	the	DET
ihlr-28381	314	17	drug	drug	NOUN
ihlr-28381	314	18	supply	supply	NOUN
ihlr-28381	314	19	chain	chain	NOUN
ihlr-28381	314	20	can	can	AUX
ihlr-28381	314	21	be	be	AUX
ihlr-28381	314	22	leveraged	leverage	VERB
ihlr-28381	314	23	against	against	ADP
ihlr-28381	314	24	generic	generic	ADJ
ihlr-28381	314	25	suitors	suitor	NOUN
ihlr-28381	314	26	.	.	PUNCT
ihlr-28381	315	1	in	in	ADP
ihlr-28381	315	2	2015	2015	NUM
ihlr-28381	315	3	,	,	PUNCT
ihlr-28381	315	4	pharmaceutical	pharmaceutical	ADJ
ihlr-28381	315	5	executive	executive	NOUN
ihlr-28381	315	6	martin	martin	PROPN
ihlr-28381	315	7	shkreli	shkreli	PROPN
ihlr-28381	315	8	gained	gain	VERB
ihlr-28381	315	9	notoriety	notoriety	NOUN
ihlr-28381	315	10	when	when	SCONJ
ihlr-28381	315	11	he	he	PRON
ihlr-28381	315	12	increased	increase	VERB
ihlr-28381	315	13	the	the	DET
ihlr-28381	315	14	price	price	NOUN
ihlr-28381	315	15	of	of	ADP
ihlr-28381	315	16	daraprim	daraprim	NOUN
ihlr-28381	315	17	—	—	PUNCT
ihlr-28381	315	18	a	a	DET
ihlr-28381	315	19	drug	drug	NOUN
ihlr-28381	315	20	used	use	VERB
ihlr-28381	315	21	to	to	PART
ihlr-28381	315	22	treat	treat	VERB
ihlr-28381	315	23	toxoplasmosis	toxoplasmosis	NOUN
ihlr-28381	315	24	,	,	PUNCT
ihlr-28381	315	25	a	a	DET
ihlr-28381	315	26	rare	rare	ADJ
ihlr-28381	315	27	parasitic	parasitic	ADJ
ihlr-28381	315	28	infection	infection	NOUN
ihlr-28381	315	29	—	—	PUNCT
ihlr-28381	315	30	from	from	ADP
ihlr-28381	315	31	$	$	SYM
ihlr-28381	315	32	17.60	17.60	NUM
ihlr-28381	315	33	to	to	PART
ihlr-28381	315	34	$	$	SYM
ihlr-28381	315	35	750.00.74	750.00.74	NUM
ihlr-28381	315	36	the	the	DET
ihlr-28381	315	37	price	price	NOUN
ihlr-28381	315	38	hike	hike	NOUN
ihlr-28381	315	39	,	,	PUNCT
ihlr-28381	315	40	aided	aid	VERB
ihlr-28381	315	41	by	by	ADP
ihlr-28381	315	42	shkreli	shkreli	PROPN
ihlr-28381	315	43	’s	’s	PART
ihlr-28381	315	44	candid	candid	ADJ
ihlr-28381	315	45	personality	personality	NOUN
ihlr-28381	315	46	and	and	CCONJ
ihlr-28381	315	47	unapologetic	unapologetic	ADJ
ihlr-28381	315	48	response	response	NOUN
ihlr-28381	315	49	,	,	PUNCT
ihlr-28381	315	50	drew	draw	VERB
ihlr-28381	315	51	criticism	criticism	NOUN
ihlr-28381	315	52	from	from	ADP
ihlr-28381	315	53	politicians	politician	NOUN
ihlr-28381	315	54	,	,	PUNCT
ihlr-28381	315	55	the	the	DET
ihlr-28381	315	56	public	public	NOUN
ihlr-28381	315	57	,	,	PUNCT
ihlr-28381	315	58	and	and	CCONJ
ihlr-28381	315	59	of	of	ADP
ihlr-28381	315	60	consequence	consequence	NOUN
ihlr-28381	315	61	,	,	PUNCT
ihlr-28381	315	62	regulators	regulator	NOUN
ihlr-28381	315	63	.	.	PUNCT
ihlr-28381	316	1	the	the	DET
ihlr-28381	316	2	ftc	ftc	PROPN
ihlr-28381	316	3	filed	file	VERB
ihlr-28381	316	4	an	an	DET
ihlr-28381	316	5	antitrust	antitrust	ADJ
ihlr-28381	316	6	lawsuit	lawsuit	NOUN
ihlr-28381	316	7	against	against	ADP
ihlr-28381	316	8	shkreli	shkreli	NOUN
ihlr-28381	316	9	which	which	PRON
ihlr-28381	316	10	revealed	reveal	VERB
ihlr-28381	316	11	an	an	DET
ihlr-28381	316	12	impressive	impressive	ADJ
ihlr-28381	316	13	pay	pay	NOUN
ihlr-28381	316	14	-	-	PUNCT
ihlr-28381	316	15	for	for	ADP
ihlr-28381	316	16	-	-	PUNCT
ihlr-28381	316	17	delay	delay	NOUN
ihlr-28381	316	18	strategy.75	strategy.75	PROPN
ihlr-28381	316	19	in	in	ADP
ihlr-28381	316	20	ftc	ftc	PROPN
ihlr-28381	316	21	.	.	PUNCT
ihlr-28381	317	1	v.	v.	PROPN
ihlr-28381	317	2	shkreli	shkreli	PROPN
ihlr-28381	317	3	,	,	PUNCT
ihlr-28381	317	4	shkreli	shkreli	PROPN
ihlr-28381	317	5	’s	’s	PART
ihlr-28381	317	6	company	company	NOUN
ihlr-28381	317	7	,	,	PUNCT
ihlr-28381	317	8	vyera	vyera	NOUN
ihlr-28381	317	9	,	,	PUNCT
ihlr-28381	318	1	lacked	lack	VERB
ihlr-28381	318	2	patent	patent	NOUN
ihlr-28381	318	3	protection	protection	NOUN
ihlr-28381	318	4	for	for	ADP
ihlr-28381	318	5	daraprim	daraprim	NOUN
ihlr-28381	318	6	,	,	PUNCT
ihlr-28381	318	7	but	but	CCONJ
ihlr-28381	318	8	successfully	successfully	ADV
ihlr-28381	318	9	delayed	delay	VERB
ihlr-28381	318	10	generic	generic	ADJ
ihlr-28381	318	11	competition	competition	NOUN
ihlr-28381	318	12	for	for	ADP
ihlr-28381	318	13	eighteen	eighteen	NUM
ihlr-28381	318	14	months	month	NOUN
ihlr-28381	318	15	(	(	PUNCT
ihlr-28381	318	16	the	the	DET
ihlr-28381	318	17	drug	drug	NOUN
ihlr-28381	318	18	was	be	AUX
ihlr-28381	318	19	actually	actually	ADV
ihlr-28381	318	20	over	over	ADP
ihlr-28381	318	21	60	60	NUM
ihlr-28381	318	22	years	year	NOUN
ihlr-28381	318	23	old	old	ADJ
ihlr-28381	318	24	,	,	PUNCT
ihlr-28381	318	25	but	but	CCONJ
ihlr-28381	318	26	the	the	DET
ihlr-28381	318	27	low	low	ADJ
ihlr-28381	318	28	price	price	NOUN
ihlr-28381	318	29	and	and	CCONJ
ihlr-28381	318	30	small	small	ADJ
ihlr-28381	318	31	patient	patient	ADJ
ihlr-28381	318	32	population	population	NOUN
ihlr-28381	318	33	made	make	VERB
ihlr-28381	318	34	daraprim	daraprim	NOUN
ihlr-28381	318	35	commercially	commercially	ADV
ihlr-28381	318	36	unattractive	unattractive	ADJ
ihlr-28381	318	37	to	to	ADP
ihlr-28381	318	38	generic	generic	ADJ
ihlr-28381	318	39	companies	company	NOUN
ihlr-28381	318	40	69	69	NUM
ihlr-28381	318	41	.	.	PUNCT
ihlr-28381	319	1	i	i	PRON
ihlr-28381	319	2	d.	d.	PROPN
ihlr-28381	319	3	70	70	NUM
ihlr-28381	319	4	.	.	PUNCT
ihlr-28381	320	1	i	i	PRON
ihlr-28381	320	2	d.	d.	PROPN
ihlr-28381	320	3	71	71	NUM
ihlr-28381	320	4	.	.	PUNCT
ihlr-28381	321	1	i	i	PRON
ihlr-28381	321	2	d.	d.	PROPN
ihlr-28381	321	3	72	72	NUM
ihlr-28381	321	4	.	.	PUNCT
ihlr-28381	322	1	i	i	PRON
ihlr-28381	322	2	d.	d.	PROPN
ihlr-28381	322	3	73	73	NUM
ihlr-28381	322	4	.	.	PUNCT
ihlr-28381	323	1	richards	richard	NOUN
ihlr-28381	323	2	et	et	PROPN
ihlr-28381	323	3	al	al	PROPN
ihlr-28381	323	4	.	.	PROPN
ihlr-28381	323	5	,	,	PUNCT
ihlr-28381	323	6	supra	supra	PROPN
ihlr-28381	323	7	note	note	VERB
ihlr-28381	323	8	41	41	NUM
ihlr-28381	323	9	.	.	PUNCT
ihlr-28381	324	1	74	74	NUM
ihlr-28381	324	2	.	.	PUNCT
ihlr-28381	325	1	ftc	ftc	PROPN
ihlr-28381	325	2	v.	v.	ADP
ihlr-28381	325	3	shkreli	shkreli	PROPN
ihlr-28381	325	4	,	,	PUNCT
ihlr-28381	325	5	581	581	NUM
ihlr-28381	325	6	f.	f.	PROPN
ihlr-28381	325	7	supp	supp	PROPN
ihlr-28381	325	8	.	.	PUNCT
ihlr-28381	326	1	3d	3d	NUM
ihlr-28381	326	2	579	579	NUM
ihlr-28381	326	3	,	,	PUNCT
ihlr-28381	326	4	601	601	NUM
ihlr-28381	326	5	(	(	PUNCT
ihlr-28381	326	6	s.d.n.y	s.d.n.y	PROPN
ihlr-28381	326	7	.	.	PROPN
ihlr-28381	326	8	2022	2022	NUM
ihlr-28381	326	9	)	)	PUNCT
ihlr-28381	326	10	.	.	PUNCT
ihlr-28381	327	1	75	75	NUM
ihlr-28381	327	2	.	.	PUNCT
ihlr-28381	328	1	i	i	PRON
ihlr-28381	328	2	d.	d.	PROPN
ihlr-28381	328	3	136	136	NUM
ihlr-28381	328	4	indiana	indiana	PROPN
ihlr-28381	328	5	health	health	PROPN
ihlr-28381	328	6	law	law	NOUN
ihlr-28381	328	7	review	review	NOUN
ihlr-28381	328	8	[	[	X
ihlr-28381	328	9	vol	vol	NOUN
ihlr-28381	328	10	.	.	NOUN
ihlr-28381	328	11	21:121	21:121	NUM
ihlr-28381	328	12	which	which	PRON
ihlr-28381	328	13	did	do	AUX
ihlr-28381	328	14	not	not	PART
ihlr-28381	328	15	pursue	pursue	VERB
ihlr-28381	328	16	generic	generic	ADJ
ihlr-28381	328	17	daraprim	daraprim	NOUN
ihlr-28381	328	18	until	until	ADP
ihlr-28381	328	19	this	this	DET
ihlr-28381	328	20	development).76	development).76	PROPN
ihlr-28381	328	21	the	the	DET
ihlr-28381	328	22	18	18	NUM
ihlr-28381	328	23	-	-	PUNCT
ihlr-28381	328	24	month	month	NOUN
ihlr-28381	328	25	delay	delay	NOUN
ihlr-28381	328	26	was	be	AUX
ihlr-28381	328	27	responsible	responsible	ADJ
ihlr-28381	328	28	for	for	ADP
ihlr-28381	328	29	almost	almost	ADV
ihlr-28381	328	30	$	$	SYM
ihlr-28381	328	31	65	65	NUM
ihlr-28381	328	32	million	million	NUM
ihlr-28381	328	33	in	in	ADP
ihlr-28381	328	34	continued	continue	VERB
ihlr-28381	328	35	monopoly	monopoly	NOUN
ihlr-28381	328	36	sales.77	sales.77	PROPN
ihlr-28381	328	37	vyera	vyera	NOUN
ihlr-28381	328	38	executives	executive	NOUN
ihlr-28381	328	39	failed	fail	VERB
ihlr-28381	328	40	to	to	PART
ihlr-28381	328	41	disguise	disguise	VERB
ihlr-28381	328	42	a	a	DET
ihlr-28381	328	43	series	series	NOUN
ihlr-28381	328	44	of	of	ADP
ihlr-28381	328	45	tactics	tactic	NOUN
ihlr-28381	328	46	and	and	CCONJ
ihlr-28381	328	47	agreements	agreement	NOUN
ihlr-28381	328	48	that	that	PRON
ihlr-28381	328	49	prevented	prevent	VERB
ihlr-28381	328	50	prospective	prospective	ADJ
ihlr-28381	328	51	generic	generic	ADJ
ihlr-28381	328	52	entrants	entrant	NOUN
ihlr-28381	328	53	from	from	ADP
ihlr-28381	328	54	obtaining	obtain	VERB
ihlr-28381	328	55	the	the	DET
ihlr-28381	328	56	supplies	supply	NOUN
ihlr-28381	328	57	necessary	necessary	ADJ
ihlr-28381	328	58	to	to	PART
ihlr-28381	328	59	receive	receive	VERB
ihlr-28381	328	60	fda	fda	PROPN
ihlr-28381	328	61	approval.78	approval.78	PROPN
ihlr-28381	328	62	to	to	PART
ihlr-28381	328	63	earn	earn	VERB
ihlr-28381	328	64	fda	fda	PROPN
ihlr-28381	328	65	approval	approval	NOUN
ihlr-28381	328	66	of	of	ADP
ihlr-28381	328	67	an	an	DET
ihlr-28381	328	68	anda	anda	NOUN
ihlr-28381	328	69	,	,	PUNCT
ihlr-28381	328	70	the	the	DET
ihlr-28381	328	71	generic	generic	PROPN
ihlr-28381	328	72	anda	anda	PROPN
ihlr-28381	328	73	filer	filer	NOUN
ihlr-28381	328	74	must	must	AUX
ihlr-28381	328	75	demonstrate	demonstrate	VERB
ihlr-28381	328	76	its	its	PRON
ihlr-28381	328	77	ability	ability	NOUN
ihlr-28381	328	78	to	to	PART
ihlr-28381	328	79	produce	produce	VERB
ihlr-28381	328	80	the	the	DET
ihlr-28381	328	81	reference	reference	NOUN
ihlr-28381	328	82	product	product	NOUN
ihlr-28381	328	83	(	(	PUNCT
ihlr-28381	328	84	the	the	DET
ihlr-28381	328	85	“	"	PUNCT
ihlr-28381	328	86	reference	reference	NOUN
ihlr-28381	328	87	product	product	NOUN
ihlr-28381	328	88	”	"	PUNCT
ihlr-28381	328	89	is	be	AUX
ihlr-28381	328	90	the	the	DET
ihlr-28381	328	91	brand	brand	NOUN
ihlr-28381	328	92	drug	drug	NOUN
ihlr-28381	328	93	the	the	DET
ihlr-28381	328	94	generic	generic	ADJ
ihlr-28381	328	95	seeks	seek	VERB
ihlr-28381	328	96	to	to	PART
ihlr-28381	328	97	emulate	emulate	VERB
ihlr-28381	328	98	)	)	PUNCT
ihlr-28381	328	99	and	and	CCONJ
ihlr-28381	328	100	comply	comply	VERB
ihlr-28381	328	101	with	with	ADP
ihlr-28381	328	102	certain	certain	ADJ
ihlr-28381	328	103	production	production	NOUN
ihlr-28381	328	104	standards.79	standards.79	NOUN
ihlr-28381	328	105	in	in	ADP
ihlr-28381	328	106	this	this	DET
ihlr-28381	328	107	process	process	NOUN
ihlr-28381	328	108	,	,	PUNCT
ihlr-28381	328	109	the	the	DET
ihlr-28381	328	110	generic	generic	ADJ
ihlr-28381	328	111	company	company	NOUN
ihlr-28381	328	112	must	must	AUX
ihlr-28381	328	113	acquire	acquire	VERB
ihlr-28381	328	114	the	the	DET
ihlr-28381	328	115	reference	reference	NOUN
ihlr-28381	328	116	product	product	NOUN
ihlr-28381	328	117	—	—	PUNCT
ihlr-28381	328	118	daraprim	daraprim	NOUN
ihlr-28381	328	119	—	—	PUNCT
ihlr-28381	328	120	as	as	ADV
ihlr-28381	328	121	well	well	ADV
ihlr-28381	328	122	as	as	ADP
ihlr-28381	328	123	the	the	DET
ihlr-28381	328	124	primary	primary	ADJ
ihlr-28381	328	125	ingredient	ingredient	NOUN
ihlr-28381	328	126	responsible	responsible	ADJ
ihlr-28381	328	127	for	for	ADP
ihlr-28381	328	128	the	the	DET
ihlr-28381	328	129	therapeutic	therapeutic	ADJ
ihlr-28381	328	130	effect	effect	NOUN
ihlr-28381	328	131	—	—	PUNCT
ihlr-28381	328	132	pyrimethamine.80	pyrimethamine.80	NOUN
ihlr-28381	328	133	through	through	ADP
ihlr-28381	328	134	a	a	DET
ihlr-28381	328	135	series	series	NOUN
ihlr-28381	328	136	of	of	ADP
ihlr-28381	328	137	agreements	agreement	NOUN
ihlr-28381	328	138	,	,	PUNCT
ihlr-28381	328	139	vyera	vyera	NOUN
ihlr-28381	328	140	positioned	position	VERB
ihlr-28381	328	141	itself	itself	PRON
ihlr-28381	328	142	as	as	SCONJ
ihlr-28381	328	143	the	the	DET
ihlr-28381	328	144	gatekeeper	gatekeeper	NOUN
ihlr-28381	328	145	of	of	ADP
ihlr-28381	328	146	the	the	DET
ihlr-28381	328	147	supplies	supply	NOUN
ihlr-28381	328	148	necessary	necessary	ADJ
ihlr-28381	328	149	to	to	PART
ihlr-28381	328	150	develop	develop	VERB
ihlr-28381	328	151	a	a	DET
ihlr-28381	328	152	generic	generic	ADJ
ihlr-28381	328	153	,	,	PUNCT
ihlr-28381	328	154	including	include	VERB
ihlr-28381	328	155	the	the	DET
ihlr-28381	328	156	active	active	ADJ
ihlr-28381	328	157	ingredient	ingredient	NOUN
ihlr-28381	328	158	—	—	PUNCT
ihlr-28381	328	159	pyrimethamine	pyrimethamine	NOUN
ihlr-28381	328	160	—	—	PUNCT
ihlr-28381	328	161	and	and	CCONJ
ihlr-28381	328	162	daraprim	daraprim	NOUN
ihlr-28381	328	163	itself.81	itself.81	ADJ
ihlr-28381	328	164	by	by	ADP
ihlr-28381	328	165	placing	place	VERB
ihlr-28381	328	166	daraprim	daraprim	NOUN
ihlr-28381	328	167	in	in	ADP
ihlr-28381	328	168	a	a	DET
ihlr-28381	328	169	closed	closed	ADJ
ihlr-28381	328	170	,	,	PUNCT
ihlr-28381	328	171	or	or	CCONJ
ihlr-28381	328	172	“	"	PUNCT
ihlr-28381	328	173	specialty	specialty	NOUN
ihlr-28381	328	174	,	,	PUNCT
ihlr-28381	328	175	”	"	PUNCT
ihlr-28381	328	176	distribution	distribution	NOUN
ihlr-28381	328	177	network	network	NOUN
ihlr-28381	328	178	,	,	PUNCT
ihlr-28381	328	179	daraprim	daraprim	PROPN
ihlr-28381	328	180	’s	’s	PART
ihlr-28381	328	181	generic	generic	ADJ
ihlr-28381	328	182	suitors	suitor	NOUN
ihlr-28381	328	183	could	could	AUX
ihlr-28381	328	184	not	not	PART
ihlr-28381	328	185	obtain	obtain	VERB
ihlr-28381	328	186	the	the	DET
ihlr-28381	328	187	drug	drug	NOUN
ihlr-28381	328	188	without	without	ADP
ihlr-28381	328	189	vyera	vyera	NOUN
ihlr-28381	328	190	’s	’s	PART
ihlr-28381	328	191	approval	approval	NOUN
ihlr-28381	328	192	,	,	PUNCT
ihlr-28381	328	193	which	which	DET
ihlr-28381	328	194	vyera	vyera	NOUN
ihlr-28381	328	195	refused	refuse	VERB
ihlr-28381	328	196	to	to	ADP
ihlr-28381	328	197	provide.82	provide.82	PROPN
ihlr-28381	328	198	vyera	vyera	NOUN
ihlr-28381	328	199	then	then	ADV
ihlr-28381	328	200	negotiated	negotiate	VERB
ihlr-28381	328	201	exclusive	exclusive	ADJ
ihlr-28381	328	202	supplier	supplier	NOUN
ihlr-28381	328	203	agreements	agreement	NOUN
ihlr-28381	328	204	with	with	ADP
ihlr-28381	328	205	the	the	DET
ihlr-28381	328	206	few	few	ADJ
ihlr-28381	328	207	authorized	authorize	VERB
ihlr-28381	328	208	sellers	seller	NOUN
ihlr-28381	328	209	of	of	ADP
ihlr-28381	328	210	pyrimethamine	pyrimethamine	NOUN
ihlr-28381	328	211	,	,	PUNCT
ihlr-28381	328	212	cutting	cut	VERB
ihlr-28381	328	213	off	off	ADP
ihlr-28381	328	214	generic	generic	ADJ
ihlr-28381	328	215	companies	company	NOUN
ihlr-28381	328	216	from	from	ADP
ihlr-28381	328	217	daraprim	daraprim	PROPN
ihlr-28381	328	218	’s	’s	PART
ihlr-28381	328	219	essential	essential	ADJ
ihlr-28381	328	220	ingredient.83	ingredient.83	NOUN
ihlr-28381	328	221	this	this	DET
ihlr-28381	328	222	case	case	NOUN
ihlr-28381	328	223	notably	notably	ADV
ihlr-28381	328	224	lacked	lack	VERB
ihlr-28381	328	225	any	any	DET
ihlr-28381	328	226	serious	serious	ADJ
ihlr-28381	328	227	pro	pro	ADJ
ihlr-28381	328	228	-	-	ADJ
ihlr-28381	328	229	competitive	competitive	ADJ
ihlr-28381	328	230	evidence	evidence	NOUN
ihlr-28381	328	231	to	to	PART
ihlr-28381	328	232	justify	justify	VERB
ihlr-28381	328	233	the	the	DET
ihlr-28381	328	234	actions	action	NOUN
ihlr-28381	328	235	,	,	PUNCT
ihlr-28381	328	236	and	and	CCONJ
ihlr-28381	328	237	thus	thus	ADV
ihlr-28381	328	238	the	the	DET
ihlr-28381	328	239	court	court	NOUN
ihlr-28381	328	240	held	hold	VERB
ihlr-28381	328	241	shkreli	shkreli	PROPN
ihlr-28381	328	242	liable	liable	ADJ
ihlr-28381	328	243	with	with	ADP
ihlr-28381	328	244	an	an	DET
ihlr-28381	328	245	unusual	unusual	ADJ
ihlr-28381	328	246	degree	degree	NOUN
ihlr-28381	328	247	of	of	ADP
ihlr-28381	328	248	ease	ease	NOUN
ihlr-28381	328	249	and	and	CCONJ
ihlr-28381	328	250	punitive	punitive	ADJ
ihlr-28381	328	251	wrath.84	wrath.84	PROPN
ihlr-28381	328	252	d.	d.	PROPN
ihlr-28381	328	253	recap	recap	NOUN
ihlr-28381	328	254	:	:	PUNCT
ihlr-28381	328	255	diversifying	diversify	VERB
ihlr-28381	328	256	delay	delay	NOUN
ihlr-28381	328	257	while	while	SCONJ
ihlr-28381	328	258	reverse	reverse	ADJ
ihlr-28381	328	259	payment	payment	NOUN
ihlr-28381	328	260	settlements	settlement	NOUN
ihlr-28381	328	261	are	be	AUX
ihlr-28381	328	262	the	the	DET
ihlr-28381	328	263	classic	classic	ADJ
ihlr-28381	328	264	examples	example	NOUN
ihlr-28381	328	265	of	of	ADP
ihlr-28381	328	266	delaying	delay	VERB
ihlr-28381	328	267	generic	generic	ADJ
ihlr-28381	328	268	entry	entry	NOUN
ihlr-28381	328	269	,	,	PUNCT
ihlr-28381	328	270	methodology	methodology	NOUN
ihlr-28381	328	271	has	have	AUX
ihlr-28381	328	272	evolved	evolve	VERB
ihlr-28381	328	273	.	.	PUNCT
ihlr-28381	329	1	today	today	NOUN
ihlr-28381	329	2	,	,	PUNCT
ihlr-28381	329	3	citizen	citizen	NOUN
ihlr-28381	329	4	petitions	petition	NOUN
ihlr-28381	329	5	,	,	PUNCT
ihlr-28381	329	6	evergreening	evergreening	NOUN
ihlr-28381	329	7	,	,	PUNCT
ihlr-28381	329	8	product	product	NOUN
ihlr-28381	329	9	hopping	hopping	NOUN
ihlr-28381	329	10	,	,	PUNCT
ihlr-28381	329	11	and	and	CCONJ
ihlr-28381	329	12	exclusive	exclusive	ADJ
ihlr-28381	329	13	supplier	supplier	NOUN
ihlr-28381	329	14	agreements	agreement	NOUN
ihlr-28381	329	15	are	be	AUX
ihlr-28381	329	16	responsible	responsible	ADJ
ihlr-28381	329	17	for	for	ADP
ihlr-28381	329	18	delayed	delay	VERB
ihlr-28381	329	19	generic	generic	ADJ
ihlr-28381	329	20	entry	entry	NOUN
ihlr-28381	329	21	in	in	ADP
ihlr-28381	329	22	addition	addition	NOUN
ihlr-28381	329	23	to	to	ADP
ihlr-28381	329	24	some	some	DET
ihlr-28381	329	25	reverse	reverse	ADJ
ihlr-28381	329	26	payment	payment	NOUN
ihlr-28381	329	27	settlements	settlement	NOUN
ihlr-28381	329	28	.	.	PUNCT
ihlr-28381	330	1	citizen	citizen	PROPN
ihlr-28381	330	2	petitions	petition	NOUN
ihlr-28381	330	3	allow	allow	VERB
ihlr-28381	330	4	firms	firm	NOUN
ihlr-28381	330	5	to	to	PART
ihlr-28381	330	6	prolong	prolong	VERB
ihlr-28381	330	7	market	market	NOUN
ihlr-28381	330	8	exclusivity	exclusivity	NOUN
ihlr-28381	330	9	by	by	ADP
ihlr-28381	330	10	raising	raise	VERB
ihlr-28381	330	11	artificial	artificial	ADJ
ihlr-28381	330	12	concerns	concern	NOUN
ihlr-28381	330	13	about	about	ADP
ihlr-28381	330	14	pending	pende	VERB
ihlr-28381	330	15	generic	generic	ADJ
ihlr-28381	330	16	products	product	NOUN
ihlr-28381	330	17	.	.	PUNCT
ihlr-28381	331	1	firms	firm	NOUN
ihlr-28381	331	2	evergreen	evergreen	VERB
ihlr-28381	331	3	existing	exist	VERB
ihlr-28381	331	4	drugs	drug	NOUN
ihlr-28381	331	5	by	by	ADP
ihlr-28381	331	6	tacking	tack	VERB
ihlr-28381	331	7	on	on	ADP
ihlr-28381	331	8	secondary	secondary	ADJ
ihlr-28381	331	9	patents	patent	NOUN
ihlr-28381	331	10	to	to	PART
ihlr-28381	331	11	extend	extend	VERB
ihlr-28381	331	12	monopoly	monopoly	NOUN
ihlr-28381	331	13	protection	protection	NOUN
ihlr-28381	331	14	beyond	beyond	ADP
ihlr-28381	331	15	expiration	expiration	NOUN
ihlr-28381	331	16	of	of	ADP
ihlr-28381	331	17	the	the	DET
ihlr-28381	331	18	primary	primary	ADJ
ihlr-28381	331	19	patent.85	patent.85	NOUN
ihlr-28381	331	20	product	product	NOUN
ihlr-28381	331	21	hopping	hopping	NOUN
ihlr-28381	331	22	occurs	occur	VERB
ihlr-28381	331	23	when	when	SCONJ
ihlr-28381	331	24	an	an	DET
ihlr-28381	331	25	innovator	innovator	NOUN
ihlr-28381	331	26	firm	firm	NOUN
ihlr-28381	331	27	deploys	deploy	VERB
ihlr-28381	331	28	marketing	marketing	NOUN
ihlr-28381	331	29	resources	resource	NOUN
ihlr-28381	331	30	to	to	PART
ihlr-28381	331	31	redirect	redirect	VERB
ihlr-28381	331	32	demand	demand	NOUN
ihlr-28381	331	33	for	for	ADP
ihlr-28381	331	34	a	a	DET
ihlr-28381	331	35	drug	drug	NOUN
ihlr-28381	331	36	facing	face	VERB
ihlr-28381	331	37	imminent	imminent	ADJ
ihlr-28381	331	38	generic	generic	ADJ
ihlr-28381	331	39	competition	competition	NOUN
ihlr-28381	331	40	to	to	ADP
ihlr-28381	331	41	a	a	DET
ihlr-28381	331	42	new	new	ADJ
ihlr-28381	331	43	market	market	NOUN
ihlr-28381	331	44	for	for	ADP
ihlr-28381	331	45	a	a	DET
ihlr-28381	331	46	slightly	slightly	ADV
ihlr-28381	331	47	amended	amend	VERB
ihlr-28381	331	48	version	version	NOUN
ihlr-28381	331	49	of	of	ADP
ihlr-28381	331	50	the	the	DET
ihlr-28381	331	51	same	same	ADJ
ihlr-28381	331	52	drug	drug	NOUN
ihlr-28381	331	53	.	.	PUNCT
ihlr-28381	332	1	if	if	SCONJ
ihlr-28381	332	2	a	a	DET
ihlr-28381	332	3	drug	drug	NOUN
ihlr-28381	332	4	has	have	VERB
ihlr-28381	332	5	no	no	DET
ihlr-28381	332	6	patent	patent	NOUN
ihlr-28381	332	7	protection	protection	NOUN
ihlr-28381	332	8	,	,	PUNCT
ihlr-28381	332	9	innovators	innovator	NOUN
ihlr-28381	332	10	can	can	AUX
ihlr-28381	332	11	still	still	ADV
ihlr-28381	332	12	protect	protect	VERB
ihlr-28381	332	13	a	a	DET
ihlr-28381	332	14	monopoly	monopoly	NOUN
ihlr-28381	332	15	market	market	NOUN
ihlr-28381	332	16	by	by	ADP
ihlr-28381	332	17	contractually	contractually	ADV
ihlr-28381	332	18	prohibiting	prohibit	VERB
ihlr-28381	332	19	suppliers	supplier	NOUN
ihlr-28381	332	20	from	from	ADP
ihlr-28381	332	21	supplying	supply	VERB
ihlr-28381	332	22	necessary	necessary	ADJ
ihlr-28381	332	23	ingredients	ingredient	NOUN
ihlr-28381	332	24	to	to	ADP
ihlr-28381	332	25	76	76	NUM
ihlr-28381	332	26	.	.	PUNCT
ihlr-28381	333	1	i	i	PRON
ihlr-28381	333	2	d.	d.	PROPN
ihlr-28381	333	3	at	at	ADP
ihlr-28381	333	4	590	590	NUM
ihlr-28381	333	5	.	.	PUNCT
ihlr-28381	334	1	77	77	NUM
ihlr-28381	334	2	.	.	PUNCT
ihlr-28381	335	1	i	i	PRON
ihlr-28381	335	2	d.	d.	PROPN
ihlr-28381	335	3	at	at	ADP
ihlr-28381	335	4	591	591	NUM
ihlr-28381	335	5	.	.	PUNCT
ihlr-28381	336	1	78	78	NUM
ihlr-28381	336	2	.	.	PUNCT
ihlr-28381	337	1	i	i	PRON
ihlr-28381	337	2	d.	d.	PROPN
ihlr-28381	337	3	at	at	ADP
ihlr-28381	337	4	633	633	NUM
ihlr-28381	337	5	-	-	SYM
ihlr-28381	337	6	34	34	NUM
ihlr-28381	337	7	.	.	NOUN
ihlr-28381	337	8	79	79	NUM
ihlr-28381	337	9	.	.	PUNCT
ihlr-28381	338	1	i	i	PRON
ihlr-28381	338	2	d.	d.	PROPN
ihlr-28381	338	3	at	at	ADP
ihlr-28381	338	4	595	595	NUM
ihlr-28381	338	5	-	-	SYM
ihlr-28381	338	6	96	96	NUM
ihlr-28381	338	7	.	.	PUNCT
ihlr-28381	338	8	80	80	NUM
ihlr-28381	338	9	.	.	PUNCT
ihlr-28381	339	1	i	i	PRON
ihlr-28381	339	2	d.	d.	PROPN
ihlr-28381	339	3	at	at	ADP
ihlr-28381	339	4	605	605	NUM
ihlr-28381	339	5	.	.	PUNCT
ihlr-28381	339	6	81	81	NUM
ihlr-28381	339	7	.	.	PUNCT
ihlr-28381	340	1	fed	fed	PROPN
ihlr-28381	340	2	.	.	PUNCT
ihlr-28381	341	1	trade	trade	NOUN
ihlr-28381	341	2	comm'n	comm'n	CCONJ
ihlr-28381	341	3	v.	v.	ADP
ihlr-28381	341	4	shkreli	shkreli	NOUN
ihlr-28381	341	5	,	,	PUNCT
ihlr-28381	341	6	581	581	NUM
ihlr-28381	341	7	f.	f.	PROPN
ihlr-28381	341	8	supp	supp	PROPN
ihlr-28381	341	9	.	.	PUNCT
ihlr-28381	342	1	3d	3d	NUM
ihlr-28381	342	2	579	579	NUM
ihlr-28381	342	3	,	,	PUNCT
ihlr-28381	342	4	605	605	NUM
ihlr-28381	342	5	(	(	PUNCT
ihlr-28381	342	6	s.d.n.y	s.d.n.y	PROPN
ihlr-28381	342	7	.	.	PROPN
ihlr-28381	342	8	2022	2022	NUM
ihlr-28381	342	9	)	)	PUNCT
ihlr-28381	342	10	.	.	PUNCT
ihlr-28381	343	1	82	82	NUM
ihlr-28381	343	2	.	.	PUNCT
ihlr-28381	344	1	i	i	PRON
ihlr-28381	344	2	d.	d.	PROPN
ihlr-28381	344	3	at	at	ADP
ihlr-28381	344	4	602	602	NUM
ihlr-28381	344	5	.	.	PUNCT
ihlr-28381	345	1	83	83	NUM
ihlr-28381	345	2	.	.	PUNCT
ihlr-28381	346	1	i	i	PRON
ihlr-28381	346	2	d.	d.	PROPN
ihlr-28381	346	3	at	at	ADP
ihlr-28381	346	4	602	602	NUM
ihlr-28381	346	5	-	-	SYM
ihlr-28381	346	6	03	03	NUM
ihlr-28381	346	7	.	.	PUNCT
ihlr-28381	347	1	84	84	NUM
ihlr-28381	347	2	.	.	PUNCT
ihlr-28381	348	1	i	i	PRON
ihlr-28381	348	2	d.	d.	PROPN
ihlr-28381	348	3	at	at	ADP
ihlr-28381	348	4	636	636	NUM
ihlr-28381	348	5	-	-	SYM
ihlr-28381	348	6	38	38	NUM
ihlr-28381	348	7	.	.	PUNCT
ihlr-28381	348	8	85	85	NUM
ihlr-28381	348	9	.	.	PUNCT
ihlr-28381	349	1	richards	richard	NOUN
ihlr-28381	349	2	et	et	PROPN
ihlr-28381	349	3	al	al	PROPN
ihlr-28381	349	4	.	.	PROPN
ihlr-28381	349	5	,	,	PUNCT
ihlr-28381	349	6	supra	supra	PROPN
ihlr-28381	349	7	note	note	PROPN
ihlr-28381	349	8	41	41	NUM
ihlr-28381	349	9	,	,	PUNCT
ihlr-28381	349	10	at	at	ADP
ihlr-28381	349	11	1	1	NUM
ihlr-28381	349	12	.	.	NOUN
ihlr-28381	349	13	2024	2024	NUM
ihlr-28381	349	14	]	]	PUNCT
ihlr-28381	349	15	incentivizing	incentivize	VERB
ihlr-28381	349	16	drug	drug	NOUN
ihlr-28381	349	17	affordability	affordability	NOUN
ihlr-28381	349	18	137	137	NUM
ihlr-28381	349	19	generic	generic	ADJ
ihlr-28381	349	20	developers	developer	NOUN
ihlr-28381	349	21	.	.	PUNCT
ihlr-28381	350	1	also	also	ADV
ihlr-28381	350	2	without	without	ADP
ihlr-28381	350	3	patent	patent	NOUN
ihlr-28381	350	4	protection	protection	NOUN
ihlr-28381	350	5	,	,	PUNCT
ihlr-28381	350	6	an	an	DET
ihlr-28381	350	7	innovator	innovator	NOUN
ihlr-28381	350	8	can	can	AUX
ihlr-28381	350	9	restrict	restrict	VERB
ihlr-28381	350	10	distribution	distribution	NOUN
ihlr-28381	350	11	of	of	ADP
ihlr-28381	350	12	the	the	DET
ihlr-28381	350	13	drug	drug	NOUN
ihlr-28381	350	14	itself	itself	PRON
ihlr-28381	350	15	to	to	PART
ihlr-28381	350	16	strain	strain	VERB
ihlr-28381	350	17	generic	generic	ADJ
ihlr-28381	350	18	developers	developer	NOUN
ihlr-28381	350	19	that	that	PRON
ihlr-28381	350	20	require	require	VERB
ihlr-28381	350	21	the	the	DET
ihlr-28381	350	22	reference	reference	NOUN
ihlr-28381	350	23	product	product	NOUN
ihlr-28381	350	24	as	as	ADP
ihlr-28381	350	25	a	a	DET
ihlr-28381	350	26	prerequisite	prerequisite	NOUN
ihlr-28381	350	27	to	to	ADP
ihlr-28381	350	28	fda	fda	PROPN
ihlr-28381	350	29	approval	approval	NOUN
ihlr-28381	350	30	.	.	PUNCT
ihlr-28381	351	1	each	each	DET
ihlr-28381	351	2	strategy	strategy	NOUN
ihlr-28381	351	3	burdens	burden	VERB
ihlr-28381	351	4	patients	patient	NOUN
ihlr-28381	351	5	and	and	CCONJ
ihlr-28381	351	6	the	the	DET
ihlr-28381	351	7	healthcare	healthcare	NOUN
ihlr-28381	351	8	system	system	NOUN
ihlr-28381	351	9	at	at	ADP
ihlr-28381	351	10	large	large	ADJ
ihlr-28381	351	11	with	with	ADP
ihlr-28381	351	12	higher	high	ADJ
ihlr-28381	351	13	prices	price	NOUN
ihlr-28381	351	14	and	and	CCONJ
ihlr-28381	351	15	lower	low	ADJ
ihlr-28381	351	16	access	access	NOUN
ihlr-28381	351	17	.	.	PUNCT
ihlr-28381	352	1	vi	vi	X
ihlr-28381	352	2	.	.	NOUN
ihlr-28381	352	3	analysis	analysis	NOUN
ihlr-28381	352	4	:	:	PUNCT
ihlr-28381	352	5	current	current	ADJ
ihlr-28381	352	6	approaches	approach	NOUN
ihlr-28381	352	7	fall	fall	VERB
ihlr-28381	352	8	short	short	ADJ
ihlr-28381	352	9	pay	pay	NOUN
ihlr-28381	352	10	-	-	PUNCT
ihlr-28381	352	11	for	for	ADP
ihlr-28381	352	12	-	-	PUNCT
ihlr-28381	352	13	delay	delay	NOUN
ihlr-28381	352	14	is	be	AUX
ihlr-28381	352	15	recognized	recognize	VERB
ihlr-28381	352	16	by	by	ADP
ihlr-28381	352	17	policymakers	policymaker	NOUN
ihlr-28381	352	18	as	as	ADP
ihlr-28381	352	19	a	a	DET
ihlr-28381	352	20	problem	problem	NOUN
ihlr-28381	352	21	.	.	PUNCT
ihlr-28381	353	1	however	however	ADV
ihlr-28381	353	2	,	,	PUNCT
ihlr-28381	353	3	the	the	DET
ihlr-28381	353	4	private	private	ADJ
ihlr-28381	353	5	firms	firm	NOUN
ihlr-28381	353	6	engaging	engage	VERB
ihlr-28381	353	7	in	in	ADP
ihlr-28381	353	8	the	the	DET
ihlr-28381	353	9	practice	practice	NOUN
ihlr-28381	353	10	are	be	AUX
ihlr-28381	353	11	nimbler	nimble	ADJ
ihlr-28381	353	12	than	than	ADP
ihlr-28381	353	13	the	the	DET
ihlr-28381	353	14	institutions	institution	NOUN
ihlr-28381	353	15	seeking	seek	VERB
ihlr-28381	353	16	to	to	PART
ihlr-28381	353	17	reign	reign	VERB
ihlr-28381	353	18	in	in	ADP
ihlr-28381	353	19	drug	drug	NOUN
ihlr-28381	353	20	prices	price	NOUN
ihlr-28381	353	21	.	.	PUNCT
ihlr-28381	354	1	the	the	DET
ihlr-28381	354	2	judiciary	judiciary	NOUN
ihlr-28381	354	3	and	and	CCONJ
ihlr-28381	354	4	the	the	DET
ihlr-28381	354	5	federal	federal	ADJ
ihlr-28381	354	6	legislature	legislature	NOUN
ihlr-28381	354	7	have	have	AUX
ihlr-28381	354	8	implemented	implement	VERB
ihlr-28381	354	9	and	and	CCONJ
ihlr-28381	354	10	proposed	propose	VERB
ihlr-28381	354	11	solutions	solution	NOUN
ihlr-28381	354	12	and	and	CCONJ
ihlr-28381	354	13	there	there	PRON
ihlr-28381	354	14	has	have	AUX
ihlr-28381	354	15	been	be	AUX
ihlr-28381	354	16	some	some	DET
ihlr-28381	354	17	effective	effective	ADJ
ihlr-28381	354	18	enforcement	enforcement	NOUN
ihlr-28381	354	19	,	,	PUNCT
ihlr-28381	354	20	but	but	CCONJ
ihlr-28381	354	21	no	no	DET
ihlr-28381	354	22	current	current	ADJ
ihlr-28381	354	23	or	or	CCONJ
ihlr-28381	354	24	proposed	propose	VERB
ihlr-28381	354	25	approach	approach	NOUN
ihlr-28381	354	26	is	be	AUX
ihlr-28381	354	27	dynamic	dynamic	ADJ
ihlr-28381	354	28	enough	enough	ADV
ihlr-28381	354	29	to	to	PART
ihlr-28381	354	30	attack	attack	VERB
ihlr-28381	354	31	the	the	DET
ihlr-28381	354	32	broad	broad	ADJ
ihlr-28381	354	33	practice	practice	NOUN
ihlr-28381	354	34	of	of	ADP
ihlr-28381	354	35	pay	pay	NOUN
ihlr-28381	354	36	-	-	PUNCT
ihlr-28381	354	37	for	for	ADP
ihlr-28381	354	38	-	-	PUNCT
ihlr-28381	354	39	delay	delay	NOUN
ihlr-28381	354	40	at	at	ADP
ihlr-28381	354	41	its	its	PRON
ihlr-28381	354	42	core	core	NOUN
ihlr-28381	354	43	.	.	PUNCT
ihlr-28381	355	1	a.	a.	NOUN
ihlr-28381	355	2	existing	exist	VERB
ihlr-28381	355	3	law	law	NOUN
ihlr-28381	355	4	:	:	PUNCT
ihlr-28381	355	5	ftc	ftc	PROPN
ihlr-28381	355	6	v.	v.	ADP
ihlr-28381	355	7	actavis	actavis	PROPN
ihlr-28381	355	8	the	the	DET
ihlr-28381	355	9	classic	classic	ADJ
ihlr-28381	355	10	iteration	iteration	NOUN
ihlr-28381	355	11	of	of	ADP
ihlr-28381	355	12	pay	pay	NOUN
ihlr-28381	355	13	-	-	PUNCT
ihlr-28381	355	14	for	for	ADP
ihlr-28381	355	15	-	-	PUNCT
ihlr-28381	355	16	delay	delay	NOUN
ihlr-28381	355	17	—	—	PUNCT
ihlr-28381	355	18	reverse	reverse	ADJ
ihlr-28381	355	19	payment	payment	NOUN
ihlr-28381	355	20	settlement	settlement	NOUN
ihlr-28381	355	21	agreements	agreement	NOUN
ihlr-28381	355	22	—	—	PUNCT
ihlr-28381	355	23	was	be	AUX
ihlr-28381	355	24	confronted	confront	VERB
ihlr-28381	355	25	by	by	ADP
ihlr-28381	355	26	the	the	DET
ihlr-28381	355	27	supreme	supreme	PROPN
ihlr-28381	355	28	court	court	PROPN
ihlr-28381	355	29	in	in	ADP
ihlr-28381	355	30	2013.86	2013.86	NUM
ihlr-28381	355	31	in	in	ADP
ihlr-28381	355	32	ftc	ftc	PROPN
ihlr-28381	355	33	v.	v.	ADP
ihlr-28381	355	34	actavis	actavis	PROPN
ihlr-28381	355	35	,	,	PUNCT
ihlr-28381	355	36	the	the	DET
ihlr-28381	355	37	ftc	ftc	PROPN
ihlr-28381	355	38	urged	urge	VERB
ihlr-28381	355	39	the	the	DET
ihlr-28381	355	40	supreme	supreme	PROPN
ihlr-28381	355	41	court	court	PROPN
ihlr-28381	355	42	to	to	PART
ihlr-28381	355	43	hold	hold	VERB
ihlr-28381	355	44	all	all	DET
ihlr-28381	355	45	reverse	reverse	ADJ
ihlr-28381	355	46	payment	payment	NOUN
ihlr-28381	355	47	settlements	settlement	NOUN
ihlr-28381	355	48	presumptively	presumptively	ADV
ihlr-28381	355	49	unlawful.87	unlawful.87	VERB
ihlr-28381	355	50	actavis	actavis	PROPN
ihlr-28381	355	51	recommended	recommend	VERB
ihlr-28381	355	52	an	an	DET
ihlr-28381	355	53	opposite	opposite	ADJ
ihlr-28381	355	54	stance	stance	NOUN
ihlr-28381	355	55	,	,	PUNCT
ihlr-28381	355	56	asserting	assert	VERB
ihlr-28381	355	57	that	that	SCONJ
ihlr-28381	355	58	reverse	reverse	ADJ
ihlr-28381	355	59	payment	payment	NOUN
ihlr-28381	355	60	settlements	settlement	NOUN
ihlr-28381	355	61	should	should	AUX
ihlr-28381	355	62	be	be	AUX
ihlr-28381	355	63	immune	immune	ADJ
ihlr-28381	355	64	from	from	ADP
ihlr-28381	355	65	antitrust	antitrust	ADJ
ihlr-28381	355	66	liability	liability	NOUN
ihlr-28381	355	67	as	as	ADV
ihlr-28381	355	68	long	long	ADV
ihlr-28381	355	69	as	as	SCONJ
ihlr-28381	355	70	the	the	DET
ihlr-28381	355	71	settlement	settlement	NOUN
ihlr-28381	355	72	’s	’s	PART
ihlr-28381	355	73	anti	anti	ADJ
ihlr-28381	355	74	-	-	ADJ
ihlr-28381	355	75	competitive	competitive	ADJ
ihlr-28381	355	76	effects	effect	NOUN
ihlr-28381	355	77	fell	fall	VERB
ihlr-28381	355	78	within	within	ADP
ihlr-28381	355	79	the	the	DET
ihlr-28381	355	80	exclusionary	exclusionary	ADJ
ihlr-28381	355	81	scope	scope	NOUN
ihlr-28381	355	82	of	of	ADP
ihlr-28381	355	83	the	the	DET
ihlr-28381	355	84	patent.88	patent.88	NOUN
ihlr-28381	355	85	the	the	DET
ihlr-28381	355	86	court	court	NOUN
ihlr-28381	355	87	declined	decline	VERB
ihlr-28381	355	88	to	to	PART
ihlr-28381	355	89	adopt	adopt	VERB
ihlr-28381	355	90	either	either	CCONJ
ihlr-28381	355	91	position	position	NOUN
ihlr-28381	355	92	and	and	CCONJ
ihlr-28381	355	93	instead	instead	ADV
ihlr-28381	355	94	established	establish	VERB
ihlr-28381	355	95	a	a	DET
ihlr-28381	355	96	“	"	PUNCT
ihlr-28381	355	97	rule	rule	NOUN
ihlr-28381	355	98	of	of	ADP
ihlr-28381	355	99	reason	reason	NOUN
ihlr-28381	355	100	”	"	PUNCT
ihlr-28381	355	101	test.89	test.89	NOUN
ihlr-28381	355	102	when	when	SCONJ
ihlr-28381	355	103	applying	apply	VERB
ihlr-28381	355	104	the	the	DET
ihlr-28381	355	105	test	test	NOUN
ihlr-28381	355	106	,	,	PUNCT
ihlr-28381	355	107	courts	court	NOUN
ihlr-28381	355	108	weigh	weigh	VERB
ihlr-28381	355	109	the	the	DET
ihlr-28381	355	110	anticompetitive	anticompetitive	ADJ
ihlr-28381	355	111	effects	effect	NOUN
ihlr-28381	355	112	of	of	ADP
ihlr-28381	355	113	a	a	DET
ihlr-28381	355	114	reverse	reverse	ADJ
ihlr-28381	355	115	payment	payment	NOUN
ihlr-28381	355	116	settlement	settlement	NOUN
ihlr-28381	355	117	against	against	ADP
ihlr-28381	355	118	any	any	DET
ihlr-28381	355	119	pro	pro	ADJ
ihlr-28381	355	120	-	-	ADJ
ihlr-28381	355	121	competitive	competitive	ADJ
ihlr-28381	355	122	justifications	justification	NOUN
ihlr-28381	355	123	,	,	PUNCT
ihlr-28381	355	124	evaluating	evaluate	VERB
ihlr-28381	355	125	the	the	DET
ihlr-28381	355	126	agreements	agreement	NOUN
ihlr-28381	355	127	on	on	ADP
ihlr-28381	355	128	a	a	DET
ihlr-28381	355	129	case	case	NOUN
ihlr-28381	355	130	-	-	PUNCT
ihlr-28381	355	131	by	by	ADP
ihlr-28381	355	132	-	-	PUNCT
ihlr-28381	355	133	case	case	NOUN
ihlr-28381	355	134	basis.90	basis.90	NOUN
ihlr-28381	355	135	thus	thus	ADV
ihlr-28381	355	136	,	,	PUNCT
ihlr-28381	355	137	reverse	reverse	VERB
ihlr-28381	355	138	payment	payment	NOUN
ihlr-28381	355	139	settlements	settlement	NOUN
ihlr-28381	355	140	in	in	ADP
ihlr-28381	355	141	patent	patent	NOUN
ihlr-28381	355	142	infringement	infringement	NOUN
ihlr-28381	355	143	suits	suit	NOUN
ihlr-28381	355	144	are	be	AUX
ihlr-28381	355	145	neither	neither	CCONJ
ihlr-28381	355	146	immune	immune	ADJ
ihlr-28381	355	147	from	from	ADP
ihlr-28381	355	148	antitrust	antitrust	ADJ
ihlr-28381	355	149	attack	attack	NOUN
ihlr-28381	355	150	,	,	PUNCT
ihlr-28381	355	151	nor	nor	CCONJ
ihlr-28381	355	152	presumptively	presumptively	ADV
ihlr-28381	355	153	unlawful.91	unlawful.91	PRON
ihlr-28381	355	154	the	the	DET
ihlr-28381	355	155	5	5	NUM
ihlr-28381	355	156	-	-	SYM
ihlr-28381	355	157	3	3	NUM
ihlr-28381	355	158	decision	decision	NOUN
ihlr-28381	355	159	stated	state	VERB
ihlr-28381	355	160	considerations	consideration	NOUN
ihlr-28381	355	161	relevant	relevant	ADJ
ihlr-28381	355	162	to	to	ADP
ihlr-28381	355	163	the	the	DET
ihlr-28381	355	164	determination	determination	NOUN
ihlr-28381	355	165	of	of	ADP
ihlr-28381	355	166	an	an	DET
ihlr-28381	355	167	agreement	agreement	NOUN
ihlr-28381	355	168	’s	’s	PART
ihlr-28381	355	169	antitrust	antitrust	ADJ
ihlr-28381	355	170	character	character	NOUN
ihlr-28381	355	171	while	while	SCONJ
ihlr-28381	355	172	also	also	ADV
ihlr-28381	355	173	navigating	navigate	VERB
ihlr-28381	355	174	considerations	consideration	NOUN
ihlr-28381	355	175	of	of	ADP
ihlr-28381	355	176	patent	patent	NOUN
ihlr-28381	355	177	law	law	NOUN
ihlr-28381	355	178	.	.	PUNCT
ihlr-28381	356	1	factors	factor	NOUN
ihlr-28381	356	2	indicative	indicative	ADJ
ihlr-28381	356	3	of	of	ADP
ihlr-28381	356	4	a	a	DET
ihlr-28381	356	5	pay	pay	VERB
ihlr-28381	356	6	-	-	PUNCT
ihlr-28381	356	7	for	for	ADP
ihlr-28381	356	8	-	-	PUNCT
ihlr-28381	356	9	delay	delay	NOUN
ihlr-28381	356	10	character	character	NOUN
ihlr-28381	356	11	importantly	importantly	ADV
ihlr-28381	356	12	include	include	VERB
ihlr-28381	356	13	the	the	DET
ihlr-28381	356	14	size	size	NOUN
ihlr-28381	356	15	of	of	ADP
ihlr-28381	356	16	the	the	DET
ihlr-28381	356	17	payment	payment	NOUN
ihlr-28381	356	18	,	,	PUNCT
ihlr-28381	356	19	as	as	SCONJ
ihlr-28381	356	20	a	a	DET
ihlr-28381	356	21	larger	large	ADJ
ihlr-28381	356	22	payment	payment	NOUN
ihlr-28381	356	23	may	may	AUX
ihlr-28381	356	24	suggest	suggest	VERB
ihlr-28381	356	25	a	a	DET
ihlr-28381	356	26	weaker	weak	ADJ
ihlr-28381	356	27	patent.92	patent.92	NOUN
ihlr-28381	356	28	attempting	attempt	VERB
ihlr-28381	356	29	to	to	PART
ihlr-28381	356	30	reconcile	reconcile	VERB
ihlr-28381	356	31	patent	patent	NOUN
ihlr-28381	356	32	rights	right	NOUN
ihlr-28381	356	33	with	with	ADP
ihlr-28381	356	34	antitrust	antitrust	ADJ
ihlr-28381	356	35	considerations	consideration	NOUN
ihlr-28381	356	36	,	,	PUNCT
ihlr-28381	356	37	the	the	DET
ihlr-28381	356	38	court	court	NOUN
ihlr-28381	356	39	stated	state	VERB
ihlr-28381	356	40	“	"	PUNCT
ihlr-28381	356	41	the	the	DET
ihlr-28381	356	42	size	size	NOUN
ihlr-28381	356	43	of	of	ADP
ihlr-28381	356	44	the	the	DET
ihlr-28381	356	45	unexplained	unexplained	ADJ
ihlr-28381	356	46	reverse	reverse	NOUN
ihlr-28381	356	47	payment	payment	NOUN
ihlr-28381	356	48	can	can	AUX
ihlr-28381	356	49	provide	provide	VERB
ihlr-28381	356	50	a	a	DET
ihlr-28381	356	51	workable	workable	ADJ
ihlr-28381	356	52	surrogate	surrogate	NOUN
ihlr-28381	356	53	for	for	ADP
ihlr-28381	356	54	a	a	DET
ihlr-28381	356	55	patent	patent	NOUN
ihlr-28381	356	56	's	's	PART
ihlr-28381	356	57	weakness	weakness	NOUN
ihlr-28381	356	58	,	,	PUNCT
ihlr-28381	356	59	all	all	ADV
ihlr-28381	356	60	without	without	ADP
ihlr-28381	356	61	forcing	force	VERB
ihlr-28381	356	62	a	a	DET
ihlr-28381	356	63	court	court	NOUN
ihlr-28381	356	64	to	to	PART
ihlr-28381	356	65	conduct	conduct	VERB
ihlr-28381	356	66	a	a	DET
ihlr-28381	356	67	detailed	detailed	ADJ
ihlr-28381	356	68	exploration	exploration	NOUN
ihlr-28381	356	69	of	of	ADP
ihlr-28381	356	70	the	the	DET
ihlr-28381	356	71	validity	validity	NOUN
ihlr-28381	356	72	of	of	ADP
ihlr-28381	356	73	the	the	DET
ihlr-28381	356	74	patent	patent	NOUN
ihlr-28381	356	75	itself	itself	PRON
ihlr-28381	356	76	.	.	PUNCT
ihlr-28381	357	1	”93	”93	ADV
ihlr-28381	357	2	another	another	DET
ihlr-28381	357	3	factor	factor	NOUN
ihlr-28381	357	4	is	be	AUX
ihlr-28381	357	5	the	the	DET
ihlr-28381	357	6	absence	absence	NOUN
ihlr-28381	357	7	of	of	ADP
ihlr-28381	357	8	an	an	DET
ihlr-28381	357	9	exchanged	exchange	VERB
ihlr-28381	357	10	service	service	NOUN
ihlr-28381	357	11	for	for	ADP
ihlr-28381	357	12	which	which	PRON
ihlr-28381	357	13	a	a	DET
ihlr-28381	357	14	large	large	ADJ
ihlr-28381	357	15	payment	payment	NOUN
ihlr-28381	357	16	may	may	AUX
ihlr-28381	357	17	be	be	AUX
ihlr-28381	357	18	compensation.94	compensation.94	VERB
ihlr-28381	357	19	by	by	ADP
ihlr-28381	357	20	applying	apply	VERB
ihlr-28381	357	21	this	this	DET
ihlr-28381	357	22	fact86	fact86	NOUN
ihlr-28381	357	23	.	.	PUNCT
ihlr-28381	358	1	see	see	VERB
ihlr-28381	358	2	ftc	ftc	PROPN
ihlr-28381	358	3	v.	v.	ADP
ihlr-28381	358	4	actavis	actavis	PROPN
ihlr-28381	358	5	,	,	PUNCT
ihlr-28381	358	6	inc	inc	PROPN
ihlr-28381	358	7	.	.	PROPN
ihlr-28381	358	8	,	,	PUNCT
ihlr-28381	358	9	570	570	NUM
ihlr-28381	358	10	u.s	u.s	PROPN
ihlr-28381	358	11	.	.	PROPN
ihlr-28381	358	12	136	136	NUM
ihlr-28381	358	13	,	,	PUNCT
ihlr-28381	358	14	141	141	NUM
ihlr-28381	358	15	(	(	PUNCT
ihlr-28381	358	16	2013	2013	NUM
ihlr-28381	358	17	)	)	PUNCT
ihlr-28381	358	18	.	.	PUNCT
ihlr-28381	359	1	87	87	NUM
ihlr-28381	359	2	.	.	PUNCT
ihlr-28381	360	1	i	i	PRON
ihlr-28381	360	2	d.	d.	PROPN
ihlr-28381	360	3	at	at	ADP
ihlr-28381	360	4	158	158	NUM
ihlr-28381	360	5	-	-	SYM
ihlr-28381	360	6	59	59	NUM
ihlr-28381	360	7	.	.	PUNCT
ihlr-28381	360	8	88	88	NUM
ihlr-28381	360	9	.	.	PUNCT
ihlr-28381	361	1	i	i	PRON
ihlr-28381	361	2	d.	d.	PROPN
ihlr-28381	361	3	89	89	NUM
ihlr-28381	361	4	.	.	PUNCT
ihlr-28381	362	1	i	i	PRON
ihlr-28381	362	2	d.	d.	PROPN
ihlr-28381	362	3	90	90	NUM
ihlr-28381	362	4	.	.	PUNCT
ihlr-28381	363	1	i	i	PRON
ihlr-28381	363	2	d.	d.	PROPN
ihlr-28381	363	3	at	at	ADP
ihlr-28381	363	4	159	159	NUM
ihlr-28381	363	5	.	.	PUNCT
ihlr-28381	363	6	91	91	NUM
ihlr-28381	363	7	.	.	PUNCT
ihlr-28381	364	1	i	i	PRON
ihlr-28381	364	2	d.	d.	PROPN
ihlr-28381	364	3	at	at	ADP
ihlr-28381	364	4	146	146	NUM
ihlr-28381	364	5	-	-	SYM
ihlr-28381	364	6	54	54	NUM
ihlr-28381	364	7	.	.	PUNCT
ihlr-28381	365	1	92	92	NUM
ihlr-28381	365	2	.	.	PUNCT
ihlr-28381	366	1	i	i	PRON
ihlr-28381	366	2	d.	d.	PROPN
ihlr-28381	366	3	at	at	ADP
ihlr-28381	366	4	158	158	NUM
ihlr-28381	366	5	.	.	PUNCT
ihlr-28381	367	1	93	93	NUM
ihlr-28381	367	2	.	.	PUNCT
ihlr-28381	368	1	i	i	PRON
ihlr-28381	368	2	d.	d.	PROPN
ihlr-28381	368	3	at	at	ADP
ihlr-28381	368	4	158	158	NUM
ihlr-28381	368	5	.	.	PUNCT
ihlr-28381	369	1	94	94	NUM
ihlr-28381	369	2	.	.	PUNCT
ihlr-28381	370	1	karas	karas	PROPN
ihlr-28381	370	2	et	et	PROPN
ihlr-28381	370	3	al	al	PROPN
ihlr-28381	370	4	.	.	PROPN
ihlr-28381	370	5	,	,	PUNCT
ihlr-28381	370	6	supra	supra	PROPN
ihlr-28381	370	7	note	note	VERB
ihlr-28381	370	8	50	50	NUM
ihlr-28381	370	9	,	,	PUNCT
ihlr-28381	370	10	at	at	ADP
ihlr-28381	370	11	963	963	NUM
ihlr-28381	370	12	.	.	PUNCT
ihlr-28381	371	1	138	138	NUM
ihlr-28381	371	2	indiana	indiana	PROPN
ihlr-28381	371	3	health	health	PROPN
ihlr-28381	371	4	law	law	PROPN
ihlr-28381	371	5	review	review	NOUN
ihlr-28381	371	6	[	[	X
ihlr-28381	371	7	vol	vol	NOUN
ihlr-28381	371	8	.	.	NOUN
ihlr-28381	371	9	21:121	21:121	NUM
ihlr-28381	371	10	specific	specific	ADJ
ihlr-28381	371	11	approach	approach	NOUN
ihlr-28381	371	12	,	,	PUNCT
ihlr-28381	371	13	there	there	PRON
ihlr-28381	371	14	is	be	VERB
ihlr-28381	371	15	a	a	DET
ihlr-28381	371	16	viable	viable	ADJ
ihlr-28381	371	17	avenue	avenue	NOUN
ihlr-28381	371	18	to	to	PART
ihlr-28381	371	19	attack	attack	VERB
ihlr-28381	371	20	egregious	egregious	ADJ
ihlr-28381	371	21	reverse	reverse	ADJ
ihlr-28381	371	22	payment	payment	NOUN
ihlr-28381	371	23	settlements	settlement	NOUN
ihlr-28381	371	24	.	.	PUNCT
ihlr-28381	372	1	of	of	ADP
ihlr-28381	372	2	course	course	ADV
ihlr-28381	372	3	,	,	PUNCT
ihlr-28381	372	4	the	the	DET
ihlr-28381	372	5	analysis	analysis	NOUN
ihlr-28381	372	6	also	also	ADV
ihlr-28381	372	7	presents	present	VERB
ihlr-28381	372	8	boxes	box	NOUN
ihlr-28381	372	9	to	to	PART
ihlr-28381	372	10	check	check	VERB
ihlr-28381	372	11	for	for	ADP
ihlr-28381	372	12	parties	party	NOUN
ihlr-28381	372	13	wishing	wish	VERB
ihlr-28381	372	14	to	to	PART
ihlr-28381	372	15	disguise	disguise	VERB
ihlr-28381	372	16	an	an	DET
ihlr-28381	372	17	anti	anti	ADJ
ihlr-28381	372	18	-	-	ADJ
ihlr-28381	372	19	competitive	competitive	ADJ
ihlr-28381	372	20	reverse	reverse	ADJ
ihlr-28381	372	21	payment	payment	NOUN
ihlr-28381	372	22	settlement	settlement	NOUN
ihlr-28381	372	23	.	.	PUNCT
ihlr-28381	373	1	commentators	commentator	NOUN
ihlr-28381	373	2	have	have	AUX
ihlr-28381	373	3	characterized	characterize	VERB
ihlr-28381	373	4	applications	application	NOUN
ihlr-28381	373	5	of	of	ADP
ihlr-28381	373	6	the	the	DET
ihlr-28381	373	7	rule	rule	NOUN
ihlr-28381	373	8	of	of	ADP
ihlr-28381	373	9	reason	reason	NOUN
ihlr-28381	373	10	test	test	NOUN
ihlr-28381	373	11	in	in	ADP
ihlr-28381	373	12	payfor	payfor	PROPN
ihlr-28381	373	13	-	-	PUNCT
ihlr-28381	373	14	delay	delay	NOUN
ihlr-28381	373	15	contexts	context	NOUN
ihlr-28381	373	16	as	as	SCONJ
ihlr-28381	373	17	“	"	PUNCT
ihlr-28381	373	18	notoriously	notoriously	ADV
ihlr-28381	373	19	convoluted	convoluted	ADJ
ihlr-28381	373	20	.	.	PUNCT
ihlr-28381	374	1	”95	”95	NOUN
ihlr-28381	374	2	this	this	DET
ihlr-28381	374	3	characterization	characterization	NOUN
ihlr-28381	374	4	draws	draw	VERB
ihlr-28381	374	5	support	support	NOUN
ihlr-28381	374	6	from	from	ADP
ihlr-28381	374	7	the	the	DET
ihlr-28381	374	8	dissenting	dissent	VERB
ihlr-28381	374	9	chief	chief	ADJ
ihlr-28381	374	10	justice	justice	NOUN
ihlr-28381	374	11	roberts	roberts	PROPN
ihlr-28381	374	12	,	,	PUNCT
ihlr-28381	374	13	who	who	PRON
ihlr-28381	374	14	wished	wish	VERB
ihlr-28381	374	15	“	"	PUNCT
ihlr-28381	374	16	good	good	ADJ
ihlr-28381	374	17	luck	luck	NOUN
ihlr-28381	374	18	to	to	ADP
ihlr-28381	374	19	the	the	DET
ihlr-28381	374	20	district	district	NOUN
ihlr-28381	374	21	courts	court	NOUN
ihlr-28381	374	22	that	that	PRON
ihlr-28381	374	23	must	must	AUX
ihlr-28381	374	24	,	,	PUNCT
ihlr-28381	374	25	when	when	SCONJ
ihlr-28381	374	26	faced	face	VERB
ihlr-28381	374	27	with	with	ADP
ihlr-28381	374	28	a	a	DET
ihlr-28381	374	29	patent	patent	NOUN
ihlr-28381	374	30	settlement	settlement	NOUN
ihlr-28381	374	31	,	,	PUNCT
ihlr-28381	374	32	weigh	weigh	VERB
ihlr-28381	374	33	the	the	DET
ihlr-28381	374	34	likely	likely	ADJ
ihlr-28381	374	35	anti	anti	ADJ
ihlr-28381	374	36	-	-	ADJ
ihlr-28381	374	37	competitive	competitive	ADJ
ihlr-28381	374	38	effects	effect	NOUN
ihlr-28381	374	39	,	,	PUNCT
ihlr-28381	374	40	redeeming	redeem	VERB
ihlr-28381	374	41	virtues	virtue	NOUN
ihlr-28381	374	42	,	,	PUNCT
ihlr-28381	374	43	market	market	NOUN
ihlr-28381	374	44	power	power	NOUN
ihlr-28381	374	45	,	,	PUNCT
ihlr-28381	374	46	and	and	CCONJ
ihlr-28381	374	47	potentially	potentially	ADV
ihlr-28381	374	48	offsetting	offset	VERB
ihlr-28381	374	49	legal	legal	ADJ
ihlr-28381	374	50	considerations	consideration	NOUN
ihlr-28381	374	51	present	present	ADJ
ihlr-28381	374	52	in	in	ADP
ihlr-28381	374	53	the	the	DET
ihlr-28381	374	54	circumstances	circumstance	NOUN
ihlr-28381	374	55	.	.	PUNCT
ihlr-28381	375	1	”96	”96	ADV
ihlr-28381	375	2	by	by	ADP
ihlr-28381	375	3	leaving	leave	VERB
ihlr-28381	375	4	room	room	NOUN
ihlr-28381	375	5	for	for	ADP
ihlr-28381	375	6	antitrust	antitrust	ADJ
ihlr-28381	375	7	liability	liability	NOUN
ihlr-28381	375	8	despite	despite	SCONJ
ihlr-28381	375	9	an	an	DET
ihlr-28381	375	10	existing	exist	VERB
ihlr-28381	375	11	patent	patent	NOUN
ihlr-28381	375	12	,	,	PUNCT
ihlr-28381	375	13	the	the	DET
ihlr-28381	375	14	5	5	NUM
ihlr-28381	375	15	-	-	SYM
ihlr-28381	375	16	3	3	NUM
ihlr-28381	375	17	ftc	ftc	PROPN
ihlr-28381	375	18	v.	v.	ADP
ihlr-28381	375	19	actavis	actavis	PROPN
ihlr-28381	375	20	opinion	opinion	NOUN
ihlr-28381	375	21	was	be	AUX
ihlr-28381	375	22	a	a	DET
ihlr-28381	375	23	step	step	NOUN
ihlr-28381	375	24	in	in	ADP
ihlr-28381	375	25	the	the	DET
ihlr-28381	375	26	direction	direction	NOUN
ihlr-28381	375	27	of	of	ADP
ihlr-28381	375	28	deterring	deter	VERB
ihlr-28381	375	29	pay	pay	NOUN
ihlr-28381	375	30	-	-	PUNCT
ihlr-28381	375	31	for	for	ADP
ihlr-28381	375	32	-	-	PUNCT
ihlr-28381	375	33	delay	delay	NOUN
ihlr-28381	375	34	.	.	PUNCT
ihlr-28381	376	1	indeed	indeed	ADV
ihlr-28381	376	2	,	,	PUNCT
ihlr-28381	376	3	the	the	DET
ihlr-28381	376	4	prevalence	prevalence	NOUN
ihlr-28381	376	5	of	of	ADP
ihlr-28381	376	6	reverse	reverse	ADJ
ihlr-28381	376	7	payment	payment	NOUN
ihlr-28381	376	8	settlements	settlement	NOUN
ihlr-28381	376	9	decreased	decrease	VERB
ihlr-28381	376	10	following	follow	VERB
ihlr-28381	376	11	the	the	DET
ihlr-28381	376	12	decision.97	decision.97	NOUN
ihlr-28381	376	13	ultimately	ultimately	ADV
ihlr-28381	376	14	,	,	PUNCT
ihlr-28381	376	15	however	however	ADV
ihlr-28381	376	16	,	,	PUNCT
ihlr-28381	376	17	the	the	DET
ihlr-28381	376	18	decision	decision	NOUN
ihlr-28381	376	19	accelerated	accelerate	VERB
ihlr-28381	376	20	a	a	DET
ihlr-28381	376	21	shift	shift	NOUN
ihlr-28381	376	22	to	to	ADP
ihlr-28381	376	23	alternatives	alternative	NOUN
ihlr-28381	376	24	like	like	ADP
ihlr-28381	376	25	citizen	citizen	NOUN
ihlr-28381	376	26	petitions	petition	NOUN
ihlr-28381	376	27	,	,	PUNCT
ihlr-28381	376	28	evergreening	evergreening	NOUN
ihlr-28381	376	29	,	,	PUNCT
ihlr-28381	376	30	product	product	NOUN
ihlr-28381	376	31	hopping	hopping	NOUN
ihlr-28381	376	32	,	,	PUNCT
ihlr-28381	376	33	and	and	CCONJ
ihlr-28381	376	34	supply	supply	NOUN
ihlr-28381	376	35	constraints	constraint	NOUN
ihlr-28381	376	36	.	.	PUNCT
ihlr-28381	377	1	further	far	ADV
ihlr-28381	377	2	,	,	PUNCT
ihlr-28381	377	3	the	the	DET
ihlr-28381	377	4	decision	decision	NOUN
ihlr-28381	377	5	caused	cause	VERB
ihlr-28381	377	6	parties	party	NOUN
ihlr-28381	377	7	to	to	PART
ihlr-28381	377	8	increase	increase	VERB
ihlr-28381	377	9	the	the	DET
ihlr-28381	377	10	complexity	complexity	NOUN
ihlr-28381	377	11	of	of	ADP
ihlr-28381	377	12	their	their	PRON
ihlr-28381	377	13	agreements	agreement	NOUN
ihlr-28381	377	14	and	and	CCONJ
ihlr-28381	377	15	therefore	therefore	ADV
ihlr-28381	377	16	the	the	DET
ihlr-28381	377	17	burden	burden	NOUN
ihlr-28381	377	18	of	of	ADP
ihlr-28381	377	19	proving	prove	VERB
ihlr-28381	377	20	illegality.98	illegality.98	ADV
ihlr-28381	377	21	since	since	SCONJ
ihlr-28381	377	22	1997	1997	NUM
ihlr-28381	377	23	(	(	PUNCT
ihlr-28381	377	24	the	the	DET
ihlr-28381	377	25	rule	rule	NOUN
ihlr-28381	377	26	of	of	ADP
ihlr-28381	377	27	reason	reason	NOUN
ihlr-28381	377	28	standard	standard	NOUN
ihlr-28381	377	29	has	have	AUX
ihlr-28381	377	30	applied	apply	VERB
ihlr-28381	377	31	to	to	ADP
ihlr-28381	377	32	other	other	ADJ
ihlr-28381	377	33	antitrust	antitrust	ADJ
ihlr-28381	377	34	issues	issue	NOUN
ihlr-28381	377	35	longer	long	ADV
ihlr-28381	377	36	than	than	SCONJ
ihlr-28381	377	37	it	it	PRON
ihlr-28381	377	38	has	have	AUX
ihlr-28381	377	39	applied	apply	VERB
ihlr-28381	377	40	to	to	PART
ihlr-28381	377	41	reverse	reverse	VERB
ihlr-28381	377	42	payment	payment	NOUN
ihlr-28381	377	43	settlements	settlement	NOUN
ihlr-28381	377	44	)	)	PUNCT
ihlr-28381	377	45	,	,	PUNCT
ihlr-28381	377	46	plaintiffs	plaintiff	NOUN
ihlr-28381	377	47	litigating	litigate	VERB
ihlr-28381	377	48	against	against	ADP
ihlr-28381	377	49	a	a	DET
ihlr-28381	377	50	rule	rule	NOUN
ihlr-28381	377	51	of	of	ADP
ihlr-28381	377	52	reason	reason	NOUN
ihlr-28381	377	53	standard	standard	NOUN
ihlr-28381	377	54	fail	fail	VERB
ihlr-28381	377	55	to	to	PART
ihlr-28381	377	56	show	show	VERB
ihlr-28381	377	57	a	a	DET
ihlr-28381	377	58	substantial	substantial	ADJ
ihlr-28381	377	59	anti	anti	ADJ
ihlr-28381	377	60	-	-	ADJ
ihlr-28381	377	61	competitive	competitive	ADJ
ihlr-28381	377	62	effect	effect	NOUN
ihlr-28381	377	63	90	90	NUM
ihlr-28381	377	64	%	%	NOUN
ihlr-28381	377	65	of	of	ADP
ihlr-28381	377	66	the	the	DET
ihlr-28381	377	67	time.99	time.99	PROPN
ihlr-28381	377	68	b.	b.	PROPN
ihlr-28381	377	69	proposed	propose	VERB
ihlr-28381	377	70	law	law	NOUN
ihlr-28381	377	71	many	many	ADJ
ihlr-28381	377	72	proposed	propose	VERB
ihlr-28381	377	73	legislative	legislative	ADJ
ihlr-28381	377	74	solutions	solution	NOUN
ihlr-28381	377	75	,	,	PUNCT
ihlr-28381	377	76	while	while	SCONJ
ihlr-28381	377	77	perhaps	perhaps	ADV
ihlr-28381	377	78	effectively	effectively	ADV
ihlr-28381	377	79	striking	strike	VERB
ihlr-28381	377	80	at	at	ADP
ihlr-28381	377	81	a	a	DET
ihlr-28381	377	82	specific	specific	ADJ
ihlr-28381	377	83	means	mean	NOUN
ihlr-28381	377	84	of	of	ADP
ihlr-28381	377	85	pay	pay	NOUN
ihlr-28381	377	86	-	-	PUNCT
ihlr-28381	377	87	for	for	ADP
ihlr-28381	377	88	-	-	PUNCT
ihlr-28381	377	89	delay	delay	NOUN
ihlr-28381	377	90	,	,	PUNCT
ihlr-28381	377	91	are	be	AUX
ihlr-28381	377	92	unlikely	unlikely	ADJ
ihlr-28381	377	93	more	more	ADJ
ihlr-28381	377	94	than	than	ADP
ihlr-28381	377	95	band	band	NOUN
ihlr-28381	377	96	-	-	PUNCT
ihlr-28381	377	97	aid	aid	NOUN
ihlr-28381	377	98	solutions	solution	NOUN
ihlr-28381	377	99	.	.	PUNCT
ihlr-28381	378	1	the	the	DET
ihlr-28381	378	2	preserve	preserve	NOUN
ihlr-28381	378	3	access	access	NOUN
ihlr-28381	378	4	to	to	ADP
ihlr-28381	378	5	affordable	affordable	ADJ
ihlr-28381	378	6	generics	generic	NOUN
ihlr-28381	378	7	and	and	CCONJ
ihlr-28381	378	8	biosimilars	biosimilars	PROPN
ihlr-28381	378	9	act	act	PROPN
ihlr-28381	378	10	(	(	PUNCT
ihlr-28381	378	11	“	"	PUNCT
ihlr-28381	378	12	paagba	paagba	NOUN
ihlr-28381	378	13	”	"	PUNCT
ihlr-28381	378	14	)	)	PUNCT
ihlr-28381	378	15	is	be	AUX
ihlr-28381	378	16	one	one	NUM
ihlr-28381	378	17	such	such	ADJ
ihlr-28381	378	18	proposal	proposal	NOUN
ihlr-28381	378	19	that	that	PRON
ihlr-28381	378	20	is	be	AUX
ihlr-28381	378	21	emblematic	emblematic	ADJ
ihlr-28381	378	22	of	of	ADP
ihlr-28381	378	23	the	the	DET
ihlr-28381	378	24	disadvantage	disadvantage	NOUN
ihlr-28381	378	25	associated	associate	VERB
ihlr-28381	378	26	with	with	ADP
ihlr-28381	378	27	current	current	ADJ
ihlr-28381	378	28	legislative	legislative	ADJ
ihlr-28381	378	29	approaches	approach	NOUN
ihlr-28381	378	30	to	to	ADP
ihlr-28381	378	31	the	the	DET
ihlr-28381	378	32	problem	problem	NOUN
ihlr-28381	378	33	.	.	PUNCT
ihlr-28381	379	1	while	while	SCONJ
ihlr-28381	379	2	pay	pay	VERB
ihlr-28381	379	3	-	-	PUNCT
ihlr-28381	379	4	for	for	ADP
ihlr-28381	379	5	-	-	PUNCT
ihlr-28381	379	6	delay	delay	NOUN
ihlr-28381	379	7	parties	party	NOUN
ihlr-28381	379	8	can	can	AUX
ihlr-28381	379	9	nimbly	nimbly	ADV
ihlr-28381	379	10	adjust	adjust	VERB
ihlr-28381	379	11	tactics	tactic	NOUN
ihlr-28381	379	12	and	and	CCONJ
ihlr-28381	379	13	employ	employ	VERB
ihlr-28381	379	14	new	new	ADJ
ihlr-28381	379	15	strategies	strategy	NOUN
ihlr-28381	379	16	to	to	PART
ihlr-28381	379	17	disguise	disguise	VERB
ihlr-28381	379	18	and	and	CCONJ
ihlr-28381	379	19	sustain	sustain	VERB
ihlr-28381	379	20	anti	anti	ADJ
ihlr-28381	379	21	-	-	ADJ
ihlr-28381	379	22	competitive	competitive	ADJ
ihlr-28381	379	23	action	action	NOUN
ihlr-28381	379	24	,	,	PUNCT
ihlr-28381	379	25	policymakers	policymaker	NOUN
ihlr-28381	379	26	laboriously	laboriously	ADV
ihlr-28381	379	27	piece	piece	VERB
ihlr-28381	379	28	together	together	ADV
ihlr-28381	379	29	bills	bill	NOUN
ihlr-28381	379	30	aimed	aim	VERB
ihlr-28381	379	31	at	at	ADP
ihlr-28381	379	32	small	small	ADJ
ihlr-28381	379	33	targets	target	NOUN
ihlr-28381	379	34	and	and	CCONJ
ihlr-28381	379	35	which	which	PRON
ihlr-28381	379	36	rarely	rarely	ADV
ihlr-28381	379	37	graduate	graduate	VERB
ihlr-28381	379	38	from	from	ADP
ihlr-28381	379	39	legislative	legislative	ADJ
ihlr-28381	379	40	committees	committee	NOUN
ihlr-28381	379	41	.	.	PUNCT
ihlr-28381	380	1	the	the	DET
ihlr-28381	380	2	paagba	paagba	NOUN
ihlr-28381	380	3	,	,	PUNCT
ihlr-28381	380	4	if	if	SCONJ
ihlr-28381	380	5	enacted	enact	VERB
ihlr-28381	380	6	,	,	PUNCT
ihlr-28381	380	7	would	would	AUX
ihlr-28381	380	8	attack	attack	VERB
ihlr-28381	380	9	reverse	reverse	ADJ
ihlr-28381	380	10	payment	payment	NOUN
ihlr-28381	380	11	settlement	settlement	NOUN
ihlr-28381	380	12	agreements	agreement	NOUN
ihlr-28381	380	13	by	by	ADP
ihlr-28381	380	14	presuming	presume	VERB
ihlr-28381	380	15	an	an	DET
ihlr-28381	380	16	antitrust	antitrust	ADJ
ihlr-28381	380	17	violation	violation	NOUN
ihlr-28381	380	18	when	when	SCONJ
ihlr-28381	380	19	infringement	infringement	NOUN
ihlr-28381	380	20	suits	suit	NOUN
ihlr-28381	380	21	settle	settle	VERB
ihlr-28381	380	22	with	with	ADP
ihlr-28381	380	23	an	an	DET
ihlr-28381	380	24	exchange	exchange	NOUN
ihlr-28381	380	25	of	of	ADP
ihlr-28381	380	26	value	value	NOUN
ihlr-28381	380	27	resulting	result	VERB
ihlr-28381	380	28	in	in	ADP
ihlr-28381	380	29	an	an	DET
ihlr-28381	380	30	anda	anda	PROPN
ihlr-28381	380	31	filer	filer	NOUN
ihlr-28381	380	32	agreeing	agree	VERB
ihlr-28381	380	33	to	to	PART
ihlr-28381	380	34	“	"	PUNCT
ihlr-28381	380	35	limit	limit	VERB
ihlr-28381	380	36	or	or	CCONJ
ihlr-28381	380	37	forgo	forgo	VERB
ihlr-28381	380	38	research	research	NOUN
ihlr-28381	380	39	,	,	PUNCT
ihlr-28381	380	40	development	development	NOUN
ihlr-28381	380	41	,	,	PUNCT
ihlr-28381	380	42	manufacturing	manufacturing	NOUN
ihlr-28381	380	43	,	,	PUNCT
ihlr-28381	380	44	marketing	marketing	NOUN
ihlr-28381	380	45	,	,	PUNCT
ihlr-28381	380	46	or	or	CCONJ
ihlr-28381	380	47	sales	sale	NOUN
ihlr-28381	380	48	of	of	ADP
ihlr-28381	380	49	the	the	DET
ihlr-28381	380	50	anda	anda	PROPN
ihlr-28381	380	51	product	product	NOUN
ihlr-28381	380	52	or	or	CCONJ
ihlr-28381	380	53	biosimilar	biosimilar	ADJ
ihlr-28381	380	54	biological	biological	ADJ
ihlr-28381	380	55	product	product	NOUN
ihlr-28381	380	56	,	,	PUNCT
ihlr-28381	380	57	as	as	ADP
ihlr-28381	380	58	applicable	applicable	ADJ
ihlr-28381	380	59	,	,	PUNCT
ihlr-28381	380	60	for	for	ADP
ihlr-28381	380	61	any	any	DET
ihlr-28381	380	62	period	period	NOUN
ihlr-28381	380	63	of	of	ADP
ihlr-28381	380	64	time	time	NOUN
ihlr-28381	380	65	.	.	PUNCT
ihlr-28381	380	66	”100	”100	PUNCT
ihlr-28381	381	1	essentially	essentially	ADV
ihlr-28381	381	2	,	,	PUNCT
ihlr-28381	381	3	the	the	DET
ihlr-28381	381	4	paagba	paagba	NOUN
ihlr-28381	381	5	would	would	AUX
ihlr-28381	381	6	skirt	skirt	VERB
ihlr-28381	381	7	the	the	DET
ihlr-28381	381	8	burden	burden	NOUN
ihlr-28381	381	9	imposed	impose	VERB
ihlr-28381	381	10	by	by	ADP
ihlr-28381	381	11	the	the	DET
ihlr-28381	381	12	supreme	supreme	PROPN
ihlr-28381	381	13	court	court	PROPN
ihlr-28381	381	14	in	in	ADP
ihlr-28381	381	15	ftc	ftc	PROPN
ihlr-28381	381	16	v.	v.	ADP
ihlr-28381	381	17	actavis	actavis	PROPN
ihlr-28381	381	18	of	of	ADP
ihlr-28381	381	19	proving	prove	VERB
ihlr-28381	381	20	anti	anti	ADJ
ihlr-28381	381	21	-	-	ADJ
ihlr-28381	381	22	competitive	competitive	ADJ
ihlr-28381	381	23	conduct	conduct	NOUN
ihlr-28381	381	24	under	under	ADP
ihlr-28381	381	25	the	the	DET
ihlr-28381	381	26	rule	rule	NOUN
ihlr-28381	381	27	of	of	ADP
ihlr-28381	381	28	reason	reason	NOUN
ihlr-28381	381	29	95	95	NUM
ihlr-28381	381	30	.	.	PUNCT
ihlr-28381	382	1	feldman	feldman	PROPN
ihlr-28381	382	2	,	,	PUNCT
ihlr-28381	382	3	supra	supra	PROPN
ihlr-28381	382	4	note	note	PROPN
ihlr-28381	382	5	10	10	NUM
ihlr-28381	382	6	,	,	PUNCT
ihlr-28381	382	7	at	at	ADP
ihlr-28381	382	8	13	13	NUM
ihlr-28381	382	9	.	.	PUNCT
ihlr-28381	382	10	96	96	NUM
ihlr-28381	382	11	.	.	PUNCT
ihlr-28381	383	1	actavis	actavis	PROPN
ihlr-28381	383	2	,	,	PUNCT
ihlr-28381	383	3	inc	inc	PROPN
ihlr-28381	383	4	.	.	PROPN
ihlr-28381	383	5	,	,	PUNCT
ihlr-28381	383	6	570	570	NUM
ihlr-28381	383	7	u.s	u.s	PROPN
ihlr-28381	383	8	.	.	PROPN
ihlr-28381	383	9	at	at	ADP
ihlr-28381	383	10	173	173	NUM
ihlr-28381	383	11	.	.	PUNCT
ihlr-28381	383	12	97	97	NUM
ihlr-28381	383	13	.	.	PUNCT
ihlr-28381	384	1	karas	karas	PROPN
ihlr-28381	384	2	et	et	PROPN
ihlr-28381	384	3	al	al	PROPN
ihlr-28381	384	4	.	.	PROPN
ihlr-28381	384	5	,	,	PUNCT
ihlr-28381	384	6	supra	supra	PROPN
ihlr-28381	384	7	note	note	VERB
ihlr-28381	384	8	50	50	NUM
ihlr-28381	384	9	,	,	PUNCT
ihlr-28381	384	10	at	at	ADP
ihlr-28381	384	11	964	964	NUM
ihlr-28381	384	12	.	.	PUNCT
ihlr-28381	385	1	98	98	NUM
ihlr-28381	385	2	.	.	PUNCT
ihlr-28381	386	1	feldman	feldman	PROPN
ihlr-28381	386	2	,	,	PUNCT
ihlr-28381	386	3	supra	supra	PROPN
ihlr-28381	386	4	note	note	PROPN
ihlr-28381	386	5	10	10	NUM
ihlr-28381	386	6	,	,	PUNCT
ihlr-28381	386	7	at	at	ADP
ihlr-28381	386	8	15	15	NUM
ihlr-28381	386	9	.	.	PUNCT
ihlr-28381	386	10	99	99	NUM
ihlr-28381	386	11	.	.	PUNCT
ihlr-28381	387	1	ncaa	ncaa	PROPN
ihlr-28381	388	1	v.	v.	PROPN
ihlr-28381	388	2	alston	alston	PROPN
ihlr-28381	388	3	,	,	PUNCT
ihlr-28381	388	4	141	141	NUM
ihlr-28381	388	5	s.	s.	PROPN
ihlr-28381	388	6	ct	ct	PROPN
ihlr-28381	388	7	.	.	PROPN
ihlr-28381	388	8	2141	2141	NUM
ihlr-28381	388	9	,	,	PUNCT
ihlr-28381	388	10	2161	2161	NUM
ihlr-28381	388	11	(	(	PUNCT
ihlr-28381	388	12	2021	2021	NUM
ihlr-28381	388	13	)	)	PUNCT
ihlr-28381	388	14	.	.	PUNCT
ihlr-28381	389	1	100	100	NUM
ihlr-28381	389	2	.	.	X
ihlr-28381	390	1	preserve	preserve	VERB
ihlr-28381	390	2	access	access	NOUN
ihlr-28381	390	3	to	to	ADP
ihlr-28381	390	4	affordable	affordable	ADJ
ihlr-28381	390	5	generics	generic	NOUN
ihlr-28381	390	6	and	and	CCONJ
ihlr-28381	390	7	biosimilars	biosimilars	PROPN
ihlr-28381	390	8	act	act	PROPN
ihlr-28381	390	9	,	,	PUNCT
ihlr-28381	390	10	s.	s.	PROPN
ihlr-28381	390	11	1428	1428	NUM
ihlr-28381	390	12	,	,	PUNCT
ihlr-28381	390	13	117th	117th	ADJ
ihlr-28381	390	14	cong	cong	NOUN
ihlr-28381	390	15	.	.	PUNCT
ihlr-28381	391	1	§	§	PROPN
ihlr-28381	391	2	27(a)(2)(a)(ii	27(a)(2)(a)(ii	NUM
ihlr-28381	391	3	)	)	PUNCT
ihlr-28381	391	4	(	(	PUNCT
ihlr-28381	391	5	as	as	SCONJ
ihlr-28381	391	6	reported	report	VERB
ihlr-28381	391	7	in	in	ADP
ihlr-28381	391	8	the	the	DET
ihlr-28381	391	9	senate	senate	PROPN
ihlr-28381	391	10	,	,	PUNCT
ihlr-28381	391	11	dec	dec	PROPN
ihlr-28381	391	12	.	.	PROPN
ihlr-28381	391	13	9	9	NUM
ihlr-28381	391	14	,	,	PUNCT
ihlr-28381	391	15	2021	2021	NUM
ihlr-28381	391	16	)	)	PUNCT
ihlr-28381	391	17	.	.	PUNCT
ihlr-28381	392	1	2024	2024	NUM
ihlr-28381	392	2	]	]	PUNCT
ihlr-28381	392	3	incentivizing	incentivize	VERB
ihlr-28381	392	4	drug	drug	NOUN
ihlr-28381	392	5	affordability	affordability	NOUN
ihlr-28381	392	6	139	139	NUM
ihlr-28381	392	7	test.101	test.101	PROPN
ihlr-28381	392	8	defendants	defendant	NOUN
ihlr-28381	392	9	would	would	AUX
ihlr-28381	392	10	then	then	ADV
ihlr-28381	392	11	be	be	AUX
ihlr-28381	392	12	tasked	task	VERB
ihlr-28381	392	13	with	with	ADP
ihlr-28381	392	14	rebutting	rebut	VERB
ihlr-28381	392	15	the	the	DET
ihlr-28381	392	16	anti	anti	ADJ
ihlr-28381	392	17	-	-	ADJ
ihlr-28381	392	18	competitive	competitive	ADJ
ihlr-28381	392	19	presumption	presumption	NOUN
ihlr-28381	392	20	by	by	ADP
ihlr-28381	392	21	clear	clear	ADJ
ihlr-28381	392	22	and	and	CCONJ
ihlr-28381	392	23	convincing	convincing	ADJ
ihlr-28381	392	24	evidence	evidence	NOUN
ihlr-28381	392	25	.	.	PUNCT
ihlr-28381	393	1	a	a	DET
ihlr-28381	393	2	legal	legal	ADJ
ihlr-28381	393	3	,	,	PUNCT
ihlr-28381	393	4	and	and	CCONJ
ihlr-28381	393	5	in	in	ADP
ihlr-28381	393	6	effect	effect	NOUN
ihlr-28381	393	7	political	political	ADJ
ihlr-28381	393	8	obstacle	obstacle	NOUN
ihlr-28381	393	9	to	to	ADP
ihlr-28381	393	10	the	the	DET
ihlr-28381	393	11	proposed	propose	VERB
ihlr-28381	393	12	paagba	paagba	NOUN
ihlr-28381	393	13	arises	arise	VERB
ihlr-28381	393	14	in	in	ADP
ihlr-28381	393	15	the	the	DET
ihlr-28381	393	16	necessary	necessary	ADJ
ihlr-28381	393	17	juxtaposition	juxtaposition	NOUN
ihlr-28381	393	18	of	of	ADP
ihlr-28381	393	19	patent	patent	NOUN
ihlr-28381	393	20	law	law	NOUN
ihlr-28381	393	21	with	with	ADP
ihlr-28381	393	22	antitrust	antitrust	ADJ
ihlr-28381	393	23	law	law	NOUN
ihlr-28381	393	24	.	.	PUNCT
ihlr-28381	394	1	in	in	ADP
ihlr-28381	394	2	contrast	contrast	NOUN
ihlr-28381	394	3	to	to	ADP
ihlr-28381	394	4	ftc	ftc	PROPN
ihlr-28381	394	5	v.	v.	ADP
ihlr-28381	394	6	actavis	actavis	PROPN
ihlr-28381	394	7	,	,	PUNCT
ihlr-28381	394	8	which	which	PRON
ihlr-28381	394	9	struck	strike	VERB
ihlr-28381	394	10	a	a	DET
ihlr-28381	394	11	balance	balance	NOUN
ihlr-28381	394	12	between	between	ADP
ihlr-28381	394	13	patent	patent	NOUN
ihlr-28381	394	14	and	and	CCONJ
ihlr-28381	394	15	antitrust	antitrust	ADJ
ihlr-28381	394	16	considerations	consideration	NOUN
ihlr-28381	394	17	,	,	PUNCT
ihlr-28381	394	18	the	the	DET
ihlr-28381	394	19	paagba	paagba	NOUN
ihlr-28381	394	20	would	would	AUX
ihlr-28381	394	21	value	value	VERB
ihlr-28381	394	22	antitrust	antitrust	ADJ
ihlr-28381	394	23	risk	risk	NOUN
ihlr-28381	394	24	above	above	ADP
ihlr-28381	394	25	patent	patent	NOUN
ihlr-28381	394	26	rights	right	NOUN
ihlr-28381	394	27	.	.	PUNCT
ihlr-28381	395	1	patents	patent	NOUN
ihlr-28381	395	2	essentially	essentially	ADV
ihlr-28381	395	3	confer	confer	VERB
ihlr-28381	395	4	antitrust	antitrust	ADJ
ihlr-28381	395	5	immunity	immunity	NOUN
ihlr-28381	395	6	to	to	ADP
ihlr-28381	395	7	their	their	PRON
ihlr-28381	395	8	holder	holder	NOUN
ihlr-28381	395	9	by	by	ADP
ihlr-28381	395	10	granting	grant	VERB
ihlr-28381	395	11	a	a	DET
ihlr-28381	395	12	temporary	temporary	ADJ
ihlr-28381	395	13	,	,	PUNCT
ihlr-28381	395	14	legal	legal	ADJ
ihlr-28381	395	15	monopoly,102	monopoly,102	NOUN
ihlr-28381	395	16	and	and	CCONJ
ihlr-28381	395	17	patents	patent	NOUN
ihlr-28381	395	18	“	"	PUNCT
ihlr-28381	395	19	shall	shall	AUX
ihlr-28381	395	20	be	be	AUX
ihlr-28381	395	21	presumed	presume	VERB
ihlr-28381	395	22	valid	valid	ADJ
ihlr-28381	395	23	”	"	PUNCT
ihlr-28381	395	24	with	with	ADP
ihlr-28381	395	25	the	the	DET
ihlr-28381	395	26	burden	burden	NOUN
ihlr-28381	395	27	of	of	ADP
ihlr-28381	395	28	establishing	establish	VERB
ihlr-28381	395	29	invalidity	invalidity	NOUN
ihlr-28381	395	30	“	"	PUNCT
ihlr-28381	395	31	on	on	ADP
ihlr-28381	395	32	the	the	DET
ihlr-28381	395	33	party	party	NOUN
ihlr-28381	395	34	asserting	assert	VERB
ihlr-28381	395	35	such	such	ADJ
ihlr-28381	395	36	invalidity	invalidity	NOUN
ihlr-28381	395	37	.	.	PUNCT
ihlr-28381	395	38	”103	”103	PUNCT
ihlr-28381	395	39	because	because	SCONJ
ihlr-28381	395	40	a	a	DET
ihlr-28381	395	41	patent	patent	NOUN
ihlr-28381	395	42	may	may	AUX
ihlr-28381	395	43	constructively	constructively	ADV
ihlr-28381	395	44	immunize	immunize	VERB
ihlr-28381	395	45	its	its	PRON
ihlr-28381	395	46	holder	holder	NOUN
ihlr-28381	395	47	against	against	ADP
ihlr-28381	395	48	antitrust	antitrust	ADJ
ihlr-28381	395	49	liability	liability	NOUN
ihlr-28381	395	50	,	,	PUNCT
ihlr-28381	395	51	the	the	DET
ihlr-28381	395	52	paagba	paagba	NOUN
ihlr-28381	395	53	’s	’s	PART
ihlr-28381	395	54	presumption	presumption	NOUN
ihlr-28381	395	55	of	of	ADP
ihlr-28381	395	56	antitrust	antitrust	ADJ
ihlr-28381	395	57	behavior	behavior	NOUN
ihlr-28381	395	58	necessarily	necessarily	ADV
ihlr-28381	395	59	requires	require	VERB
ihlr-28381	395	60	a	a	DET
ihlr-28381	395	61	simultaneous	simultaneous	ADJ
ihlr-28381	395	62	presumption	presumption	NOUN
ihlr-28381	395	63	of	of	ADP
ihlr-28381	395	64	the	the	DET
ihlr-28381	395	65	patent	patent	NOUN
ihlr-28381	395	66	’s	’s	PART
ihlr-28381	395	67	invalidity	invalidity	NOUN
ihlr-28381	395	68	.	.	PUNCT
ihlr-28381	396	1	due	due	ADP
ihlr-28381	396	2	to	to	ADP
ihlr-28381	396	3	the	the	DET
ihlr-28381	396	4	suspicious	suspicious	ADJ
ihlr-28381	396	5	nature	nature	NOUN
ihlr-28381	396	6	of	of	ADP
ihlr-28381	396	7	reverse	reverse	ADJ
ihlr-28381	396	8	payment	payment	NOUN
ihlr-28381	396	9	settlements	settlement	NOUN
ihlr-28381	396	10	,	,	PUNCT
ihlr-28381	396	11	the	the	DET
ihlr-28381	396	12	supreme	supreme	PROPN
ihlr-28381	396	13	court	court	PROPN
ihlr-28381	396	14	in	in	ADP
ihlr-28381	396	15	actavis	actavis	PROPN
ihlr-28381	396	16	allowed	allow	VERB
ihlr-28381	396	17	antitrust	antitrust	ADJ
ihlr-28381	396	18	claims	claim	NOUN
ihlr-28381	396	19	to	to	PART
ihlr-28381	396	20	proceed	proceed	VERB
ihlr-28381	396	21	through	through	ADP
ihlr-28381	396	22	a	a	DET
ihlr-28381	396	23	rule	rule	NOUN
ihlr-28381	396	24	of	of	ADP
ihlr-28381	396	25	reason	reason	NOUN
ihlr-28381	396	26	test	test	NOUN
ihlr-28381	396	27	notwithstanding	notwithstanding	ADP
ihlr-28381	396	28	presumed	presume	VERB
ihlr-28381	396	29	patent	patent	NOUN
ihlr-28381	396	30	validity	validity	NOUN
ihlr-28381	396	31	but	but	CCONJ
ihlr-28381	396	32	rejected	reject	VERB
ihlr-28381	396	33	the	the	DET
ihlr-28381	396	34	ftc	ftc	PROPN
ihlr-28381	396	35	’s	’s	PART
ihlr-28381	396	36	position	position	NOUN
ihlr-28381	396	37	that	that	SCONJ
ihlr-28381	396	38	illegality	illegality	NOUN
ihlr-28381	396	39	of	of	ADP
ihlr-28381	396	40	reverse	reverse	ADJ
ihlr-28381	396	41	payment	payment	NOUN
ihlr-28381	396	42	settlements	settlement	NOUN
ihlr-28381	396	43	should	should	AUX
ihlr-28381	396	44	be	be	AUX
ihlr-28381	396	45	presumed.104	presumed.104	NOUN
ihlr-28381	396	46	while	while	SCONJ
ihlr-28381	396	47	actavis	actavis	PROPN
ihlr-28381	396	48	sought	seek	VERB
ihlr-28381	396	49	an	an	DET
ihlr-28381	396	50	equilibrium	equilibrium	NOUN
ihlr-28381	396	51	between	between	ADP
ihlr-28381	396	52	patent	patent	NOUN
ihlr-28381	396	53	and	and	CCONJ
ihlr-28381	396	54	antitrust	antitrust	ADJ
ihlr-28381	396	55	considerations	consideration	NOUN
ihlr-28381	396	56	,	,	PUNCT
ihlr-28381	396	57	the	the	DET
ihlr-28381	396	58	paagba	paagba	NOUN
ihlr-28381	396	59	would	would	AUX
ihlr-28381	396	60	summarily	summarily	ADV
ihlr-28381	396	61	override	override	VERB
ihlr-28381	396	62	patent	patent	NOUN
ihlr-28381	396	63	rights	right	NOUN
ihlr-28381	396	64	in	in	ADP
ihlr-28381	396	65	cases	case	NOUN
ihlr-28381	396	66	of	of	ADP
ihlr-28381	396	67	reverse	reverse	ADJ
ihlr-28381	396	68	payment	payment	NOUN
ihlr-28381	396	69	settlements	settlement	NOUN
ihlr-28381	396	70	.	.	PUNCT
ihlr-28381	397	1	such	such	DET
ihlr-28381	397	2	a	a	DET
ihlr-28381	397	3	departure	departure	NOUN
ihlr-28381	397	4	from	from	ADP
ihlr-28381	397	5	established	establish	VERB
ihlr-28381	397	6	treatment	treatment	NOUN
ihlr-28381	397	7	of	of	ADP
ihlr-28381	397	8	intellectual	intellectual	ADJ
ihlr-28381	397	9	property	property	NOUN
ihlr-28381	397	10	—	—	PUNCT
ihlr-28381	397	11	presuming	presume	VERB
ihlr-28381	397	12	antitrust	antitrust	ADJ
ihlr-28381	397	13	behavior	behavior	NOUN
ihlr-28381	397	14	,	,	PUNCT
ihlr-28381	397	15	effectively	effectively	ADV
ihlr-28381	397	16	presuming	presume	VERB
ihlr-28381	397	17	patent	patent	NOUN
ihlr-28381	397	18	invalidity	invalidity	NOUN
ihlr-28381	397	19	,	,	PUNCT
ihlr-28381	397	20	and	and	CCONJ
ihlr-28381	397	21	placing	place	VERB
ihlr-28381	397	22	the	the	DET
ihlr-28381	397	23	initial	initial	ADJ
ihlr-28381	397	24	burden	burden	NOUN
ihlr-28381	397	25	of	of	ADP
ihlr-28381	397	26	proof	proof	NOUN
ihlr-28381	397	27	on	on	ADP
ihlr-28381	397	28	the	the	DET
ihlr-28381	397	29	patent	patent	NOUN
ihlr-28381	397	30	holder	holder	NOUN
ihlr-28381	397	31	—	—	PUNCT
ihlr-28381	397	32	has	have	AUX
ihlr-28381	397	33	struggled	struggle	VERB
ihlr-28381	397	34	to	to	PART
ihlr-28381	397	35	gain	gain	VERB
ihlr-28381	397	36	traction	traction	NOUN
ihlr-28381	397	37	,	,	PUNCT
ihlr-28381	397	38	perhaps	perhaps	ADV
ihlr-28381	397	39	because	because	SCONJ
ihlr-28381	397	40	of	of	ADP
ihlr-28381	397	41	the	the	DET
ihlr-28381	397	42	reasonable	reasonable	ADJ
ihlr-28381	397	43	proposition	proposition	NOUN
ihlr-28381	397	44	that	that	SCONJ
ihlr-28381	397	45	the	the	DET
ihlr-28381	397	46	presumption	presumption	NOUN
ihlr-28381	397	47	of	of	ADP
ihlr-28381	397	48	validity	validity	NOUN
ihlr-28381	397	49	is	be	AUX
ihlr-28381	397	50	“	"	PUNCT
ihlr-28381	397	51	rightly	rightly	ADV
ihlr-28381	397	52	based	base	VERB
ihlr-28381	397	53	on	on	ADP
ihlr-28381	397	54	the	the	DET
ihlr-28381	397	55	expertise	expertise	NOUN
ihlr-28381	397	56	of	of	ADP
ihlr-28381	397	57	patent	patent	NOUN
ihlr-28381	397	58	examiners	examiner	NOUN
ihlr-28381	397	59	presumed	presume	VERB
ihlr-28381	397	60	to	to	PART
ihlr-28381	397	61	have	have	AUX
ihlr-28381	397	62	done	do	VERB
ihlr-28381	397	63	their	their	PRON
ihlr-28381	397	64	job	job	NOUN
ihlr-28381	397	65	.	.	PUNCT
ihlr-28381	397	66	”105	”105	ADJ
ihlr-28381	397	67	even	even	ADV
ihlr-28381	397	68	if	if	SCONJ
ihlr-28381	397	69	the	the	DET
ihlr-28381	397	70	paagba	paagba	NOUN
ihlr-28381	397	71	overcame	overcome	VERB
ihlr-28381	397	72	political	political	ADJ
ihlr-28381	397	73	and	and	CCONJ
ihlr-28381	397	74	interest	interest	NOUN
ihlr-28381	397	75	group	group	NOUN
ihlr-28381	397	76	opposition	opposition	NOUN
ihlr-28381	397	77	,	,	PUNCT
ihlr-28381	397	78	it	it	PRON
ihlr-28381	397	79	offers	offer	VERB
ihlr-28381	397	80	minimal	minimal	ADJ
ihlr-28381	397	81	benefit	benefit	NOUN
ihlr-28381	397	82	because	because	SCONJ
ihlr-28381	397	83	it	it	PRON
ihlr-28381	397	84	addresses	address	VERB
ihlr-28381	397	85	one	one	NUM
ihlr-28381	397	86	of	of	ADP
ihlr-28381	397	87	many	many	ADJ
ihlr-28381	397	88	techniques	technique	NOUN
ihlr-28381	397	89	used	use	VERB
ihlr-28381	397	90	to	to	PART
ihlr-28381	397	91	prolong	prolong	VERB
ihlr-28381	397	92	market	market	NOUN
ihlr-28381	397	93	exclusivity	exclusivity	NOUN
ihlr-28381	397	94	.	.	PUNCT
ihlr-28381	398	1	if	if	SCONJ
ihlr-28381	398	2	the	the	DET
ihlr-28381	398	3	risk	risk	NOUN
ihlr-28381	398	4	of	of	ADP
ihlr-28381	398	5	liability	liability	NOUN
ihlr-28381	398	6	associated	associate	VERB
ihlr-28381	398	7	with	with	ADP
ihlr-28381	398	8	reverse	reverse	ADJ
ihlr-28381	398	9	settlement	settlement	NOUN
ihlr-28381	398	10	payments	payment	NOUN
ihlr-28381	398	11	increases	increase	NOUN
ihlr-28381	398	12	,	,	PUNCT
ihlr-28381	398	13	brands	brand	NOUN
ihlr-28381	398	14	will	will	AUX
ihlr-28381	398	15	take	take	VERB
ihlr-28381	398	16	another	another	DET
ihlr-28381	398	17	angle	angle	NOUN
ihlr-28381	398	18	.	.	PUNCT
ihlr-28381	399	1	for	for	ADP
ihlr-28381	399	2	instance	instance	NOUN
ihlr-28381	399	3	,	,	PUNCT
ihlr-28381	399	4	instead	instead	ADV
ihlr-28381	399	5	of	of	ADP
ihlr-28381	399	6	reverse	reverse	VERB
ihlr-28381	399	7	payment	payment	NOUN
ihlr-28381	399	8	settlements	settlement	NOUN
ihlr-28381	399	9	,	,	PUNCT
ihlr-28381	399	10	brands	brand	NOUN
ihlr-28381	399	11	would	would	AUX
ihlr-28381	399	12	increase	increase	VERB
ihlr-28381	399	13	the	the	DET
ihlr-28381	399	14	number	number	NOUN
ihlr-28381	399	15	of	of	ADP
ihlr-28381	399	16	patents	patent	NOUN
ihlr-28381	399	17	filed	file	VERB
ihlr-28381	399	18	on	on	ADP
ihlr-28381	399	19	the	the	DET
ihlr-28381	399	20	drug	drug	NOUN
ihlr-28381	399	21	and	and	CCONJ
ihlr-28381	399	22	create	create	VERB
ihlr-28381	399	23	a	a	DET
ihlr-28381	399	24	“	"	PUNCT
ihlr-28381	399	25	patent	patent	NOUN
ihlr-28381	399	26	thicket	thicket	NOUN
ihlr-28381	399	27	.	.	PUNCT
ihlr-28381	399	28	”106	”106	PUNCT
ihlr-28381	399	29	over	over	ADP
ihlr-28381	399	30	the	the	DET
ihlr-28381	399	31	course	course	NOUN
ihlr-28381	399	32	of	of	ADP
ihlr-28381	399	33	years	year	NOUN
ihlr-28381	399	34	,	,	PUNCT
ihlr-28381	399	35	congress	congress	PROPN
ihlr-28381	399	36	could	could	AUX
ihlr-28381	399	37	theoretically	theoretically	ADV
ihlr-28381	399	38	legislate	legislate	VERB
ihlr-28381	399	39	pressure	pressure	NOUN
ihlr-28381	399	40	on	on	ADP
ihlr-28381	399	41	different	different	ADJ
ihlr-28381	399	42	methods	method	NOUN
ihlr-28381	399	43	of	of	ADP
ihlr-28381	399	44	delaying	delay	VERB
ihlr-28381	399	45	generics	generic	NOUN
ihlr-28381	399	46	,	,	PUNCT
ihlr-28381	399	47	only	only	ADV
ihlr-28381	399	48	to	to	PART
ihlr-28381	399	49	be	be	AUX
ihlr-28381	399	50	front	front	ADJ
ihlr-28381	399	51	-	-	PUNCT
ihlr-28381	399	52	run	run	NOUN
ihlr-28381	399	53	by	by	ADP
ihlr-28381	399	54	offenders	offender	NOUN
ihlr-28381	399	55	leveraging	leverage	VERB
ihlr-28381	399	56	new	new	ADJ
ihlr-28381	399	57	tactics	tactic	NOUN
ihlr-28381	399	58	to	to	PART
ihlr-28381	399	59	achieve	achieve	VERB
ihlr-28381	399	60	the	the	DET
ihlr-28381	399	61	same	same	ADJ
ihlr-28381	399	62	result	result	NOUN
ihlr-28381	399	63	—	—	PUNCT
ihlr-28381	399	64	minimal	minimal	ADJ
ihlr-28381	399	65	competition	competition	NOUN
ihlr-28381	399	66	and	and	CCONJ
ihlr-28381	399	67	high	high	ADJ
ihlr-28381	399	68	prices	price	NOUN
ihlr-28381	399	69	.	.	PUNCT
ihlr-28381	400	1	dozens	dozen	NOUN
ihlr-28381	400	2	of	of	ADP
ihlr-28381	400	3	bills	bill	NOUN
ihlr-28381	400	4	akin	akin	ADJ
ihlr-28381	400	5	to	to	ADP
ihlr-28381	400	6	the	the	DET
ihlr-28381	400	7	paagba	paagba	NOUN
ihlr-28381	400	8	have	have	AUX
ihlr-28381	400	9	been	be	AUX
ihlr-28381	400	10	considered	consider	VERB
ihlr-28381	400	11	in	in	ADP
ihlr-28381	400	12	the	the	DET
ihlr-28381	400	13	wake	wake	NOUN
ihlr-28381	400	14	of	of	ADP
ihlr-28381	400	15	actavis	actavis	NOUN
ihlr-28381	400	16	,	,	PUNCT
ihlr-28381	400	17	producing	produce	VERB
ihlr-28381	400	18	little	little	ADJ
ihlr-28381	400	19	material	material	ADJ
ihlr-28381	400	20	progress	progress	NOUN
ihlr-28381	400	21	.	.	PUNCT
ihlr-28381	401	1	rather	rather	ADV
ihlr-28381	401	2	than	than	ADP
ihlr-28381	401	3	focusing	focus	VERB
ihlr-28381	401	4	efforts	effort	NOUN
ihlr-28381	401	5	on	on	ADP
ihlr-28381	401	6	futile	futile	ADJ
ihlr-28381	401	7	attempts	attempt	NOUN
ihlr-28381	401	8	to	to	PART
ihlr-28381	401	9	tighten	tighten	VERB
ihlr-28381	401	10	the	the	DET
ihlr-28381	401	11	regulatory	regulatory	ADJ
ihlr-28381	401	12	grip	grip	NOUN
ihlr-28381	401	13	on	on	ADP
ihlr-28381	401	14	innovators	innovator	NOUN
ihlr-28381	401	15	and	and	CCONJ
ihlr-28381	401	16	generics	generic	NOUN
ihlr-28381	401	17	,	,	PUNCT
ihlr-28381	401	18	policymakers	policymaker	NOUN
ihlr-28381	401	19	should	should	AUX
ihlr-28381	401	20	examine	examine	VERB
ihlr-28381	401	21	the	the	DET
ihlr-28381	401	22	bigger	big	ADJ
ihlr-28381	401	23	picture	picture	NOUN
ihlr-28381	401	24	.	.	PUNCT
ihlr-28381	402	1	instead	instead	ADV
ihlr-28381	402	2	of	of	ADP
ihlr-28381	402	3	trying	try	VERB
ihlr-28381	402	4	and	and	CCONJ
ihlr-28381	402	5	failing	fail	VERB
ihlr-28381	402	6	to	to	PART
ihlr-28381	402	7	punish	punish	VERB
ihlr-28381	402	8	anticompetitive	anticompetitive	ADJ
ihlr-28381	402	9	conduct	conduct	NOUN
ihlr-28381	402	10	after	after	ADP
ihlr-28381	402	11	the	the	DET
ihlr-28381	402	12	fact	fact	NOUN
ihlr-28381	402	13	,	,	PUNCT
ihlr-28381	402	14	congress	congress	PROPN
ihlr-28381	402	15	should	should	AUX
ihlr-28381	402	16	implement	implement	VERB
ihlr-28381	402	17	a	a	DET
ihlr-28381	402	18	non	non	ADJ
ihlr-28381	402	19	-	-	ADJ
ihlr-28381	402	20	punitive	punitive	ADJ
ihlr-28381	402	21	101	101	NUM
ihlr-28381	402	22	.	.	PUNCT
ihlr-28381	403	1	richards	richard	NOUN
ihlr-28381	403	2	et	et	PROPN
ihlr-28381	403	3	al	al	PROPN
ihlr-28381	403	4	.	.	PROPN
ihlr-28381	403	5	,	,	PUNCT
ihlr-28381	403	6	supra	supra	PROPN
ihlr-28381	403	7	note	note	VERB
ihlr-28381	403	8	41	41	NUM
ihlr-28381	403	9	.	.	PUNCT
ihlr-28381	403	10	102	102	NUM
ihlr-28381	403	11	.	.	PUNCT
ihlr-28381	404	1	actavis	actavis	PROPN
ihlr-28381	404	2	,	,	PUNCT
ihlr-28381	404	3	inc	inc	PROPN
ihlr-28381	404	4	.	.	PROPN
ihlr-28381	404	5	,	,	PUNCT
ihlr-28381	404	6	570	570	NUM
ihlr-28381	404	7	u.s	u.s	PROPN
ihlr-28381	404	8	.	.	PROPN
ihlr-28381	404	9	at	at	ADP
ihlr-28381	404	10	136	136	NUM
ihlr-28381	404	11	.	.	PUNCT
ihlr-28381	405	1	103	103	NUM
ihlr-28381	405	2	.	.	NOUN
ihlr-28381	405	3	35	35	NUM
ihlr-28381	405	4	u.s.c	u.s.c	NOUN
ihlr-28381	405	5	.	.	PUNCT
ihlr-28381	406	1	§	§	PROPN
ihlr-28381	406	2	282(a	282(a	NOUN
ihlr-28381	406	3	)	)	PUNCT
ihlr-28381	406	4	(	(	PUNCT
ihlr-28381	406	5	2022	2022	NUM
ihlr-28381	406	6	)	)	PUNCT
ihlr-28381	406	7	.	.	PUNCT
ihlr-28381	407	1	104	104	NUM
ihlr-28381	407	2	.	.	PUNCT
ihlr-28381	408	1	actavis	actavis	PROPN
ihlr-28381	408	2	,	,	PUNCT
ihlr-28381	408	3	inc	inc	PROPN
ihlr-28381	408	4	.	.	PROPN
ihlr-28381	408	5	,	,	PUNCT
ihlr-28381	408	6	570	570	NUM
ihlr-28381	408	7	u.s	u.s	PROPN
ihlr-28381	408	8	.	.	PROPN
ihlr-28381	408	9	at	at	ADP
ihlr-28381	408	10	138	138	NUM
ihlr-28381	408	11	.	.	PUNCT
ihlr-28381	408	12	105	105	NUM
ihlr-28381	408	13	.	.	PUNCT
ihlr-28381	409	1	in	in	ADP
ihlr-28381	409	2	re	re	PROPN
ihlr-28381	409	3	humira	humira	PROPN
ihlr-28381	409	4	(	(	PUNCT
ihlr-28381	409	5	adalimumab	adalimumab	NOUN
ihlr-28381	409	6	)	)	PUNCT
ihlr-28381	409	7	antitrust	antitrust	ADJ
ihlr-28381	409	8	litig	litig	NOUN
ihlr-28381	409	9	.	.	PUNCT
ihlr-28381	410	1	,	,	PUNCT
ihlr-28381	410	2	465	465	NUM
ihlr-28381	410	3	f.	f.	NOUN
ihlr-28381	410	4	supp	supp	PROPN
ihlr-28381	410	5	.	.	PUNCT
ihlr-28381	411	1	3d	3d	NUM
ihlr-28381	411	2	811	811	NUM
ihlr-28381	411	3	,	,	PUNCT
ihlr-28381	411	4	834	834	NUM
ihlr-28381	411	5	(	(	PUNCT
ihlr-28381	411	6	n.d	n.d	PROPN
ihlr-28381	411	7	.	.	PROPN
ihlr-28381	411	8	ill	ill	PROPN
ihlr-28381	411	9	.	.	PROPN
ihlr-28381	411	10	2020	2020	NUM
ihlr-28381	411	11	)	)	PUNCT
ihlr-28381	411	12	,	,	PUNCT
ihlr-28381	411	13	aff'd	aff'd	NOUN
ihlr-28381	411	14	sub	sub	PROPN
ihlr-28381	411	15	nom	nom	PROPN
ihlr-28381	411	16	.	.	PROPN
ihlr-28381	411	17	see	see	PROPN
ihlr-28381	411	18	also	also	ADV
ihlr-28381	411	19	,	,	PUNCT
ihlr-28381	411	20	mayor	mayor	NOUN
ihlr-28381	411	21	of	of	ADP
ihlr-28381	411	22	baltimore	baltimore	PROPN
ihlr-28381	411	23	v.	v.	PROPN
ihlr-28381	411	24	abbvie	abbvie	PROPN
ihlr-28381	411	25	,	,	PUNCT
ihlr-28381	411	26	inc	inc	PROPN
ihlr-28381	411	27	.	.	PROPN
ihlr-28381	411	28	,	,	PUNCT
ihlr-28381	411	29	42	42	NUM
ihlr-28381	411	30	f.4th	f.4th	NOUN
ihlr-28381	411	31	709	709	NUM
ihlr-28381	411	32	(	(	PUNCT
ihlr-28381	411	33	7th	7th	ADJ
ihlr-28381	411	34	cir	cir	NOUN
ihlr-28381	411	35	.	.	PUNCT
ihlr-28381	411	36	2022	2022	NUM
ihlr-28381	411	37	)	)	PUNCT
ihlr-28381	411	38	(	(	PUNCT
ihlr-28381	411	39	quoting	quote	VERB
ihlr-28381	411	40	brooktree	brooktree	PROPN
ihlr-28381	411	41	corp	corp	PROPN
ihlr-28381	411	42	.	.	PROPN
ihlr-28381	411	43	v.	v.	ADP
ihlr-28381	411	44	advanced	advanced	PROPN
ihlr-28381	411	45	micro	micro	PROPN
ihlr-28381	411	46	devices	devices	PROPN
ihlr-28381	411	47	,	,	PUNCT
ihlr-28381	411	48	inc	inc	PROPN
ihlr-28381	411	49	.	.	PROPN
ihlr-28381	411	50	,	,	PUNCT
ihlr-28381	411	51	977	977	NUM
ihlr-28381	411	52	f.2d	f.2d	NOUN
ihlr-28381	411	53	1555	1555	NUM
ihlr-28381	411	54	,	,	PUNCT
ihlr-28381	411	55	1574	1574	NUM
ihlr-28381	411	56	(	(	PUNCT
ihlr-28381	411	57	fed	fed	PROPN
ihlr-28381	411	58	.	.	PUNCT
ihlr-28381	411	59	cir	cir	PROPN
ihlr-28381	411	60	.	.	PROPN
ihlr-28381	411	61	1992	1992	NUM
ihlr-28381	411	62	)	)	PUNCT
ihlr-28381	411	63	.	.	PUNCT
ihlr-28381	412	1	106	106	NUM
ihlr-28381	412	2	.	.	PUNCT
ihlr-28381	413	1	richards	richard	NOUN
ihlr-28381	413	2	et	et	PROPN
ihlr-28381	413	3	al	al	PROPN
ihlr-28381	413	4	.	.	PROPN
ihlr-28381	413	5	,	,	PUNCT
ihlr-28381	413	6	supra	supra	PROPN
ihlr-28381	413	7	note	note	VERB
ihlr-28381	413	8	41	41	NUM
ihlr-28381	413	9	.	.	PUNCT
ihlr-28381	414	1	140	140	NUM
ihlr-28381	414	2	indiana	indiana	PROPN
ihlr-28381	414	3	health	health	PROPN
ihlr-28381	414	4	law	law	PROPN
ihlr-28381	414	5	review	review	NOUN
ihlr-28381	414	6	[	[	X
ihlr-28381	414	7	vol	vol	NOUN
ihlr-28381	414	8	.	.	NOUN
ihlr-28381	414	9	21:121	21:121	NUM
ihlr-28381	414	10	solution	solution	NOUN
ihlr-28381	414	11	by	by	ADP
ihlr-28381	414	12	incentivizing	incentivize	VERB
ihlr-28381	414	13	firms	firm	NOUN
ihlr-28381	414	14	away	away	ADV
ihlr-28381	414	15	from	from	ADP
ihlr-28381	414	16	pay	pay	NOUN
ihlr-28381	414	17	-	-	PUNCT
ihlr-28381	414	18	for	for	ADP
ihlr-28381	414	19	-	-	PUNCT
ihlr-28381	414	20	delay	delay	NOUN
ihlr-28381	414	21	strategies	strategy	NOUN
ihlr-28381	414	22	.	.	PUNCT
ihlr-28381	415	1	vii	vii	PROPN
ihlr-28381	415	2	.	.	PUNCT
ihlr-28381	416	1	incentivizing	incentivize	VERB
ihlr-28381	416	2	affordability	affordability	NOUN
ihlr-28381	416	3	:	:	PUNCT
ihlr-28381	416	4	priority	priority	NOUN
ihlr-28381	416	5	review	review	NOUN
ihlr-28381	416	6	&	&	CCONJ
ihlr-28381	416	7	wildcard	wildcard	ADJ
ihlr-28381	416	8	exclusivity	exclusivity	NOUN
ihlr-28381	416	9	because	because	SCONJ
ihlr-28381	416	10	the	the	DET
ihlr-28381	416	11	push	push	NOUN
ihlr-28381	416	12	of	of	ADP
ihlr-28381	416	13	penalty	penalty	NOUN
ihlr-28381	416	14	-	-	PUNCT
ihlr-28381	416	15	based	base	VERB
ihlr-28381	416	16	approaches	approach	NOUN
ihlr-28381	416	17	rarely	rarely	ADV
ihlr-28381	416	18	materializes	materialize	VERB
ihlr-28381	416	19	,	,	PUNCT
ihlr-28381	416	20	the	the	DET
ihlr-28381	416	21	pull	pull	NOUN
ihlr-28381	416	22	of	of	ADP
ihlr-28381	416	23	two	two	NUM
ihlr-28381	416	24	incentive	incentive	NOUN
ihlr-28381	416	25	-	-	PUNCT
ihlr-28381	416	26	based	base	VERB
ihlr-28381	416	27	approaches	approach	NOUN
ihlr-28381	416	28	should	should	AUX
ihlr-28381	416	29	be	be	AUX
ihlr-28381	416	30	explored	explore	VERB
ihlr-28381	416	31	:	:	PUNCT
ihlr-28381	416	32	(	(	PUNCT
ihlr-28381	416	33	1	1	X
ihlr-28381	416	34	)	)	PUNCT
ihlr-28381	416	35	fda	fda	PROPN
ihlr-28381	416	36	priority	priority	PROPN
ihlr-28381	416	37	review	review	NOUN
ihlr-28381	416	38	vouchers	voucher	NOUN
ihlr-28381	416	39	(	(	PUNCT
ihlr-28381	416	40	“	"	PUNCT
ihlr-28381	416	41	prvs	prvs	NOUN
ihlr-28381	416	42	”	"	PUNCT
ihlr-28381	416	43	are	be	AUX
ihlr-28381	416	44	not	not	PART
ihlr-28381	416	45	uncommonly	uncommonly	ADV
ihlr-28381	416	46	valued	value	VERB
ihlr-28381	416	47	in	in	ADP
ihlr-28381	416	48	the	the	DET
ihlr-28381	416	49	hundreds	hundred	NOUN
ihlr-28381	416	50	of	of	ADP
ihlr-28381	416	51	millions),107	millions),107	NOUN
ihlr-28381	416	52	and	and	CCONJ
ihlr-28381	416	53	(	(	PUNCT
ihlr-28381	416	54	2	2	NUM
ihlr-28381	416	55	)	)	PUNCT
ihlr-28381	416	56	transferable	transferable	NOUN
ihlr-28381	416	57	wildcard	wildcard	ADJ
ihlr-28381	416	58	exclusivity	exclusivity	NOUN
ihlr-28381	416	59	vouchers	voucher	NOUN
ihlr-28381	416	60	(	(	PUNCT
ihlr-28381	416	61	“	"	PUNCT
ihlr-28381	416	62	wildcards	wildcard	NOUN
ihlr-28381	416	63	”	"	PUNCT
ihlr-28381	416	64	)	)	PUNCT
ihlr-28381	416	65	.	.	PUNCT
ihlr-28381	417	1	with	with	ADP
ihlr-28381	417	2	built	build	VERB
ihlr-28381	417	3	-	-	PUNCT
ihlr-28381	417	4	in	in	ADP
ihlr-28381	417	5	safeguards	safeguard	NOUN
ihlr-28381	417	6	against	against	ADP
ihlr-28381	417	7	abuse	abuse	NOUN
ihlr-28381	417	8	,	,	PUNCT
ihlr-28381	417	9	issuing	issue	VERB
ihlr-28381	417	10	these	these	DET
ihlr-28381	417	11	assets	asset	NOUN
ihlr-28381	417	12	to	to	ADP
ihlr-28381	417	13	firms	firm	NOUN
ihlr-28381	417	14	in	in	ADP
ihlr-28381	417	15	exchange	exchange	NOUN
ihlr-28381	417	16	for	for	ADP
ihlr-28381	417	17	unilateral	unilateral	ADJ
ihlr-28381	417	18	price	price	NOUN
ihlr-28381	417	19	decreases	decrease	NOUN
ihlr-28381	417	20	or	or	CCONJ
ihlr-28381	417	21	facilitation	facilitation	NOUN
ihlr-28381	417	22	of	of	ADP
ihlr-28381	417	23	generic	generic	ADJ
ihlr-28381	417	24	entry	entry	NOUN
ihlr-28381	417	25	could	could	AUX
ihlr-28381	417	26	reduce	reduce	VERB
ihlr-28381	417	27	the	the	DET
ihlr-28381	417	28	appeal	appeal	NOUN
ihlr-28381	417	29	of	of	ADP
ihlr-28381	417	30	pay	pay	NOUN
ihlr-28381	417	31	-	-	PUNCT
ihlr-28381	417	32	fordelay	fordelay	NOUN
ihlr-28381	417	33	and	and	CCONJ
ihlr-28381	417	34	thereby	thereby	ADV
ihlr-28381	417	35	improve	improve	VERB
ihlr-28381	417	36	affordability	affordability	NOUN
ihlr-28381	417	37	and	and	CCONJ
ihlr-28381	417	38	access	access	NOUN
ihlr-28381	417	39	.	.	PUNCT
ihlr-28381	418	1	a.	a.	NOUN
ihlr-28381	418	2	priority	priority	PROPN
ihlr-28381	418	3	review	review	NOUN
ihlr-28381	418	4	vouchers	voucher	NOUN
ihlr-28381	418	5	priority	priority	NOUN
ihlr-28381	418	6	review	review	NOUN
ihlr-28381	418	7	vouchers	voucher	NOUN
ihlr-28381	418	8	reduce	reduce	VERB
ihlr-28381	418	9	the	the	DET
ihlr-28381	418	10	fda	fda	PROPN
ihlr-28381	418	11	review	review	NOUN
ihlr-28381	418	12	period	period	NOUN
ihlr-28381	418	13	of	of	ADP
ihlr-28381	418	14	any	any	DET
ihlr-28381	418	15	new	new	ADJ
ihlr-28381	418	16	drug	drug	NOUN
ihlr-28381	418	17	application	application	NOUN
ihlr-28381	418	18	(	(	PUNCT
ihlr-28381	418	19	“	"	PUNCT
ihlr-28381	418	20	nda	nda	PROPN
ihlr-28381	418	21	”	"	PUNCT
ihlr-28381	418	22	)	)	PUNCT
ihlr-28381	418	23	by	by	ADP
ihlr-28381	418	24	four	four	NUM
ihlr-28381	418	25	months	month	NOUN
ihlr-28381	418	26	(	(	PUNCT
ihlr-28381	418	27	ten	ten	NUM
ihlr-28381	418	28	months	month	NOUN
ihlr-28381	418	29	shortened	shorten	VERB
ihlr-28381	418	30	to	to	ADP
ihlr-28381	418	31	six	six	NUM
ihlr-28381	418	32	months).108	months).108	NOUN
ihlr-28381	418	33	prvs	prvs	NOUN
ihlr-28381	418	34	are	be	AUX
ihlr-28381	418	35	currently	currently	ADV
ihlr-28381	418	36	used	use	VERB
ihlr-28381	418	37	to	to	PART
ihlr-28381	418	38	incentivize	incentivize	VERB
ihlr-28381	418	39	low	low	ADJ
ihlr-28381	418	40	profitability	profitability	NOUN
ihlr-28381	418	41	,	,	PUNCT
ihlr-28381	418	42	high	high	ADJ
ihlr-28381	418	43	-	-	PUNCT
ihlr-28381	418	44	need	need	NOUN
ihlr-28381	418	45	research	research	NOUN
ihlr-28381	418	46	and	and	CCONJ
ihlr-28381	418	47	development	development	NOUN
ihlr-28381	418	48	in	in	ADP
ihlr-28381	418	49	the	the	DET
ihlr-28381	418	50	areas	area	NOUN
ihlr-28381	418	51	of	of	ADP
ihlr-28381	418	52	tropical	tropical	ADJ
ihlr-28381	418	53	disease	disease	NOUN
ihlr-28381	418	54	,	,	PUNCT
ihlr-28381	418	55	rare	rare	ADJ
ihlr-28381	418	56	pediatric	pediatric	ADJ
ihlr-28381	418	57	disease	disease	NOUN
ihlr-28381	418	58	,	,	PUNCT
ihlr-28381	418	59	and	and	CCONJ
ihlr-28381	418	60	illnesses	illness	NOUN
ihlr-28381	418	61	related	relate	VERB
ihlr-28381	418	62	to	to	ADP
ihlr-28381	418	63	public	public	ADJ
ihlr-28381	418	64	health	health	NOUN
ihlr-28381	418	65	emergencies.109	emergencies.109	VERB
ihlr-28381	418	66	companies	company	NOUN
ihlr-28381	418	67	sponsoring	sponsor	VERB
ihlr-28381	418	68	development	development	NOUN
ihlr-28381	418	69	in	in	ADP
ihlr-28381	418	70	these	these	DET
ihlr-28381	418	71	areas	area	NOUN
ihlr-28381	418	72	are	be	AUX
ihlr-28381	418	73	awarded	award	VERB
ihlr-28381	418	74	prvs	prvs	NOUN
ihlr-28381	418	75	,	,	PUNCT
ihlr-28381	418	76	which	which	PRON
ihlr-28381	418	77	are	be	AUX
ihlr-28381	418	78	ultimately	ultimately	ADV
ihlr-28381	418	79	redeemed	redeem	VERB
ihlr-28381	418	80	by	by	ADP
ihlr-28381	418	81	the	the	DET
ihlr-28381	418	82	awardee	awardee	NOUN
ihlr-28381	418	83	,	,	PUNCT
ihlr-28381	418	84	or	or	CCONJ
ihlr-28381	418	85	by	by	ADP
ihlr-28381	418	86	another	another	DET
ihlr-28381	418	87	company	company	NOUN
ihlr-28381	418	88	that	that	PRON
ihlr-28381	418	89	purchased	purchase	VERB
ihlr-28381	418	90	the	the	DET
ihlr-28381	418	91	prv	prv	PROPN
ihlr-28381	418	92	from	from	ADP
ihlr-28381	418	93	the	the	DET
ihlr-28381	418	94	awardee	awardee	NOUN
ihlr-28381	418	95	,	,	PUNCT
ihlr-28381	418	96	for	for	ADP
ihlr-28381	418	97	accelerated	accelerated	ADJ
ihlr-28381	418	98	review	review	NOUN
ihlr-28381	418	99	of	of	ADP
ihlr-28381	418	100	any	any	DET
ihlr-28381	418	101	nda	nda	NOUN
ihlr-28381	418	102	.	.	PUNCT
ihlr-28381	419	1	bringing	bring	VERB
ihlr-28381	419	2	a	a	DET
ihlr-28381	419	3	patented	patented	ADJ
ihlr-28381	419	4	drug	drug	NOUN
ihlr-28381	419	5	to	to	PART
ihlr-28381	419	6	market	market	VERB
ihlr-28381	419	7	four	four	NUM
ihlr-28381	419	8	months	month	NOUN
ihlr-28381	419	9	faster	fast	ADV
ihlr-28381	419	10	through	through	ADP
ihlr-28381	419	11	a	a	DET
ihlr-28381	419	12	prv	prv	PROPN
ihlr-28381	419	13	translates	translate	VERB
ihlr-28381	419	14	to	to	ADP
ihlr-28381	419	15	four	four	NUM
ihlr-28381	419	16	additional	additional	ADJ
ihlr-28381	419	17	months	month	NOUN
ihlr-28381	419	18	of	of	ADP
ihlr-28381	419	19	monopoly	monopoly	NOUN
ihlr-28381	419	20	pricing	pricing	NOUN
ihlr-28381	419	21	—	—	PUNCT
ihlr-28381	419	22	without	without	ADP
ihlr-28381	419	23	having	have	VERB
ihlr-28381	419	24	to	to	PART
ihlr-28381	419	25	delay	delay	VERB
ihlr-28381	419	26	generic	generic	ADJ
ihlr-28381	419	27	entry	entry	NOUN
ihlr-28381	419	28	.	.	PUNCT
ihlr-28381	420	1	factoring	factor	VERB
ihlr-28381	420	2	in	in	ADP
ihlr-28381	420	3	the	the	DET
ihlr-28381	420	4	cost	cost	NOUN
ihlr-28381	420	5	of	of	ADP
ihlr-28381	420	6	delaying	delay	VERB
ihlr-28381	420	7	generic	generic	ADJ
ihlr-28381	420	8	entry	entry	NOUN
ihlr-28381	420	9	(	(	PUNCT
ihlr-28381	420	10	e.g.	e.g.	ADV
ihlr-28381	420	11	,	,	PUNCT
ihlr-28381	420	12	litigation	litigation	NOUN
ihlr-28381	420	13	,	,	PUNCT
ihlr-28381	420	14	document	document	NOUN
ihlr-28381	420	15	preparation	preparation	NOUN
ihlr-28381	420	16	,	,	PUNCT
ihlr-28381	420	17	filing	filing	NOUN
ihlr-28381	420	18	fees	fee	NOUN
ihlr-28381	420	19	,	,	PUNCT
ihlr-28381	420	20	reverse	reverse	VERB
ihlr-28381	420	21	payment	payment	NOUN
ihlr-28381	420	22	settlements	settlement	NOUN
ihlr-28381	420	23	)	)	PUNCT
ihlr-28381	420	24	,	,	PUNCT
ihlr-28381	420	25	it	it	PRON
ihlr-28381	420	26	is	be	AUX
ihlr-28381	420	27	fully	fully	ADV
ihlr-28381	420	28	possible	possible	ADJ
ihlr-28381	420	29	that	that	SCONJ
ihlr-28381	420	30	obtaining	obtain	VERB
ihlr-28381	420	31	a	a	DET
ihlr-28381	420	32	prv	prv	PROPN
ihlr-28381	420	33	would	would	AUX
ihlr-28381	420	34	outweigh	outweigh	VERB
ihlr-28381	420	35	delaying	delay	VERB
ihlr-28381	420	36	generic	generic	ADJ
ihlr-28381	420	37	entry	entry	NOUN
ihlr-28381	420	38	.	.	PUNCT
ihlr-28381	421	1	even	even	ADV
ihlr-28381	421	2	without	without	ADP
ihlr-28381	421	3	factoring	factor	VERB
ihlr-28381	421	4	in	in	ADP
ihlr-28381	421	5	the	the	DET
ihlr-28381	421	6	cost	cost	NOUN
ihlr-28381	421	7	of	of	ADP
ihlr-28381	421	8	delay	delay	NOUN
ihlr-28381	421	9	efforts	effort	NOUN
ihlr-28381	421	10	,	,	PUNCT
ihlr-28381	421	11	in	in	ADP
ihlr-28381	421	12	some	some	DET
ihlr-28381	421	13	situations	situation	NOUN
ihlr-28381	421	14	,	,	PUNCT
ihlr-28381	421	15	the	the	DET
ihlr-28381	421	16	market	market	NOUN
ihlr-28381	421	17	value	value	NOUN
ihlr-28381	421	18	or	or	CCONJ
ihlr-28381	421	19	sale	sale	NOUN
ihlr-28381	421	20	price	price	NOUN
ihlr-28381	421	21	of	of	ADP
ihlr-28381	421	22	a	a	DET
ihlr-28381	421	23	prv	prv	PROPN
ihlr-28381	421	24	would	would	AUX
ihlr-28381	421	25	ideally	ideally	ADV
ihlr-28381	421	26	exceed	exceed	VERB
ihlr-28381	421	27	the	the	DET
ihlr-28381	421	28	value	value	NOUN
ihlr-28381	421	29	of	of	ADP
ihlr-28381	421	30	prolonged	prolonged	ADJ
ihlr-28381	421	31	monopoly	monopoly	NOUN
ihlr-28381	421	32	pricing	pricing	NOUN
ihlr-28381	421	33	achievable	achievable	ADJ
ihlr-28381	421	34	through	through	ADP
ihlr-28381	421	35	pay	pay	NOUN
ihlr-28381	421	36	-	-	PUNCT
ihlr-28381	421	37	for	for	ADP
ihlr-28381	421	38	-	-	PUNCT
ihlr-28381	421	39	delay	delay	NOUN
ihlr-28381	421	40	.	.	PUNCT
ihlr-28381	422	1	further	far	ADV
ihlr-28381	422	2	,	,	PUNCT
ihlr-28381	422	3	using	use	VERB
ihlr-28381	422	4	prvs	prvs	NOUN
ihlr-28381	422	5	increases	increase	VERB
ihlr-28381	422	6	the	the	DET
ihlr-28381	422	7	likelihood	likelihood	NOUN
ihlr-28381	422	8	that	that	SCONJ
ihlr-28381	422	9	profits	profit	NOUN
ihlr-28381	422	10	will	will	AUX
ihlr-28381	422	11	be	be	AUX
ihlr-28381	422	12	reinvested	reinveste	VERB
ihlr-28381	422	13	in	in	ADP
ihlr-28381	422	14	research	research	NOUN
ihlr-28381	422	15	and	and	CCONJ
ihlr-28381	422	16	development	development	NOUN
ihlr-28381	422	17	because	because	SCONJ
ihlr-28381	422	18	after	after	ADV
ihlr-28381	422	19	all	all	ADV
ihlr-28381	422	20	,	,	PUNCT
ihlr-28381	422	21	the	the	DET
ihlr-28381	422	22	voucher	voucher	NOUN
ihlr-28381	422	23	is	be	AUX
ihlr-28381	422	24	used	use	VERB
ihlr-28381	422	25	to	to	PART
ihlr-28381	422	26	review	review	VERB
ihlr-28381	422	27	a	a	DET
ihlr-28381	422	28	new	new	ADJ
ihlr-28381	422	29	drug	drug	NOUN
ihlr-28381	422	30	application	application	NOUN
ihlr-28381	422	31	.	.	PUNCT
ihlr-28381	423	1	allowing	allow	VERB
ihlr-28381	423	2	the	the	DET
ihlr-28381	423	3	fda	fda	PROPN
ihlr-28381	423	4	to	to	PART
ihlr-28381	423	5	flex	flex	VERB
ihlr-28381	423	6	the	the	DET
ihlr-28381	423	7	pace	pace	NOUN
ihlr-28381	423	8	of	of	ADP
ihlr-28381	423	9	accelerated	accelerate	VERB
ihlr-28381	423	10	approval	approval	NOUN
ihlr-28381	423	11	based	base	VERB
ihlr-28381	423	12	on	on	ADP
ihlr-28381	423	13	the	the	DET
ihlr-28381	423	14	quality	quality	NOUN
ihlr-28381	423	15	of	of	ADP
ihlr-28381	423	16	the	the	DET
ihlr-28381	423	17	company	company	NOUN
ihlr-28381	423	18	’s	’s	PART
ihlr-28381	423	19	pro	pro	ADJ
ihlr-28381	423	20	-	-	ADJ
ihlr-28381	423	21	competitive	competitive	ADJ
ihlr-28381	423	22	,	,	PUNCT
ihlr-28381	423	23	price	price	NOUN
ihlr-28381	423	24	-	-	PUNCT
ihlr-28381	423	25	lowering	lower	VERB
ihlr-28381	423	26	conduct	conduct	NOUN
ihlr-28381	423	27	would	would	AUX
ihlr-28381	423	28	also	also	ADV
ihlr-28381	423	29	add	add	VERB
ihlr-28381	423	30	to	to	ADP
ihlr-28381	423	31	the	the	DET
ihlr-28381	423	32	effectiveness	effectiveness	NOUN
ihlr-28381	423	33	of	of	ADP
ihlr-28381	423	34	this	this	DET
ihlr-28381	423	35	approach	approach	NOUN
ihlr-28381	423	36	.	.	PUNCT
ihlr-28381	424	1	the	the	DET
ihlr-28381	424	2	marketability	marketability	NOUN
ihlr-28381	424	3	of	of	ADP
ihlr-28381	424	4	prvs	prvs	NOUN
ihlr-28381	424	5	is	be	AUX
ihlr-28381	424	6	essential	essential	ADJ
ihlr-28381	424	7	to	to	ADP
ihlr-28381	424	8	their	their	PRON
ihlr-28381	424	9	appeal.110	appeal.110	NOUN
ihlr-28381	424	10	since	since	SCONJ
ihlr-28381	424	11	the	the	DET
ihlr-28381	424	12	fda	fda	PROPN
ihlr-28381	424	13	began	begin	VERB
ihlr-28381	424	14	awarding	award	VERB
ihlr-28381	424	15	prvs	prvs	NOUN
ihlr-28381	424	16	in	in	ADP
ihlr-28381	424	17	2007	2007	NUM
ihlr-28381	424	18	,	,	PUNCT
ihlr-28381	424	19	the	the	DET
ihlr-28381	424	20	government	government	NOUN
ihlr-28381	424	21	accountability	accountability	NOUN
ihlr-28381	424	22	office	office	NOUN
ihlr-28381	424	23	has	have	AUX
ihlr-28381	424	24	used	use	VERB
ihlr-28381	424	25	107	107	NUM
ihlr-28381	424	26	.	.	PUNCT
ihlr-28381	425	1	u.s	u.s	PROPN
ihlr-28381	425	2	.	.	PROPN
ihlr-28381	425	3	gov’t	gov’t	PROPN
ihlr-28381	425	4	accountability	accountability	NOUN
ihlr-28381	425	5	off	off	ADP
ihlr-28381	425	6	.	.	PUNCT
ihlr-28381	425	7	,	,	PUNCT
ihlr-28381	425	8	gao-20	gao-20	NOUN
ihlr-28381	425	9	-	-	PUNCT
ihlr-28381	425	10	251	251	NUM
ihlr-28381	425	11	,	,	PUNCT
ihlr-28381	425	12	drug	drug	NOUN
ihlr-28381	425	13	development	development	NOUN
ihlr-28381	425	14	:	:	PUNCT
ihlr-28381	425	15	fda	fda	PROPN
ihlr-28381	425	16	’s	’s	PART
ihlr-28381	425	17	priority	priority	PROPN
ihlr-28381	425	18	review	review	NOUN
ihlr-28381	425	19	voucher	voucher	ADJ
ihlr-28381	425	20	programs	program	NOUN
ihlr-28381	425	21	(	(	PUNCT
ihlr-28381	425	22	jan	jan	PROPN
ihlr-28381	425	23	.	.	PROPN
ihlr-28381	425	24	2020	2020	NUM
ihlr-28381	425	25	)	)	PUNCT
ihlr-28381	425	26	,	,	PUNCT
ihlr-28381	425	27	https://www.gao.gov/assets/gao-20-251.pdf	https://www.gao.gov/assets/gao-20-251.pdf	PUNCT
ihlr-28381	426	1	[	[	X
ihlr-28381	426	2	https://perma.cc/cnq8-fku6	https://perma.cc/cnq8-fku6	X
ihlr-28381	426	3	]	]	X
ihlr-28381	426	4	.	.	PUNCT
ihlr-28381	427	1	108	108	NUM
ihlr-28381	427	2	.	.	PUNCT
ihlr-28381	428	1	u.s	u.s	PROPN
ihlr-28381	428	2	.	.	PROPN
ihlr-28381	428	3	gov’t	gov’t	PROPN
ihlr-28381	428	4	accountability	accountability	NOUN
ihlr-28381	428	5	off	off	ADP
ihlr-28381	428	6	.	.	PUNCT
ihlr-28381	428	7	,	,	PUNCT
ihlr-28381	428	8	supra	supra	PROPN
ihlr-28381	428	9	note	note	PROPN
ihlr-28381	428	10	105	105	NUM
ihlr-28381	428	11	,	,	PUNCT
ihlr-28381	428	12	at	at	ADP
ihlr-28381	428	13	2	2	NUM
ihlr-28381	428	14	.	.	NUM
ihlr-28381	428	15	109	109	NUM
ihlr-28381	428	16	.	.	PUNCT
ihlr-28381	428	17	food	food	NOUN
ihlr-28381	428	18	and	and	CCONJ
ihlr-28381	428	19	drug	drug	PROPN
ihlr-28381	428	20	administration	administration	PROPN
ihlr-28381	428	21	amendments	amendment	NOUN
ihlr-28381	428	22	act	act	VERB
ihlr-28381	428	23	of	of	ADP
ihlr-28381	428	24	2007	2007	NUM
ihlr-28381	428	25	,	,	PUNCT
ihlr-28381	428	26	pub	pub	NOUN
ihlr-28381	428	27	.	.	PUNCT
ihlr-28381	429	1	l.	l.	PROPN
ihlr-28381	429	2	no	no	INTJ
ihlr-28381	429	3	.	.	NOUN
ihlr-28381	430	1	110	110	NUM
ihlr-28381	430	2	-	-	SYM
ihlr-28381	430	3	85	85	NUM
ihlr-28381	430	4	,	,	PUNCT
ihlr-28381	430	5	§	§	PROPN
ihlr-28381	430	6	1102	1102	NUM
ihlr-28381	430	7	,	,	PUNCT
ihlr-28381	430	8	121	121	NUM
ihlr-28381	430	9	stat	stat	NOUN
ihlr-28381	430	10	.	.	PUNCT
ihlr-28381	431	1	823	823	NUM
ihlr-28381	431	2	,	,	PUNCT
ihlr-28381	431	3	972	972	NUM
ihlr-28381	431	4	(	(	PUNCT
ihlr-28381	431	5	2007	2007	NUM
ihlr-28381	431	6	)	)	PUNCT
ihlr-28381	431	7	;	;	PUNCT
ihlr-28381	431	8	food	food	NOUN
ihlr-28381	431	9	and	and	CCONJ
ihlr-28381	431	10	drug	drug	PROPN
ihlr-28381	431	11	administration	administration	PROPN
ihlr-28381	431	12	safety	safety	PROPN
ihlr-28381	431	13	and	and	CCONJ
ihlr-28381	431	14	innovation	innovation	NOUN
ihlr-28381	431	15	act	act	PROPN
ihlr-28381	431	16	,	,	PUNCT
ihlr-28381	431	17	pub	pub	NOUN
ihlr-28381	431	18	.	.	PUNCT
ihlr-28381	432	1	l.	l.	PROPN
ihlr-28381	432	2	no	no	INTJ
ihlr-28381	432	3	.	.	PROPN
ihlr-28381	433	1	112	112	NUM
ihlr-28381	433	2	-	-	SYM
ihlr-28381	433	3	144	144	NUM
ihlr-28381	433	4	,	,	PUNCT
ihlr-28381	433	5	§	§	PROPN
ihlr-28381	433	6	908	908	NUM
ihlr-28381	433	7	,	,	PUNCT
ihlr-28381	433	8	126	126	NUM
ihlr-28381	433	9	stat	stat	NOUN
ihlr-28381	433	10	.	.	PUNCT
ihlr-28381	434	1	993	993	NUM
ihlr-28381	434	2	,	,	PUNCT
ihlr-28381	434	3	1094	1094	NUM
ihlr-28381	434	4	(	(	PUNCT
ihlr-28381	434	5	2012	2012	NUM
ihlr-28381	434	6	)	)	PUNCT
ihlr-28381	434	7	;	;	PUNCT
ihlr-28381	434	8	21st	21st	ADJ
ihlr-28381	434	9	century	century	NOUN
ihlr-28381	434	10	cures	cure	NOUN
ihlr-28381	434	11	act	act	VERB
ihlr-28381	434	12	,	,	PUNCT
ihlr-28381	434	13	pub	pub	NOUN
ihlr-28381	434	14	.	.	PUNCT
ihlr-28381	435	1	l.	l.	PROPN
ihlr-28381	435	2	no	no	INTJ
ihlr-28381	435	3	.	.	PROPN
ihlr-28381	436	1	114	114	NUM
ihlr-28381	436	2	-	-	SYM
ihlr-28381	436	3	255	255	NUM
ihlr-28381	436	4	,	,	PUNCT
ihlr-28381	436	5	§	§	PROPN
ihlr-28381	436	6	3086	3086	NUM
ihlr-28381	436	7	,	,	PUNCT
ihlr-28381	436	8	130	130	NUM
ihlr-28381	436	9	stat	stat	NOUN
ihlr-28381	436	10	.	.	PUNCT
ihlr-28381	437	1	1033	1033	NUM
ihlr-28381	437	2	,	,	PUNCT
ihlr-28381	437	3	1145	1145	NUM
ihlr-28381	437	4	(	(	PUNCT
ihlr-28381	437	5	2016	2016	NUM
ihlr-28381	437	6	)	)	PUNCT
ihlr-28381	437	7	;	;	PUNCT
ihlr-28381	437	8	u.s	u.s	PROPN
ihlr-28381	437	9	.	.	PROPN
ihlr-28381	437	10	gov’t	gov’t	NOUN
ihlr-28381	437	11	accountability	accountability	NOUN
ihlr-28381	437	12	off	off	ADP
ihlr-28381	437	13	.	.	PUNCT
ihlr-28381	438	1	,	,	PUNCT
ihlr-28381	438	2	supra	supra	PROPN
ihlr-28381	438	3	note	note	PROPN
ihlr-28381	438	4	105	105	NUM
ihlr-28381	438	5	.	.	PUNCT
ihlr-28381	439	1	110	110	NUM
ihlr-28381	439	2	.	.	PUNCT
ihlr-28381	440	1	i	i	PRON
ihlr-28381	440	2	d.	d.	PROPN
ihlr-28381	440	3	at	at	ADP
ihlr-28381	440	4	13	13	NUM
ihlr-28381	440	5	-	-	SYM
ihlr-28381	440	6	14	14	NUM
ihlr-28381	440	7	.	.	PUNCT
ihlr-28381	440	8	2024	2024	NUM
ihlr-28381	440	9	]	]	PUNCT
ihlr-28381	440	10	incentivizing	incentivize	VERB
ihlr-28381	440	11	drug	drug	NOUN
ihlr-28381	440	12	affordability	affordability	NOUN
ihlr-28381	440	13	141	141	NUM
ihlr-28381	440	14	available	available	ADJ
ihlr-28381	440	15	data	datum	NOUN
ihlr-28381	440	16	to	to	PART
ihlr-28381	440	17	report	report	VERB
ihlr-28381	440	18	prv	prv	PROPN
ihlr-28381	440	19	sale	sale	NOUN
ihlr-28381	440	20	prices	price	NOUN
ihlr-28381	440	21	ranging	range	VERB
ihlr-28381	440	22	from	from	ADP
ihlr-28381	440	23	$	$	SYM
ihlr-28381	440	24	67.5	67.5	NUM
ihlr-28381	440	25	million	million	NUM
ihlr-28381	440	26	to	to	PART
ihlr-28381	440	27	$	$	SYM
ihlr-28381	440	28	350	350	NUM
ihlr-28381	440	29	million.111	million.111	VERB
ihlr-28381	440	30	if	if	SCONJ
ihlr-28381	440	31	appropriately	appropriately	ADV
ihlr-28381	440	32	implemented	implement	VERB
ihlr-28381	440	33	,	,	PUNCT
ihlr-28381	440	34	this	this	DET
ihlr-28381	440	35	program	program	NOUN
ihlr-28381	440	36	could	could	AUX
ihlr-28381	440	37	bring	bring	VERB
ihlr-28381	440	38	both	both	CCONJ
ihlr-28381	440	39	innovative	innovative	ADJ
ihlr-28381	440	40	and	and	CCONJ
ihlr-28381	440	41	generic	generic	ADJ
ihlr-28381	440	42	drugs	drug	NOUN
ihlr-28381	440	43	to	to	PART
ihlr-28381	440	44	market	market	VERB
ihlr-28381	440	45	faster	fast	ADV
ihlr-28381	440	46	.	.	PUNCT
ihlr-28381	441	1	the	the	DET
ihlr-28381	441	2	effect	effect	NOUN
ihlr-28381	441	3	is	be	AUX
ihlr-28381	441	4	a	a	DET
ihlr-28381	441	5	positive	positive	ADJ
ihlr-28381	441	6	-	-	PUNCT
ihlr-28381	441	7	sum	sum	NOUN
ihlr-28381	441	8	game	game	NOUN
ihlr-28381	441	9	,	,	PUNCT
ihlr-28381	441	10	where	where	SCONJ
ihlr-28381	441	11	all	all	DET
ihlr-28381	441	12	stakeholders	stakeholder	NOUN
ihlr-28381	441	13	—	—	PUNCT
ihlr-28381	441	14	brand	brand	NOUN
ihlr-28381	441	15	-	-	PUNCT
ihlr-28381	441	16	name	name	NOUN
ihlr-28381	441	17	companies	company	NOUN
ihlr-28381	441	18	,	,	PUNCT
ihlr-28381	441	19	generic	generic	ADJ
ihlr-28381	441	20	companies	company	NOUN
ihlr-28381	441	21	,	,	PUNCT
ihlr-28381	441	22	patients	patient	NOUN
ihlr-28381	441	23	,	,	PUNCT
ihlr-28381	441	24	taxpayers	taxpayer	NOUN
ihlr-28381	441	25	—	—	PUNCT
ihlr-28381	441	26	can	can	AUX
ihlr-28381	441	27	make	make	VERB
ihlr-28381	441	28	and	and	CCONJ
ihlr-28381	441	29	save	save	VERB
ihlr-28381	441	30	money	money	NOUN
ihlr-28381	441	31	together	together	ADV
ihlr-28381	441	32	.	.	PUNCT
ihlr-28381	442	1	an	an	DET
ihlr-28381	442	2	expanded	expand	VERB
ihlr-28381	442	3	prv	prv	PROPN
ihlr-28381	442	4	program	program	NOUN
ihlr-28381	442	5	is	be	AUX
ihlr-28381	442	6	not	not	PART
ihlr-28381	442	7	without	without	ADP
ihlr-28381	442	8	drawbacks	drawback	NOUN
ihlr-28381	442	9	.	.	PUNCT
ihlr-28381	443	1	one	one	NUM
ihlr-28381	443	2	major	major	ADJ
ihlr-28381	443	3	hindrance	hindrance	NOUN
ihlr-28381	443	4	to	to	ADP
ihlr-28381	443	5	prv	prv	PROPN
ihlr-28381	443	6	expansion	expansion	NOUN
ihlr-28381	443	7	is	be	AUX
ihlr-28381	443	8	the	the	DET
ihlr-28381	443	9	inflationary	inflationary	ADJ
ihlr-28381	443	10	effect	effect	NOUN
ihlr-28381	443	11	of	of	ADP
ihlr-28381	443	12	introducing	introduce	VERB
ihlr-28381	443	13	more	more	ADJ
ihlr-28381	443	14	prvs	prvs	NOUN
ihlr-28381	443	15	to	to	ADP
ihlr-28381	443	16	the	the	DET
ihlr-28381	443	17	market	market	NOUN
ihlr-28381	443	18	.	.	PUNCT
ihlr-28381	444	1	however	however	ADV
ihlr-28381	444	2	,	,	PUNCT
ihlr-28381	444	3	if	if	SCONJ
ihlr-28381	444	4	the	the	DET
ihlr-28381	444	5	fda	fda	PROPN
ihlr-28381	444	6	has	have	VERB
ihlr-28381	444	7	the	the	DET
ihlr-28381	444	8	latitude	latitude	NOUN
ihlr-28381	444	9	to	to	PART
ihlr-28381	444	10	tailor	tailor	VERB
ihlr-28381	444	11	the	the	DET
ihlr-28381	444	12	value	value	NOUN
ihlr-28381	444	13	of	of	ADP
ihlr-28381	444	14	the	the	DET
ihlr-28381	444	15	prvs	prvs	NOUN
ihlr-28381	444	16	by	by	ADP
ihlr-28381	444	17	varying	vary	VERB
ihlr-28381	444	18	the	the	DET
ihlr-28381	444	19	timeframes	timeframe	NOUN
ihlr-28381	444	20	and	and	CCONJ
ihlr-28381	444	21	setting	set	VERB
ihlr-28381	444	22	expiration	expiration	NOUN
ihlr-28381	444	23	dates	date	NOUN
ihlr-28381	444	24	,	,	PUNCT
ihlr-28381	444	25	the	the	DET
ihlr-28381	444	26	agency	agency	NOUN
ihlr-28381	444	27	could	could	AUX
ihlr-28381	444	28	ensure	ensure	VERB
ihlr-28381	444	29	the	the	DET
ihlr-28381	444	30	prvs	prvs	NOUN
ihlr-28381	444	31	retain	retain	VERB
ihlr-28381	444	32	value	value	NOUN
ihlr-28381	444	33	regardless	regardless	ADV
ihlr-28381	444	34	of	of	ADP
ihlr-28381	444	35	how	how	SCONJ
ihlr-28381	444	36	many	many	ADJ
ihlr-28381	444	37	are	be	AUX
ihlr-28381	444	38	issued	issue	VERB
ihlr-28381	444	39	.	.	PUNCT
ihlr-28381	445	1	this	this	DET
ihlr-28381	445	2	solution	solution	NOUN
ihlr-28381	445	3	in	in	ADP
ihlr-28381	445	4	turn	turn	NOUN
ihlr-28381	445	5	requires	require	VERB
ihlr-28381	445	6	more	more	ADJ
ihlr-28381	445	7	bandwidth	bandwidth	NOUN
ihlr-28381	445	8	from	from	ADP
ihlr-28381	445	9	the	the	DET
ihlr-28381	445	10	fda	fda	PROPN
ihlr-28381	445	11	,	,	PUNCT
ihlr-28381	445	12	which	which	PRON
ihlr-28381	445	13	is	be	AUX
ihlr-28381	445	14	a	a	DET
ihlr-28381	445	15	drawback	drawback	NOUN
ihlr-28381	445	16	in	in	ADP
ihlr-28381	445	17	its	its	PRON
ihlr-28381	445	18	own	own	ADJ
ihlr-28381	445	19	right	right	NOUN
ihlr-28381	445	20	.	.	PUNCT
ihlr-28381	446	1	if	if	SCONJ
ihlr-28381	446	2	adopted	adopt	VERB
ihlr-28381	446	3	,	,	PUNCT
ihlr-28381	446	4	this	this	DET
ihlr-28381	446	5	expansion	expansion	NOUN
ihlr-28381	446	6	requires	require	VERB
ihlr-28381	446	7	a	a	DET
ihlr-28381	446	8	complementary	complementary	ADJ
ihlr-28381	446	9	increase	increase	NOUN
ihlr-28381	446	10	in	in	ADP
ihlr-28381	446	11	fda	fda	PROPN
ihlr-28381	446	12	funding	funding	NOUN
ihlr-28381	446	13	to	to	PART
ihlr-28381	446	14	make	make	VERB
ihlr-28381	446	15	sure	sure	ADJ
ihlr-28381	446	16	the	the	DET
ihlr-28381	446	17	agency	agency	NOUN
ihlr-28381	446	18	is	be	AUX
ihlr-28381	446	19	appropriately	appropriately	ADV
ihlr-28381	446	20	staffed	staff	VERB
ihlr-28381	446	21	to	to	PART
ihlr-28381	446	22	administer	administer	VERB
ihlr-28381	446	23	the	the	DET
ihlr-28381	446	24	program	program	NOUN
ihlr-28381	446	25	.	.	PUNCT
ihlr-28381	447	1	a	a	DET
ihlr-28381	447	2	prv	prv	PROPN
ihlr-28381	447	3	inventive	inventive	ADJ
ihlr-28381	447	4	program	program	NOUN
ihlr-28381	447	5	could	could	AUX
ihlr-28381	447	6	also	also	ADV
ihlr-28381	447	7	be	be	AUX
ihlr-28381	447	8	improved	improve	VERB
ihlr-28381	447	9	upon	upon	SCONJ
ihlr-28381	447	10	by	by	ADP
ihlr-28381	447	11	designing	design	VERB
ihlr-28381	447	12	a	a	DET
ihlr-28381	447	13	larger	large	ADJ
ihlr-28381	447	14	menu	menu	NOUN
ihlr-28381	447	15	of	of	ADP
ihlr-28381	447	16	incentives	incentive	NOUN
ihlr-28381	447	17	outside	outside	ADP
ihlr-28381	447	18	the	the	DET
ihlr-28381	447	19	scope	scope	NOUN
ihlr-28381	447	20	of	of	ADP
ihlr-28381	447	21	this	this	DET
ihlr-28381	447	22	note	note	NOUN
ihlr-28381	447	23	,	,	PUNCT
ihlr-28381	447	24	such	such	ADJ
ihlr-28381	447	25	as	as	ADP
ihlr-28381	447	26	tax	tax	NOUN
ihlr-28381	447	27	credits	credit	NOUN
ihlr-28381	447	28	and	and	CCONJ
ihlr-28381	447	29	fda	fda	PROPN
ihlr-28381	447	30	user	user	NOUN
ihlr-28381	447	31	fee	fee	NOUN
ihlr-28381	447	32	waivers	waiver	NOUN
ihlr-28381	447	33	.	.	PUNCT
ihlr-28381	448	1	however	however	ADV
ihlr-28381	448	2	,	,	PUNCT
ihlr-28381	448	3	introducing	introduce	VERB
ihlr-28381	448	4	more	more	ADJ
ihlr-28381	448	5	incentives	incentive	NOUN
ihlr-28381	448	6	would	would	AUX
ihlr-28381	448	7	do	do	VERB
ihlr-28381	448	8	little	little	ADJ
ihlr-28381	448	9	,	,	PUNCT
ihlr-28381	448	10	if	if	SCONJ
ihlr-28381	448	11	anything	anything	PRON
ihlr-28381	448	12	,	,	PUNCT
ihlr-28381	448	13	to	to	PART
ihlr-28381	448	14	mitigate	mitigate	VERB
ihlr-28381	448	15	prv	prv	NOUN
ihlr-28381	448	16	-	-	PUNCT
ihlr-28381	448	17	specific	specific	ADJ
ihlr-28381	448	18	drawbacks	drawback	NOUN
ihlr-28381	448	19	,	,	PUNCT
ihlr-28381	448	20	and	and	CCONJ
ihlr-28381	448	21	additional	additional	ADJ
ihlr-28381	448	22	incentives	incentive	NOUN
ihlr-28381	448	23	would	would	AUX
ihlr-28381	448	24	again	again	ADV
ihlr-28381	448	25	implicate	implicate	VERB
ihlr-28381	448	26	fda	fda	PROPN
ihlr-28381	448	27	bandwidth	bandwidth	NOUN
ihlr-28381	448	28	.	.	PUNCT
ihlr-28381	449	1	futility	futility	NOUN
ihlr-28381	449	2	risks	risk	NOUN
ihlr-28381	449	3	ultimately	ultimately	ADV
ihlr-28381	449	4	counsel	counsel	VERB
ihlr-28381	449	5	against	against	ADP
ihlr-28381	449	6	prv	prv	PROPN
ihlr-28381	449	7	expansion	expansion	NOUN
ihlr-28381	449	8	.	.	PUNCT
ihlr-28381	450	1	from	from	ADP
ihlr-28381	450	2	the	the	DET
ihlr-28381	450	3	2009	2009	NUM
ihlr-28381	450	4	inception	inception	NOUN
ihlr-28381	450	5	of	of	ADP
ihlr-28381	450	6	the	the	DET
ihlr-28381	450	7	prv	prv	PROPN
ihlr-28381	450	8	program	program	NOUN
ihlr-28381	450	9	through	through	ADP
ihlr-28381	450	10	2019	2019	NUM
ihlr-28381	450	11	,	,	PUNCT
ihlr-28381	450	12	thirty	thirty	NUM
ihlr-28381	450	13	-	-	PUNCT
ihlr-28381	450	14	one	one	NUM
ihlr-28381	450	15	prvs	prvs	NOUN
ihlr-28381	450	16	had	have	AUX
ihlr-28381	450	17	been	be	AUX
ihlr-28381	450	18	issued	issue	VERB
ihlr-28381	450	19	—	—	PUNCT
ihlr-28381	450	20	seventeen	seventeen	NUM
ihlr-28381	450	21	have	have	AUX
ihlr-28381	450	22	been	be	AUX
ihlr-28381	450	23	sold	sell	VERB
ihlr-28381	450	24	,	,	PUNCT
ihlr-28381	450	25	and	and	CCONJ
ihlr-28381	450	26	sixteen	sixteen	NUM
ihlr-28381	450	27	have	have	AUX
ihlr-28381	450	28	been	be	AUX
ihlr-28381	450	29	redeemed	redeem	VERB
ihlr-28381	450	30	(	(	PUNCT
ihlr-28381	450	31	some	some	DET
ihlr-28381	450	32	prvs	prvs	NOUN
ihlr-28381	450	33	have	have	AUX
ihlr-28381	450	34	been	be	AUX
ihlr-28381	450	35	both	both	PRON
ihlr-28381	450	36	sold	sell	VERB
ihlr-28381	450	37	and	and	CCONJ
ihlr-28381	450	38	redeemed	redeem	VERB
ihlr-28381	450	39	,	,	PUNCT
ihlr-28381	450	40	hence	hence	ADV
ihlr-28381	450	41	the	the	DET
ihlr-28381	450	42	combined	combine	VERB
ihlr-28381	450	43	amount	amount	NOUN
ihlr-28381	450	44	sold	sell	VERB
ihlr-28381	450	45	and	and	CCONJ
ihlr-28381	450	46	redeemed	redeem	VERB
ihlr-28381	450	47	exceeds	exceed	NOUN
ihlr-28381	450	48	the	the	DET
ihlr-28381	450	49	total	total	ADJ
ihlr-28381	450	50	number	number	NOUN
ihlr-28381	450	51	of	of	ADP
ihlr-28381	450	52	prvs	prvs	NOUN
ihlr-28381	450	53	issued).112	issued).112	PROPN
ihlr-28381	450	54	for	for	ADP
ihlr-28381	450	55	an	an	DET
ihlr-28381	450	56	illustration	illustration	NOUN
ihlr-28381	450	57	of	of	ADP
ihlr-28381	450	58	prv	prv	PROPN
ihlr-28381	450	59	issuances	issuance	NOUN
ihlr-28381	450	60	and	and	CCONJ
ihlr-28381	450	61	redemptions	redemption	NOUN
ihlr-28381	450	62	,	,	PUNCT
ihlr-28381	450	63	see	see	VERB
ihlr-28381	450	64	figure	figure	NOUN
ihlr-28381	450	65	2	2	NUM
ihlr-28381	450	66	.	.	PUNCT
ihlr-28381	450	67	figure	figure	VERB
ihlr-28381	450	68	2113	2113	NUM
ihlr-28381	450	69	111	111	NUM
ihlr-28381	450	70	.	.	PUNCT
ihlr-28381	451	1	i	i	PRON
ihlr-28381	451	2	d.	d.	PROPN
ihlr-28381	451	3	112	112	NUM
ihlr-28381	451	4	.	.	PUNCT
ihlr-28381	452	1	u.s	u.s	PROPN
ihlr-28381	452	2	.	.	PROPN
ihlr-28381	452	3	gov’t	gov’t	PROPN
ihlr-28381	452	4	accountability	accountability	NOUN
ihlr-28381	452	5	off	off	ADP
ihlr-28381	452	6	.	.	PUNCT
ihlr-28381	452	7	,	,	PUNCT
ihlr-28381	452	8	supra	supra	PROPN
ihlr-28381	452	9	note	note	PROPN
ihlr-28381	452	10	105	105	NUM
ihlr-28381	452	11	.	.	NOUN
ihlr-28381	452	12	113	113	NUM
ihlr-28381	452	13	.	.	PUNCT
ihlr-28381	453	1	i	i	PRON
ihlr-28381	453	2	d.	d.	PROPN
ihlr-28381	453	3	142	142	NUM
ihlr-28381	453	4	indiana	indiana	PROPN
ihlr-28381	453	5	health	health	PROPN
ihlr-28381	453	6	law	law	PROPN
ihlr-28381	453	7	review	review	NOUN
ihlr-28381	454	1	[	[	X
ihlr-28381	454	2	vol	vol	NOUN
ihlr-28381	454	3	.	.	NOUN
ihlr-28381	454	4	21:121	21:121	NUM
ihlr-28381	454	5	the	the	DET
ihlr-28381	454	6	prv	prv	PROPN
ihlr-28381	454	7	program	program	PROPN
ihlr-28381	454	8	—	—	PUNCT
ihlr-28381	454	9	in	in	ADP
ihlr-28381	454	10	its	its	PRON
ihlr-28381	454	11	fourteenth	fourteenth	ADJ
ihlr-28381	454	12	year	year	NOUN
ihlr-28381	454	13	of	of	ADP
ihlr-28381	454	14	existence	existence	NOUN
ihlr-28381	454	15	in	in	ADP
ihlr-28381	454	16	2023	2023	NUM
ihlr-28381	454	17	—	—	PUNCT
ihlr-28381	454	18	is	be	AUX
ihlr-28381	454	19	already	already	ADV
ihlr-28381	454	20	experiencing	experience	VERB
ihlr-28381	454	21	inflation	inflation	NOUN
ihlr-28381	454	22	which	which	PRON
ihlr-28381	454	23	would	would	AUX
ihlr-28381	454	24	be	be	AUX
ihlr-28381	454	25	exacerbated	exacerbate	VERB
ihlr-28381	454	26	by	by	ADP
ihlr-28381	454	27	a	a	DET
ihlr-28381	454	28	major	major	ADJ
ihlr-28381	454	29	expansion	expansion	NOUN
ihlr-28381	454	30	of	of	ADP
ihlr-28381	454	31	the	the	DET
ihlr-28381	454	32	program	program	NOUN
ihlr-28381	454	33	.	.	PUNCT
ihlr-28381	455	1	the	the	DET
ihlr-28381	455	2	program	program	NOUN
ihlr-28381	455	3	has	have	AUX
ihlr-28381	455	4	already	already	ADV
ihlr-28381	455	5	expanded	expand	VERB
ihlr-28381	455	6	to	to	PART
ihlr-28381	455	7	incentivize	incentivize	VERB
ihlr-28381	455	8	three	three	NUM
ihlr-28381	455	9	distinct	distinct	ADJ
ihlr-28381	455	10	areas	area	NOUN
ihlr-28381	455	11	of	of	ADP
ihlr-28381	455	12	drug	drug	NOUN
ihlr-28381	455	13	development	development	NOUN
ihlr-28381	455	14	,	,	PUNCT
ihlr-28381	455	15	and	and	CCONJ
ihlr-28381	455	16	the	the	DET
ihlr-28381	455	17	marginal	marginal	ADJ
ihlr-28381	455	18	utility	utility	NOUN
ihlr-28381	455	19	of	of	ADP
ihlr-28381	455	20	obtaining	obtain	VERB
ihlr-28381	455	21	a	a	DET
ihlr-28381	455	22	prv	prv	PROPN
ihlr-28381	455	23	shrinks	shrink	VERB
ihlr-28381	455	24	with	with	ADP
ihlr-28381	455	25	each	each	DET
ihlr-28381	455	26	additional	additional	ADJ
ihlr-28381	455	27	prv	prv	PROPN
ihlr-28381	455	28	entering	enter	VERB
ihlr-28381	455	29	circulation	circulation	NOUN
ihlr-28381	455	30	.	.	PUNCT
ihlr-28381	456	1	the	the	DET
ihlr-28381	456	2	steady	steady	ADJ
ihlr-28381	456	3	decrease	decrease	NOUN
ihlr-28381	456	4	in	in	ADP
ihlr-28381	456	5	prv	prv	PROPN
ihlr-28381	456	6	sale	sale	NOUN
ihlr-28381	456	7	prices	price	NOUN
ihlr-28381	456	8	is	be	AUX
ihlr-28381	456	9	depicted	depict	VERB
ihlr-28381	456	10	by	by	ADP
ihlr-28381	456	11	figure	figure	NOUN
ihlr-28381	456	12	3	3	NUM
ihlr-28381	456	13	,	,	PUNCT
ihlr-28381	456	14	below	below	ADV
ihlr-28381	456	15	.	.	PUNCT
ihlr-28381	457	1	figure	figure	NOUN
ihlr-28381	457	2	3114	3114	NUM
ihlr-28381	457	3	if	if	SCONJ
ihlr-28381	457	4	prvs	prvs	NOUN
ihlr-28381	457	5	were	be	AUX
ihlr-28381	457	6	effective	effective	ADJ
ihlr-28381	457	7	incentives	incentive	NOUN
ihlr-28381	457	8	in	in	ADP
ihlr-28381	457	9	the	the	DET
ihlr-28381	457	10	context	context	NOUN
ihlr-28381	457	11	explored	explore	VERB
ihlr-28381	457	12	by	by	ADP
ihlr-28381	457	13	this	this	DET
ihlr-28381	457	14	note	note	NOUN
ihlr-28381	457	15	,	,	PUNCT
ihlr-28381	457	16	many	many	ADJ
ihlr-28381	457	17	would	would	AUX
ihlr-28381	457	18	be	be	AUX
ihlr-28381	457	19	issued	issue	VERB
ihlr-28381	457	20	and	and	CCONJ
ihlr-28381	457	21	drug	drug	NOUN
ihlr-28381	457	22	prices	price	NOUN
ihlr-28381	457	23	would	would	AUX
ihlr-28381	457	24	decrease	decrease	VERB
ihlr-28381	457	25	.	.	PUNCT
ihlr-28381	458	1	however	however	ADV
ihlr-28381	458	2	,	,	PUNCT
ihlr-28381	458	3	increasing	increase	VERB
ihlr-28381	458	4	the	the	DET
ihlr-28381	458	5	prevalence	prevalence	NOUN
ihlr-28381	458	6	of	of	ADP
ihlr-28381	458	7	prvs	prvs	NOUN
ihlr-28381	458	8	would	would	AUX
ihlr-28381	458	9	eventually	eventually	ADV
ihlr-28381	458	10	saturate	saturate	VERB
ihlr-28381	458	11	the	the	DET
ihlr-28381	458	12	prv	prv	PROPN
ihlr-28381	458	13	market	market	NOUN
ihlr-28381	458	14	to	to	ADP
ihlr-28381	458	15	a	a	DET
ihlr-28381	458	16	point	point	NOUN
ihlr-28381	458	17	where	where	SCONJ
ihlr-28381	458	18	the	the	DET
ihlr-28381	458	19	value	value	NOUN
ihlr-28381	458	20	of	of	ADP
ihlr-28381	458	21	earning	earn	VERB
ihlr-28381	458	22	a	a	DET
ihlr-28381	458	23	prv	prv	PROPN
ihlr-28381	458	24	would	would	AUX
ihlr-28381	458	25	seldom	seldom	ADV
ihlr-28381	458	26	rival	rival	VERB
ihlr-28381	458	27	the	the	DET
ihlr-28381	458	28	opportunity	opportunity	NOUN
ihlr-28381	458	29	cost	cost	NOUN
ihlr-28381	458	30	of	of	ADP
ihlr-28381	458	31	delaying	delay	VERB
ihlr-28381	458	32	generic	generic	ADJ
ihlr-28381	458	33	entry	entry	NOUN
ihlr-28381	458	34	.	.	PUNCT
ihlr-28381	459	1	although	although	SCONJ
ihlr-28381	459	2	only	only	ADV
ihlr-28381	459	3	some	some	DET
ihlr-28381	459	4	prv	prv	PROPN
ihlr-28381	459	5	sale	sale	NOUN
ihlr-28381	459	6	prices	price	NOUN
ihlr-28381	459	7	have	have	AUX
ihlr-28381	459	8	been	be	AUX
ihlr-28381	459	9	publicized	publicize	VERB
ihlr-28381	459	10	,	,	PUNCT
ihlr-28381	459	11	it	it	PRON
ihlr-28381	459	12	is	be	AUX
ihlr-28381	459	13	difficult	difficult	ADJ
ihlr-28381	459	14	to	to	PART
ihlr-28381	459	15	dispute	dispute	VERB
ihlr-28381	459	16	the	the	DET
ihlr-28381	459	17	economic	economic	ADJ
ihlr-28381	459	18	reasoning	reasoning	NOUN
ihlr-28381	459	19	that	that	SCONJ
ihlr-28381	459	20	higher	high	ADJ
ihlr-28381	459	21	prv	prv	PROPN
ihlr-28381	459	22	supply	supply	NOUN
ihlr-28381	459	23	causes	cause	VERB
ihlr-28381	459	24	lower	low	ADJ
ihlr-28381	459	25	prv	prv	PROPN
ihlr-28381	459	26	demand	demand	NOUN
ihlr-28381	459	27	,	,	PUNCT
ihlr-28381	459	28	and	and	CCONJ
ihlr-28381	459	29	thus	thus	ADV
ihlr-28381	459	30	lower	low	ADJ
ihlr-28381	459	31	prv	prv	PROPN
ihlr-28381	459	32	sale	sale	NOUN
ihlr-28381	459	33	prices	price	NOUN
ihlr-28381	459	34	.	.	PUNCT
ihlr-28381	460	1	in	in	ADP
ihlr-28381	460	2	other	other	ADJ
ihlr-28381	460	3	words	word	NOUN
ihlr-28381	460	4	,	,	PUNCT
ihlr-28381	460	5	the	the	DET
ihlr-28381	460	6	program	program	NOUN
ihlr-28381	460	7	’s	’s	PART
ihlr-28381	460	8	success	success	NOUN
ihlr-28381	460	9	in	in	ADP
ihlr-28381	460	10	lowering	lower	VERB
ihlr-28381	460	11	drug	drug	NOUN
ihlr-28381	460	12	prices	price	NOUN
ihlr-28381	460	13	would	would	AUX
ihlr-28381	460	14	be	be	AUX
ihlr-28381	460	15	unlikely	unlikely	ADJ
ihlr-28381	460	16	to	to	PART
ihlr-28381	460	17	last	last	VERB
ihlr-28381	460	18	.	.	PUNCT
ihlr-28381	461	1	this	this	PRON
ihlr-28381	461	2	is	be	AUX
ihlr-28381	461	3	not	not	PART
ihlr-28381	461	4	to	to	PART
ihlr-28381	461	5	say	say	VERB
ihlr-28381	461	6	the	the	DET
ihlr-28381	461	7	prvs	prvs	NOUN
ihlr-28381	461	8	would	would	AUX
ihlr-28381	461	9	ever	ever	ADV
ihlr-28381	461	10	be	be	AUX
ihlr-28381	461	11	valueless	valueless	NOUN
ihlr-28381	461	12	,	,	PUNCT
ihlr-28381	461	13	but	but	CCONJ
ihlr-28381	461	14	as	as	ADP
ihlr-28381	461	15	more	more	ADJ
ihlr-28381	461	16	prvs	prvs	NOUN
ihlr-28381	461	17	are	be	AUX
ihlr-28381	461	18	issued	issue	VERB
ihlr-28381	461	19	it	it	PRON
ihlr-28381	461	20	becomes	become	VERB
ihlr-28381	461	21	less	less	ADV
ihlr-28381	461	22	and	and	CCONJ
ihlr-28381	461	23	less	less	ADV
ihlr-28381	461	24	likely	likely	ADJ
ihlr-28381	461	25	that	that	SCONJ
ihlr-28381	461	26	the	the	DET
ihlr-28381	461	27	prvs	prvs	NOUN
ihlr-28381	461	28	value	value	NOUN
ihlr-28381	461	29	would	would	AUX
ihlr-28381	461	30	outweigh	outweigh	VERB
ihlr-28381	461	31	the	the	DET
ihlr-28381	461	32	value	value	NOUN
ihlr-28381	461	33	of	of	ADP
ihlr-28381	461	34	longer	long	ADJ
ihlr-28381	461	35	market	market	NOUN
ihlr-28381	461	36	exclusivity	exclusivity	NOUN
ihlr-28381	461	37	.	.	PUNCT
ihlr-28381	462	1	the	the	DET
ihlr-28381	462	2	prv	prv	PROPN
ihlr-28381	462	3	program	program	PROPN
ihlr-28381	462	4	has	have	AUX
ihlr-28381	462	5	already	already	ADV
ihlr-28381	462	6	expanded	expand	VERB
ihlr-28381	462	7	to	to	PART
ihlr-28381	462	8	include	include	VERB
ihlr-28381	462	9	three	three	NUM
ihlr-28381	462	10	areas	area	NOUN
ihlr-28381	462	11	,	,	PUNCT
ihlr-28381	462	12	and	and	CCONJ
ihlr-28381	462	13	expanding	expand	VERB
ihlr-28381	462	14	it	it	PRON
ihlr-28381	462	15	once	once	ADV
ihlr-28381	462	16	again	again	ADV
ihlr-28381	462	17	to	to	PART
ihlr-28381	462	18	encourage	encourage	VERB
ihlr-28381	462	19	indefinite	indefinite	ADJ
ihlr-28381	462	20	prv	prv	PROPN
ihlr-28381	462	21	issuances	issuance	NOUN
ihlr-28381	462	22	could	could	AUX
ihlr-28381	462	23	quickly	quickly	ADV
ihlr-28381	462	24	exhaust	exhaust	VERB
ihlr-28381	462	25	the	the	DET
ihlr-28381	462	26	program	program	NOUN
ihlr-28381	462	27	’s	’s	PART
ihlr-28381	462	28	value	value	NOUN
ihlr-28381	462	29	.	.	PUNCT
ihlr-28381	463	1	not	not	PART
ihlr-28381	463	2	only	only	ADV
ihlr-28381	463	3	would	would	AUX
ihlr-28381	463	4	this	this	PRON
ihlr-28381	463	5	render	render	VERB
ihlr-28381	463	6	prvs	prvs	NOUN
ihlr-28381	463	7	moot	moot	NOUN
ihlr-28381	463	8	as	as	ADP
ihlr-28381	463	9	an	an	DET
ihlr-28381	463	10	incentive	incentive	NOUN
ihlr-28381	463	11	to	to	PART
ihlr-28381	463	12	price	price	NOUN
ihlr-28381	463	13	reduction	reduction	NOUN
ihlr-28381	463	14	,	,	PUNCT
ihlr-28381	463	15	but	but	CCONJ
ihlr-28381	463	16	the	the	DET
ihlr-28381	463	17	inflationary	inflationary	ADJ
ihlr-28381	463	18	harm	harm	NOUN
ihlr-28381	463	19	would	would	AUX
ihlr-28381	463	20	metastasize	metastasize	VERB
ihlr-28381	463	21	to	to	ADP
ihlr-28381	463	22	existing	exist	VERB
ihlr-28381	463	23	targets	target	NOUN
ihlr-28381	463	24	of	of	ADP
ihlr-28381	463	25	the	the	DET
ihlr-28381	463	26	prv	prv	PROPN
ihlr-28381	463	27	incentive	incentive	PROPN
ihlr-28381	463	28	program	program	NOUN
ihlr-28381	463	29	,	,	PUNCT
ihlr-28381	463	30	namely	namely	ADV
ihlr-28381	463	31	tropical	tropical	ADJ
ihlr-28381	463	32	disease	disease	NOUN
ihlr-28381	463	33	,	,	PUNCT
ihlr-28381	463	34	rare	rare	ADJ
ihlr-28381	463	35	pediatric	pediatric	ADJ
ihlr-28381	463	36	disease	disease	NOUN
ihlr-28381	463	37	,	,	PUNCT
ihlr-28381	463	38	and	and	CCONJ
ihlr-28381	463	39	public	public	ADJ
ihlr-28381	463	40	health	health	NOUN
ihlr-28381	463	41	emergency	emergency	NOUN
ihlr-28381	463	42	countermeasures	countermeasure	NOUN
ihlr-28381	463	43	.	.	PUNCT
ihlr-28381	464	1	furthermore	furthermore	ADV
ihlr-28381	464	2	,	,	PUNCT
ihlr-28381	464	3	fda	fda	PROPN
ihlr-28381	464	4	bandwidth	bandwidth	NOUN
ihlr-28381	464	5	is	be	AUX
ihlr-28381	464	6	finite	finite	ADJ
ihlr-28381	464	7	.	.	PUNCT
ihlr-28381	465	1	the	the	DET
ihlr-28381	465	2	program	program	NOUN
ihlr-28381	465	3	’s	’s	PART
ihlr-28381	465	4	success	success	NOUN
ihlr-28381	465	5	and	and	CCONJ
ihlr-28381	465	6	more	more	ADJ
ihlr-28381	465	7	prv	prv	PROPN
ihlr-28381	465	8	issuances	issuance	NOUN
ihlr-28381	465	9	would	would	AUX
ihlr-28381	465	10	strain	strain	VERB
ihlr-28381	465	11	fda	fda	PROPN
ihlr-28381	465	12	resources	resource	NOUN
ihlr-28381	465	13	.	.	PUNCT
ihlr-28381	466	1	eventually	eventually	ADV
ihlr-28381	466	2	,	,	PUNCT
ihlr-28381	466	3	it	it	PRON
ihlr-28381	466	4	would	would	AUX
ihlr-28381	466	5	be	be	AUX
ihlr-28381	466	6	impossible	impossible	ADJ
ihlr-28381	466	7	for	for	ADP
ihlr-28381	466	8	the	the	DET
ihlr-28381	466	9	114	114	NUM
ihlr-28381	466	10	.	.	PUNCT
ihlr-28381	467	1	i	i	PRON
ihlr-28381	467	2	d.	d.	PROPN
ihlr-28381	467	3	at	at	ADP
ihlr-28381	467	4	15	15	NUM
ihlr-28381	467	5	.	.	PUNCT
ihlr-28381	467	6	2024	2024	NUM
ihlr-28381	467	7	]	]	PUNCT
ihlr-28381	467	8	incentivizing	incentivize	VERB
ihlr-28381	467	9	drug	drug	NOUN
ihlr-28381	467	10	affordability	affordability	NOUN
ihlr-28381	467	11	143	143	NUM
ihlr-28381	467	12	fda	fda	PROPN
ihlr-28381	467	13	to	to	PART
ihlr-28381	467	14	meet	meet	VERB
ihlr-28381	467	15	the	the	DET
ihlr-28381	467	16	shorter	short	ADJ
ihlr-28381	467	17	timeframes	timeframe	NOUN
ihlr-28381	467	18	of	of	ADP
ihlr-28381	467	19	priority	priority	NOUN
ihlr-28381	467	20	review	review	NOUN
ihlr-28381	467	21	.	.	PUNCT
ihlr-28381	468	1	there	there	PRON
ihlr-28381	468	2	are	be	VERB
ihlr-28381	468	3	already	already	ADV
ihlr-28381	468	4	examples	example	NOUN
ihlr-28381	468	5	where	where	SCONJ
ihlr-28381	468	6	the	the	DET
ihlr-28381	468	7	fda	fda	PROPN
ihlr-28381	468	8	had	have	VERB
ihlr-28381	468	9	to	to	PART
ihlr-28381	468	10	extend	extend	VERB
ihlr-28381	468	11	prv	prv	PROPN
ihlr-28381	468	12	deadlines	deadline	NOUN
ihlr-28381	468	13	,	,	PUNCT
ihlr-28381	468	14	thereby	thereby	ADV
ihlr-28381	468	15	muting	mute	VERB
ihlr-28381	468	16	the	the	DET
ihlr-28381	468	17	advantage	advantage	NOUN
ihlr-28381	468	18	of	of	ADP
ihlr-28381	468	19	using	use	VERB
ihlr-28381	468	20	a	a	DET
ihlr-28381	468	21	prv	prv	PROPN
ihlr-28381	468	22	.	.	PUNCT
ihlr-28381	469	1	in	in	ADP
ihlr-28381	469	2	november	november	PROPN
ihlr-28381	469	3	2022	2022	NUM
ihlr-28381	469	4	,	,	PUNCT
ihlr-28381	469	5	argenyx	argenyx	PROPN
ihlr-28381	469	6	spent	spend	VERB
ihlr-28381	469	7	$	$	SYM
ihlr-28381	469	8	102	102	NUM
ihlr-28381	469	9	million	million	NUM
ihlr-28381	469	10	acquiring	acquire	VERB
ihlr-28381	469	11	a	a	DET
ihlr-28381	469	12	prv	prv	NOUN
ihlr-28381	469	13	from	from	ADP
ihlr-28381	469	14	bluebird	bluebird	PROPN
ihlr-28381	469	15	bio	bio	PROPN
ihlr-28381	469	16	,	,	PUNCT
ihlr-28381	469	17	which	which	DET
ihlr-28381	469	18	argenyx	argenyx	PROPN
ihlr-28381	469	19	submitted	submit	VERB
ihlr-28381	469	20	to	to	PART
ihlr-28381	469	21	shorten	shorten	VERB
ihlr-28381	469	22	fda	fda	PROPN
ihlr-28381	469	23	review	review	PROPN
ihlr-28381	469	24	of	of	ADP
ihlr-28381	469	25	vygart	vygart	NOUN
ihlr-28381	469	26	—	—	PUNCT
ihlr-28381	469	27	used	use	VERB
ihlr-28381	469	28	to	to	PART
ihlr-28381	469	29	treat	treat	VERB
ihlr-28381	469	30	generalized	generalized	ADJ
ihlr-28381	469	31	myasthenia	myasthenia	NOUN
ihlr-28381	469	32	gravis	gravis	NOUN
ihlr-28381	469	33	in	in	ADP
ihlr-28381	469	34	adults	adult	NOUN
ihlr-28381	469	35	—	—	PUNCT
ihlr-28381	469	36	by	by	ADP
ihlr-28381	469	37	four	four	NUM
ihlr-28381	469	38	months.115	months.115	NOUN
ihlr-28381	469	39	in	in	ADP
ihlr-28381	469	40	january	january	PROPN
ihlr-28381	469	41	2023	2023	NUM
ihlr-28381	469	42	,	,	PUNCT
ihlr-28381	469	43	the	the	PRON
ihlr-28381	469	44	fda	fda	PROPN
ihlr-28381	469	45	informed	inform	VERB
ihlr-28381	469	46	argenyx	argenyx	PROPN
ihlr-28381	469	47	that	that	SCONJ
ihlr-28381	469	48	the	the	DET
ihlr-28381	469	49	pdufa	pdufa	NOUN
ihlr-28381	469	50	date	date	NOUN
ihlr-28381	469	51	(	(	PUNCT
ihlr-28381	469	52	prescription	prescription	NOUN
ihlr-28381	469	53	drug	drug	NOUN
ihlr-28381	469	54	user	user	NOUN
ihlr-28381	469	55	fee	fee	PROPN
ihlr-28381	469	56	act	act	PROPN
ihlr-28381	469	57	date	date	NOUN
ihlr-28381	469	58	;	;	PUNCT
ihlr-28381	469	59	the	the	DET
ihlr-28381	469	60	date	date	NOUN
ihlr-28381	469	61	by	by	ADP
ihlr-28381	469	62	which	which	PRON
ihlr-28381	469	63	fda	fda	PROPN
ihlr-28381	469	64	must	must	AUX
ihlr-28381	469	65	respond	respond	VERB
ihlr-28381	469	66	to	to	ADP
ihlr-28381	469	67	new	new	ADJ
ihlr-28381	469	68	drug	drug	NOUN
ihlr-28381	469	69	applications	application	NOUN
ihlr-28381	469	70	)	)	PUNCT
ihlr-28381	469	71	would	would	AUX
ihlr-28381	469	72	be	be	AUX
ihlr-28381	469	73	extended	extend	VERB
ihlr-28381	469	74	from	from	ADP
ihlr-28381	469	75	march	march	PROPN
ihlr-28381	469	76	20	20	NUM
ihlr-28381	469	77	,	,	PUNCT
ihlr-28381	469	78	2023	2023	NUM
ihlr-28381	469	79	to	to	ADP
ihlr-28381	469	80	june	june	PROPN
ihlr-28381	469	81	20	20	NUM
ihlr-28381	469	82	,	,	PUNCT
ihlr-28381	469	83	2023	2023	NUM
ihlr-28381	469	84	“	"	PUNCT
ihlr-28381	469	85	to	to	PART
ihlr-28381	469	86	allow	allow	VERB
ihlr-28381	469	87	sufficient	sufficient	ADJ
ihlr-28381	469	88	time	time	NOUN
ihlr-28381	469	89	to	to	PART
ihlr-28381	469	90	review	review	VERB
ihlr-28381	469	91	.	.	PUNCT
ihlr-28381	469	92	”116	”116	PUNCT
ihlr-28381	470	1	another	another	DET
ihlr-28381	470	2	recent	recent	ADJ
ihlr-28381	470	3	example	example	NOUN
ihlr-28381	470	4	of	of	ADP
ihlr-28381	470	5	the	the	DET
ihlr-28381	470	6	fda	fda	PROPN
ihlr-28381	470	7	’s	’s	PART
ihlr-28381	470	8	bounded	bounded	ADJ
ihlr-28381	470	9	capacity	capacity	NOUN
ihlr-28381	470	10	impacted	impact	VERB
ihlr-28381	470	11	japan	japan	PROPN
ihlr-28381	470	12	-	-	PUNCT
ihlr-28381	470	13	based	base	VERB
ihlr-28381	470	14	astellas	astellas	NOUN
ihlr-28381	470	15	pharma	pharma	PROPN
ihlr-28381	470	16	and	and	CCONJ
ihlr-28381	470	17	the	the	DET
ihlr-28381	470	18	company	company	NOUN
ihlr-28381	470	19	’s	’s	PART
ihlr-28381	470	20	menopause	menopause	NOUN
ihlr-28381	470	21	drug	drug	NOUN
ihlr-28381	470	22	candidate	candidate	NOUN
ihlr-28381	470	23	,	,	PUNCT
ihlr-28381	470	24	fezolinetant	fezolinetant	ADJ
ihlr-28381	470	25	.	.	PUNCT
ihlr-28381	471	1	in	in	ADP
ihlr-28381	471	2	a	a	DET
ihlr-28381	471	3	high	high	ADJ
ihlr-28381	471	4	-	-	PUNCT
ihlr-28381	471	5	stakes	stake	NOUN
ihlr-28381	471	6	push	push	VERB
ihlr-28381	471	7	to	to	PART
ihlr-28381	471	8	be	be	AUX
ihlr-28381	471	9	the	the	DET
ihlr-28381	471	10	first	first	ADJ
ihlr-28381	471	11	to	to	ADP
ihlr-28381	471	12	market	market	NOUN
ihlr-28381	471	13	,	,	PUNCT
ihlr-28381	471	14	astellas	astella	NOUN
ihlr-28381	471	15	used	use	VERB
ihlr-28381	471	16	a	a	DET
ihlr-28381	471	17	prv	prv	PROPN
ihlr-28381	471	18	—	—	PUNCT
ihlr-28381	471	19	valued	value	VERB
ihlr-28381	471	20	at	at	ADP
ihlr-28381	471	21	$	$	SYM
ihlr-28381	471	22	97	97	NUM
ihlr-28381	471	23	million	million	NUM
ihlr-28381	471	24	on	on	ADP
ihlr-28381	471	25	astellas	astella	NOUN
ihlr-28381	471	26	’	'	PUNCT
ihlr-28381	471	27	books	book	NOUN
ihlr-28381	471	28	—	—	PUNCT
ihlr-28381	471	29	to	to	PART
ihlr-28381	471	30	trim	trim	VERB
ihlr-28381	471	31	four	four	NUM
ihlr-28381	471	32	months	month	NOUN
ihlr-28381	471	33	off	off	ADP
ihlr-28381	471	34	the	the	DET
ihlr-28381	471	35	fda	fda	PROPN
ihlr-28381	471	36	’s	’s	PART
ihlr-28381	471	37	review	review	NOUN
ihlr-28381	471	38	of	of	ADP
ihlr-28381	471	39	fezolinetant	fezolinetant	NOUN
ihlr-28381	471	40	,	,	PUNCT
ihlr-28381	471	41	establishing	establish	VERB
ihlr-28381	471	42	a	a	DET
ihlr-28381	471	43	pdufa	pdufa	NOUN
ihlr-28381	471	44	date	date	NOUN
ihlr-28381	471	45	of	of	ADP
ihlr-28381	471	46	february	february	PROPN
ihlr-28381	471	47	22	22	NUM
ihlr-28381	471	48	,	,	PUNCT
ihlr-28381	471	49	2023.117	2023.117	NUM
ihlr-28381	471	50	on	on	ADP
ihlr-28381	471	51	february	february	PROPN
ihlr-28381	471	52	,	,	PUNCT
ihlr-28381	471	53	17	17	NUM
ihlr-28381	471	54	—	—	PUNCT
ihlr-28381	471	55	just	just	ADV
ihlr-28381	471	56	five	five	NUM
ihlr-28381	471	57	days	day	NOUN
ihlr-28381	471	58	before	before	ADP
ihlr-28381	471	59	the	the	DET
ihlr-28381	471	60	deadline	deadline	NOUN
ihlr-28381	471	61	—	—	PUNCT
ihlr-28381	471	62	astellas	astella	NOUN
ihlr-28381	471	63	was	be	AUX
ihlr-28381	471	64	notified	notify	VERB
ihlr-28381	471	65	“	"	PUNCT
ihlr-28381	471	66	that	that	SCONJ
ihlr-28381	471	67	the	the	DET
ihlr-28381	471	68	fda	fda	PROPN
ihlr-28381	471	69	is	be	AUX
ihlr-28381	471	70	extending	extend	VERB
ihlr-28381	471	71	the	the	DET
ihlr-28381	471	72	pdufa	pdufa	NOUN
ihlr-28381	471	73	goal	goal	NOUN
ihlr-28381	471	74	date	date	NOUN
ihlr-28381	471	75	by	by	ADP
ihlr-28381	471	76	three	three	NUM
ihlr-28381	471	77	months	month	NOUN
ihlr-28381	471	78	,	,	PUNCT
ihlr-28381	471	79	to	to	PART
ihlr-28381	471	80	may	may	PROPN
ihlr-28381	471	81	22	22	NUM
ihlr-28381	471	82	,	,	PUNCT
ihlr-28381	471	83	2023	2023	NUM
ihlr-28381	471	84	,	,	PUNCT
ihlr-28381	471	85	to	to	PART
ihlr-28381	471	86	allow	allow	VERB
ihlr-28381	471	87	more	more	ADJ
ihlr-28381	471	88	time	time	NOUN
ihlr-28381	471	89	to	to	PART
ihlr-28381	471	90	complete	complete	VERB
ihlr-28381	471	91	their	their	PRON
ihlr-28381	471	92	review	review	NOUN
ihlr-28381	471	93	.	.	PUNCT
ihlr-28381	472	1	”118	”118	VERB
ihlr-28381	473	1	the	the	DET
ihlr-28381	473	2	institute	institute	NOUN
ihlr-28381	473	3	for	for	ADP
ihlr-28381	473	4	clinical	clinical	ADJ
ihlr-28381	473	5	and	and	CCONJ
ihlr-28381	473	6	economic	economic	ADJ
ihlr-28381	473	7	review	review	NOUN
ihlr-28381	473	8	(	(	PUNCT
ihlr-28381	473	9	icer)—a	icer)—a	ADJ
ihlr-28381	473	10	nonprofit	nonprofit	NOUN
ihlr-28381	473	11	dedicated	dedicated	ADJ
ihlr-28381	473	12	to	to	ADP
ihlr-28381	473	13	studying	study	VERB
ihlr-28381	473	14	the	the	DET
ihlr-28381	473	15	cost	cost	NOUN
ihlr-28381	473	16	-	-	PUNCT
ihlr-28381	473	17	effectiveness	effectiveness	NOUN
ihlr-28381	473	18	of	of	ADP
ihlr-28381	473	19	medicine	medicine	NOUN
ihlr-28381	473	20	—	—	PUNCT
ihlr-28381	473	21	estimated	estimate	VERB
ihlr-28381	473	22	that	that	SCONJ
ihlr-28381	473	23	3,340,000	3,340,000	NUM
ihlr-28381	473	24	patients	patient	NOUN
ihlr-28381	473	25	would	would	AUX
ihlr-28381	473	26	begin	begin	VERB
ihlr-28381	473	27	fezolinetant	fezolinetant	ADJ
ihlr-28381	473	28	treatment	treatment	NOUN
ihlr-28381	473	29	each	each	DET
ihlr-28381	473	30	year	year	NOUN
ihlr-28381	473	31	,	,	PUNCT
ihlr-28381	473	32	and	and	CCONJ
ihlr-28381	473	33	recommended	recommend	VERB
ihlr-28381	473	34	a	a	DET
ihlr-28381	473	35	price	price	NOUN
ihlr-28381	473	36	between	between	ADP
ihlr-28381	473	37	$	$	SYM
ihlr-28381	473	38	2,000	2,000	NUM
ihlr-28381	473	39	and	and	CCONJ
ihlr-28381	473	40	$	$	SYM
ihlr-28381	473	41	2,500	2,500	NUM
ihlr-28381	473	42	per	per	ADP
ihlr-28381	473	43	year.119	year.119	NOUN
ihlr-28381	473	44	assuming	assume	VERB
ihlr-28381	473	45	approval	approval	NOUN
ihlr-28381	473	46	and	and	CCONJ
ihlr-28381	473	47	a	a	DET
ihlr-28381	473	48	highly	highly	ADV
ihlr-28381	473	49	efficient	efficient	ADJ
ihlr-28381	473	50	launch	launch	NOUN
ihlr-28381	473	51	,	,	PUNCT
ihlr-28381	473	52	the	the	DET
ihlr-28381	473	53	three	three	NUM
ihlr-28381	473	54	-	-	PUNCT
ihlr-28381	473	55	month	month	NOUN
ihlr-28381	473	56	delay	delay	NOUN
ihlr-28381	473	57	could	could	AUX
ihlr-28381	473	58	directly	directly	ADV
ihlr-28381	473	59	reduce	reduce	VERB
ihlr-28381	473	60	astellas	astella	NOUN
ihlr-28381	473	61	’	'	PUNCT
ihlr-28381	473	62	fezolinetant	fezolinetant	ADJ
ihlr-28381	473	63	sales	sale	NOUN
ihlr-28381	473	64	by	by	ADP
ihlr-28381	473	65	hundreds	hundred	NOUN
ihlr-28381	473	66	of	of	ADP
ihlr-28381	473	67	millions	million	NOUN
ihlr-28381	473	68	of	of	ADP
ihlr-28381	473	69	dollars	dollar	NOUN
ihlr-28381	473	70	.	.	PUNCT
ihlr-28381	474	1	the	the	DET
ihlr-28381	474	2	pertinent	pertinent	ADJ
ihlr-28381	474	3	point	point	NOUN
ihlr-28381	474	4	here	here	ADV
ihlr-28381	474	5	,	,	PUNCT
ihlr-28381	474	6	however	however	ADV
ihlr-28381	474	7	,	,	PUNCT
ihlr-28381	474	8	is	be	AUX
ihlr-28381	474	9	that	that	SCONJ
ihlr-28381	474	10	the	the	DET
ihlr-28381	474	11	prv	prv	PROPN
ihlr-28381	474	12	failed	fail	VERB
ihlr-28381	474	13	to	to	PART
ihlr-28381	474	14	materialize	materialize	VERB
ihlr-28381	474	15	into	into	ADP
ihlr-28381	474	16	any	any	DET
ihlr-28381	474	17	competitive	competitive	ADJ
ihlr-28381	474	18	advantage	advantage	NOUN
ihlr-28381	474	19	.	.	PUNCT
ihlr-28381	475	1	the	the	DET
ihlr-28381	475	2	setbacks	setback	NOUN
ihlr-28381	475	3	befalling	befall	VERB
ihlr-28381	475	4	argenyx	argenyx	NOUN
ihlr-28381	475	5	and	and	CCONJ
ihlr-28381	475	6	astellas	astellas	NOUN
ihlr-28381	475	7	highlight	highlight	VERB
ihlr-28381	475	8	the	the	DET
ihlr-28381	475	9	boundaries	boundary	NOUN
ihlr-28381	475	10	of	of	ADP
ihlr-28381	475	11	fda	fda	PROPN
ihlr-28381	475	12	capacity	capacity	NOUN
ihlr-28381	475	13	in	in	ADP
ihlr-28381	475	14	the	the	DET
ihlr-28381	475	15	priority	priority	NOUN
ihlr-28381	475	16	review	review	NOUN
ihlr-28381	475	17	context	context	NOUN
ihlr-28381	475	18	and	and	CCONJ
ihlr-28381	475	19	suggest	suggest	VERB
ihlr-28381	475	20	that	that	SCONJ
ihlr-28381	475	21	the	the	DET
ihlr-28381	475	22	effect	effect	NOUN
ihlr-28381	475	23	of	of	ADP
ihlr-28381	475	24	prv	prv	PROPN
ihlr-28381	475	25	expansion	expansion	NOUN
ihlr-28381	475	26	explored	explore	VERB
ihlr-28381	475	27	in	in	ADP
ihlr-28381	475	28	this	this	DET
ihlr-28381	475	29	note	note	NOUN
ihlr-28381	475	30	,	,	PUNCT
ihlr-28381	475	31	even	even	ADV
ihlr-28381	475	32	if	if	SCONJ
ihlr-28381	475	33	authorized	authorize	VERB
ihlr-28381	475	34	by	by	ADP
ihlr-28381	475	35	congress	congress	PROPN
ihlr-28381	475	36	,	,	PUNCT
ihlr-28381	475	37	would	would	AUX
ihlr-28381	475	38	struggle	struggle	VERB
ihlr-28381	475	39	to	to	PART
ihlr-28381	475	40	materialize	materialize	VERB
ihlr-28381	475	41	at	at	ADP
ihlr-28381	475	42	scale	scale	NOUN
ihlr-28381	475	43	.	.	PUNCT
ihlr-28381	476	1	115	115	NUM
ihlr-28381	476	2	.	.	PUNCT
ihlr-28381	477	1	nicole	nicole	PROPN
ihlr-28381	477	2	defeudis	defeudis	PROPN
ihlr-28381	477	3	,	,	PUNCT
ihlr-28381	477	4	argenx	argenx	NOUN
ihlr-28381	477	5	purchases	purchase	VERB
ihlr-28381	477	6	$	$	SYM
ihlr-28381	477	7	100m+	100m+	NUM
ihlr-28381	477	8	fda	fda	PROPN
ihlr-28381	477	9	priority	priority	PROPN
ihlr-28381	477	10	review	review	PROPN
ihlr-28381	477	11	voucher	voucher	ADV
ihlr-28381	477	12	from	from	ADP
ihlr-28381	477	13	bluebird	bluebird	PROPN
ihlr-28381	477	14	bio	bio	PROPN
ihlr-28381	477	15	,	,	PUNCT
ihlr-28381	477	16	endpoints	endpoint	VERB
ihlr-28381	477	17	news	news	PROPN
ihlr-28381	477	18	(	(	PUNCT
ihlr-28381	477	19	nov	nov	PROPN
ihlr-28381	477	20	.	.	PROPN
ihlr-28381	477	21	30	30	NUM
ihlr-28381	477	22	,	,	PUNCT
ihlr-28381	477	23	2022	2022	NUM
ihlr-28381	477	24	)	)	PUNCT
ihlr-28381	477	25	,	,	PUNCT
ihlr-28381	477	26	https://endpts.com/argenx-purchases-100m-fdapriority-review-voucher-from-bluebird-bio/	https://endpts.com/argenx-purchases-100m-fdapriority-review-voucher-from-bluebird-bio/	PROPN
ihlr-28381	478	1	[	[	X
ihlr-28381	478	2	https://perma.cc/tf3q-nnms	https://perma.cc/tf3q-nnms	X
ihlr-28381	478	3	]	]	PUNCT
ihlr-28381	478	4	.	.	PUNCT
ihlr-28381	479	1	116	116	NUM
ihlr-28381	479	2	.	.	PUNCT
ihlr-28381	480	1	argenyx	argenyx	PROPN
ihlr-28381	480	2	receives	receive	VERB
ihlr-28381	480	3	notification	notification	NOUN
ihlr-28381	480	4	of	of	ADP
ihlr-28381	480	5	pdufa	pdufa	NOUN
ihlr-28381	480	6	date	date	NOUN
ihlr-28381	480	7	extension	extension	NOUN
ihlr-28381	480	8	for	for	ADP
ihlr-28381	480	9	sc	sc	PROPN
ihlr-28381	480	10	efgartigimod	efgartigimod	NOUN
ihlr-28381	480	11	,	,	PUNCT
ihlr-28381	480	12	globenewswire	globenewswire	NOUN
ihlr-28381	480	13	(	(	PUNCT
ihlr-28381	480	14	jan	jan	PROPN
ihlr-28381	480	15	.	.	PROPN
ihlr-28381	480	16	27	27	NUM
ihlr-28381	480	17	,	,	PUNCT
ihlr-28381	480	18	2023	2023	NUM
ihlr-28381	480	19	)	)	PUNCT
ihlr-28381	480	20	,	,	PUNCT
ihlr-28381	480	21	https://www.globenewswire.com/news-release/2023/01/	https://www.globenewswire.com/news-release/2023/01/	PROPN
ihlr-28381	480	22	27/2596602/0	27/2596602/0	NUM
ihlr-28381	480	23	/	/	SYM
ihlr-28381	480	24	en	en	NOUN
ihlr-28381	480	25	/	/	SYM
ihlr-28381	480	26	argenx	argenx	NOUN
ihlr-28381	480	27	-	-	PUNCT
ihlr-28381	480	28	receives	receive	NOUN
ihlr-28381	480	29	-	-	PUNCT
ihlr-28381	480	30	notification	notification	NOUN
ihlr-28381	480	31	-	-	PUNCT
ihlr-28381	480	32	of	of	ADP
ihlr-28381	480	33	-	-	PUNCT
ihlr-28381	480	34	pdufa	pdufa	NOUN
ihlr-28381	480	35	-	-	PUNCT
ihlr-28381	480	36	date	date	NOUN
ihlr-28381	480	37	-	-	PUNCT
ihlr-28381	480	38	extension	extension	NOUN
ihlr-28381	480	39	-	-	PUNCT
ihlr-28381	480	40	for	for	ADP
ihlr-28381	480	41	-	-	PUNCT
ihlr-28381	480	42	scefgartigimod.html	scefgartigimod.html	NOUN
ihlr-28381	480	43	[	[	X
ihlr-28381	480	44	https://perma.cc/dk7b-ka8b	https://perma.cc/dk7b-ka8b	NOUN
ihlr-28381	480	45	]	]	X
ihlr-28381	480	46	.	.	PUNCT
ihlr-28381	481	1	117	117	NUM
ihlr-28381	481	2	.	.	PUNCT
ihlr-28381	482	1	katherine	katherine	PROPN
ihlr-28381	482	2	lewin	lewin	PROPN
ihlr-28381	482	3	,	,	PUNCT
ihlr-28381	482	4	astellas	astellas	NOUN
ihlr-28381	482	5	'	'	PART
ihlr-28381	482	6	menopause	menopause	NOUN
ihlr-28381	482	7	drug	drug	NOUN
ihlr-28381	482	8	hit	hit	VERB
ihlr-28381	482	9	by	by	ADP
ihlr-28381	482	10	fda	fda	PROPN
ihlr-28381	482	11	delay	delay	NOUN
ihlr-28381	482	12	after	after	ADP
ihlr-28381	482	13	spending	spend	VERB
ihlr-28381	482	14	$	$	SYM
ihlr-28381	482	15	97	97	NUM
ihlr-28381	482	16	m	m	NOUN
ihlr-28381	482	17	on	on	ADP
ihlr-28381	482	18	a	a	DET
ihlr-28381	482	19	priority	priority	NOUN
ihlr-28381	482	20	review	review	NOUN
ihlr-28381	482	21	voucher	voucher	ADJ
ihlr-28381	482	22	,	,	PUNCT
ihlr-28381	482	23	endpoints	endpoint	NOUN
ihlr-28381	482	24	news	news	PROPN
ihlr-28381	482	25	(	(	PUNCT
ihlr-28381	482	26	feb	feb	PROPN
ihlr-28381	482	27	.	.	PROPN
ihlr-28381	482	28	21	21	NUM
ihlr-28381	482	29	,	,	PUNCT
ihlr-28381	482	30	2023	2023	NUM
ihlr-28381	482	31	)	)	PUNCT
ihlr-28381	482	32	,	,	PUNCT
ihlr-28381	482	33	https://endpts.com/astellasmenopause-drug-hit-by-fda-delay-after-spending-97m-on-a-priority-review-voucher/	https://endpts.com/astellasmenopause-drug-hit-by-fda-delay-after-spending-97m-on-a-priority-review-voucher/	VERB
ihlr-28381	483	1	[	[	X
ihlr-28381	483	2	https://perma.cc/5eau-2bjr	https://perma.cc/5eau-2bjr	PROPN
ihlr-28381	483	3	]	]	PUNCT
ihlr-28381	483	4	.	.	PUNCT
ihlr-28381	484	1	118	118	NUM
ihlr-28381	484	2	.	.	PUNCT
ihlr-28381	485	1	astellas	astella	NOUN
ihlr-28381	485	2	provides	provide	VERB
ihlr-28381	485	3	update	update	NOUN
ihlr-28381	485	4	on	on	ADP
ihlr-28381	485	5	fezolinetant	fezolinetant	ADJ
ihlr-28381	485	6	new	new	ADJ
ihlr-28381	485	7	drug	drug	NOUN
ihlr-28381	485	8	application	application	NOUN
ihlr-28381	485	9	in	in	ADP
ihlr-28381	485	10	u.s	u.s	PROPN
ihlr-28381	485	11	.	.	PROPN
ihlr-28381	485	12	,	,	PUNCT
ihlr-28381	485	13	pr	pr	PROPN
ihlr-28381	485	14	newswire	newswire	PROPN
ihlr-28381	485	15	(	(	PUNCT
ihlr-28381	485	16	feb	feb	PROPN
ihlr-28381	485	17	.	.	PROPN
ihlr-28381	485	18	19	19	NUM
ihlr-28381	485	19	,	,	PUNCT
ihlr-28381	485	20	2023	2023	NUM
ihlr-28381	485	21	)	)	PUNCT
ihlr-28381	485	22	,	,	PUNCT
ihlr-28381	485	23	https://www.prnewswire.com/news-releases/astellas-provides-update-onfezolinetant-new-drug-application-in-us-301750449.html	https://www.prnewswire.com/news-releases/astellas-provides-update-onfezolinetant-new-drug-application-in-us-301750449.html	PUNCT
ihlr-28381	486	1	[	[	X
ihlr-28381	486	2	https://perma.cc/6d9m-svfq	https://perma.cc/6d9m-svfq	X
ihlr-28381	486	3	]	]	NOUN
ihlr-28381	486	4	.	.	PUNCT
ihlr-28381	487	1	119	119	NUM
ihlr-28381	487	2	.	.	PUNCT
ihlr-28381	488	1	francesca	francesca	PROPN
ihlr-28381	488	2	l.	l.	PROPN
ihlr-28381	488	3	beaudoin	beaudoin	PROPN
ihlr-28381	488	4	et	et	PROPN
ihlr-28381	488	5	al	al	PROPN
ihlr-28381	488	6	.	.	PROPN
ihlr-28381	488	7	,	,	PUNCT
ihlr-28381	488	8	fezolinetant	fezolinetant	VERB
ihlr-28381	488	9	for	for	ADP
ihlr-28381	488	10	moderate	moderate	ADJ
ihlr-28381	488	11	to	to	ADP
ihlr-28381	488	12	severe	severe	ADJ
ihlr-28381	488	13	vasomotor	vasomotor	NOUN
ihlr-28381	488	14	symptoms	symptom	NOUN
ihlr-28381	488	15	associated	associate	VERB
ihlr-28381	488	16	with	with	ADP
ihlr-28381	488	17	menopause	menopause	NOUN
ihlr-28381	488	18	:	:	PUNCT
ihlr-28381	488	19	effectiveness	effectiveness	NOUN
ihlr-28381	488	20	and	and	CCONJ
ihlr-28381	488	21	value	value	NOUN
ihlr-28381	488	22	,	,	PUNCT
ihlr-28381	488	23	inst	inst	PROPN
ihlr-28381	488	24	.	.	PROPN
ihlr-28381	489	1	clinical	clinical	PROPN
ihlr-28381	489	2	&	&	CCONJ
ihlr-28381	489	3	econ	econ	PROPN
ihlr-28381	489	4	.	.	PUNCT
ihlr-28381	490	1	rev	rev	PROPN
ihlr-28381	490	2	.	.	PROPN
ihlr-28381	491	1	at	at	ADP
ihlr-28381	491	2	58	58	NUM
ihlr-28381	491	3	(	(	PUNCT
ihlr-28381	491	4	dec	dec	PROPN
ihlr-28381	491	5	.	.	PROPN
ihlr-28381	491	6	1	1	NUM
ihlr-28381	491	7	,	,	PUNCT
ihlr-28381	491	8	2022	2022	NUM
ihlr-28381	491	9	)	)	PUNCT
ihlr-28381	491	10	,	,	PUNCT
ihlr-28381	491	11	https://icer.org/wp-content/uploads/2022/06/icer_menopause_evidencereport_12012022.pdf	https://icer.org/wp-content/uploads/2022/06/icer_menopause_evidencereport_12012022.pdf	NOUN
ihlr-28381	492	1	[	[	X
ihlr-28381	492	2	https://perma.cc/u8aa-uu4s	https://perma.cc/u8aa-uu4s	NOUN
ihlr-28381	492	3	]	]	X
ihlr-28381	492	4	.	.	PUNCT
ihlr-28381	493	1	144	144	NUM
ihlr-28381	493	2	indiana	indiana	PROPN
ihlr-28381	493	3	health	health	PROPN
ihlr-28381	493	4	law	law	PROPN
ihlr-28381	493	5	review	review	NOUN
ihlr-28381	493	6	[	[	X
ihlr-28381	493	7	vol	vol	NOUN
ihlr-28381	493	8	.	.	PUNCT
ihlr-28381	493	9	21:121	21:121	NUM
ihlr-28381	493	10	fortunately	fortunately	ADV
ihlr-28381	493	11	,	,	PUNCT
ihlr-28381	493	12	there	there	PRON
ihlr-28381	493	13	may	may	AUX
ihlr-28381	493	14	be	be	AUX
ihlr-28381	493	15	another	another	DET
ihlr-28381	493	16	low	low	ADJ
ihlr-28381	493	17	-	-	PUNCT
ihlr-28381	493	18	friction	friction	NOUN
ihlr-28381	493	19	avenue	avenue	NOUN
ihlr-28381	493	20	to	to	PART
ihlr-28381	493	21	lower	lower	VERB
ihlr-28381	493	22	drug	drug	NOUN
ihlr-28381	493	23	spending	spending	NOUN
ihlr-28381	493	24	.	.	PUNCT
ihlr-28381	494	1	in	in	ADP
ihlr-28381	494	2	a	a	DET
ihlr-28381	494	3	gao	gao	PROPN
ihlr-28381	494	4	study	study	NOUN
ihlr-28381	494	5	,	,	PUNCT
ihlr-28381	494	6	the	the	DET
ihlr-28381	494	7	existing	exist	VERB
ihlr-28381	494	8	prv	prv	PROPN
ihlr-28381	494	9	program	program	NOUN
ihlr-28381	494	10	was	be	AUX
ihlr-28381	494	11	evaluated	evaluate	VERB
ihlr-28381	494	12	,	,	PUNCT
ihlr-28381	494	13	and	and	CCONJ
ihlr-28381	494	14	potential	potential	ADJ
ihlr-28381	494	15	alternatives	alternative	NOUN
ihlr-28381	494	16	explored.120	explored.120	ADJ
ihlr-28381	494	17	stakeholders	stakeholder	NOUN
ihlr-28381	494	18	interviewed	interview	VERB
ihlr-28381	494	19	by	by	ADP
ihlr-28381	494	20	the	the	DET
ihlr-28381	494	21	gao	gao	PROPN
ihlr-28381	494	22	suggested	suggest	VERB
ihlr-28381	494	23	alternative	alternative	ADJ
ihlr-28381	494	24	incentives	incentive	NOUN
ihlr-28381	494	25	which	which	PRON
ihlr-28381	494	26	,	,	PUNCT
ihlr-28381	494	27	among	among	ADP
ihlr-28381	494	28	industry	industry	NOUN
ihlr-28381	494	29	participants	participant	NOUN
ihlr-28381	494	30	,	,	PUNCT
ihlr-28381	494	31	were	be	AUX
ihlr-28381	494	32	viewed	view	VERB
ihlr-28381	494	33	as	as	ADP
ihlr-28381	494	34	superior	superior	ADJ
ihlr-28381	494	35	to	to	ADP
ihlr-28381	494	36	prvs.121	prvs.121	ADJ
ihlr-28381	494	37	gao	gao	PROPN
ihlr-28381	494	38	interviewees	interviewee	NOUN
ihlr-28381	494	39	and	and	CCONJ
ihlr-28381	494	40	literature	literature	NOUN
ihlr-28381	494	41	specifically	specifically	ADV
ihlr-28381	494	42	identified	identify	VERB
ihlr-28381	494	43	incentives	incentive	NOUN
ihlr-28381	494	44	related	relate	VERB
ihlr-28381	494	45	to	to	ADP
ihlr-28381	494	46	market	market	NOUN
ihlr-28381	494	47	exclusivity.122	exclusivity.122	NOUN
ihlr-28381	494	48	not	not	PART
ihlr-28381	494	49	only	only	ADV
ihlr-28381	494	50	was	be	AUX
ihlr-28381	494	51	exclusivity	exclusivity	NOUN
ihlr-28381	494	52	more	more	ADV
ihlr-28381	494	53	attractive	attractive	ADJ
ihlr-28381	494	54	to	to	ADP
ihlr-28381	494	55	stakeholders	stakeholder	NOUN
ihlr-28381	494	56	than	than	ADP
ihlr-28381	494	57	prvs	prvs	NOUN
ihlr-28381	494	58	,	,	PUNCT
ihlr-28381	494	59	but	but	CCONJ
ihlr-28381	494	60	the	the	DET
ihlr-28381	494	61	major	major	ADJ
ihlr-28381	494	62	drawbacks	drawback	NOUN
ihlr-28381	494	63	of	of	ADP
ihlr-28381	494	64	an	an	DET
ihlr-28381	494	65	expanded	expand	VERB
ihlr-28381	494	66	prv	prv	PROPN
ihlr-28381	494	67	incentive	incentive	NOUN
ihlr-28381	494	68	—	—	PUNCT
ihlr-28381	494	69	inflationary	inflationary	ADJ
ihlr-28381	494	70	effect	effect	NOUN
ihlr-28381	494	71	on	on	ADP
ihlr-28381	494	72	prv	prv	PROPN
ihlr-28381	494	73	value	value	NOUN
ihlr-28381	494	74	,	,	PUNCT
ihlr-28381	494	75	fda	fda	PROPN
ihlr-28381	494	76	bandwidth	bandwidth	NOUN
ihlr-28381	494	77	,	,	PUNCT
ihlr-28381	494	78	overall	overall	ADJ
ihlr-28381	494	79	exhaustion	exhaustion	NOUN
ihlr-28381	494	80	of	of	ADP
ihlr-28381	494	81	prv	prv	PROPN
ihlr-28381	494	82	system	system	PROPN
ihlr-28381	494	83	—	—	PUNCT
ihlr-28381	494	84	are	be	AUX
ihlr-28381	494	85	less	less	ADV
ihlr-28381	494	86	applicable	applicable	ADJ
ihlr-28381	494	87	to	to	ADP
ihlr-28381	494	88	an	an	DET
ihlr-28381	494	89	appropriately	appropriately	ADV
ihlr-28381	494	90	tailored	tailor	VERB
ihlr-28381	494	91	market	market	NOUN
ihlr-28381	494	92	exclusivity	exclusivity	NOUN
ihlr-28381	494	93	incentive	incentive	NOUN
ihlr-28381	494	94	.	.	PUNCT
ihlr-28381	495	1	b.	b.	PROPN
ihlr-28381	495	2	wildcard	wildcard	PROPN
ihlr-28381	495	3	exclusivity	exclusivity	NOUN
ihlr-28381	495	4	vouchers	voucher	VERB
ihlr-28381	495	5	the	the	DET
ihlr-28381	495	6	preferred	preferred	ADJ
ihlr-28381	495	7	solution	solution	NOUN
ihlr-28381	495	8	recommended	recommend	VERB
ihlr-28381	495	9	by	by	ADP
ihlr-28381	495	10	this	this	DET
ihlr-28381	495	11	note	note	NOUN
ihlr-28381	495	12	is	be	AUX
ihlr-28381	495	13	a	a	DET
ihlr-28381	495	14	transferable	transferable	NOUN
ihlr-28381	495	15	,	,	PUNCT
ihlr-28381	495	16	wildcard	wildcard	ADJ
ihlr-28381	495	17	exclusivity	exclusivity	NOUN
ihlr-28381	495	18	voucher	voucher	NOUN
ihlr-28381	495	19	(	(	PUNCT
ihlr-28381	495	20	“	"	PUNCT
ihlr-28381	495	21	wildcard	wildcard	ADJ
ihlr-28381	495	22	”	"	PUNCT
ihlr-28381	495	23	)	)	PUNCT
ihlr-28381	495	24	.	.	PUNCT
ihlr-28381	496	1	drug	drug	NOUN
ihlr-28381	496	2	developers	developer	NOUN
ihlr-28381	496	3	that	that	PRON
ihlr-28381	496	4	facilitate	facilitate	VERB
ihlr-28381	496	5	generic	generic	ADJ
ihlr-28381	496	6	entry	entry	NOUN
ihlr-28381	496	7	or	or	CCONJ
ihlr-28381	496	8	unilaterally	unilaterally	ADV
ihlr-28381	496	9	reduce	reduce	VERB
ihlr-28381	496	10	price	price	NOUN
ihlr-28381	496	11	would	would	AUX
ihlr-28381	496	12	be	be	AUX
ihlr-28381	496	13	awarded	award	VERB
ihlr-28381	496	14	a	a	DET
ihlr-28381	496	15	wildcard	wildcard	ADJ
ihlr-28381	496	16	exclusivity	exclusivity	NOUN
ihlr-28381	496	17	voucher	voucher	NOUN
ihlr-28381	496	18	,	,	PUNCT
ihlr-28381	496	19	to	to	PART
ihlr-28381	496	20	be	be	AUX
ihlr-28381	496	21	redeemed	redeem	VERB
ihlr-28381	496	22	for	for	ADP
ihlr-28381	496	23	extended	extended	ADJ
ihlr-28381	496	24	market	market	NOUN
ihlr-28381	496	25	exclusivity	exclusivity	NOUN
ihlr-28381	496	26	for	for	ADP
ihlr-28381	496	27	another	another	DET
ihlr-28381	496	28	drug	drug	NOUN
ihlr-28381	496	29	,	,	PUNCT
ihlr-28381	496	30	or	or	CCONJ
ihlr-28381	496	31	sale	sale	NOUN
ihlr-28381	496	32	to	to	ADP
ihlr-28381	496	33	another	another	DET
ihlr-28381	496	34	drug	drug	NOUN
ihlr-28381	496	35	developer	developer	NOUN
ihlr-28381	496	36	.	.	PUNCT
ihlr-28381	497	1	this	this	DET
ihlr-28381	497	2	wildcard	wildcard	ADJ
ihlr-28381	497	3	incentive	incentive	NOUN
ihlr-28381	497	4	,	,	PUNCT
ihlr-28381	497	5	appropriately	appropriately	ADV
ihlr-28381	497	6	limited	limit	VERB
ihlr-28381	497	7	,	,	PUNCT
ihlr-28381	497	8	would	would	AUX
ihlr-28381	497	9	offer	offer	VERB
ihlr-28381	497	10	innovators	innovator	NOUN
ihlr-28381	497	11	a	a	DET
ihlr-28381	497	12	lawful	lawful	ADJ
ihlr-28381	497	13	,	,	PUNCT
ihlr-28381	497	14	transparent	transparent	ADJ
ihlr-28381	497	15	,	,	PUNCT
ihlr-28381	497	16	predictable	predictable	ADJ
ihlr-28381	497	17	path	path	NOUN
ihlr-28381	497	18	to	to	PART
ihlr-28381	497	19	value	value	VERB
ihlr-28381	497	20	without	without	ADP
ihlr-28381	497	21	sacrificing	sacrifice	VERB
ihlr-28381	497	22	competition	competition	NOUN
ihlr-28381	497	23	and	and	CCONJ
ihlr-28381	497	24	affordability	affordability	NOUN
ihlr-28381	497	25	in	in	ADP
ihlr-28381	497	26	the	the	DET
ihlr-28381	497	27	process	process	NOUN
ihlr-28381	497	28	.	.	PUNCT
ihlr-28381	498	1	unadopted	unadopte	VERB
ihlr-28381	498	2	in	in	ADP
ihlr-28381	498	3	any	any	DET
ihlr-28381	498	4	form	form	NOUN
ihlr-28381	498	5	in	in	ADP
ihlr-28381	498	6	the	the	DET
ihlr-28381	498	7	u.s	u.s	PROPN
ihlr-28381	498	8	.	.	PROPN
ihlr-28381	498	9	,	,	PUNCT
ihlr-28381	498	10	wildcard	wildcard	ADJ
ihlr-28381	498	11	exclusivity	exclusivity	NOUN
ihlr-28381	498	12	has	have	AUX
ihlr-28381	498	13	been	be	AUX
ihlr-28381	498	14	explored	explore	VERB
ihlr-28381	498	15	by	by	ADP
ihlr-28381	498	16	some	some	DET
ihlr-28381	498	17	industry	industry	NOUN
ihlr-28381	498	18	stakeholders	stakeholder	NOUN
ihlr-28381	498	19	and	and	CCONJ
ihlr-28381	498	20	u.s	u.s	PROPN
ihlr-28381	498	21	.	.	PROPN
ihlr-28381	498	22	policymakers	policymaker	NOUN
ihlr-28381	498	23	as	as	ADP
ihlr-28381	498	24	a	a	DET
ihlr-28381	498	25	means	means	NOUN
ihlr-28381	498	26	to	to	PART
ihlr-28381	498	27	incentivize	incentivize	VERB
ihlr-28381	498	28	antibiotic	antibiotic	ADJ
ihlr-28381	498	29	development.123	development.123	NOUN
ihlr-28381	498	30	however	however	ADV
ihlr-28381	498	31	,	,	PUNCT
ihlr-28381	498	32	leveraging	leverage	VERB
ihlr-28381	498	33	wildcard	wildcard	ADJ
ihlr-28381	498	34	exclusivity	exclusivity	NOUN
ihlr-28381	498	35	to	to	PART
ihlr-28381	498	36	induce	induce	VERB
ihlr-28381	498	37	lower	low	ADJ
ihlr-28381	498	38	drug	drug	NOUN
ihlr-28381	498	39	expenditures	expenditure	NOUN
ihlr-28381	498	40	is	be	AUX
ihlr-28381	498	41	novel	novel	ADJ
ihlr-28381	498	42	.	.	PUNCT
ihlr-28381	499	1	(	(	PUNCT
ihlr-28381	499	2	a	a	X
ihlr-28381	499	3	)	)	PUNCT
ihlr-28381	499	4	outlining	outline	VERB
ihlr-28381	499	5	the	the	DET
ihlr-28381	499	6	wildcard	wildcard	ADJ
ihlr-28381	499	7	exclusivity	exclusivity	NOUN
ihlr-28381	499	8	program	program	NOUN
ihlr-28381	499	9	a	a	DET
ihlr-28381	499	10	wildcard	wildcard	ADJ
ihlr-28381	499	11	exclusivity	exclusivity	NOUN
ihlr-28381	499	12	program	program	NOUN
ihlr-28381	499	13	would	would	AUX
ihlr-28381	499	14	reward	reward	VERB
ihlr-28381	499	15	price	price	NOUN
ihlr-28381	499	16	reductions	reduction	NOUN
ihlr-28381	499	17	and	and	CCONJ
ihlr-28381	499	18	faster	fast	ADJ
ihlr-28381	499	19	generic	generic	ADJ
ihlr-28381	499	20	competition	competition	NOUN
ihlr-28381	499	21	with	with	ADP
ihlr-28381	499	22	wildcard	wildcard	ADJ
ihlr-28381	499	23	exclusivity	exclusivity	NOUN
ihlr-28381	499	24	vouchers	voucher	NOUN
ihlr-28381	499	25	.	.	PUNCT
ihlr-28381	500	1	a	a	DET
ihlr-28381	500	2	firm	firm	NOUN
ihlr-28381	500	3	seeking	seek	VERB
ihlr-28381	500	4	to	to	PART
ihlr-28381	500	5	qualify	qualify	VERB
ihlr-28381	500	6	should	should	AUX
ihlr-28381	500	7	file	file	VERB
ihlr-28381	500	8	an	an	DET
ihlr-28381	500	9	application	application	NOUN
ihlr-28381	500	10	with	with	ADP
ihlr-28381	500	11	the	the	DET
ihlr-28381	500	12	fda	fda	PROPN
ihlr-28381	500	13	,	,	PUNCT
ihlr-28381	500	14	or	or	CCONJ
ihlr-28381	500	15	other	other	ADJ
ihlr-28381	500	16	government	government	NOUN
ihlr-28381	500	17	body	body	NOUN
ihlr-28381	500	18	,	,	PUNCT
ihlr-28381	500	19	forecasting	forecast	VERB
ihlr-28381	500	20	the	the	DET
ihlr-28381	500	21	future	future	ADJ
ihlr-28381	500	22	savings	saving	NOUN
ihlr-28381	500	23	of	of	ADP
ihlr-28381	500	24	a	a	DET
ihlr-28381	500	25	price	price	NOUN
ihlr-28381	500	26	-	-	PUNCT
ihlr-28381	500	27	reduction	reduction	NOUN
ihlr-28381	500	28	.	.	PUNCT
ihlr-28381	501	1	the	the	DET
ihlr-28381	501	2	estimated	estimate	VERB
ihlr-28381	501	3	figure	figure	NOUN
ihlr-28381	501	4	might	might	AUX
ihlr-28381	501	5	reasonably	reasonably	ADV
ihlr-28381	501	6	be	be	AUX
ihlr-28381	501	7	derived	derive	VERB
ihlr-28381	501	8	by	by	ADP
ihlr-28381	501	9	multiplying	multiply	VERB
ihlr-28381	501	10	the	the	DET
ihlr-28381	501	11	difference	difference	NOUN
ihlr-28381	501	12	between	between	ADP
ihlr-28381	501	13	previous	previous	ADJ
ihlr-28381	501	14	brand	brand	NOUN
ihlr-28381	501	15	price	price	NOUN
ihlr-28381	501	16	and	and	CCONJ
ihlr-28381	501	17	expected	expect	VERB
ihlr-28381	501	18	generic	generic	ADJ
ihlr-28381	501	19	price	price	NOUN
ihlr-28381	501	20	by	by	ADP
ihlr-28381	501	21	volume	volume	NOUN
ihlr-28381	501	22	,	,	PUNCT
ihlr-28381	501	23	with	with	ADP
ihlr-28381	501	24	volume	volume	NOUN
ihlr-28381	501	25	calculated	calculate	VERB
ihlr-28381	501	26	based	base	VERB
ihlr-28381	501	27	on	on	ADP
ihlr-28381	501	28	average	average	ADJ
ihlr-28381	501	29	prescription	prescription	NOUN
ihlr-28381	501	30	volume	volume	NOUN
ihlr-28381	501	31	per	per	ADP
ihlr-28381	501	32	year	year	NOUN
ihlr-28381	501	33	multiplied	multiply	VERB
ihlr-28381	501	34	by	by	ADP
ihlr-28381	501	35	the	the	DET
ihlr-28381	501	36	number	number	NOUN
ihlr-28381	501	37	of	of	ADP
ihlr-28381	501	38	years	year	NOUN
ihlr-28381	501	39	before	before	ADP
ihlr-28381	501	40	patent	patent	NOUN
ihlr-28381	501	41	expiration	expiration	NOUN
ihlr-28381	501	42	that	that	PRON
ihlr-28381	501	43	the	the	DET
ihlr-28381	501	44	price	price	NOUN
ihlr-28381	501	45	reduction	reduction	NOUN
ihlr-28381	501	46	occurs	occur	VERB
ihlr-28381	501	47	.	.	PUNCT
ihlr-28381	502	1	if	if	SCONJ
ihlr-28381	502	2	the	the	DET
ihlr-28381	502	3	projected	project	VERB
ihlr-28381	502	4	savings	saving	NOUN
ihlr-28381	502	5	resemble	resemble	VERB
ihlr-28381	502	6	those	those	PRON
ihlr-28381	502	7	typically	typically	ADV
ihlr-28381	502	8	created	create	VERB
ihlr-28381	502	9	by	by	ADP
ihlr-28381	502	10	generic	generic	ADJ
ihlr-28381	502	11	entry	entry	NOUN
ihlr-28381	502	12	—	—	PUNCT
ihlr-28381	502	13	discount	discount	NOUN
ihlr-28381	502	14	of	of	ADP
ihlr-28381	502	15	20	20	NUM
ihlr-28381	502	16	%	%	NOUN
ihlr-28381	502	17	in	in	ADP
ihlr-28381	502	18	first	first	ADJ
ihlr-28381	502	19	180	180	NUM
ihlr-28381	502	20	days	day	NOUN
ihlr-28381	502	21	and	and	CCONJ
ihlr-28381	502	22	incrementally	incrementally	ADV
ihlr-28381	502	23	increasing	increase	VERB
ihlr-28381	502	24	thereafter	thereafter	ADV
ihlr-28381	502	25	—	—	PUNCT
ihlr-28381	502	26	the	the	DET
ihlr-28381	502	27	firm	firm	NOUN
ihlr-28381	502	28	is	be	AUX
ihlr-28381	502	29	rewarded	reward	VERB
ihlr-28381	502	30	with	with	ADP
ihlr-28381	502	31	a	a	DET
ihlr-28381	502	32	wildcard	wildcard	ADJ
ihlr-28381	502	33	exclusivity	exclusivity	NOUN
ihlr-28381	502	34	voucher.124	voucher.124	NOUN
ihlr-28381	502	35	to	to	PART
ihlr-28381	502	36	ensure	ensure	VERB
ihlr-28381	502	37	material	material	ADJ
ihlr-28381	502	38	savings	saving	NOUN
ihlr-28381	502	39	,	,	PUNCT
ihlr-28381	502	40	the	the	DET
ihlr-28381	502	41	discount	discount	NOUN
ihlr-28381	502	42	must	must	AUX
ihlr-28381	502	43	reach	reach	VERB
ihlr-28381	502	44	the	the	DET
ihlr-28381	502	45	typical	typical	ADJ
ihlr-28381	502	46	peak	peak	NOUN
ihlr-28381	502	47	120	120	NUM
ihlr-28381	502	48	.	.	PUNCT
ihlr-28381	503	1	u.s	u.s	PROPN
ihlr-28381	503	2	.	.	PROPN
ihlr-28381	503	3	gov’t	gov’t	PROPN
ihlr-28381	503	4	accountability	accountability	NOUN
ihlr-28381	503	5	off	off	ADP
ihlr-28381	503	6	.	.	PUNCT
ihlr-28381	503	7	,	,	PUNCT
ihlr-28381	503	8	supra	supra	PROPN
ihlr-28381	503	9	note	note	PROPN
ihlr-28381	503	10	105	105	NUM
ihlr-28381	503	11	.	.	NOUN
ihlr-28381	504	1	121	121	NUM
ihlr-28381	504	2	.	.	PUNCT
ihlr-28381	505	1	i	i	PRON
ihlr-28381	505	2	d.	d.	PROPN
ihlr-28381	505	3	at	at	ADP
ihlr-28381	505	4	29	29	NUM
ihlr-28381	505	5	.	.	PUNCT
ihlr-28381	506	1	122	122	NUM
ihlr-28381	506	2	.	.	PUNCT
ihlr-28381	507	1	i	i	PRON
ihlr-28381	507	2	d.	d.	PROPN
ihlr-28381	507	3	123	123	NUM
ihlr-28381	507	4	.	.	PUNCT
ihlr-28381	508	1	kurt	kurt	PROPN
ihlr-28381	508	2	karst	karst	PROPN
ihlr-28381	508	3	,	,	PUNCT
ihlr-28381	508	4	“	"	PUNCT
ihlr-28381	508	5	wildcard	wildcard	ADJ
ihlr-28381	508	6	exclusivity	exclusivity	NOUN
ihlr-28381	508	7	”	"	PUNCT
ihlr-28381	508	8	returns	return	NOUN
ihlr-28381	508	9	:	:	PUNCT
ihlr-28381	508	10	pcast	pcast	NOUN
ihlr-28381	508	11	recommends	recommend	VERB
ihlr-28381	508	12	consideration	consideration	NOUN
ihlr-28381	508	13	of	of	ADP
ihlr-28381	508	14	a	a	DET
ihlr-28381	508	15	tradable	tradable	ADJ
ihlr-28381	508	16	voucher	voucher	NOUN
ihlr-28381	508	17	to	to	PART
ihlr-28381	508	18	reward	reward	VERB
ihlr-28381	508	19	successful	successful	ADJ
ihlr-28381	508	20	antibiotic	antibiotic	ADJ
ihlr-28381	508	21	development	development	NOUN
ihlr-28381	508	22	,	,	PUNCT
ihlr-28381	508	23	fda	fda	PROPN
ihlr-28381	508	24	law	law	PROPN
ihlr-28381	508	25	blog	blog	NOUN
ihlr-28381	508	26	(	(	PUNCT
ihlr-28381	508	27	sep	sep	PROPN
ihlr-28381	508	28	.	.	PROPN
ihlr-28381	508	29	29	29	NUM
ihlr-28381	508	30	,	,	PUNCT
ihlr-28381	508	31	2014	2014	NUM
ihlr-28381	508	32	)	)	PUNCT
ihlr-28381	508	33	,	,	PUNCT
ihlr-28381	508	34	https://www.thefdalawblog.com/2014/09/wildcard-exclusivity-returns-pcast-recommendsconsideration-of-a-tradable-voucher-to-reward-successf/	https://www.thefdalawblog.com/2014/09/wildcard-exclusivity-returns-pcast-recommendsconsideration-of-a-tradable-voucher-to-reward-successf/	X
ihlr-28381	509	1	[	[	X
ihlr-28381	509	2	https://perma.cc/7bwv-pdu4	https://perma.cc/7bwv-pdu4	PROPN
ihlr-28381	509	3	]	]	PUNCT
ihlr-28381	509	4	.	.	PUNCT
ihlr-28381	510	1	124	124	NUM
ihlr-28381	510	2	.	.	PUNCT
ihlr-28381	511	1	feldman	feldman	PROPN
ihlr-28381	511	2	&	&	CCONJ
ihlr-28381	511	3	frondorf	frondorf	PROPN
ihlr-28381	511	4	,	,	PUNCT
ihlr-28381	511	5	supra	supra	PROPN
ihlr-28381	511	6	note	note	PROPN
ihlr-28381	511	7	21	21	NUM
ihlr-28381	511	8	,	,	PUNCT
ihlr-28381	511	9	at	at	ADP
ihlr-28381	511	10	500	500	NUM
ihlr-28381	511	11	-	-	SYM
ihlr-28381	511	12	01	01	NUM
ihlr-28381	511	13	.	.	NOUN
ihlr-28381	511	14	2024	2024	NUM
ihlr-28381	511	15	]	]	PUNCT
ihlr-28381	511	16	incentivizing	incentivize	VERB
ihlr-28381	511	17	drug	drug	NOUN
ihlr-28381	511	18	affordability	affordability	NOUN
ihlr-28381	511	19	145	145	NUM
ihlr-28381	511	20	generic	generic	ADJ
ihlr-28381	511	21	discount—75	discount—75	PROPN
ihlr-28381	511	22	-	-	PUNCT
ihlr-28381	511	23	80%--at	80%--at	NUM
ihlr-28381	511	24	least	least	ADV
ihlr-28381	511	25	180	180	NUM
ihlr-28381	511	26	days	day	NOUN
ihlr-28381	511	27	prior	prior	ADV
ihlr-28381	511	28	to	to	ADP
ihlr-28381	511	29	primary	primary	ADJ
ihlr-28381	511	30	patent	patent	NOUN
ihlr-28381	512	1	expiration.125	expiration.125	PROPN
ihlr-28381	512	2	once	once	SCONJ
ihlr-28381	512	3	price	price	NOUN
ihlr-28381	512	4	drops	drop	NOUN
ihlr-28381	512	5	occur	occur	VERB
ihlr-28381	512	6	,	,	PUNCT
ihlr-28381	512	7	they	they	PRON
ihlr-28381	512	8	may	may	AUX
ihlr-28381	512	9	not	not	PART
ihlr-28381	512	10	be	be	AUX
ihlr-28381	512	11	undone	undo	VERB
ihlr-28381	512	12	without	without	ADP
ihlr-28381	512	13	repaying	repay	VERB
ihlr-28381	512	14	a	a	DET
ihlr-28381	512	15	sum	sum	NOUN
ihlr-28381	512	16	equal	equal	ADJ
ihlr-28381	512	17	to	to	ADP
ihlr-28381	512	18	projected	project	VERB
ihlr-28381	512	19	savings	saving	NOUN
ihlr-28381	512	20	.	.	PUNCT
ihlr-28381	513	1	if	if	SCONJ
ihlr-28381	513	2	actual	actual	ADJ
ihlr-28381	513	3	savings	saving	NOUN
ihlr-28381	513	4	fall	fall	VERB
ihlr-28381	513	5	short	short	ADV
ihlr-28381	513	6	of	of	ADP
ihlr-28381	513	7	forecasted	forecast	VERB
ihlr-28381	513	8	savings	saving	NOUN
ihlr-28381	513	9	,	,	PUNCT
ihlr-28381	513	10	the	the	DET
ihlr-28381	513	11	firm	firm	NOUN
ihlr-28381	513	12	may	may	AUX
ihlr-28381	513	13	be	be	AUX
ihlr-28381	513	14	forced	force	VERB
ihlr-28381	513	15	to	to	PART
ihlr-28381	513	16	pay	pay	VERB
ihlr-28381	513	17	a	a	DET
ihlr-28381	513	18	rebate	rebate	NOUN
ihlr-28381	513	19	equal	equal	ADJ
ihlr-28381	513	20	to	to	ADP
ihlr-28381	513	21	the	the	DET
ihlr-28381	513	22	difference	difference	NOUN
ihlr-28381	513	23	between	between	ADP
ihlr-28381	513	24	estimated	estimated	ADJ
ihlr-28381	513	25	and	and	CCONJ
ihlr-28381	513	26	actual	actual	ADJ
ihlr-28381	513	27	savings	saving	NOUN
ihlr-28381	513	28	.	.	PUNCT
ihlr-28381	514	1	thus	thus	ADV
ihlr-28381	514	2	,	,	PUNCT
ihlr-28381	514	3	the	the	DET
ihlr-28381	514	4	savings	saving	NOUN
ihlr-28381	514	5	number	number	NOUN
ihlr-28381	514	6	is	be	AUX
ihlr-28381	514	7	essentially	essentially	ADV
ihlr-28381	514	8	“	"	PUNCT
ihlr-28381	514	9	locked	lock	VERB
ihlr-28381	514	10	in	in	ADP
ihlr-28381	514	11	”	"	PUNCT
ihlr-28381	514	12	and	and	CCONJ
ihlr-28381	514	13	may	may	AUX
ihlr-28381	514	14	be	be	AUX
ihlr-28381	514	15	relied	rely	VERB
ihlr-28381	514	16	upon	upon	SCONJ
ihlr-28381	514	17	by	by	ADP
ihlr-28381	514	18	fda	fda	PROPN
ihlr-28381	514	19	/	/	SYM
ihlr-28381	514	20	hhs	hhs	PROPN
ihlr-28381	514	21	in	in	ADP
ihlr-28381	514	22	awarding	award	VERB
ihlr-28381	514	23	the	the	DET
ihlr-28381	514	24	wildcard	wildcard	ADJ
ihlr-28381	514	25	voucher	voucher	NOUN
ihlr-28381	514	26	.	.	PUNCT
ihlr-28381	515	1	like	like	ADP
ihlr-28381	515	2	a	a	DET
ihlr-28381	515	3	prv	prv	PROPN
ihlr-28381	515	4	,	,	PUNCT
ihlr-28381	515	5	the	the	DET
ihlr-28381	515	6	wildcard	wildcard	NOUN
ihlr-28381	515	7	would	would	AUX
ihlr-28381	515	8	be	be	AUX
ihlr-28381	515	9	transferable	transferable	ADJ
ihlr-28381	515	10	(	(	PUNCT
ihlr-28381	515	11	sellable	sellable	ADJ
ihlr-28381	515	12	)	)	PUNCT
ihlr-28381	515	13	,	,	PUNCT
ihlr-28381	515	14	and	and	CCONJ
ihlr-28381	515	15	this	this	DET
ihlr-28381	515	16	transferability	transferability	NOUN
ihlr-28381	515	17	component	component	NOUN
ihlr-28381	515	18	would	would	AUX
ihlr-28381	515	19	help	help	VERB
ihlr-28381	515	20	increase	increase	VERB
ihlr-28381	515	21	r&d	r&d	NOUN
ihlr-28381	515	22	in	in	ADP
ihlr-28381	515	23	addition	addition	NOUN
ihlr-28381	515	24	to	to	ADP
ihlr-28381	515	25	increasing	increase	VERB
ihlr-28381	515	26	the	the	DET
ihlr-28381	515	27	value	value	NOUN
ihlr-28381	515	28	of	of	ADP
ihlr-28381	515	29	the	the	DET
ihlr-28381	515	30	wildcard	wildcard	NOUN
ihlr-28381	515	31	.	.	PUNCT
ihlr-28381	516	1	if	if	SCONJ
ihlr-28381	516	2	the	the	DET
ihlr-28381	516	3	firm	firm	NOUN
ihlr-28381	516	4	that	that	PRON
ihlr-28381	516	5	earns	earn	VERB
ihlr-28381	516	6	the	the	DET
ihlr-28381	516	7	wildcard	wildcard	NOUN
ihlr-28381	516	8	has	have	VERB
ihlr-28381	516	9	no	no	DET
ihlr-28381	516	10	product	product	NOUN
ihlr-28381	516	11	that	that	PRON
ihlr-28381	516	12	foreseeably	foreseeably	ADV
ihlr-28381	516	13	stands	stand	VERB
ihlr-28381	516	14	to	to	PART
ihlr-28381	516	15	benefit	benefit	VERB
ihlr-28381	516	16	from	from	ADP
ihlr-28381	516	17	extended	extended	ADJ
ihlr-28381	516	18	market	market	NOUN
ihlr-28381	516	19	exclusivity	exclusivity	NOUN
ihlr-28381	516	20	,	,	PUNCT
ihlr-28381	516	21	obtaining	obtain	VERB
ihlr-28381	516	22	a	a	DET
ihlr-28381	516	23	wildcard	wildcard	NOUN
ihlr-28381	516	24	remains	remain	VERB
ihlr-28381	516	25	valuable	valuable	ADJ
ihlr-28381	516	26	because	because	SCONJ
ihlr-28381	516	27	the	the	DET
ihlr-28381	516	28	firm	firm	NOUN
ihlr-28381	516	29	can	can	AUX
ihlr-28381	516	30	sell	sell	VERB
ihlr-28381	516	31	the	the	DET
ihlr-28381	516	32	wildcard	wildcard	NOUN
ihlr-28381	516	33	to	to	ADP
ihlr-28381	516	34	another	another	DET
ihlr-28381	516	35	manufacturer	manufacturer	NOUN
ihlr-28381	516	36	standing	stand	VERB
ihlr-28381	516	37	to	to	PART
ihlr-28381	516	38	benefit	benefit	VERB
ihlr-28381	516	39	from	from	ADP
ihlr-28381	516	40	its	its	PRON
ihlr-28381	516	41	use	use	NOUN
ihlr-28381	516	42	.	.	PUNCT
ihlr-28381	517	1	thus	thus	ADV
ihlr-28381	517	2	,	,	PUNCT
ihlr-28381	517	3	the	the	DET
ihlr-28381	517	4	value	value	NOUN
ihlr-28381	517	5	of	of	ADP
ihlr-28381	517	6	transferability	transferability	NOUN
ihlr-28381	517	7	is	be	AUX
ihlr-28381	517	8	responsible	responsible	ADJ
ihlr-28381	517	9	for	for	ADP
ihlr-28381	517	10	an	an	DET
ihlr-28381	517	11	indispensable	indispensable	ADJ
ihlr-28381	517	12	portion	portion	NOUN
ihlr-28381	517	13	of	of	ADP
ihlr-28381	517	14	the	the	DET
ihlr-28381	517	15	wildcard	wildcard	NOUN
ihlr-28381	517	16	’s	’s	PART
ihlr-28381	517	17	ability	ability	NOUN
ihlr-28381	517	18	to	to	PART
ihlr-28381	517	19	function	function	VERB
ihlr-28381	517	20	as	as	ADP
ihlr-28381	517	21	an	an	DET
ihlr-28381	517	22	incentive	incentive	NOUN
ihlr-28381	517	23	.	.	PUNCT
ihlr-28381	518	1	because	because	SCONJ
ihlr-28381	518	2	transferability	transferability	NOUN
ihlr-28381	518	3	is	be	AUX
ihlr-28381	518	4	a	a	DET
ihlr-28381	518	5	significant	significant	ADJ
ihlr-28381	518	6	flexibility	flexibility	NOUN
ihlr-28381	518	7	advantageous	advantageous	ADJ
ihlr-28381	518	8	to	to	ADP
ihlr-28381	518	9	brands	brand	NOUN
ihlr-28381	518	10	and	and	CCONJ
ihlr-28381	518	11	because	because	SCONJ
ihlr-28381	518	12	wildcards	wildcard	NOUN
ihlr-28381	518	13	indeed	indeed	ADV
ihlr-28381	518	14	work	work	VERB
ihlr-28381	518	15	to	to	PART
ihlr-28381	518	16	extend	extend	VERB
ihlr-28381	518	17	monopolies	monopoly	NOUN
ihlr-28381	518	18	,	,	PUNCT
ihlr-28381	518	19	several	several	ADJ
ihlr-28381	518	20	limitations	limitation	NOUN
ihlr-28381	518	21	on	on	ADP
ihlr-28381	518	22	wildcard	wildcard	ADJ
ihlr-28381	518	23	usage	usage	NOUN
ihlr-28381	518	24	would	would	AUX
ihlr-28381	518	25	prohibit	prohibit	VERB
ihlr-28381	518	26	unreasonable	unreasonable	ADJ
ihlr-28381	518	27	extensions	extension	NOUN
ihlr-28381	518	28	—	—	PUNCT
ihlr-28381	518	29	often	often	ADV
ihlr-28381	518	30	attributable	attributable	ADJ
ihlr-28381	518	31	to	to	PART
ihlr-28381	518	32	pay	pay	VERB
ihlr-28381	518	33	-	-	PUNCT
ihlr-28381	518	34	for	for	ADP
ihlr-28381	518	35	-	-	PUNCT
ihlr-28381	518	36	delay	delay	NOUN
ihlr-28381	518	37	in	in	ADP
ihlr-28381	518	38	the	the	DET
ihlr-28381	518	39	current	current	ADJ
ihlr-28381	518	40	environment	environment	NOUN
ihlr-28381	518	41	—	—	PUNCT
ihlr-28381	518	42	and	and	CCONJ
ihlr-28381	518	43	ensure	ensure	VERB
ihlr-28381	518	44	the	the	DET
ihlr-28381	518	45	wildcard	wildcard	NOUN
ihlr-28381	518	46	provides	provide	VERB
ihlr-28381	518	47	consumers	consumer	NOUN
ihlr-28381	518	48	with	with	ADP
ihlr-28381	518	49	a	a	DET
ihlr-28381	518	50	net	net	ADJ
ihlr-28381	518	51	gain	gain	NOUN
ihlr-28381	518	52	.	.	PUNCT
ihlr-28381	519	1	(	(	PUNCT
ihlr-28381	519	2	b	b	X
ihlr-28381	519	3	)	)	PUNCT
ihlr-28381	519	4	risks	risk	NOUN
ihlr-28381	519	5	and	and	CCONJ
ihlr-28381	519	6	mitigants	mitigant	NOUN
ihlr-28381	519	7	several	several	ADJ
ihlr-28381	519	8	vulnerabilities	vulnerability	NOUN
ihlr-28381	519	9	must	must	AUX
ihlr-28381	519	10	be	be	AUX
ihlr-28381	519	11	addressed	address	VERB
ihlr-28381	519	12	to	to	PART
ihlr-28381	519	13	ensure	ensure	VERB
ihlr-28381	519	14	the	the	DET
ihlr-28381	519	15	program	program	NOUN
ihlr-28381	519	16	results	result	NOUN
ihlr-28381	519	17	in	in	ADP
ihlr-28381	519	18	net	net	ADJ
ihlr-28381	519	19	savings	saving	NOUN
ihlr-28381	519	20	.	.	PUNCT
ihlr-28381	520	1	the	the	DET
ihlr-28381	520	2	first	first	ADJ
ihlr-28381	520	3	important	important	ADJ
ihlr-28381	520	4	limitation	limitation	NOUN
ihlr-28381	520	5	to	to	PART
ihlr-28381	520	6	set	set	VERB
ihlr-28381	520	7	on	on	ADP
ihlr-28381	520	8	wildcard	wildcard	ADJ
ihlr-28381	520	9	usage	usage	NOUN
ihlr-28381	520	10	should	should	AUX
ihlr-28381	520	11	be	be	AUX
ihlr-28381	520	12	to	to	PART
ihlr-28381	520	13	establish	establish	VERB
ihlr-28381	520	14	a	a	DET
ihlr-28381	520	15	maximum	maximum	ADJ
ihlr-28381	520	16	monopoly	monopoly	NOUN
ihlr-28381	520	17	length	length	NOUN
ihlr-28381	520	18	that	that	PRON
ihlr-28381	520	19	wildcard	wildcard	ADJ
ihlr-28381	520	20	redemption	redemption	NOUN
ihlr-28381	520	21	can	can	AUX
ihlr-28381	520	22	result	result	VERB
ihlr-28381	520	23	in	in	ADP
ihlr-28381	520	24	.	.	PUNCT
ihlr-28381	521	1	the	the	DET
ihlr-28381	521	2	feasibility	feasibility	NOUN
ihlr-28381	521	3	of	of	ADP
ihlr-28381	521	4	three	three	NUM
ihlr-28381	521	5	sub	sub	NOUN
ihlr-28381	521	6	-	-	NOUN
ihlr-28381	521	7	approaches	approach	NOUN
ihlr-28381	521	8	to	to	ADP
ihlr-28381	521	9	this	this	DET
ihlr-28381	521	10	limitation	limitation	NOUN
ihlr-28381	521	11	should	should	AUX
ihlr-28381	521	12	be	be	AUX
ihlr-28381	521	13	explored	explore	VERB
ihlr-28381	521	14	further	far	ADV
ihlr-28381	521	15	.	.	PUNCT
ihlr-28381	522	1	the	the	DET
ihlr-28381	522	2	first	first	ADJ
ihlr-28381	522	3	sub	sub	NOUN
ihlr-28381	522	4	-	-	NOUN
ihlr-28381	522	5	approach	approach	ADJ
ihlr-28381	522	6	:	:	PUNCT
ihlr-28381	522	7	prohibit	prohibit	VERB
ihlr-28381	522	8	wildcard	wildcard	ADJ
ihlr-28381	522	9	use	use	NOUN
ihlr-28381	522	10	where	where	SCONJ
ihlr-28381	522	11	it	it	PRON
ihlr-28381	522	12	would	would	AUX
ihlr-28381	522	13	result	result	VERB
ihlr-28381	522	14	in	in	ADP
ihlr-28381	522	15	exclusivity	exclusivity	NOUN
ihlr-28381	522	16	greater	great	ADJ
ihlr-28381	522	17	than	than	ADP
ihlr-28381	522	18	14	14	NUM
ihlr-28381	522	19	years	year	NOUN
ihlr-28381	522	20	.	.	PUNCT
ihlr-28381	523	1	the	the	DET
ihlr-28381	523	2	second	second	ADJ
ihlr-28381	523	3	:	:	PUNCT
ihlr-28381	523	4	prohibit	prohibit	VERB
ihlr-28381	523	5	wildcard	wildcard	ADJ
ihlr-28381	523	6	use	use	NOUN
ihlr-28381	523	7	where	where	SCONJ
ihlr-28381	523	8	it	it	PRON
ihlr-28381	523	9	would	would	AUX
ihlr-28381	523	10	result	result	VERB
ihlr-28381	523	11	in	in	ADP
ihlr-28381	523	12	an	an	DET
ihlr-28381	523	13	exclusivity	exclusivity	NOUN
ihlr-28381	523	14	period	period	NOUN
ihlr-28381	523	15	exceeding	exceed	VERB
ihlr-28381	523	16	the	the	DET
ihlr-28381	523	17	average	average	ADJ
ihlr-28381	523	18	small	small	ADJ
ihlr-28381	523	19	-	-	PUNCT
ihlr-28381	523	20	molecule	molecule	NOUN
ihlr-28381	523	21	or	or	CCONJ
ihlr-28381	523	22	biologic	biologic	NOUN
ihlr-28381	523	23	exclusivity	exclusivity	NOUN
ihlr-28381	523	24	period	period	NOUN
ihlr-28381	523	25	,	,	PUNCT
ihlr-28381	523	26	as	as	ADV
ihlr-28381	523	27	applicable	applicable	ADJ
ihlr-28381	523	28	.	.	PUNCT
ihlr-28381	524	1	the	the	DET
ihlr-28381	524	2	average	average	ADJ
ihlr-28381	524	3	exclusivity	exclusivity	NOUN
ihlr-28381	524	4	period	period	NOUN
ihlr-28381	524	5	could	could	AUX
ihlr-28381	524	6	be	be	AUX
ihlr-28381	524	7	calculated	calculate	VERB
ihlr-28381	524	8	based	base	VERB
ihlr-28381	524	9	on	on	ADP
ihlr-28381	524	10	industry	industry	NOUN
ihlr-28381	524	11	-	-	PUNCT
ihlr-28381	524	12	wide	wide	ADJ
ihlr-28381	524	13	inputs	input	NOUN
ihlr-28381	524	14	available	available	ADJ
ihlr-28381	524	15	in	in	ADP
ihlr-28381	524	16	the	the	DET
ihlr-28381	524	17	fda	fda	PROPN
ihlr-28381	524	18	orange	orange	PROPN
ihlr-28381	524	19	book	book	PROPN
ihlr-28381	524	20	.	.	PUNCT
ihlr-28381	525	1	the	the	DET
ihlr-28381	525	2	third	third	ADJ
ihlr-28381	525	3	and	and	CCONJ
ihlr-28381	525	4	perhaps	perhaps	ADV
ihlr-28381	525	5	most	most	ADV
ihlr-28381	525	6	straight	straight	ADJ
ihlr-28381	525	7	forward	forward	ADV
ihlr-28381	525	8	sub	sub	NOUN
ihlr-28381	525	9	-	-	ADJ
ihlr-28381	525	10	approach	approach	NOUN
ihlr-28381	525	11	is	be	AUX
ihlr-28381	525	12	to	to	PART
ihlr-28381	525	13	allow	allow	VERB
ihlr-28381	525	14	wildcard	wildcard	ADJ
ihlr-28381	525	15	redemption	redemption	NOUN
ihlr-28381	525	16	where	where	SCONJ
ihlr-28381	525	17	it	it	PRON
ihlr-28381	525	18	would	would	AUX
ihlr-28381	525	19	result	result	VERB
ihlr-28381	525	20	in	in	ADP
ihlr-28381	525	21	“	"	PUNCT
ihlr-28381	525	22	extended	extended	ADJ
ihlr-28381	525	23	monopolies	monopoly	NOUN
ihlr-28381	525	24	,	,	PUNCT
ihlr-28381	525	25	”	"	PUNCT
ihlr-28381	525	26	but	but	CCONJ
ihlr-28381	525	27	prohibit	prohibit	VERB
ihlr-28381	525	28	usage	usage	NOUN
ihlr-28381	525	29	if	if	SCONJ
ihlr-28381	525	30	it	it	PRON
ihlr-28381	525	31	would	would	AUX
ihlr-28381	525	32	result	result	VERB
ihlr-28381	525	33	in	in	ADP
ihlr-28381	525	34	a	a	DET
ihlr-28381	525	35	“	"	PUNCT
ihlr-28381	525	36	long	long	ADJ
ihlr-28381	525	37	-	-	PUNCT
ihlr-28381	525	38	monopoly	monopoly	NOUN
ihlr-28381	525	39	.	.	PUNCT
ihlr-28381	525	40	”	"	PUNCT
ihlr-28381	526	1	extended	extended	ADJ
ihlr-28381	526	2	-	-	PUNCT
ihlr-28381	526	3	monopoly	monopoly	NOUN
ihlr-28381	526	4	drugs	drug	NOUN
ihlr-28381	526	5	are	be	AUX
ihlr-28381	526	6	drugs	drug	NOUN
ihlr-28381	526	7	“	"	PUNCT
ihlr-28381	526	8	for	for	ADP
ihlr-28381	526	9	which	which	PRON
ihlr-28381	526	10	at	at	ADP
ihlr-28381	526	11	least	least	ADV
ihlr-28381	526	12	12	12	NUM
ihlr-28381	526	13	years	year	NOUN
ihlr-28381	526	14	,	,	PUNCT
ihlr-28381	526	15	but	but	CCONJ
ihlr-28381	526	16	fewer	few	ADJ
ihlr-28381	526	17	than	than	ADP
ihlr-28381	526	18	16	16	NUM
ihlr-28381	526	19	years	year	NOUN
ihlr-28381	526	20	,	,	PUNCT
ihlr-28381	526	21	have	have	AUX
ihlr-28381	526	22	elapsed	elapse	VERB
ihlr-28381	526	23	since	since	SCONJ
ihlr-28381	526	24	the	the	DET
ihlr-28381	526	25	date	date	NOUN
ihlr-28381	526	26	of	of	ADP
ihlr-28381	526	27	approval	approval	NOUN
ihlr-28381	526	28	of	of	ADP
ihlr-28381	526	29	such	such	ADJ
ihlr-28381	526	30	drug	drug	NOUN
ihlr-28381	526	31	.	.	PUNCT
ihlr-28381	527	1	”126	”126	PART
ihlr-28381	527	2	long	long	ADJ
ihlr-28381	527	3	-	-	PUNCT
ihlr-28381	527	4	monopoly	monopoly	NOUN
ihlr-28381	527	5	drugs	drug	NOUN
ihlr-28381	527	6	are	be	AUX
ihlr-28381	527	7	drugs	drug	NOUN
ihlr-28381	527	8	for	for	ADP
ihlr-28381	527	9	which	which	PRON
ihlr-28381	527	10	greater	great	ADJ
ihlr-28381	527	11	than	than	ADP
ihlr-28381	527	12	16	16	NUM
ihlr-28381	527	13	years	year	NOUN
ihlr-28381	527	14	have	have	AUX
ihlr-28381	527	15	elapsed	elapse	VERB
ihlr-28381	527	16	since	since	SCONJ
ihlr-28381	527	17	approval.127	approval.127	DET
ihlr-28381	527	18	one	one	NUM
ihlr-28381	527	19	of	of	ADP
ihlr-28381	527	20	these	these	DET
ihlr-28381	527	21	sub	sub	NOUN
ihlr-28381	527	22	-	-	NOUN
ihlr-28381	527	23	approaches	approach	NOUN
ihlr-28381	527	24	could	could	AUX
ihlr-28381	527	25	be	be	AUX
ihlr-28381	527	26	adopted	adopt	VERB
ihlr-28381	527	27	,	,	PUNCT
ihlr-28381	527	28	or	or	CCONJ
ihlr-28381	527	29	all	all	DET
ihlr-28381	527	30	three	three	NUM
ihlr-28381	527	31	could	could	AUX
ihlr-28381	527	32	be	be	AUX
ihlr-28381	527	33	utilized	utilize	VERB
ihlr-28381	527	34	on	on	ADP
ihlr-28381	527	35	a	a	DET
ihlr-28381	527	36	case	case	NOUN
ihlr-28381	527	37	-	-	PUNCT
ihlr-28381	527	38	by	by	ADP
ihlr-28381	527	39	-	-	PUNCT
ihlr-28381	527	40	case	case	NOUN
ihlr-28381	527	41	basis	basis	NOUN
ihlr-28381	527	42	.	.	PUNCT
ihlr-28381	528	1	fact	fact	NOUN
ihlr-28381	528	2	-	-	PUNCT
ihlr-28381	528	3	specific	specific	ADJ
ihlr-28381	528	4	,	,	PUNCT
ihlr-28381	528	5	caseby	caseby	ADJ
ihlr-28381	528	6	-	-	PUNCT
ihlr-28381	528	7	case	case	NOUN
ihlr-28381	528	8	utilization	utilization	NOUN
ihlr-28381	528	9	of	of	ADP
ihlr-28381	528	10	all	all	DET
ihlr-28381	528	11	three	three	NUM
ihlr-28381	528	12	may	may	AUX
ihlr-28381	528	13	be	be	AUX
ihlr-28381	528	14	appropriate	appropriate	ADJ
ihlr-28381	528	15	given	give	VERB
ihlr-28381	528	16	significant	significant	ADJ
ihlr-28381	528	17	differences	difference	NOUN
ihlr-28381	528	18	between	between	ADP
ihlr-28381	528	19	biologics	biologic	NOUN
ihlr-28381	528	20	and	and	CCONJ
ihlr-28381	528	21	small	small	ADJ
ihlr-28381	528	22	-	-	PUNCT
ihlr-28381	528	23	molecule	molecule	NOUN
ihlr-28381	528	24	drugs	drug	NOUN
ihlr-28381	528	25	(	(	PUNCT
ihlr-28381	528	26	and	and	CCONJ
ihlr-28381	528	27	between	between	ADP
ihlr-28381	528	28	biosimilars	biosimilar	NOUN
ihlr-28381	528	29	and	and	CCONJ
ihlr-28381	528	30	generics	generic	NOUN
ihlr-28381	528	31	for	for	ADP
ihlr-28381	528	32	that	that	DET
ihlr-28381	528	33	matter)128	matter)128	NOUN
ihlr-28381	528	34	as	as	ADV
ihlr-28381	528	35	far	far	ADV
ihlr-28381	528	36	as	as	ADP
ihlr-28381	528	37	r&d	r&d	NOUN
ihlr-28381	528	38	cost	cost	NOUN
ihlr-28381	528	39	,	,	PUNCT
ihlr-28381	528	40	value	value	NOUN
ihlr-28381	528	41	creation	creation	NOUN
ihlr-28381	528	42	,	,	PUNCT
ihlr-28381	528	43	and	and	CCONJ
ihlr-28381	528	44	approval	approval	NOUN
ihlr-28381	528	45	125	125	NUM
ihlr-28381	528	46	.	.	PUNCT
ihlr-28381	529	1	i	i	PRON
ihlr-28381	529	2	d.	d.	PROPN
ihlr-28381	529	3	126	126	NUM
ihlr-28381	529	4	.	.	PUNCT
ihlr-28381	530	1	42	42	NUM
ihlr-28381	530	2	u.s.c	u.s.c	ADJ
ihlr-28381	530	3	.	.	PUNCT
ihlr-28381	531	1	§	§	PROPN
ihlr-28381	531	2	1320f-3(c)(4	1320f-3(c)(4	NUM
ihlr-28381	531	3	)	)	PUNCT
ihlr-28381	531	4	(	(	PUNCT
ihlr-28381	531	5	2022	2022	NUM
ihlr-28381	531	6	)	)	PUNCT
ihlr-28381	531	7	.	.	PUNCT
ihlr-28381	532	1	127	127	NUM
ihlr-28381	532	2	.	.	X
ihlr-28381	533	1	42	42	NUM
ihlr-28381	533	2	u.s.c	u.s.c	ADJ
ihlr-28381	533	3	.	.	PUNCT
ihlr-28381	534	1	§	§	PROPN
ihlr-28381	534	2	1320f-3(c)(5	1320f-3(c)(5	PROPN
ihlr-28381	534	3	)	)	PUNCT
ihlr-28381	534	4	(	(	PUNCT
ihlr-28381	534	5	2022	2022	NUM
ihlr-28381	534	6	)	)	PUNCT
ihlr-28381	534	7	.	.	PUNCT
ihlr-28381	535	1	128	128	NUM
ihlr-28381	535	2	.	.	PUNCT
ihlr-28381	536	1	biologics	biologic	NOUN
ihlr-28381	536	2	are	be	AUX
ihlr-28381	536	3	derived	derive	VERB
ihlr-28381	536	4	from	from	ADP
ihlr-28381	536	5	living	live	VERB
ihlr-28381	536	6	organisms	organism	NOUN
ihlr-28381	536	7	,	,	PUNCT
ihlr-28381	536	8	while	while	SCONJ
ihlr-28381	536	9	small	small	ADJ
ihlr-28381	536	10	-	-	PUNCT
ihlr-28381	536	11	molecule	molecule	NOUN
ihlr-28381	536	12	drugs	drug	NOUN
ihlr-28381	536	13	are	be	AUX
ihlr-28381	536	14	derived	derive	VERB
ihlr-28381	536	15	from	from	ADP
ihlr-28381	536	16	chemicals	chemical	NOUN
ihlr-28381	536	17	.	.	PUNCT
ihlr-28381	537	1	biosimilars	biosimilar	NOUN
ihlr-28381	537	2	are	be	AUX
ihlr-28381	537	3	to	to	ADP
ihlr-28381	537	4	biologics	biologic	NOUN
ihlr-28381	537	5	as	as	SCONJ
ihlr-28381	537	6	generics	generic	NOUN
ihlr-28381	537	7	are	be	AUX
ihlr-28381	537	8	to	to	ADP
ihlr-28381	537	9	small	small	ADJ
ihlr-28381	537	10	-	-	PUNCT
ihlr-28381	537	11	molecule	molecule	NOUN
ihlr-28381	537	12	drugs	drug	NOUN
ihlr-28381	537	13	.	.	PUNCT
ihlr-28381	538	1	there	there	PRON
ihlr-28381	538	2	are	be	VERB
ihlr-28381	538	3	146	146	NUM
ihlr-28381	538	4	indiana	indiana	PROPN
ihlr-28381	538	5	health	health	PROPN
ihlr-28381	538	6	law	law	PROPN
ihlr-28381	538	7	review	review	NOUN
ihlr-28381	538	8	[	[	X
ihlr-28381	538	9	vol	vol	NOUN
ihlr-28381	538	10	.	.	NOUN
ihlr-28381	538	11	21:121	21:121	NUM
ihlr-28381	538	12	pathways	pathway	NOUN
ihlr-28381	538	13	.	.	PUNCT
ihlr-28381	539	1	regardless	regardless	ADV
ihlr-28381	539	2	of	of	ADP
ihlr-28381	539	3	which	which	DET
ihlr-28381	539	4	method	method	NOUN
ihlr-28381	539	5	governs	govern	VERB
ihlr-28381	539	6	the	the	DET
ihlr-28381	539	7	cap	cap	NOUN
ihlr-28381	539	8	on	on	ADP
ihlr-28381	539	9	monopoly	monopoly	NOUN
ihlr-28381	539	10	extension	extension	NOUN
ihlr-28381	539	11	,	,	PUNCT
ihlr-28381	539	12	wildcards	wildcard	NOUN
ihlr-28381	539	13	should	should	AUX
ihlr-28381	539	14	never	never	ADV
ihlr-28381	539	15	contribute	contribute	VERB
ihlr-28381	539	16	to	to	ADP
ihlr-28381	539	17	exceptional	exceptional	ADJ
ihlr-28381	539	18	delays	delay	NOUN
ihlr-28381	539	19	in	in	ADP
ihlr-28381	539	20	competition	competition	NOUN
ihlr-28381	539	21	and	and	CCONJ
ihlr-28381	539	22	unjustified	unjustified	ADJ
ihlr-28381	539	23	prolonging	prolonging	NOUN
ihlr-28381	539	24	of	of	ADP
ihlr-28381	539	25	monopoly	monopoly	NOUN
ihlr-28381	539	26	prices	price	NOUN
ihlr-28381	539	27	,	,	PUNCT
ihlr-28381	539	28	which	which	PRON
ihlr-28381	539	29	is	be	AUX
ihlr-28381	539	30	the	the	DET
ihlr-28381	539	31	problem	problem	NOUN
ihlr-28381	539	32	it	it	PRON
ihlr-28381	539	33	seeks	seek	VERB
ihlr-28381	539	34	to	to	PART
ihlr-28381	539	35	address	address	VERB
ihlr-28381	539	36	.	.	PUNCT
ihlr-28381	540	1	regarding	regard	VERB
ihlr-28381	540	2	another	another	DET
ihlr-28381	540	3	limitation	limitation	NOUN
ihlr-28381	540	4	,	,	PUNCT
ihlr-28381	540	5	wildcards	wildcard	NOUN
ihlr-28381	540	6	should	should	AUX
ihlr-28381	540	7	not	not	PART
ihlr-28381	540	8	operate	operate	VERB
ihlr-28381	540	9	to	to	PART
ihlr-28381	540	10	create	create	VERB
ihlr-28381	540	11	uncertainty	uncertainty	NOUN
ihlr-28381	540	12	for	for	ADP
ihlr-28381	540	13	generic	generic	ADJ
ihlr-28381	540	14	firms	firm	NOUN
ihlr-28381	540	15	.	.	PUNCT
ihlr-28381	541	1	wildcard	wildcard	ADJ
ihlr-28381	541	2	redemption	redemption	NOUN
ihlr-28381	541	3	for	for	ADP
ihlr-28381	541	4	a	a	DET
ihlr-28381	541	5	specific	specific	ADJ
ihlr-28381	541	6	drug	drug	NOUN
ihlr-28381	541	7	should	should	AUX
ihlr-28381	541	8	occur	occur	VERB
ihlr-28381	541	9	no	no	PRON
ihlr-28381	541	10	later	later	ADV
ihlr-28381	541	11	than	than	ADP
ihlr-28381	541	12	two	two	NUM
ihlr-28381	541	13	years	year	NOUN
ihlr-28381	541	14	after	after	ADP
ihlr-28381	541	15	a	a	DET
ihlr-28381	541	16	drug	drug	NOUN
ihlr-28381	541	17	’s	’s	PART
ihlr-28381	541	18	initial	initial	ADJ
ihlr-28381	541	19	fda	fda	PROPN
ihlr-28381	541	20	approval	approval	NOUN
ihlr-28381	541	21	(	(	PUNCT
ihlr-28381	541	22	or	or	CCONJ
ihlr-28381	541	23	an	an	DET
ihlr-28381	541	24	alternative	alternative	ADJ
ihlr-28381	541	25	deadline	deadline	NOUN
ihlr-28381	541	26	determined	determine	VERB
ihlr-28381	541	27	with	with	ADP
ihlr-28381	541	28	input	input	NOUN
ihlr-28381	541	29	from	from	ADP
ihlr-28381	541	30	generic	generic	ADJ
ihlr-28381	541	31	subject	subject	NOUN
ihlr-28381	541	32	matter	matter	NOUN
ihlr-28381	541	33	experts	expert	NOUN
ihlr-28381	541	34	or	or	CCONJ
ihlr-28381	541	35	a	a	DET
ihlr-28381	541	36	notice	notice	NOUN
ihlr-28381	541	37	and	and	CCONJ
ihlr-28381	541	38	comment	comment	NOUN
ihlr-28381	541	39	period	period	NOUN
ihlr-28381	541	40	)	)	PUNCT
ihlr-28381	541	41	.	.	PUNCT
ihlr-28381	542	1	requiring	require	VERB
ihlr-28381	542	2	the	the	DET
ihlr-28381	542	3	wildcard	wildcard	NOUN
ihlr-28381	542	4	to	to	PART
ihlr-28381	542	5	be	be	AUX
ihlr-28381	542	6	redeemed	redeem	VERB
ihlr-28381	542	7	early	early	ADV
ihlr-28381	542	8	in	in	ADP
ihlr-28381	542	9	a	a	DET
ihlr-28381	542	10	product	product	NOUN
ihlr-28381	542	11	’s	’s	PART
ihlr-28381	542	12	market	market	NOUN
ihlr-28381	542	13	lifecycle	lifecycle	NOUN
ihlr-28381	542	14	provides	provide	VERB
ihlr-28381	542	15	visibility	visibility	NOUN
ihlr-28381	542	16	regarding	regard	VERB
ihlr-28381	542	17	the	the	DET
ihlr-28381	542	18	legal	legal	ADJ
ihlr-28381	542	19	conclusion	conclusion	NOUN
ihlr-28381	542	20	of	of	ADP
ihlr-28381	542	21	brand	brand	NOUN
ihlr-28381	542	22	name	name	NOUN
ihlr-28381	542	23	monopolies	monopoly	NOUN
ihlr-28381	542	24	.	.	PUNCT
ihlr-28381	543	1	generic	generic	ADJ
ihlr-28381	543	2	firms	firm	NOUN
ihlr-28381	543	3	must	must	AUX
ihlr-28381	543	4	be	be	AUX
ihlr-28381	543	5	able	able	ADJ
ihlr-28381	543	6	to	to	PART
ihlr-28381	543	7	reliably	reliably	ADV
ihlr-28381	543	8	invest	invest	VERB
ihlr-28381	543	9	in	in	ADP
ihlr-28381	543	10	the	the	DET
ihlr-28381	543	11	years	year	NOUN
ihlr-28381	543	12	-	-	PUNCT
ihlr-28381	543	13	long	long	ADJ
ihlr-28381	543	14	generic	generic	ADJ
ihlr-28381	543	15	drug	drug	NOUN
ihlr-28381	543	16	development	development	NOUN
ihlr-28381	543	17	process	process	NOUN
ihlr-28381	543	18	,	,	PUNCT
ihlr-28381	543	19	without	without	ADP
ihlr-28381	543	20	risk	risk	NOUN
ihlr-28381	543	21	of	of	ADP
ihlr-28381	543	22	being	be	AUX
ihlr-28381	543	23	“	"	PUNCT
ihlr-28381	543	24	blindsided	blindsided	ADJ
ihlr-28381	543	25	”	"	PUNCT
ihlr-28381	543	26	by	by	ADP
ihlr-28381	543	27	a	a	DET
ihlr-28381	543	28	late	late	ADJ
ihlr-28381	543	29	wildcard	wildcard	ADJ
ihlr-28381	543	30	redemption.129	redemption.129	NOUN
ihlr-28381	543	31	allowing	allow	VERB
ihlr-28381	543	32	brands	brand	NOUN
ihlr-28381	543	33	to	to	PART
ihlr-28381	543	34	bolt	bolt	VERB
ihlr-28381	543	35	on	on	ADP
ihlr-28381	543	36	exclusivity	exclusivity	NOUN
ihlr-28381	543	37	late	late	ADV
ihlr-28381	543	38	in	in	ADP
ihlr-28381	543	39	their	their	PRON
ihlr-28381	543	40	product	product	NOUN
ihlr-28381	543	41	’s	’s	PART
ihlr-28381	543	42	exclusivity	exclusivity	NOUN
ihlr-28381	543	43	period	period	NOUN
ihlr-28381	543	44	would	would	AUX
ihlr-28381	543	45	add	add	VERB
ihlr-28381	543	46	uncertainty	uncertainty	NOUN
ihlr-28381	543	47	to	to	ADP
ihlr-28381	543	48	the	the	DET
ihlr-28381	543	49	generic	generic	ADJ
ihlr-28381	543	50	business	business	NOUN
ihlr-28381	543	51	model	model	NOUN
ihlr-28381	543	52	that	that	PRON
ihlr-28381	543	53	would	would	AUX
ihlr-28381	543	54	disincentivize	disincentivize	VERB
ihlr-28381	543	55	investment	investment	NOUN
ihlr-28381	543	56	.	.	PUNCT
ihlr-28381	544	1	therefore	therefore	ADV
ihlr-28381	544	2	,	,	PUNCT
ihlr-28381	544	3	brand	brand	NOUN
ihlr-28381	544	4	companies	company	NOUN
ihlr-28381	544	5	should	should	AUX
ihlr-28381	544	6	be	be	AUX
ihlr-28381	544	7	estopped	estop	VERB
ihlr-28381	544	8	from	from	ADP
ihlr-28381	544	9	redeeming	redeem	VERB
ihlr-28381	544	10	wildcards	wildcard	NOUN
ihlr-28381	544	11	after	after	SCONJ
ihlr-28381	544	12	generic	generic	ADJ
ihlr-28381	544	13	makers	maker	NOUN
ihlr-28381	544	14	have	have	AUX
ihlr-28381	544	15	materially	materially	ADV
ihlr-28381	544	16	invested	invest	VERB
ihlr-28381	544	17	in	in	ADP
ihlr-28381	544	18	the	the	DET
ihlr-28381	544	19	generic	generic	ADJ
ihlr-28381	544	20	development	development	NOUN
ihlr-28381	544	21	process	process	NOUN
ihlr-28381	544	22	.	.	PUNCT
ihlr-28381	545	1	requiring	require	VERB
ihlr-28381	545	2	prompt	prompt	ADJ
ihlr-28381	545	3	redemption	redemption	NOUN
ihlr-28381	545	4	of	of	ADP
ihlr-28381	545	5	wildcards	wildcard	NOUN
ihlr-28381	545	6	protects	protect	VERB
ihlr-28381	545	7	the	the	DET
ihlr-28381	545	8	predictability	predictability	NOUN
ihlr-28381	545	9	essential	essential	ADJ
ihlr-28381	545	10	to	to	ADP
ihlr-28381	545	11	generic	generic	ADJ
ihlr-28381	545	12	development	development	NOUN
ihlr-28381	545	13	.	.	PUNCT
ihlr-28381	546	1	(	(	PUNCT
ihlr-28381	546	2	c	c	X
ihlr-28381	546	3	)	)	PUNCT
ihlr-28381	546	4	preventing	prevent	VERB
ihlr-28381	546	5	abuse	abuse	NOUN
ihlr-28381	546	6	the	the	DET
ihlr-28381	546	7	surface	surface	NOUN
ihlr-28381	546	8	irony	irony	NOUN
ihlr-28381	546	9	of	of	ADP
ihlr-28381	546	10	addressing	address	VERB
ihlr-28381	546	11	the	the	DET
ihlr-28381	546	12	problem	problem	NOUN
ihlr-28381	546	13	with	with	ADP
ihlr-28381	546	14	additional	additional	ADJ
ihlr-28381	546	15	market	market	NOUN
ihlr-28381	546	16	exclusivity	exclusivity	NOUN
ihlr-28381	546	17	must	must	AUX
ihlr-28381	546	18	be	be	AUX
ihlr-28381	546	19	overcome	overcome	VERB
ihlr-28381	546	20	by	by	ADP
ihlr-28381	546	21	eliminating	eliminate	VERB
ihlr-28381	546	22	the	the	DET
ihlr-28381	546	23	risk	risk	NOUN
ihlr-28381	546	24	of	of	ADP
ihlr-28381	546	25	abuse	abuse	NOUN
ihlr-28381	546	26	.	.	PUNCT
ihlr-28381	547	1	consider	consider	VERB
ihlr-28381	547	2	circumstances	circumstance	NOUN
ihlr-28381	547	3	where	where	SCONJ
ihlr-28381	547	4	a	a	DET
ihlr-28381	547	5	firm	firm	NOUN
ihlr-28381	547	6	facilitates	facilitate	VERB
ihlr-28381	547	7	generic	generic	ADJ
ihlr-28381	547	8	competition	competition	NOUN
ihlr-28381	547	9	or	or	CCONJ
ihlr-28381	547	10	unilateral	unilateral	ADJ
ihlr-28381	547	11	price	price	NOUN
ihlr-28381	547	12	reduction	reduction	NOUN
ihlr-28381	547	13	,	,	PUNCT
ihlr-28381	547	14	generates	generate	VERB
ihlr-28381	547	15	$	$	SYM
ihlr-28381	547	16	5	5	NUM
ihlr-28381	547	17	in	in	ADP
ihlr-28381	547	18	savings	saving	NOUN
ihlr-28381	547	19	(	(	PUNCT
ihlr-28381	547	20	derived	derive	VERB
ihlr-28381	547	21	by	by	ADP
ihlr-28381	547	22	multiplying	multiply	VERB
ihlr-28381	547	23	the	the	DET
ihlr-28381	547	24	difference	difference	NOUN
ihlr-28381	547	25	between	between	ADP
ihlr-28381	547	26	the	the	DET
ihlr-28381	547	27	former	former	ADJ
ihlr-28381	547	28	brand	brand	NOUN
ihlr-28381	547	29	price	price	NOUN
ihlr-28381	547	30	minus	minus	CCONJ
ihlr-28381	547	31	generic	generic	ADJ
ihlr-28381	547	32	price	price	NOUN
ihlr-28381	547	33	by	by	ADP
ihlr-28381	547	34	volume	volume	NOUN
ihlr-28381	547	35	.	.	PUNCT
ihlr-28381	548	1	volume	volume	NOUN
ihlr-28381	548	2	determined	determine	VERB
ihlr-28381	548	3	using	use	VERB
ihlr-28381	548	4	average	average	ADJ
ihlr-28381	548	5	prescription	prescription	NOUN
ihlr-28381	548	6	volume	volume	NOUN
ihlr-28381	548	7	/	/	SYM
ihlr-28381	548	8	year	year	NOUN
ihlr-28381	548	9	multiplied	multiply	VERB
ihlr-28381	548	10	by	by	ADP
ihlr-28381	548	11	the	the	DET
ihlr-28381	548	12	years	year	NOUN
ihlr-28381	548	13	prior	prior	ADV
ihlr-28381	548	14	to	to	ADP
ihlr-28381	548	15	patent	patent	NOUN
ihlr-28381	548	16	expiration	expiration	NOUN
ihlr-28381	548	17	that	that	SCONJ
ihlr-28381	548	18	the	the	DET
ihlr-28381	548	19	price	price	NOUN
ihlr-28381	548	20	reduction	reduction	NOUN
ihlr-28381	548	21	occurs	occur	VERB
ihlr-28381	548	22	.	.	PUNCT
ihlr-28381	548	23	)	)	PUNCT
ihlr-28381	548	24	,	,	PUNCT
ihlr-28381	548	25	and	and	CCONJ
ihlr-28381	548	26	then	then	ADV
ihlr-28381	548	27	sells	sell	VERB
ihlr-28381	548	28	the	the	DET
ihlr-28381	548	29	wildcard	wildcard	NOUN
ihlr-28381	548	30	to	to	ADP
ihlr-28381	548	31	a	a	DET
ihlr-28381	548	32	firm	firm	NOUN
ihlr-28381	548	33	which	which	PRON
ihlr-28381	548	34	uses	use	VERB
ihlr-28381	548	35	it	it	PRON
ihlr-28381	548	36	to	to	PART
ihlr-28381	548	37	prolong	prolong	VERB
ihlr-28381	548	38	monopoly	monopoly	NOUN
ihlr-28381	548	39	sales	sale	NOUN
ihlr-28381	548	40	,	,	PUNCT
ihlr-28381	548	41	and	and	CCONJ
ihlr-28381	548	42	thus	thus	ADV
ihlr-28381	548	43	cost	cost	NOUN
ihlr-28381	548	44	,	,	PUNCT
ihlr-28381	548	45	that	that	PRON
ihlr-28381	548	46	exceed	exceed	VERB
ihlr-28381	548	47	the	the	DET
ihlr-28381	548	48	savings	saving	NOUN
ihlr-28381	548	49	(	(	PUNCT
ihlr-28381	548	50	$	$	SYM
ihlr-28381	548	51	5	5	NUM
ihlr-28381	548	52	)	)	PUNCT
ihlr-28381	548	53	originally	originally	ADV
ihlr-28381	548	54	generated	generate	VERB
ihlr-28381	548	55	.	.	PUNCT
ihlr-28381	549	1	if	if	SCONJ
ihlr-28381	549	2	unaddressed	unaddresse	VERB
ihlr-28381	549	3	,	,	PUNCT
ihlr-28381	549	4	this	this	DET
ihlr-28381	549	5	dynamic	dynamic	NOUN
ihlr-28381	549	6	would	would	AUX
ihlr-28381	549	7	completely	completely	ADV
ihlr-28381	549	8	undermine	undermine	VERB
ihlr-28381	549	9	the	the	DET
ihlr-28381	549	10	program	program	NOUN
ihlr-28381	549	11	.	.	PUNCT
ihlr-28381	550	1	to	to	PART
ihlr-28381	550	2	eliminate	eliminate	VERB
ihlr-28381	550	3	potential	potential	NOUN
ihlr-28381	550	4	for	for	ADP
ihlr-28381	550	5	abuse	abuse	NOUN
ihlr-28381	550	6	,	,	PUNCT
ihlr-28381	550	7	the	the	DET
ihlr-28381	550	8	fda	fda	PROPN
ihlr-28381	550	9	or	or	CCONJ
ihlr-28381	550	10	other	other	ADJ
ihlr-28381	550	11	hhs	hhs	PROPN
ihlr-28381	550	12	agency	agency	NOUN
ihlr-28381	550	13	must	must	AUX
ihlr-28381	550	14	be	be	AUX
ihlr-28381	550	15	armed	arm	VERB
ihlr-28381	550	16	with	with	ADP
ihlr-28381	550	17	broad	broad	ADJ
ihlr-28381	550	18	discretion	discretion	NOUN
ihlr-28381	550	19	regarding	regard	VERB
ihlr-28381	550	20	acceptance	acceptance	NOUN
ihlr-28381	550	21	of	of	ADP
ihlr-28381	550	22	wildcard	wildcard	ADJ
ihlr-28381	550	23	redemption	redemption	NOUN
ihlr-28381	550	24	.	.	PUNCT
ihlr-28381	551	1	specifically	specifically	ADV
ihlr-28381	551	2	,	,	PUNCT
ihlr-28381	551	3	the	the	DET
ihlr-28381	551	4	government	government	NOUN
ihlr-28381	551	5	must	must	AUX
ihlr-28381	551	6	be	be	AUX
ihlr-28381	551	7	allowed	allow	VERB
ihlr-28381	551	8	to	to	PART
ihlr-28381	551	9	reject	reject	VERB
ihlr-28381	551	10	or	or	CCONJ
ihlr-28381	551	11	otherwise	otherwise	ADV
ihlr-28381	551	12	block	block	VERB
ihlr-28381	551	13	wildcard	wildcard	ADJ
ihlr-28381	551	14	redemption	redemption	NOUN
ihlr-28381	551	15	on	on	ADP
ihlr-28381	551	16	the	the	DET
ihlr-28381	551	17	basis	basis	NOUN
ihlr-28381	551	18	that	that	SCONJ
ihlr-28381	551	19	wildcard	wildcard	ADJ
ihlr-28381	551	20	attributable	attributable	ADJ
ihlr-28381	551	21	cost	cost	NOUN
ihlr-28381	551	22	(	(	PUNCT
ihlr-28381	551	23	the	the	DET
ihlr-28381	551	24	future	future	ADJ
ihlr-28381	551	25	extended	extended	ADJ
ihlr-28381	551	26	monopoly	monopoly	NOUN
ihlr-28381	551	27	sales	sale	NOUN
ihlr-28381	551	28	protected	protect	VERB
ihlr-28381	551	29	by	by	ADP
ihlr-28381	551	30	wildcard	wildcard	ADJ
ihlr-28381	551	31	redemption	redemption	NOUN
ihlr-28381	551	32	)	)	PUNCT
ihlr-28381	551	33	exceeds	exceed	VERB
ihlr-28381	551	34	wildcard	wildcard	ADJ
ihlr-28381	551	35	attributable	attributable	ADJ
ihlr-28381	551	36	savings	saving	NOUN
ihlr-28381	551	37	(	(	PUNCT
ihlr-28381	551	38	or	or	CCONJ
ihlr-28381	551	39	forecasted	forecast	VERB
ihlr-28381	551	40	wildcard	wildcard	ADJ
ihlr-28381	551	41	attributable	attributable	ADJ
ihlr-28381	551	42	savings	saving	NOUN
ihlr-28381	551	43	)	)	PUNCT
ihlr-28381	551	44	.	.	PUNCT
ihlr-28381	552	1	thus	thus	ADV
ihlr-28381	552	2	,	,	PUNCT
ihlr-28381	552	3	a	a	DET
ihlr-28381	552	4	wildcard	wildcard	NOUN
ihlr-28381	552	5	should	should	AUX
ihlr-28381	552	6	not	not	PART
ihlr-28381	552	7	be	be	AUX
ihlr-28381	552	8	redeemable	redeemable	ADJ
ihlr-28381	552	9	in	in	ADP
ihlr-28381	552	10	situations	situation	NOUN
ihlr-28381	552	11	where	where	SCONJ
ihlr-28381	552	12	the	the	DET
ihlr-28381	552	13	cost	cost	NOUN
ihlr-28381	552	14	of	of	ADP
ihlr-28381	552	15	wildcard	wildcard	ADJ
ihlr-28381	552	16	exclusivity	exclusivity	NOUN
ihlr-28381	552	17	very	very	ADV
ihlr-28381	552	18	meaningful	meaningful	ADJ
ihlr-28381	552	19	differences	difference	NOUN
ihlr-28381	552	20	between	between	ADP
ihlr-28381	552	21	biosimilars	biosimilar	NOUN
ihlr-28381	552	22	and	and	CCONJ
ihlr-28381	552	23	generics	generic	NOUN
ihlr-28381	552	24	–	–	PUNCT
ihlr-28381	552	25	for	for	ADP
ihlr-28381	552	26	instance	instance	NOUN
ihlr-28381	552	27	,	,	PUNCT
ihlr-28381	552	28	biosimilars	biosimilar	NOUN
ihlr-28381	552	29	are	be	AUX
ihlr-28381	552	30	not	not	PART
ihlr-28381	552	31	covered	cover	VERB
ihlr-28381	552	32	by	by	ADP
ihlr-28381	552	33	hatch	hatch	NOUN
ihlr-28381	552	34	-	-	PUNCT
ihlr-28381	552	35	waxman	waxman	NOUN
ihlr-28381	552	36	.	.	PUNCT
ihlr-28381	553	1	the	the	DET
ihlr-28381	553	2	substance	substance	NOUN
ihlr-28381	553	3	of	of	ADP
ihlr-28381	553	4	this	this	DET
ihlr-28381	553	5	note	note	NOUN
ihlr-28381	553	6	is	be	AUX
ihlr-28381	553	7	limited	limit	VERB
ihlr-28381	553	8	to	to	ADP
ihlr-28381	553	9	generics	generic	NOUN
ihlr-28381	553	10	and	and	CCONJ
ihlr-28381	553	11	small	small	ADJ
ihlr-28381	553	12	-	-	PUNCT
ihlr-28381	553	13	molecule	molecule	NOUN
ihlr-28381	553	14	drugs	drug	NOUN
ihlr-28381	553	15	,	,	PUNCT
ihlr-28381	553	16	but	but	CCONJ
ihlr-28381	553	17	a	a	DET
ihlr-28381	553	18	parallel	parallel	ADJ
ihlr-28381	553	19	application	application	NOUN
ihlr-28381	553	20	of	of	ADP
ihlr-28381	553	21	the	the	DET
ihlr-28381	553	22	wildcard	wildcard	ADJ
ihlr-28381	553	23	concept	concept	NOUN
ihlr-28381	553	24	to	to	ADP
ihlr-28381	553	25	biologics	biologic	NOUN
ihlr-28381	553	26	and	and	CCONJ
ihlr-28381	553	27	biosimilars	biosimilar	NOUN
ihlr-28381	553	28	is	be	AUX
ihlr-28381	553	29	worthy	worthy	ADJ
ihlr-28381	553	30	of	of	ADP
ihlr-28381	553	31	exploration	exploration	NOUN
ihlr-28381	553	32	.	.	PUNCT
ihlr-28381	554	1	129	129	NUM
ihlr-28381	554	2	.	.	PUNCT
ihlr-28381	555	1	the	the	DET
ihlr-28381	555	2	science	science	NOUN
ihlr-28381	555	3	of	of	ADP
ihlr-28381	555	4	biosimilars	biosimilar	NOUN
ihlr-28381	555	5	:	:	PUNCT
ihlr-28381	555	6	let	let	VERB
ihlr-28381	555	7	’s	’s	NOUN
ihlr-28381	555	8	see	see	VERB
ihlr-28381	555	9	how	how	SCONJ
ihlr-28381	555	10	biosimilars	biosimilar	NOUN
ihlr-28381	555	11	are	be	AUX
ihlr-28381	555	12	developed	develop	VERB
ihlr-28381	555	13	,	,	PUNCT
ihlr-28381	555	14	pfizer	pfizer	NOUN
ihlr-28381	555	15	(	(	PUNCT
ihlr-28381	555	16	aug	aug	PROPN
ihlr-28381	555	17	.	.	NOUN
ihlr-28381	555	18	2021	2021	NUM
ihlr-28381	555	19	)	)	PUNCT
ihlr-28381	555	20	(	(	PUNCT
ihlr-28381	555	21	comparing	compare	VERB
ihlr-28381	555	22	biosimilar	biosimilar	ADJ
ihlr-28381	555	23	development	development	NOUN
ihlr-28381	555	24	to	to	ADP
ihlr-28381	555	25	generic	generic	ADJ
ihlr-28381	555	26	development	development	NOUN
ihlr-28381	555	27	)	)	PUNCT
ihlr-28381	555	28	,	,	PUNCT
ihlr-28381	556	1	https://www.pfizerbiosimilars	https://www.pfizerbiosimilars	PROPN
ihlr-28381	556	2	.	.	PUNCT
ihlr-28381	556	3	com	com	NOUN
ihlr-28381	556	4	/	/	SYM
ihlr-28381	556	5	biosimilars	biosimilars	NOUN
ihlr-28381	556	6	-	-	PUNCT
ihlr-28381	556	7	development	development	NOUN
ihlr-28381	556	8	[	[	X
ihlr-28381	556	9	https://perma.cc/ky6r-murp	https://perma.cc/ky6r-murp	X
ihlr-28381	556	10	]	]	PUNCT
ihlr-28381	556	11	.	.	PUNCT
ihlr-28381	557	1	2024	2024	NUM
ihlr-28381	557	2	]	]	PUNCT
ihlr-28381	557	3	incentivizing	incentivize	VERB
ihlr-28381	557	4	drug	drug	NOUN
ihlr-28381	557	5	affordability	affordability	NOUN
ihlr-28381	557	6	147	147	NUM
ihlr-28381	557	7	exceeds	exceed	VERB
ihlr-28381	557	8	the	the	DET
ihlr-28381	557	9	savings	saving	NOUN
ihlr-28381	557	10	that	that	PRON
ihlr-28381	557	11	earned	earn	VERB
ihlr-28381	557	12	the	the	DET
ihlr-28381	557	13	wildcard	wildcard	NOUN
ihlr-28381	557	14	in	in	ADP
ihlr-28381	557	15	the	the	DET
ihlr-28381	557	16	first	first	ADJ
ihlr-28381	557	17	place	place	NOUN
ihlr-28381	557	18	.	.	PUNCT
ihlr-28381	558	1	the	the	DET
ihlr-28381	558	2	wildcard	wildcard	ADJ
ihlr-28381	558	3	program	program	NOUN
ihlr-28381	558	4	would	would	AUX
ihlr-28381	558	5	create	create	VERB
ihlr-28381	558	6	savings	saving	NOUN
ihlr-28381	558	7	up	up	ADP
ihlr-28381	558	8	front	front	NOUN
ihlr-28381	558	9	when	when	SCONJ
ihlr-28381	558	10	the	the	DET
ihlr-28381	558	11	wildcard	wildcard	NOUN
ihlr-28381	558	12	is	be	AUX
ihlr-28381	558	13	awarded	award	VERB
ihlr-28381	558	14	,	,	PUNCT
ihlr-28381	558	15	before	before	ADP
ihlr-28381	558	16	creating	create	VERB
ihlr-28381	558	17	costs	cost	NOUN
ihlr-28381	558	18	later	later	ADV
ihlr-28381	558	19	when	when	SCONJ
ihlr-28381	558	20	the	the	DET
ihlr-28381	558	21	wildcard	wildcard	NOUN
ihlr-28381	558	22	is	be	AUX
ihlr-28381	558	23	redeemed	redeem	VERB
ihlr-28381	558	24	to	to	PART
ihlr-28381	558	25	prolong	prolong	VERB
ihlr-28381	558	26	market	market	NOUN
ihlr-28381	558	27	exclusivity	exclusivity	NOUN
ihlr-28381	558	28	(	(	PUNCT
ihlr-28381	558	29	i.e.	i.e.	X
ihlr-28381	558	30	,	,	PUNCT
ihlr-28381	558	31	monopoly	monopoly	NOUN
ihlr-28381	558	32	prices	price	NOUN
ihlr-28381	558	33	)	)	PUNCT
ihlr-28381	558	34	,	,	PUNCT
ihlr-28381	558	35	but	but	CCONJ
ihlr-28381	558	36	the	the	DET
ihlr-28381	558	37	savings	saving	NOUN
ihlr-28381	558	38	would	would	AUX
ihlr-28381	558	39	exceed	exceed	VERB
ihlr-28381	558	40	the	the	DET
ihlr-28381	558	41	cost	cost	NOUN
ihlr-28381	558	42	—	—	PUNCT
ihlr-28381	558	43	the	the	DET
ihlr-28381	558	44	program	program	NOUN
ihlr-28381	558	45	must	must	AUX
ihlr-28381	558	46	be	be	AUX
ihlr-28381	558	47	qualified	qualify	VERB
ihlr-28381	558	48	by	by	ADP
ihlr-28381	558	49	a	a	DET
ihlr-28381	558	50	requirement	requirement	NOUN
ihlr-28381	558	51	that	that	SCONJ
ihlr-28381	558	52	savings	saving	NOUN
ihlr-28381	558	53	outweigh	outweigh	VERB
ihlr-28381	558	54	costs	cost	NOUN
ihlr-28381	558	55	.	.	PUNCT
ihlr-28381	559	1	bound	bind	VERB
ihlr-28381	559	2	by	by	ADP
ihlr-28381	559	3	the	the	DET
ihlr-28381	559	4	condition	condition	NOUN
ihlr-28381	559	5	that	that	SCONJ
ihlr-28381	559	6	wildcard	wildcard	ADJ
ihlr-28381	559	7	savings	saving	NOUN
ihlr-28381	559	8	exceed	exceed	VERB
ihlr-28381	559	9	wildcard	wildcard	ADJ
ihlr-28381	559	10	costs	cost	NOUN
ihlr-28381	559	11	,	,	PUNCT
ihlr-28381	559	12	parties	party	NOUN
ihlr-28381	559	13	will	will	AUX
ihlr-28381	559	14	navigate	navigate	VERB
ihlr-28381	559	15	a	a	DET
ihlr-28381	559	16	process	process	NOUN
ihlr-28381	559	17	that	that	PRON
ihlr-28381	559	18	safeguards	safeguard	VERB
ihlr-28381	559	19	this	this	DET
ihlr-28381	559	20	principle	principle	NOUN
ihlr-28381	559	21	.	.	PUNCT
ihlr-28381	560	1	to	to	PART
ihlr-28381	560	2	redeem	redeem	VERB
ihlr-28381	560	3	a	a	DET
ihlr-28381	560	4	wildcard	wildcard	NOUN
ihlr-28381	560	5	and	and	CCONJ
ihlr-28381	560	6	reap	reap	VERB
ihlr-28381	560	7	the	the	DET
ihlr-28381	560	8	benefits	benefit	NOUN
ihlr-28381	560	9	of	of	ADP
ihlr-28381	560	10	monopoly	monopoly	NOUN
ihlr-28381	560	11	extension	extension	NOUN
ihlr-28381	560	12	,	,	PUNCT
ihlr-28381	560	13	the	the	DET
ihlr-28381	560	14	redeemer	redeemer	NOUN
ihlr-28381	560	15	should	should	AUX
ihlr-28381	560	16	undergo	undergo	VERB
ihlr-28381	560	17	a	a	DET
ihlr-28381	560	18	process	process	NOUN
ihlr-28381	560	19	similar	similar	ADJ
ihlr-28381	560	20	to	to	ADP
ihlr-28381	560	21	that	that	PRON
ihlr-28381	560	22	undertaken	undertake	VERB
ihlr-28381	560	23	by	by	ADP
ihlr-28381	560	24	the	the	DET
ihlr-28381	560	25	original	original	ADJ
ihlr-28381	560	26	wildcard	wildcard	ADJ
ihlr-28381	560	27	awardee	awardee	NOUN
ihlr-28381	560	28	,	,	PUNCT
ihlr-28381	560	29	whether	whether	SCONJ
ihlr-28381	560	30	it	it	PRON
ihlr-28381	560	31	be	be	VERB
ihlr-28381	560	32	the	the	DET
ihlr-28381	560	33	same	same	ADJ
ihlr-28381	560	34	firm	firm	NOUN
ihlr-28381	560	35	or	or	CCONJ
ihlr-28381	560	36	a	a	DET
ihlr-28381	560	37	firm	firm	NOUN
ihlr-28381	560	38	that	that	PRON
ihlr-28381	560	39	purchased	purchase	VERB
ihlr-28381	560	40	the	the	DET
ihlr-28381	560	41	wildcard	wildcard	NOUN
ihlr-28381	560	42	from	from	ADP
ihlr-28381	560	43	the	the	DET
ihlr-28381	560	44	original	original	ADJ
ihlr-28381	560	45	awardee	awardee	NOUN
ihlr-28381	560	46	.	.	PUNCT
ihlr-28381	561	1	records	record	NOUN
ihlr-28381	561	2	of	of	ADP
ihlr-28381	561	3	the	the	DET
ihlr-28381	561	4	savings	saving	NOUN
ihlr-28381	561	5	generated	generate	VERB
ihlr-28381	561	6	or	or	CCONJ
ihlr-28381	561	7	forecasted	forecast	VERB
ihlr-28381	561	8	would	would	AUX
ihlr-28381	561	9	exist	exist	VERB
ihlr-28381	561	10	on	on	ADP
ihlr-28381	561	11	record	record	NOUN
ihlr-28381	561	12	as	as	ADP
ihlr-28381	561	13	part	part	NOUN
ihlr-28381	561	14	of	of	ADP
ihlr-28381	561	15	the	the	DET
ihlr-28381	561	16	original	original	ADJ
ihlr-28381	561	17	wildcard	wildcard	ADJ
ihlr-28381	561	18	voucher	voucher	ADJ
ihlr-28381	561	19	application	application	NOUN
ihlr-28381	561	20	.	.	PUNCT
ihlr-28381	562	1	the	the	DET
ihlr-28381	562	2	party	party	NOUN
ihlr-28381	562	3	seeking	seek	VERB
ihlr-28381	562	4	to	to	PART
ihlr-28381	562	5	redeem	redeem	VERB
ihlr-28381	562	6	the	the	DET
ihlr-28381	562	7	wildcard	wildcard	NOUN
ihlr-28381	562	8	should	should	AUX
ihlr-28381	562	9	submit	submit	VERB
ihlr-28381	562	10	to	to	ADP
ihlr-28381	562	11	the	the	DET
ihlr-28381	562	12	fda	fda	PROPN
ihlr-28381	562	13	or	or	CCONJ
ihlr-28381	562	14	other	other	ADJ
ihlr-28381	562	15	designated	designate	VERB
ihlr-28381	562	16	federal	federal	ADJ
ihlr-28381	562	17	body	body	NOUN
ihlr-28381	562	18	a	a	DET
ihlr-28381	562	19	wildcard	wildcard	ADJ
ihlr-28381	562	20	redemption	redemption	NOUN
ihlr-28381	562	21	application	application	NOUN
ihlr-28381	562	22	that	that	PRON
ihlr-28381	562	23	forecasts	forecast	VERB
ihlr-28381	562	24	wildcard	wildcard	ADJ
ihlr-28381	562	25	attributable	attributable	ADJ
ihlr-28381	562	26	revenue	revenue	NOUN
ihlr-28381	562	27	.	.	PUNCT
ihlr-28381	563	1	if	if	SCONJ
ihlr-28381	563	2	the	the	DET
ihlr-28381	563	3	redeemer	redeemer	NOUN
ihlr-28381	563	4	’s	’s	PART
ihlr-28381	563	5	forecasted	forecast	VERB
ihlr-28381	563	6	wildcard	wildcard	ADJ
ihlr-28381	563	7	attributable	attributable	ADJ
ihlr-28381	563	8	revenue	revenue	NOUN
ihlr-28381	563	9	exceeds	exceed	VERB
ihlr-28381	563	10	the	the	DET
ihlr-28381	563	11	awardeegenerated	awardeegenerate	VERB
ihlr-28381	563	12	wildcard	wildcard	ADJ
ihlr-28381	563	13	attributable	attributable	ADJ
ihlr-28381	563	14	savings	saving	NOUN
ihlr-28381	563	15	,	,	PUNCT
ihlr-28381	563	16	the	the	DET
ihlr-28381	563	17	wildcard	wildcard	NOUN
ihlr-28381	563	18	may	may	AUX
ihlr-28381	563	19	not	not	PART
ihlr-28381	563	20	be	be	AUX
ihlr-28381	563	21	redeemed	redeem	VERB
ihlr-28381	563	22	because	because	SCONJ
ihlr-28381	563	23	the	the	DET
ihlr-28381	563	24	result	result	NOUN
ihlr-28381	563	25	would	would	AUX
ihlr-28381	563	26	be	be	AUX
ihlr-28381	563	27	higher	high	ADJ
ihlr-28381	563	28	net	net	ADJ
ihlr-28381	563	29	drug	drug	NOUN
ihlr-28381	563	30	spending	spending	NOUN
ihlr-28381	563	31	.	.	PUNCT
ihlr-28381	564	1	also	also	ADV
ihlr-28381	564	2	in	in	ADP
ihlr-28381	564	3	tandem	tandem	NOUN
ihlr-28381	564	4	with	with	ADP
ihlr-28381	564	5	the	the	DET
ihlr-28381	564	6	front	front	ADJ
ihlr-28381	564	7	-	-	PUNCT
ihlr-28381	564	8	end	end	NOUN
ihlr-28381	564	9	wildcard	wildcard	ADJ
ihlr-28381	564	10	awardee	awardee	NOUN
ihlr-28381	564	11	application	application	NOUN
ihlr-28381	564	12	,	,	PUNCT
ihlr-28381	564	13	the	the	DET
ihlr-28381	564	14	redeemer	redeemer	NOUN
ihlr-28381	564	15	on	on	ADP
ihlr-28381	564	16	the	the	DET
ihlr-28381	564	17	back	back	NOUN
ihlr-28381	564	18	-	-	PUNCT
ihlr-28381	564	19	end	end	NOUN
ihlr-28381	564	20	must	must	AUX
ihlr-28381	564	21	attest	attest	VERB
ihlr-28381	564	22	that	that	SCONJ
ihlr-28381	564	23	savings	saving	NOUN
ihlr-28381	564	24	will	will	AUX
ihlr-28381	564	25	outweigh	outweigh	VERB
ihlr-28381	564	26	costs	cost	NOUN
ihlr-28381	564	27	.	.	PUNCT
ihlr-28381	565	1	if	if	SCONJ
ihlr-28381	565	2	savings	saving	NOUN
ihlr-28381	565	3	do	do	AUX
ihlr-28381	565	4	not	not	PART
ihlr-28381	565	5	outweigh	outweigh	VERB
ihlr-28381	565	6	cost	cost	NOUN
ihlr-28381	565	7	,	,	PUNCT
ihlr-28381	565	8	the	the	DET
ihlr-28381	565	9	redeemer	redeemer	NOUN
ihlr-28381	565	10	must	must	AUX
ihlr-28381	565	11	be	be	AUX
ihlr-28381	565	12	liable	liable	ADJ
ihlr-28381	565	13	for	for	ADP
ihlr-28381	565	14	any	any	DET
ihlr-28381	565	15	balance	balance	NOUN
ihlr-28381	565	16	by	by	ADP
ihlr-28381	565	17	which	which	PRON
ihlr-28381	565	18	actual	actual	ADJ
ihlr-28381	565	19	wildcard	wildcard	ADJ
ihlr-28381	565	20	costs	cost	NOUN
ihlr-28381	565	21	exceed	exceed	VERB
ihlr-28381	565	22	actual	actual	ADJ
ihlr-28381	565	23	wildcard	wildcard	ADJ
ihlr-28381	565	24	savings	saving	NOUN
ihlr-28381	565	25	.	.	PUNCT
ihlr-28381	566	1	(	(	PUNCT
ihlr-28381	566	2	d	d	X
ihlr-28381	566	3	)	)	PUNCT
ihlr-28381	566	4	wildcards	wildcard	NOUN
ihlr-28381	566	5	as	as	ADP
ihlr-28381	566	6	the	the	DET
ihlr-28381	566	7	optimal	optimal	ADJ
ihlr-28381	566	8	incentive	incentive	NOUN
ihlr-28381	566	9	although	although	SCONJ
ihlr-28381	566	10	novel	novel	NOUN
ihlr-28381	566	11	and	and	CCONJ
ihlr-28381	566	12	untested	untested	ADJ
ihlr-28381	566	13	,	,	PUNCT
ihlr-28381	566	14	wildcard	wildcard	ADJ
ihlr-28381	566	15	exclusivity	exclusivity	NOUN
ihlr-28381	566	16	offers	offer	VERB
ihlr-28381	566	17	superiority	superiority	NOUN
ihlr-28381	566	18	over	over	ADP
ihlr-28381	566	19	the	the	DET
ihlr-28381	566	20	expansion	expansion	NOUN
ihlr-28381	566	21	of	of	ADP
ihlr-28381	566	22	an	an	DET
ihlr-28381	566	23	already	already	ADV
ihlr-28381	566	24	twice	twice	ADV
ihlr-28381	566	25	-	-	PUNCT
ihlr-28381	566	26	expanded	expand	VERB
ihlr-28381	566	27	prv	prv	PROPN
ihlr-28381	566	28	program	program	NOUN
ihlr-28381	566	29	with	with	ADP
ihlr-28381	566	30	onerous	onerous	ADJ
ihlr-28381	566	31	administrative	administrative	ADJ
ihlr-28381	566	32	burdens	burden	NOUN
ihlr-28381	566	33	and	and	CCONJ
ihlr-28381	566	34	whose	whose	DET
ihlr-28381	566	35	incentive	incentive	NOUN
ihlr-28381	566	36	value	value	NOUN
ihlr-28381	566	37	shrinks	shrink	VERB
ihlr-28381	566	38	with	with	ADP
ihlr-28381	566	39	each	each	DET
ihlr-28381	566	40	prv	prv	PROPN
ihlr-28381	566	41	issued	issue	VERB
ihlr-28381	566	42	.	.	PUNCT
ihlr-28381	567	1	between	between	ADP
ihlr-28381	567	2	the	the	DET
ihlr-28381	567	3	first	first	ADJ
ihlr-28381	567	4	and	and	CCONJ
ihlr-28381	567	5	second	second	ADJ
ihlr-28381	567	6	drafts	draft	NOUN
ihlr-28381	567	7	of	of	ADP
ihlr-28381	567	8	this	this	DET
ihlr-28381	567	9	note	note	NOUN
ihlr-28381	567	10	,	,	PUNCT
ihlr-28381	567	11	the	the	DET
ihlr-28381	567	12	fda	fda	PROPN
ihlr-28381	567	13	has	have	AUX
ihlr-28381	567	14	twice	twice	ADV
ihlr-28381	567	15	been	be	AUX
ihlr-28381	567	16	unable	unable	ADJ
ihlr-28381	567	17	to	to	PART
ihlr-28381	567	18	satisfy	satisfy	VERB
ihlr-28381	567	19	priority	priority	NOUN
ihlr-28381	567	20	review	review	NOUN
ihlr-28381	567	21	deadlines.130	deadlines.130	NOUN
ihlr-28381	567	22	advocating	advocate	VERB
ihlr-28381	567	23	for	for	ADP
ihlr-28381	567	24	an	an	DET
ihlr-28381	567	25	indefinite	indefinite	ADJ
ihlr-28381	567	26	number	number	NOUN
ihlr-28381	567	27	of	of	ADP
ihlr-28381	567	28	additional	additional	ADJ
ihlr-28381	567	29	prv	prv	PROPN
ihlr-28381	567	30	issuances	issuance	NOUN
ihlr-28381	567	31	would	would	AUX
ihlr-28381	567	32	be	be	AUX
ihlr-28381	567	33	naïve	naïve	ADJ
ihlr-28381	567	34	in	in	ADP
ihlr-28381	567	35	this	this	DET
ihlr-28381	567	36	climate	climate	NOUN
ihlr-28381	567	37	,	,	PUNCT
ihlr-28381	567	38	even	even	ADV
ihlr-28381	567	39	if	if	SCONJ
ihlr-28381	567	40	such	such	DET
ihlr-28381	567	41	a	a	DET
ihlr-28381	567	42	proposal	proposal	NOUN
ihlr-28381	567	43	might	might	AUX
ihlr-28381	567	44	achieve	achieve	VERB
ihlr-28381	567	45	savings	saving	NOUN
ihlr-28381	567	46	in	in	ADP
ihlr-28381	567	47	optimal	optimal	ADJ
ihlr-28381	567	48	conditions	condition	NOUN
ihlr-28381	567	49	.	.	PUNCT
ihlr-28381	568	1	the	the	DET
ihlr-28381	568	2	wildcard	wildcard	NOUN
ihlr-28381	568	3	,	,	PUNCT
ihlr-28381	568	4	on	on	ADP
ihlr-28381	568	5	the	the	DET
ihlr-28381	568	6	other	other	ADJ
ihlr-28381	568	7	hand	hand	NOUN
ihlr-28381	568	8	,	,	PUNCT
ihlr-28381	568	9	requires	require	VERB
ihlr-28381	568	10	no	no	DET
ihlr-28381	568	11	scientific	scientific	ADJ
ihlr-28381	568	12	review	review	NOUN
ihlr-28381	568	13	and	and	CCONJ
ihlr-28381	568	14	spreads	spread	VERB
ihlr-28381	568	15	administrative	administrative	ADJ
ihlr-28381	568	16	burdens	burden	NOUN
ihlr-28381	568	17	and	and	CCONJ
ihlr-28381	568	18	costs	cost	NOUN
ihlr-28381	568	19	among	among	ADP
ihlr-28381	568	20	parties	party	NOUN
ihlr-28381	568	21	.	.	PUNCT
ihlr-28381	569	1	regarding	regard	VERB
ihlr-28381	569	2	application	application	NOUN
ihlr-28381	569	3	information	information	NOUN
ihlr-28381	569	4	and	and	CCONJ
ihlr-28381	569	5	forecasting	forecasting	NOUN
ihlr-28381	569	6	data	datum	NOUN
ihlr-28381	569	7	,	,	PUNCT
ihlr-28381	569	8	synergies	synergy	NOUN
ihlr-28381	569	9	exist	exist	VERB
ihlr-28381	569	10	on	on	ADP
ihlr-28381	569	11	the	the	DET
ihlr-28381	569	12	applicant	applicant	ADJ
ihlr-28381	569	13	side	side	NOUN
ihlr-28381	569	14	as	as	SCONJ
ihlr-28381	569	15	many	many	ADJ
ihlr-28381	569	16	firms	firm	NOUN
ihlr-28381	569	17	will	will	AUX
ihlr-28381	569	18	have	have	VERB
ihlr-28381	569	19	sales	sale	NOUN
ihlr-28381	569	20	projections	projection	NOUN
ihlr-28381	569	21	and	and	CCONJ
ihlr-28381	569	22	the	the	DET
ihlr-28381	569	23	estimated	estimate	VERB
ihlr-28381	569	24	impact	impact	NOUN
ihlr-28381	569	25	of	of	ADP
ihlr-28381	569	26	generic	generic	ADJ
ihlr-28381	569	27	competition	competition	NOUN
ihlr-28381	569	28	baked	bake	VERB
ihlr-28381	569	29	into	into	ADP
ihlr-28381	569	30	an	an	DET
ihlr-28381	569	31	existing	exist	VERB
ihlr-28381	569	32	strategic	strategic	ADJ
ihlr-28381	569	33	plan	plan	NOUN
ihlr-28381	569	34	or	or	CCONJ
ihlr-28381	569	35	,	,	PUNCT
ihlr-28381	569	36	with	with	ADP
ihlr-28381	569	37	respect	respect	NOUN
ihlr-28381	569	38	to	to	ADP
ihlr-28381	569	39	historical	historical	ADJ
ihlr-28381	569	40	data	datum	NOUN
ihlr-28381	569	41	,	,	PUNCT
ihlr-28381	569	42	otherwise	otherwise	ADV
ihlr-28381	569	43	readily	readily	ADV
ihlr-28381	569	44	available	available	ADJ
ihlr-28381	569	45	in	in	ADP
ihlr-28381	569	46	order	order	NOUN
ihlr-28381	569	47	to	to	PART
ihlr-28381	569	48	comply	comply	VERB
ihlr-28381	569	49	with	with	ADP
ihlr-28381	569	50	sec	sec	PROPN
ihlr-28381	569	51	reporting	reporting	NOUN
ihlr-28381	569	52	requirements	requirement	NOUN
ihlr-28381	569	53	.	.	PUNCT
ihlr-28381	570	1	in	in	ADP
ihlr-28381	570	2	short	short	ADJ
ihlr-28381	570	3	,	,	PUNCT
ihlr-28381	570	4	the	the	DET
ihlr-28381	570	5	“	"	PUNCT
ihlr-28381	570	6	ask	ask	NOUN
ihlr-28381	570	7	”	"	PUNCT
ihlr-28381	570	8	is	be	AUX
ihlr-28381	570	9	lower	low	ADJ
ihlr-28381	570	10	for	for	ADP
ihlr-28381	570	11	the	the	DET
ihlr-28381	570	12	fda	fda	PROPN
ihlr-28381	570	13	,	,	PUNCT
ihlr-28381	570	14	and	and	CCONJ
ihlr-28381	570	15	the	the	DET
ihlr-28381	570	16	value	value	NOUN
ihlr-28381	570	17	of	of	ADP
ihlr-28381	570	18	a	a	DET
ihlr-28381	570	19	wildcard	wildcard	NOUN
ihlr-28381	570	20	on	on	ADP
ihlr-28381	570	21	the	the	DET
ihlr-28381	570	22	balance	balance	NOUN
ihlr-28381	570	23	sheet	sheet	NOUN
ihlr-28381	570	24	far	far	ADV
ihlr-28381	570	25	outweighs	outweigh	VERB
ihlr-28381	570	26	the	the	DET
ihlr-28381	570	27	administrative	administrative	ADJ
ihlr-28381	570	28	cost	cost	NOUN
ihlr-28381	570	29	absorbed	absorb	VERB
ihlr-28381	570	30	by	by	ADP
ihlr-28381	570	31	the	the	DET
ihlr-28381	570	32	hopeful	hopeful	ADJ
ihlr-28381	570	33	awardee	awardee	NOUN
ihlr-28381	570	34	or	or	CCONJ
ihlr-28381	570	35	party	party	NOUN
ihlr-28381	570	36	seeking	seek	VERB
ihlr-28381	570	37	to	to	PART
ihlr-28381	570	38	redeem	redeem	VERB
ihlr-28381	570	39	the	the	DET
ihlr-28381	570	40	wildcard	wildcard	NOUN
ihlr-28381	570	41	.	.	PUNCT
ihlr-28381	571	1	not	not	PART
ihlr-28381	571	2	only	only	ADV
ihlr-28381	571	3	does	do	AUX
ihlr-28381	571	4	the	the	DET
ihlr-28381	571	5	wildcard	wildcard	ADJ
ihlr-28381	571	6	program	program	NOUN
ihlr-28381	571	7	not	not	PART
ihlr-28381	571	8	ask	ask	VERB
ihlr-28381	571	9	the	the	DET
ihlr-28381	571	10	fda	fda	PROPN
ihlr-28381	571	11	to	to	PART
ihlr-28381	571	12	condense	condense	VERB
ihlr-28381	571	13	a	a	DET
ihlr-28381	571	14	tenmonth	tenmonth	NOUN
ihlr-28381	571	15	process	process	NOUN
ihlr-28381	571	16	into	into	ADP
ihlr-28381	571	17	six	six	NUM
ihlr-28381	571	18	months	month	NOUN
ihlr-28381	571	19	,	,	PUNCT
ihlr-28381	571	20	but	but	CCONJ
ihlr-28381	571	21	the	the	DET
ihlr-28381	571	22	wildcard	wildcard	NOUN
ihlr-28381	571	23	also	also	ADV
ihlr-28381	571	24	fits	fit	VERB
ihlr-28381	571	25	the	the	DET
ihlr-28381	571	26	“	"	PUNCT
ihlr-28381	571	27	transferable	transferable	ADJ
ihlr-28381	571	28	exclusivity	exclusivity	NOUN
ihlr-28381	571	29	”	"	PUNCT
ihlr-28381	571	30	profile	profile	NOUN
ihlr-28381	571	31	which	which	PRON
ihlr-28381	571	32	the	the	DET
ihlr-28381	571	33	pharmaceutical	pharmaceutical	NOUN
ihlr-28381	571	34	industry	industry	NOUN
ihlr-28381	571	35	has	have	VERB
ihlr-28381	571	36	a	a	DET
ihlr-28381	571	37	great	great	ADJ
ihlr-28381	571	38	appetite	appetite	NOUN
ihlr-28381	571	39	for	for	ADP
ihlr-28381	571	40	and	and	CCONJ
ihlr-28381	571	41	130	130	NUM
ihlr-28381	571	42	.	.	PUNCT
ihlr-28381	572	1	argenyx	argenyx	PROPN
ihlr-28381	572	2	receives	receive	VERB
ihlr-28381	572	3	notification	notification	NOUN
ihlr-28381	572	4	of	of	ADP
ihlr-28381	572	5	pdufa	pdufa	NOUN
ihlr-28381	572	6	date	date	NOUN
ihlr-28381	572	7	extension	extension	NOUN
ihlr-28381	572	8	for	for	ADP
ihlr-28381	572	9	sc	sc	PROPN
ihlr-28381	572	10	efgartigimod	efgartigimod	NOUN
ihlr-28381	572	11	,	,	PUNCT
ihlr-28381	572	12	supra	supra	PROPN
ihlr-28381	572	13	note	note	PROPN
ihlr-28381	572	14	114	114	NUM
ihlr-28381	572	15	;	;	PUNCT
ihlr-28381	572	16	lewin	lewin	PROPN
ihlr-28381	572	17	,	,	PUNCT
ihlr-28381	572	18	supra	supra	PROPN
ihlr-28381	572	19	note	note	NOUN
ihlr-28381	572	20	115	115	NUM
ihlr-28381	572	21	.	.	PUNCT
ihlr-28381	573	1	148	148	NUM
ihlr-28381	573	2	indiana	indiana	PROPN
ihlr-28381	573	3	health	health	NOUN
ihlr-28381	573	4	law	law	NOUN
ihlr-28381	573	5	review	review	NOUN
ihlr-28381	573	6	[	[	X
ihlr-28381	573	7	vol	vol	NOUN
ihlr-28381	573	8	.	.	PUNCT
ihlr-28381	573	9	21:121	21:121	NUM
ihlr-28381	573	10	expressly	expressly	ADV
ihlr-28381	573	11	favors	favor	VERB
ihlr-28381	573	12	over	over	ADP
ihlr-28381	573	13	prvs.131	prvs.131	NOUN
ihlr-28381	573	14	as	as	SCONJ
ihlr-28381	573	15	proposed	propose	VERB
ihlr-28381	573	16	in	in	ADP
ihlr-28381	573	17	this	this	DET
ihlr-28381	573	18	note	note	NOUN
ihlr-28381	573	19	,	,	PUNCT
ihlr-28381	573	20	the	the	DET
ihlr-28381	573	21	wildcard	wildcard	ADJ
ihlr-28381	573	22	system	system	NOUN
ihlr-28381	573	23	avoids	avoid	VERB
ihlr-28381	573	24	a	a	DET
ihlr-28381	573	25	“	"	PUNCT
ihlr-28381	573	26	ready	ready	ADJ
ihlr-28381	573	27	-	-	PUNCT
ihlr-28381	573	28	fire	fire	NOUN
ihlr-28381	573	29	-	-	PUNCT
ihlr-28381	573	30	aim	aim	NOUN
ihlr-28381	573	31	”	"	PUNCT
ihlr-28381	573	32	approach	approach	NOUN
ihlr-28381	573	33	to	to	ADP
ihlr-28381	573	34	granting	grant	VERB
ihlr-28381	573	35	monopoly	monopoly	NOUN
ihlr-28381	573	36	extensions	extension	NOUN
ihlr-28381	573	37	and	and	CCONJ
ihlr-28381	573	38	is	be	AUX
ihlr-28381	573	39	tempered	temper	VERB
ihlr-28381	573	40	by	by	ADP
ihlr-28381	573	41	limitations	limitation	NOUN
ihlr-28381	573	42	that	that	PRON
ihlr-28381	573	43	define	define	VERB
ihlr-28381	573	44	:	:	PUNCT
ihlr-28381	573	45	(	(	PUNCT
ihlr-28381	573	46	1	1	X
ihlr-28381	573	47	)	)	PUNCT
ihlr-28381	573	48	prerequisites	prerequisite	NOUN
ihlr-28381	573	49	for	for	ADP
ihlr-28381	573	50	earning	earn	VERB
ihlr-28381	573	51	a	a	DET
ihlr-28381	573	52	wildcard	wildcard	NOUN
ihlr-28381	573	53	,	,	PUNCT
ihlr-28381	573	54	(	(	PUNCT
ihlr-28381	573	55	2	2	X
ihlr-28381	573	56	)	)	PUNCT
ihlr-28381	573	57	prerequisites	prerequisite	NOUN
ihlr-28381	573	58	for	for	ADP
ihlr-28381	573	59	redeeming	redeem	VERB
ihlr-28381	573	60	a	a	DET
ihlr-28381	573	61	wildcard	wildcard	NOUN
ihlr-28381	573	62	,	,	PUNCT
ihlr-28381	573	63	and	and	CCONJ
ihlr-28381	573	64	(	(	PUNCT
ihlr-28381	573	65	3	3	X
ihlr-28381	573	66	)	)	PUNCT
ihlr-28381	573	67	consequences	consequence	NOUN
ihlr-28381	573	68	of	of	ADP
ihlr-28381	573	69	repayment	repayment	NOUN
ihlr-28381	573	70	,	,	PUNCT
ihlr-28381	573	71	to	to	PART
ihlr-28381	573	72	be	be	AUX
ihlr-28381	573	73	imposed	impose	VERB
ihlr-28381	573	74	on	on	ADP
ihlr-28381	573	75	awardees	awardee	NOUN
ihlr-28381	573	76	and	and	CCONJ
ihlr-28381	573	77	redeemers	redeemer	NOUN
ihlr-28381	573	78	who	who	PRON
ihlr-28381	573	79	fail	fail	VERB
ihlr-28381	573	80	to	to	PART
ihlr-28381	573	81	consummate	consummate	VERB
ihlr-28381	573	82	the	the	DET
ihlr-28381	573	83	savings	saving	NOUN
ihlr-28381	573	84	forecasted	forecast	VERB
ihlr-28381	573	85	in	in	ADP
ihlr-28381	573	86	wildcard	wildcard	ADJ
ihlr-28381	573	87	award	award	NOUN
ihlr-28381	573	88	or	or	CCONJ
ihlr-28381	573	89	wildcard	wildcard	ADJ
ihlr-28381	573	90	redemption	redemption	NOUN
ihlr-28381	573	91	applications	application	NOUN
ihlr-28381	573	92	.	.	PUNCT
ihlr-28381	574	1	wildcards	wildcard	NOUN
ihlr-28381	574	2	have	have	VERB
ihlr-28381	574	3	a	a	DET
ihlr-28381	574	4	dual	dual	ADJ
ihlr-28381	574	5	effect	effect	NOUN
ihlr-28381	574	6	—	—	PUNCT
ihlr-28381	574	7	first	first	ADV
ihlr-28381	574	8	a	a	DET
ihlr-28381	574	9	spending	spending	NOUN
ihlr-28381	574	10	reduction	reduction	NOUN
ihlr-28381	574	11	,	,	PUNCT
ihlr-28381	574	12	and	and	CCONJ
ihlr-28381	574	13	then	then	ADV
ihlr-28381	574	14	a	a	DET
ihlr-28381	574	15	spending	spending	NOUN
ihlr-28381	574	16	increase	increase	NOUN
ihlr-28381	574	17	—	—	PUNCT
ihlr-28381	574	18	but	but	CCONJ
ihlr-28381	574	19	because	because	SCONJ
ihlr-28381	574	20	the	the	DET
ihlr-28381	574	21	saving	saving	NOUN
ihlr-28381	574	22	occurs	occur	VERB
ihlr-28381	574	23	and	and	CCONJ
ihlr-28381	574	24	is	be	AUX
ihlr-28381	574	25	recorded	record	VERB
ihlr-28381	574	26	first	first	ADV
ihlr-28381	574	27	,	,	PUNCT
ihlr-28381	574	28	it	it	PRON
ihlr-28381	574	29	can	can	AUX
ihlr-28381	574	30	be	be	AUX
ihlr-28381	574	31	ensured	ensure	VERB
ihlr-28381	574	32	that	that	SCONJ
ihlr-28381	574	33	the	the	DET
ihlr-28381	574	34	later	later	ADJ
ihlr-28381	574	35	spending	spending	NOUN
ihlr-28381	574	36	does	do	AUX
ihlr-28381	574	37	not	not	PART
ihlr-28381	574	38	exceed	exceed	VERB
ihlr-28381	574	39	the	the	DET
ihlr-28381	574	40	earlier	early	ADJ
ihlr-28381	574	41	amount	amount	NOUN
ihlr-28381	574	42	saved	save	VERB
ihlr-28381	574	43	,	,	PUNCT
ihlr-28381	574	44	and	and	CCONJ
ihlr-28381	574	45	thus	thus	ADV
ihlr-28381	574	46	that	that	SCONJ
ihlr-28381	574	47	each	each	DET
ihlr-28381	574	48	wildcard	wildcard	ADJ
ihlr-28381	574	49	results	result	NOUN
ihlr-28381	574	50	in	in	ADP
ihlr-28381	574	51	net	net	ADJ
ihlr-28381	574	52	savings	saving	NOUN
ihlr-28381	574	53	.	.	PUNCT
ihlr-28381	575	1	the	the	DET
ihlr-28381	575	2	goal	goal	NOUN
ihlr-28381	575	3	of	of	ADP
ihlr-28381	575	4	the	the	DET
ihlr-28381	575	5	program	program	NOUN
ihlr-28381	575	6	,	,	PUNCT
ihlr-28381	575	7	and	and	CCONJ
ihlr-28381	575	8	that	that	SCONJ
ihlr-28381	575	9	of	of	ADP
ihlr-28381	575	10	each	each	DET
ihlr-28381	575	11	wildcard	wildcard	ADJ
ihlr-28381	575	12	issued	issue	VERB
ihlr-28381	575	13	,	,	PUNCT
ihlr-28381	575	14	is	be	AUX
ihlr-28381	575	15	clear	clear	ADJ
ihlr-28381	575	16	—	—	PUNCT
ihlr-28381	575	17	accelerate	accelerate	VERB
ihlr-28381	575	18	price	price	NOUN
ihlr-28381	575	19	reduction	reduction	NOUN
ihlr-28381	575	20	and	and	CCONJ
ihlr-28381	575	21	grow	grow	VERB
ihlr-28381	575	22	access	access	NOUN
ihlr-28381	575	23	.	.	PUNCT
ihlr-28381	576	1	the	the	DET
ihlr-28381	576	2	obligation	obligation	NOUN
ihlr-28381	576	3	of	of	ADP
ihlr-28381	576	4	awardees	awardee	NOUN
ihlr-28381	576	5	and	and	CCONJ
ihlr-28381	576	6	redeemers	redeemer	NOUN
ihlr-28381	576	7	to	to	PART
ihlr-28381	576	8	fulfill	fulfill	VERB
ihlr-28381	576	9	the	the	DET
ihlr-28381	576	10	savings	saving	NOUN
ihlr-28381	576	11	goal	goal	NOUN
ihlr-28381	576	12	of	of	ADP
ihlr-28381	576	13	each	each	DET
ihlr-28381	576	14	wildcard	wildcard	ADJ
ihlr-28381	576	15	amounts	amount	NOUN
ihlr-28381	576	16	to	to	ADP
ihlr-28381	576	17	an	an	DET
ihlr-28381	576	18	insurance	insurance	NOUN
ihlr-28381	576	19	policy	policy	NOUN
ihlr-28381	576	20	against	against	ADP
ihlr-28381	576	21	situations	situation	NOUN
ihlr-28381	576	22	where	where	SCONJ
ihlr-28381	576	23	,	,	PUNCT
ihlr-28381	576	24	but	but	CCONJ
ihlr-28381	576	25	for	for	ADP
ihlr-28381	576	26	the	the	DET
ihlr-28381	576	27	drug	drug	NOUN
ihlr-28381	576	28	maker	maker	NOUN
ihlr-28381	576	29	’s	’s	PART
ihlr-28381	576	30	obligation	obligation	NOUN
ihlr-28381	576	31	to	to	PART
ihlr-28381	576	32	pay	pay	VERB
ihlr-28381	576	33	off	off	ADP
ihlr-28381	576	34	any	any	DET
ihlr-28381	576	35	negative	negative	ADJ
ihlr-28381	576	36	balance	balance	NOUN
ihlr-28381	576	37	between	between	ADP
ihlr-28381	576	38	projected	project	VERB
ihlr-28381	576	39	and	and	CCONJ
ihlr-28381	576	40	actual	actual	ADJ
ihlr-28381	576	41	savings	saving	NOUN
ihlr-28381	576	42	,	,	PUNCT
ihlr-28381	576	43	wildcard	wildcard	ADJ
ihlr-28381	576	44	attributable	attributable	ADJ
ihlr-28381	576	45	spending	spending	NOUN
ihlr-28381	576	46	would	would	AUX
ihlr-28381	576	47	exceed	exceed	VERB
ihlr-28381	576	48	wildcard	wildcard	ADJ
ihlr-28381	576	49	attributable	attributable	ADJ
ihlr-28381	576	50	saving	saving	NOUN
ihlr-28381	576	51	.	.	PUNCT
ihlr-28381	577	1	viii	viii	PROPN
ihlr-28381	577	2	.	.	PUNCT
ihlr-28381	578	1	conclusion	conclusion	NOUN
ihlr-28381	578	2	delayed	delay	VERB
ihlr-28381	578	3	generic	generic	ADJ
ihlr-28381	578	4	entry	entry	NOUN
ihlr-28381	578	5	caused	cause	VERB
ihlr-28381	578	6	by	by	ADP
ihlr-28381	578	7	the	the	DET
ihlr-28381	578	8	anti	anti	ADJ
ihlr-28381	578	9	-	-	ADJ
ihlr-28381	578	10	competitive	competitive	ADJ
ihlr-28381	578	11	actions	action	NOUN
ihlr-28381	578	12	of	of	ADP
ihlr-28381	578	13	players	player	NOUN
ihlr-28381	578	14	in	in	ADP
ihlr-28381	578	15	the	the	DET
ihlr-28381	578	16	pharmaceutical	pharmaceutical	NOUN
ihlr-28381	578	17	industry	industry	NOUN
ihlr-28381	578	18	annually	annually	ADV
ihlr-28381	578	19	adds	add	VERB
ihlr-28381	578	20	billions	billion	NOUN
ihlr-28381	578	21	of	of	ADP
ihlr-28381	578	22	dollars	dollar	NOUN
ihlr-28381	578	23	in	in	ADP
ihlr-28381	578	24	cost	cost	NOUN
ihlr-28381	578	25	to	to	ADP
ihlr-28381	578	26	the	the	DET
ihlr-28381	578	27	u.s	u.s	PROPN
ihlr-28381	578	28	.	.	PROPN
ihlr-28381	578	29	healthcare	healthcare	PROPN
ihlr-28381	578	30	system.132	system.132	NUM
ihlr-28381	578	31	attempts	attempt	NOUN
ihlr-28381	578	32	to	to	PART
ihlr-28381	578	33	quantify	quantify	VERB
ihlr-28381	578	34	the	the	DET
ihlr-28381	578	35	annual	annual	ADJ
ihlr-28381	578	36	burden	burden	NOUN
ihlr-28381	578	37	have	have	AUX
ihlr-28381	578	38	estimated	estimate	VERB
ihlr-28381	578	39	a	a	DET
ihlr-28381	578	40	range	range	NOUN
ihlr-28381	578	41	from	from	ADP
ihlr-28381	578	42	$	$	SYM
ihlr-28381	578	43	3.5	3.5	NUM
ihlr-28381	578	44	billion	billion	NUM
ihlr-28381	578	45	to	to	PART
ihlr-28381	578	46	$	$	SYM
ihlr-28381	578	47	37	37	NUM
ihlr-28381	578	48	billion.133	billion.133	NOUN
ihlr-28381	578	49	the	the	DET
ihlr-28381	578	50	unnecessary	unnecessary	ADJ
ihlr-28381	578	51	cost	cost	NOUN
ihlr-28381	578	52	of	of	ADP
ihlr-28381	578	53	pay	pay	NOUN
ihlr-28381	578	54	-	-	PUNCT
ihlr-28381	578	55	for	for	ADP
ihlr-28381	578	56	-	-	PUNCT
ihlr-28381	578	57	delay	delay	NOUN
ihlr-28381	578	58	contributes	contribute	VERB
ihlr-28381	578	59	to	to	ADP
ihlr-28381	578	60	high	high	ADJ
ihlr-28381	578	61	prescription	prescription	NOUN
ihlr-28381	578	62	drug	drug	NOUN
ihlr-28381	578	63	spending	spending	NOUN
ihlr-28381	578	64	,	,	PUNCT
ihlr-28381	578	65	which	which	PRON
ihlr-28381	578	66	translates	translate	VERB
ihlr-28381	578	67	to	to	ADP
ihlr-28381	578	68	poor	poor	ADJ
ihlr-28381	578	69	health	health	NOUN
ihlr-28381	578	70	outcomes	outcome	NOUN
ihlr-28381	578	71	for	for	ADP
ihlr-28381	578	72	patients	patient	NOUN
ihlr-28381	578	73	who	who	PRON
ihlr-28381	578	74	avoid	avoid	VERB
ihlr-28381	578	75	medication	medication	NOUN
ihlr-28381	578	76	due	due	ADP
ihlr-28381	578	77	to	to	ADP
ihlr-28381	578	78	price.134	price.134	VERB
ihlr-28381	578	79	attributable	attributable	ADJ
ihlr-28381	578	80	in	in	ADP
ihlr-28381	578	81	part	part	NOUN
ihlr-28381	578	82	to	to	ADP
ihlr-28381	578	83	the	the	DET
ihlr-28381	578	84	complexity	complexity	NOUN
ihlr-28381	578	85	of	of	ADP
ihlr-28381	578	86	the	the	DET
ihlr-28381	578	87	pharmaceutical	pharmaceutical	ADJ
ihlr-28381	578	88	industry	industry	NOUN
ihlr-28381	578	89	(	(	PUNCT
ihlr-28381	578	90	including	include	VERB
ihlr-28381	578	91	positive	positive	ADJ
ihlr-28381	578	92	use	use	NOUN
ihlr-28381	578	93	cases	case	NOUN
ihlr-28381	578	94	for	for	ADP
ihlr-28381	578	95	reverse	reverse	ADJ
ihlr-28381	578	96	payment	payment	NOUN
ihlr-28381	578	97	settlements	settlement	NOUN
ihlr-28381	578	98	,	,	PUNCT
ihlr-28381	578	99	citizen	citizen	NOUN
ihlr-28381	578	100	petitions	petition	NOUN
ihlr-28381	578	101	,	,	PUNCT
ihlr-28381	578	102	and	and	CCONJ
ihlr-28381	578	103	other	other	ADJ
ihlr-28381	578	104	conduct	conduct	NOUN
ihlr-28381	578	105	described	describe	VERB
ihlr-28381	578	106	in	in	ADP
ihlr-28381	578	107	a	a	DET
ihlr-28381	578	108	negative	negative	ADJ
ihlr-28381	578	109	light	light	NOUN
ihlr-28381	578	110	in	in	ADP
ihlr-28381	578	111	this	this	DET
ihlr-28381	578	112	note	note	NOUN
ihlr-28381	578	113	)	)	PUNCT
ihlr-28381	578	114	and	and	CCONJ
ihlr-28381	578	115	in	in	ADP
ihlr-28381	578	116	spite	spite	NOUN
ihlr-28381	578	117	of	of	ADP
ihlr-28381	578	118	the	the	DET
ihlr-28381	578	119	dollar	dollar	NOUN
ihlr-28381	578	120	and	and	CCONJ
ihlr-28381	578	121	personal	personal	ADJ
ihlr-28381	578	122	health	health	NOUN
ihlr-28381	578	123	costs	cost	NOUN
ihlr-28381	578	124	,	,	PUNCT
ihlr-28381	578	125	historic	historic	ADJ
ihlr-28381	578	126	approaches	approach	NOUN
ihlr-28381	578	127	to	to	ADP
ihlr-28381	578	128	combatting	combat	VERB
ihlr-28381	578	129	pay	pay	NOUN
ihlr-28381	578	130	-	-	PUNCT
ihlr-28381	578	131	for	for	ADP
ihlr-28381	578	132	-	-	PUNCT
ihlr-28381	578	133	delay	delay	NOUN
ihlr-28381	578	134	are	be	AUX
ihlr-28381	578	135	limited	limited	ADJ
ihlr-28381	578	136	and	and	CCONJ
ihlr-28381	578	137	difficult	difficult	ADJ
ihlr-28381	578	138	to	to	PART
ihlr-28381	578	139	enforce	enforce	VERB
ihlr-28381	578	140	.	.	PUNCT
ihlr-28381	579	1	this	this	DET
ihlr-28381	579	2	note	note	NOUN
ihlr-28381	579	3	described	describe	VERB
ihlr-28381	579	4	two	two	NUM
ihlr-28381	579	5	low	low	ADJ
ihlr-28381	579	6	-	-	PUNCT
ihlr-28381	579	7	friction	friction	NOUN
ihlr-28381	579	8	approaches	approach	NOUN
ihlr-28381	579	9	—	—	PUNCT
ihlr-28381	579	10	attractive	attractive	ADJ
ihlr-28381	579	11	to	to	ADP
ihlr-28381	579	12	all	all	DET
ihlr-28381	579	13	stakeholders	stakeholder	NOUN
ihlr-28381	579	14	and	and	CCONJ
ihlr-28381	579	15	unlikely	unlikely	ADJ
ihlr-28381	579	16	to	to	PART
ihlr-28381	579	17	encounter	encounter	VERB
ihlr-28381	579	18	serious	serious	ADJ
ihlr-28381	579	19	resistance	resistance	NOUN
ihlr-28381	579	20	—	—	PUNCT
ihlr-28381	579	21	and	and	CCONJ
ihlr-28381	579	22	ultimately	ultimately	ADV
ihlr-28381	579	23	endorses	endorse	VERB
ihlr-28381	579	24	a	a	DET
ihlr-28381	579	25	wildcard	wildcard	ADJ
ihlr-28381	579	26	incentive	incentive	NOUN
ihlr-28381	579	27	program	program	NOUN
ihlr-28381	579	28	offering	offer	VERB
ihlr-28381	579	29	extended	extend	VERB
ihlr-28381	579	30	market	market	NOUN
ihlr-28381	579	31	exclusivity	exclusivity	NOUN
ihlr-28381	579	32	for	for	ADP
ihlr-28381	579	33	one	one	NUM
ihlr-28381	579	34	drug	drug	NOUN
ihlr-28381	579	35	,	,	PUNCT
ihlr-28381	579	36	in	in	ADP
ihlr-28381	579	37	exchange	exchange	NOUN
ihlr-28381	579	38	for	for	ADP
ihlr-28381	579	39	shortened	shorten	VERB
ihlr-28381	579	40	exclusivity	exclusivity	NOUN
ihlr-28381	579	41	for	for	ADP
ihlr-28381	579	42	another	another	DET
ihlr-28381	579	43	drug	drug	NOUN
ihlr-28381	579	44	,	,	PUNCT
ihlr-28381	579	45	as	as	ADV
ihlr-28381	579	46	long	long	ADV
ihlr-28381	579	47	as	as	ADP
ihlr-28381	579	48	“	"	PUNCT
ihlr-28381	579	49	wildcard	wildcard	ADJ
ihlr-28381	579	50	attributable	attributable	ADJ
ihlr-28381	579	51	savings	saving	NOUN
ihlr-28381	579	52	”	"	PUNCT
ihlr-28381	579	53	exceed	exceed	VERB
ihlr-28381	579	54	“	"	PUNCT
ihlr-28381	579	55	wildcard	wildcard	ADJ
ihlr-28381	579	56	attributable	attributable	ADJ
ihlr-28381	579	57	spending	spending	NOUN
ihlr-28381	579	58	.	.	PUNCT
ihlr-28381	579	59	”	"	PUNCT
ihlr-28381	580	1	if	if	SCONJ
ihlr-28381	580	2	the	the	DET
ihlr-28381	580	3	incentive	incentive	NOUN
ihlr-28381	580	4	program	program	NOUN
ihlr-28381	580	5	proposed	propose	VERB
ihlr-28381	580	6	in	in	ADP
ihlr-28381	580	7	this	this	DET
ihlr-28381	580	8	note	note	NOUN
ihlr-28381	580	9	prevents	prevent	VERB
ihlr-28381	580	10	just	just	ADV
ihlr-28381	580	11	a	a	DET
ihlr-28381	580	12	quarter	quarter	NOUN
ihlr-28381	580	13	of	of	ADP
ihlr-28381	580	14	the	the	DET
ihlr-28381	580	15	annual	annual	ADJ
ihlr-28381	580	16	cost	cost	NOUN
ihlr-28381	580	17	of	of	ADP
ihlr-28381	580	18	delayed	delay	VERB
ihlr-28381	580	19	generic	generic	ADJ
ihlr-28381	580	20	competition	competition	NOUN
ihlr-28381	580	21	from	from	ADP
ihlr-28381	580	22	accumulating	accumulate	VERB
ihlr-28381	580	23	,	,	PUNCT
ihlr-28381	580	24	billions	billion	NOUN
ihlr-28381	580	25	of	of	ADP
ihlr-28381	580	26	patient	patient	NOUN
ihlr-28381	580	27	and	and	CCONJ
ihlr-28381	580	28	public	public	ADJ
ihlr-28381	580	29	dollars	dollar	NOUN
ihlr-28381	580	30	would	would	AUX
ihlr-28381	580	31	be	be	AUX
ihlr-28381	580	32	saved	save	VERB
ihlr-28381	580	33	and	and	CCONJ
ihlr-28381	580	34	more	more	ADJ
ihlr-28381	580	35	americans	americans	PROPN
ihlr-28381	580	36	could	could	AUX
ihlr-28381	580	37	afford	afford	VERB
ihlr-28381	580	38	their	their	PRON
ihlr-28381	580	39	prescriptions	prescription	NOUN
ihlr-28381	580	40	.	.	PUNCT
ihlr-28381	581	1	while	while	SCONJ
ihlr-28381	581	2	appropriately	appropriately	ADV
ihlr-28381	581	3	limited	limit	VERB
ihlr-28381	581	4	to	to	PART
ihlr-28381	581	5	avoid	avoid	VERB
ihlr-28381	581	6	unintended	unintended	ADJ
ihlr-28381	581	7	cost	cost	NOUN
ihlr-28381	581	8	increases	increase	NOUN
ihlr-28381	581	9	,	,	PUNCT
ihlr-28381	581	10	transferable	transferable	ADJ
ihlr-28381	581	11	wildcard	wildcard	ADJ
ihlr-28381	581	12	exclusivity	exclusivity	NOUN
ihlr-28381	581	13	vouchers	voucher	NOUN
ihlr-28381	581	14	would	would	AUX
ihlr-28381	581	15	remain	remain	VERB
ihlr-28381	581	16	highly	highly	ADV
ihlr-28381	581	17	valuable	valuable	ADJ
ihlr-28381	581	18	and	and	CCONJ
ihlr-28381	581	19	therefore	therefore	ADV
ihlr-28381	581	20	successfully	successfully	ADV
ihlr-28381	581	21	induce	induce	VERB
ihlr-28381	581	22	lower	low	ADJ
ihlr-28381	581	23	drug	drug	NOUN
ihlr-28381	581	24	prices	price	NOUN
ihlr-28381	581	25	,	,	PUNCT
ihlr-28381	581	26	either	either	CCONJ
ihlr-28381	581	27	directly	directly	ADV
ihlr-28381	581	28	through	through	ADP
ihlr-28381	581	29	unilateral	unilateral	ADJ
ihlr-28381	581	30	price	price	NOUN
ihlr-28381	581	31	reductions	reduction	NOUN
ihlr-28381	581	32	or	or	CCONJ
ihlr-28381	581	33	indirectly	indirectly	ADV
ihlr-28381	581	34	through	through	ADP
ihlr-28381	581	35	earlier	early	ADJ
ihlr-28381	581	36	generic	generic	ADJ
ihlr-28381	581	37	entry	entry	NOUN
ihlr-28381	581	38	.	.	PUNCT
ihlr-28381	582	1	the	the	DET
ihlr-28381	582	2	american	american	ADJ
ihlr-28381	582	3	public	public	NOUN
ihlr-28381	582	4	,	,	PUNCT
ihlr-28381	582	5	and	and	CCONJ
ihlr-28381	582	6	especially	especially	ADV
ihlr-28381	582	7	patients	patient	NOUN
ihlr-28381	582	8	,	,	PUNCT
ihlr-28381	582	9	collectively	collectively	ADV
ihlr-28381	582	10	share	share	VERB
ihlr-28381	582	11	the	the	DET
ihlr-28381	582	12	cost	cost	NOUN
ihlr-28381	582	13	of	of	ADP
ihlr-28381	582	14	131	131	NUM
ihlr-28381	582	15	.	.	PUNCT
ihlr-28381	583	1	u.s	u.s	PROPN
ihlr-28381	583	2	.	.	PROPN
ihlr-28381	583	3	gov’t	gov’t	PROPN
ihlr-28381	583	4	accountability	accountability	NOUN
ihlr-28381	583	5	off	off	ADP
ihlr-28381	583	6	.	.	PUNCT
ihlr-28381	583	7	,	,	PUNCT
ihlr-28381	583	8	supra	supra	PROPN
ihlr-28381	583	9	note	note	PROPN
ihlr-28381	583	10	105	105	NUM
ihlr-28381	583	11	.	.	PUNCT
ihlr-28381	584	1	132	132	NUM
ihlr-28381	584	2	.	.	PUNCT
ihlr-28381	585	1	feldman	feldman	PROPN
ihlr-28381	585	2	,	,	PUNCT
ihlr-28381	585	3	supra	supra	PROPN
ihlr-28381	585	4	note	note	PROPN
ihlr-28381	585	5	10	10	NUM
ihlr-28381	585	6	,	,	PUNCT
ihlr-28381	585	7	at	at	ADP
ihlr-28381	585	8	32	32	NUM
ihlr-28381	585	9	-	-	SYM
ihlr-28381	585	10	33	33	NUM
ihlr-28381	585	11	.	.	PUNCT
ihlr-28381	586	1	133	133	NUM
ihlr-28381	586	2	.	.	PUNCT
ihlr-28381	587	1	i	i	PRON
ihlr-28381	587	2	d.	d.	PROPN
ihlr-28381	587	3	134	134	NUM
ihlr-28381	587	4	.	.	PUNCT
ihlr-28381	588	1	kaiser	kaiser	PROPN
ihlr-28381	588	2	fam	fam	PROPN
ihlr-28381	588	3	.	.	PROPN
ihlr-28381	588	4	found	find	VERB
ihlr-28381	588	5	.	.	PUNCT
ihlr-28381	589	1	,	,	PUNCT
ihlr-28381	589	2	supra	supra	PROPN
ihlr-28381	589	3	note	note	VERB
ihlr-28381	589	4	6	6	NUM
ihlr-28381	589	5	.	.	NOUN
ihlr-28381	589	6	2024	2024	NUM
ihlr-28381	589	7	]	]	PUNCT
ihlr-28381	589	8	incentivizing	incentivize	VERB
ihlr-28381	589	9	drug	drug	NOUN
ihlr-28381	589	10	affordability	affordability	NOUN
ihlr-28381	589	11	149	149	NUM
ihlr-28381	589	12	pay	pay	NOUN
ihlr-28381	589	13	-	-	PUNCT
ihlr-28381	589	14	for	for	ADP
ihlr-28381	589	15	-	-	PUNCT
ihlr-28381	589	16	delay	delay	NOUN
ihlr-28381	589	17	either	either	CCONJ
ihlr-28381	589	18	directly	directly	ADV
ihlr-28381	589	19	or	or	CCONJ
ihlr-28381	589	20	indirectly	indirectly	ADV
ihlr-28381	589	21	.	.	PUNCT
ihlr-28381	590	1	despite	despite	SCONJ
ihlr-28381	590	2	the	the	DET
ihlr-28381	590	3	practice	practice	NOUN
ihlr-28381	590	4	’s	’s	PART
ihlr-28381	590	5	notoriety	notoriety	NOUN
ihlr-28381	590	6	,	,	PUNCT
ihlr-28381	590	7	victories	victory	NOUN
ihlr-28381	590	8	in	in	ADP
ihlr-28381	590	9	reducing	reduce	VERB
ihlr-28381	590	10	pay	pay	NOUN
ihlr-28381	590	11	-	-	PUNCT
ihlr-28381	590	12	for	for	ADP
ihlr-28381	590	13	-	-	PUNCT
ihlr-28381	590	14	delay	delay	NOUN
ihlr-28381	590	15	are	be	AUX
ihlr-28381	590	16	few	few	ADJ
ihlr-28381	590	17	and	and	CCONJ
ihlr-28381	590	18	far	far	ADV
ihlr-28381	590	19	between	between	ADP
ihlr-28381	590	20	.	.	PUNCT
ihlr-28381	590	21	of	of	ADP
ihlr-28381	590	22	the	the	DET
ihlr-28381	590	23	examples	example	NOUN
ihlr-28381	590	24	of	of	ADP
ihlr-28381	590	25	progress	progress	NOUN
ihlr-28381	590	26	discussed	discuss	VERB
ihlr-28381	590	27	in	in	ADP
ihlr-28381	590	28	this	this	DET
ihlr-28381	590	29	note	note	NOUN
ihlr-28381	590	30	,	,	PUNCT
ihlr-28381	590	31	most	most	ADJ
ihlr-28381	590	32	can	can	AUX
ihlr-28381	590	33	be	be	AUX
ihlr-28381	590	34	circumvented	circumvent	VERB
ihlr-28381	590	35	.	.	PUNCT
ihlr-28381	591	1	thus	thus	ADV
ihlr-28381	591	2	,	,	PUNCT
ihlr-28381	591	3	instead	instead	ADV
ihlr-28381	591	4	of	of	ADP
ihlr-28381	591	5	attempting	attempt	VERB
ihlr-28381	591	6	and	and	CCONJ
ihlr-28381	591	7	failing	fail	VERB
ihlr-28381	591	8	to	to	PART
ihlr-28381	591	9	identify	identify	VERB
ihlr-28381	591	10	and	and	CCONJ
ihlr-28381	591	11	punish	punish	VERB
ihlr-28381	591	12	wrong	wrong	ADJ
ihlr-28381	591	13	,	,	PUNCT
ihlr-28381	591	14	lawmakers	lawmaker	NOUN
ihlr-28381	591	15	should	should	AUX
ihlr-28381	591	16	reward	reward	VERB
ihlr-28381	591	17	right	right	ADV
ihlr-28381	591	18	.	.	PUNCT
ihlr-28381	592	1	rewarding	reward	VERB
ihlr-28381	592	2	innovators	innovator	NOUN
ihlr-28381	592	3	with	with	ADP
ihlr-28381	592	4	a	a	DET
ihlr-28381	592	5	marketable	marketable	ADJ
ihlr-28381	592	6	asset	asset	NOUN
ihlr-28381	592	7	,	,	PUNCT
ihlr-28381	592	8	in	in	ADP
ihlr-28381	592	9	exchange	exchange	NOUN
ihlr-28381	592	10	for	for	ADP
ihlr-28381	592	11	facilitating	facilitate	VERB
ihlr-28381	592	12	generic	generic	ADJ
ihlr-28381	592	13	competition	competition	NOUN
ihlr-28381	592	14	in	in	ADP
ihlr-28381	592	15	monopoly	monopoly	NOUN
ihlr-28381	592	16	markets	market	NOUN
ihlr-28381	592	17	,	,	PUNCT
ihlr-28381	592	18	will	will	AUX
ihlr-28381	592	19	bring	bring	VERB
ihlr-28381	592	20	cheaper	cheap	ADJ
ihlr-28381	592	21	drugs	drug	NOUN
ihlr-28381	592	22	to	to	ADP
ihlr-28381	592	23	patients	patient	NOUN
ihlr-28381	592	24	faster	fast	ADV
ihlr-28381	592	25	without	without	ADP
ihlr-28381	592	26	deterring	deter	VERB
ihlr-28381	592	27	private	private	ADJ
ihlr-28381	592	28	investment	investment	NOUN
ihlr-28381	592	29	in	in	ADP
ihlr-28381	592	30	innovation	innovation	NOUN
ihlr-28381	592	31	.	.	PUNCT
ihlr-28381	593	1	as	as	ADP
ihlr-28381	593	2	a	a	DET
ihlr-28381	593	3	viable	viable	ADJ
ihlr-28381	593	4	,	,	PUNCT
ihlr-28381	593	5	positivesum	positivesum	NOUN
ihlr-28381	593	6	solution	solution	NOUN
ihlr-28381	593	7	,	,	PUNCT
ihlr-28381	593	8	the	the	DET
ihlr-28381	593	9	proposed	propose	VERB
ihlr-28381	593	10	wildcard	wildcard	PROPN
ihlr-28381	593	11	exclusivity	exclusivity	NOUN
ihlr-28381	593	12	program	program	NOUN
ihlr-28381	593	13	should	should	AUX
ihlr-28381	593	14	be	be	AUX
ihlr-28381	593	15	discussed	discuss	VERB
ihlr-28381	593	16	and	and	CCONJ
ihlr-28381	593	17	expanded	expand	VERB
ihlr-28381	593	18	upon	upon	SCONJ
ihlr-28381	593	19	by	by	ADP
ihlr-28381	593	20	policymakers	policymaker	NOUN
ihlr-28381	593	21	,	,	PUNCT
ihlr-28381	593	22	generic	generic	ADJ
ihlr-28381	593	23	firms	firm	NOUN
ihlr-28381	593	24	,	,	PUNCT
ihlr-28381	593	25	innovator	innovator	NOUN
ihlr-28381	593	26	firms	firm	NOUN
ihlr-28381	593	27	,	,	PUNCT
ihlr-28381	593	28	and	and	CCONJ
ihlr-28381	593	29	other	other	ADJ
ihlr-28381	593	30	stakeholders	stakeholder	NOUN
ihlr-28381	593	31	.	.	PUNCT
ihlr-28381	594	1	refined	refine	VERB
ihlr-28381	594	2	with	with	ADP
ihlr-28381	594	3	stakeholder	stakeholder	NOUN
ihlr-28381	594	4	input	input	NOUN
ihlr-28381	594	5	,	,	PUNCT
ihlr-28381	594	6	a	a	DET
ihlr-28381	594	7	carefully	carefully	ADV
ihlr-28381	594	8	implemented	implement	VERB
ihlr-28381	594	9	wildcard	wildcard	ADJ
ihlr-28381	594	10	exclusivity	exclusivity	NOUN
ihlr-28381	594	11	program	program	NOUN
ihlr-28381	594	12	may	may	AUX
ihlr-28381	594	13	blaze	blaze	VERB
ihlr-28381	594	14	a	a	DET
ihlr-28381	594	15	new	new	ADJ
ihlr-28381	594	16	trail	trail	NOUN
ihlr-28381	594	17	on	on	ADP
ihlr-28381	594	18	the	the	DET
ihlr-28381	594	19	pay	pay	VERB
ihlr-28381	594	20	-	-	PUNCT
ihlr-28381	594	21	for	for	ADP
ihlr-28381	594	22	-	-	PUNCT
ihlr-28381	594	23	delay	delay	NOUN
ihlr-28381	594	24	frontier	frontier	NOUN
ihlr-28381	594	25	and	and	CCONJ
ihlr-28381	594	26	produce	produce	VERB
ihlr-28381	594	27	an	an	DET
ihlr-28381	594	28	unprecedented	unprecedented	ADJ
ihlr-28381	594	29	symbiosis	symbiosis	NOUN
ihlr-28381	594	30	among	among	ADP
ihlr-28381	594	31	generic	generic	ADJ
ihlr-28381	594	32	and	and	CCONJ
ihlr-28381	594	33	innovator	innovator	NOUN
ihlr-28381	594	34	companies	company	NOUN
ihlr-28381	594	35	.	.	PUNCT